Chasing selectivity : Peptides as nucleophilic catalysts in enantioselective electrophile transfer reactions by Zell, Daniela
 
Chasing Selectivity: Peptides as Nucleophilic 
Catalysts in Enantioselective Electrophile Transfer 
Reactions 
 
Dissertation zur Erlangung des Doktorgrades 
der Naturwissenschaftlichen Fachbereiche  
im Fachgebiet Organische Chemie 
der Justus-Liebig-Universität Gießen 
 
 
Vorgelegt von 
Daniela Zell 
aus Werdorf  
 
Gießen 2013 
 
 
 
ii	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   iii 
Die vorliegende Arbeit wurde im Zeitraum von Oktober 2008 bis Januar 2013 am Institut für 
Organische Chemie der Justus-Liebig-Universität Gießen unter der Betreuung von Herrn 
Prof. Dr. Peter R. Schreiner, Ph.D. angefertigt. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   v 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Für meine Eltern und Christian 
 
 
vi	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   vii 
 
 
 
 
 
 
 
 
„Nur wenige wissen, wie viel man wissen muss, um zu wissen, wie wenig man weiß.” 
 
– Werner Heisenberg – 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   ix 
 
 
Versicherung nach § 17 der Promotionsordnung 
 
“Ich erkläre: Ich habe die vorliegende Dissertation selbstständig, ohne unerlaubte fremde 
Hilfe und nur mit den Hilfen angefertigt, die ich in der Dissertation angegeben habe. 
Alle Textstellen, die wörtlich oder sinngemäß aus veröffentlichten Schriften entnommen sind, 
und alle Angaben, die auf mündlichen Auskünften beruhen, sind als solche kenntlich 
gemacht. Bei den von mir durchgeführten und erwähnten Untersuchungen habe ich die 
Grundsätze guter wissenschaftlicher Praxis, wie sie in der „Satzung der Justus-Liebig-
Universität Gießen zur Sicherung guter wissenschaftlicher Praxis” niedergelegt sind, 
eingehalten.“ 
 
 
 
 
 
Ort, Datum             Unterschrift 
 
 
 
 
 
 
 
 
 
 
 
x	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   xi 
Table of Contents 
 
1.  Motivation/ Structure of the doctoral thesis    14 
2.            General Introduction       16  
2.1            Synthesis of Esters via Acyl Transfer onto Alcohols   18 
2.1.1      Organocatalytic Synthesis of Esters      18 
2.1.1.1 N-Heterocyclic Carbenes as Catalysts for Acyl Transfer onto   18 
Alcohols 
2.1.1.2 Asymmetric Acyl Transfer       21 
2.1.1.2.1 Enantioselective Acyl Transfer Using DMAP-Derivatives   22 
2.1.1.2.2 Phosphine and Phosphinite Mediated Enantioselective   37  
  Acyl Transfer 
2.1.1.2.3 Amidines and Vicinal Diamines as Catalysts for    41  
 Enantioselective Acyl Transfer 
2.1.1.2.4 Enantioselective Acyl Transfer via N-Alkylimidazoles   56 
2.1.1.2.5 N-Heterocyclic Carbenes as Catalysts for Enantioselective   67 
 Acyl Transfer 
2.1.1.2.6 Enantioselective Ring Opening of Meso-Anhydrides Utilizing   72 
Cinchona Alkaloid-Derivatives   
2.1.2 Metal-Complex Mediated Enantioselective Synthesis of Esters  84 
2.1.2.1 Cu(II)-Complex Mediated Acylation Reactions    84 
2.1.2.1.1 Kinetic Resolution Utilizing Cu-Complexes     85 
2.1.2.1.2 Desymmetrization of Meso-1,2-diols Mediated by a Cu(II)-Complex 88 
2.1.2.2 Combination of Metal Complexes and Enzymes in Dynamic  90  
Kinetic Resolutions of Racemic Alcohols  
2.1.2.2.1 Dynamic Kinetic Resolution of Alcohols Utilizing Ruthenium-  91 
Complexes for Racemization and Enzymes for Selective Acyl Transfer  
2.1.2.2.2  Dynamic Kinetic Resolution of Alcohols Utilizing an Aluminum-  100 
Complex for Racemization and Enzymes for Selective Acyl Transfer  
3.            Lipophilic Oligopeptides for Chemo- and Enantioselective   108 
Acyl Transfer Reactions onto Alcohols 
4.            Investigation of a Secondary Structure of Boc-L-(π-Me)-            141 
His-AGly-L-Cha-L-Phe-OMe via NMR- and IR-Spectroscopy 
5.            Transfer of Different Electrophiles Utilizing Boc-L-(π-Me)-            145 
His-AGly-L-Cha-L-Phe-OMe 
5.1            Asymmetric Phosphorylation- and Sulfonylation-Reactions Mediated       145 
by Boc-L-(π-Me)-His-AGly-L-Cha-L-Phe-OMe 
xii	  
5.2            Enantioselective Ring Opening of Meso-Anhydrides Mediated             149 
by Boc-L-(π-Me)-His-AGly-L-Cha-L-Phe-OMe 
6.            Exploring the Substrate Scope of Kinetic Resolutions Catalyzed  
by Boc-L-(π-Me)-His-AGly-L-Cha-L-Phe-OMe 
      6.1  Acylative Kinetic Resolution of trans-Cyclohexane-1,2-dithiol                   151 
           and trans-2-Mercaptocyclohexane-1-ol                
6.2            Acylative Kinetic Resolution of trans-1,2-Diaminocyclohexane            152  
and trans-Aminocyclohexane-1-ol 
6.3 Acylative Kinetic Resolution of 1,1’-Bi-2,2’-naphthol             154 
7. Synthesis of Adamantane Amino Acids as Building Blocks for  
Peptidic Catalysts 
7.1  Adamantane Cores in Nature, Chemistry and Pharmaceuticals            156 
7.2 Synthesis of 3-[(9-Fluorenyl)methoxycarbonylamino]-tricyclo            158 
[3.3.1.13.7]decane-1-carboxylic acid 
7.3 Synthesis of 1-[(9-Fluorenyl)methoxycarbonylamino]-tricyclo            158 
[3.3.1.13.7]decane-3-acetic acid 
7.4 Syntheses of 3-[(9-Fluorenyl)methoxycarbonylmethylamino]-                   161               
tricyclo[3.3.1.13.7]decane-1-carboxylic acid and 3-[(9-
Fluorenyl)methoxycarbonylmethylamino]-tricyclo[3.3.1.13.7] 
decane-1-acetic acid 
7.5 Syntheses of 3-[(9-Fluorenyl)methoxycarbonylmethylamino]-5,7-            164 
dimethyl-tricyclo[3.3.1.13.7]decane-1-carboxylic and 3-[(9-
Fluorenyl)methoxycarbonylmethylamino]-5-methyltricyclo[3.3.1.13.7] 
decane-1-carboxylic acid 
7.6 Synthesis of E- and Z-4-tert-Butoxycarbonylmethylamino-tricyclo            165 
[3.3.1.13.7]decane-1-carboxylic acid 
8.            Modification of Current Peptide Platform Boc-L-(π-Me)-His- 
AGly-L-Cha-L-Phe-OMe 
8.1 Acylative Kinetic Resolution of trans-Cyclohexane-1,2-diol             166 
with Modified Peptides   
8.2  Acylative Kinetic Resolution of Rac-1-Phenylethanol Mediated             172 
by Modified Peptides  
8.3 Acylative Kinetic Resolution of trans-Cyclohexane-1,3-diol            174 
Mediated by Modified Peptides 
8.4 Acylative Kinetic Resolution of 1,1’-Bi-2,2’-naphthol Mediated by            176 
Modified Peptides 
9.   NHC-Containing Peptides 
	   	   xiii 
9.1 Syntheses of NHC-Precursor-Containing Peptides and Their             177  
Application as Catalysts in Benzoin Condensations 
9.2 Oxidative Esterification Reactions Utilizing Peptidic NHCs   186 
10. Outlook 
10.1  Immobilization of Boc-L-(π-Me)-His-AGly- L-Cha-L-Phe-OMe  189 
10.2 Dynamic Kinetic Resolution of trans-Cyclohexane-1,2-diol   191 
via Combination of Boc-L- (π-Me)-His-AGly-L-Cha-L-Phe-OMe  
and a Metal-Complex 
11.  Abstract         193 
12. Experimental Part        195 
13. NMR-Spectra         276 
14. Abbreviations        310 
15. Acknowledgment        313 
16. References         315 
 
Motivation	  	  
14 
1. Motivation 
Today, there is a high demand for enantiopure building blocks in chemistry and 
pharmaceutical industry. Additionally to enzymatic approaches, various enantioselective 
catalysts have been discovered mainly by trial and error processes in the last decade. In 
2008 Schreiner et al. introduced a highly enantioselective tetrapeptide for the acylative 
kinetic resolution (KR) of rac-cycloalkane-1,2-diols. 
This thesis tries to shed some light on the factors that are responsible for the excellent 
selectivity of Boc-L-(π-Me)-His-AGly-L-Cha-L-Phe-OMe in the kinetic resolution (KR) of rac-
cycloalkane-1,2-diols and may therefore lead to a more rational catalyst design in future. For 
that reason, all components (substrate, electrophile and catalyst) of the reaction should be 
individually varied and the influence on the selectivity detected as well as compared to the 
model system. The modified peptides should also be tested as catalysts in KRs and 
desymmetrizations of new substrates. The conformation of Boc-L-(π-Me)-His-AGly-L-Cha-L-
Phe-OMe (e.g., β-turn) in solution should be investigated by NMR- and IR-spectroscopy, as 
well as by computational methods. 
In a second project we envisioned the modification of the catalytically active Boc-π-methyl 
histidine amino acid. Methylation of the τ-position of the imidazole moiety should produce 
N,N’-dimethyl histidinium iodide, which can be in-situ transformed into a free NHC by base 
and would offer an easy access to new asymmetric reactions (e.g., benzoin condensations 
and oxidative esterification). 
 
 
Structure oft the doctoral thesis 
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Structure of the doctoral thesis 
1. The book chapter “Acylation-type Reactions: Synthesis of Esters via Acyl Transfer” 
for "Volume 6: Heteroatom Manipulation" which is part of “Comprehensive Organic 
Synthesis 2nd Edition”, is utilized to introduce the topic of enantioselective acyl 
transfer and to show the state of the art. This work will be published by Elsevier in 
2014. 
              Abstract:  
Acyl transfer reactions are one of the most common transformations in organic synthesis as 
well as in nature. Though many methods (acidic catalysis, basic catalysis and nucleophilic 
catalysis, e.g., DMAP) for the acylation of alcohols have been known for centuries, 
asymmetric approaches were just realized in the last 15–20 years. Asymmetric acyl transfer 
onto alcohols presents a powerful tool for the synthesis of enantiopure substrates, which are 
important building blocks for the synthesis of natural products, pharmaceuticals and chiral 
ligands. The introduction explains the differences between kinetic resolution, dynamic kinetic 
resolution and desymmetrization and shows how the catalytic efficacy of a KR is typically 
expressed (Kagan’s equation). This article summarizes organocatalysts and metal-
complexes capable of an enantioselective acyl transfer. Substrate scope, reaction 
conditions, selectivities, mechanism, and the accessibility of the catalysts are organized by 
type of catalyst. The performances of the catalysts are discussed and, if possible, 
comparisons towards efficiency are made. Additionally, examples for the utilization of chiral 
acylation catalysts in natural product synthesis are presented in each section. 
 
2. „Lipophilic Oligopeptides for Chemo- and Enantioselective Acyl Transfer Reactions 
onto Alcohols“ is submitted for publication: Christian E. Müller,# Daniela Zell,# Radim 
Hrdina, Raffael C. Wende, Lukas Wanka, Sören M. M. Schuler, and Peter R. 
Schreiner*.  
 
3. Unpublished results. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
# These authors contributed equally to this work. 
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Acylation-type Reactions: Synthesis of Esters via Acyl Transfer* 
Daniela Zell and Peter R. Schreiner 
Institute of Organic Chemistry, Justus-Liebig University, Heinrich-Buff-Ring 58, 35392 
Giessen, Germany; prs@org.chemie.uni-giessen.de 
 
2. General Introduction 
Though esterifications were part of daily life over millennia, Carl Wilhelm Scheele in 
1782 apparently was the first chemist reporting the acid-catalyzed esterification of organic 
acids with alcohols.1,2  In the 19th century chemists like Meyer,3,4 Berthelot,5 and Fischer6 
explored the fundamentals of this type of reaction.  Today, esterification reactions are some 
of the most common chemical transformations in nature, in the chemical laboratory, and 
even in industry (e.g., synthesis of polyesters).  Having an increasing demand for 
enantiomerically pure substrates (e.g., for use as pharmaceuticals, as flavors, as aroma or 
agricultural chemicals), efficient ways of synthesizing enantiopure products in high yields are 
required.  Optically pure substrates can be obtained by utilizing chromatographic methods, 
crystallization processes or selective transformations such as kinetic resolution of racemic 
substrates by acyl transfer; additionally, enantiopure molecules can be prepared by 
desymmetrization of prochiral molecules.  Nature uses enzymes for the selective transfer of 
acyl groups onto a large variety of substrates.  The isolation of specific enzymes led to their 
application as catalysts for enantioselective acyl-transfer reactions.   
This chapter introduces catalysts that are highly effective in the selective acylation of 
alcohols.  Esterification reactions are widely used in this field because acylation agents such 
as anhydrides are commercially available and because acyl-transfer proceeds under mild 
reaction conditions utilizing a large variety of catalysts (enzymes, small molecules, metal 
complexes). 
Classic Brønsted acid catalysis is one of the oldest and most popular methods for the 
esterification of alcohols and therefore will not be discussed in this chapter.  This article 
focuses on new and, in particular, on asymmetric, non-enzymatic approaches for acyl-
transfer onto alcohols.  
 
* “Acylation-type Reactions: Synthesis of Esters via Acyl Transfer” is a chapter in “Volume 6: Heteroatom 
Manipulation”, which is part of “Comprehensive Organic Synthesis 2nd Edition” edited by G. Morlander, P. 
Knochel, J. Johnson, K. Mikami, I. Marek, S.-M. Ma & J. Zhang, A. Fürstner, S. Burke, M. C. White, J. Clayden, 
and C. Welch. This work will be published in 2014 by Elsevier. The use of the book chapter “Acylation-type 
Reactions: Synthesis of Esters via Acyl Transfer” as introduction was permitted by S. Burke.  
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Depending on the starting material, two principally different acyl transfer processes 
can occur.  The first is to start from a racemic substrate whereby one enantiomer is much 
more rapidly acylated by a chiral catalyst than the other.  Under optimal conditions 50% of 
enantiopure ester and 50% of enantiopure starting alcohol can be isolated at 50% conversion 
(kinetic resolution, KR).7,8  One obvious drawback of this approach is the limitation of the 
product yield to 50%.  The efficiency of a KR can be expressed utilizing Kagan’s equation.9  
This method is applicable for reaction following first order kinetics in the absence of nonlinear 
effects.  The selectivity (S-value) can be determined using the following approximations: 
 
 
 
S = kfast/kslow
 
ee = enantiomeric excess predicted for the starting material 
ee ´= enantiomeric excess predicted for the product 
C = conversion 
S-values greater than 20 guarantee high enantiomeric excesses for the product as well as 
the starting material and a conversion close to 50%.  S-values lower than ten are usually not 
practically useful in organic syntheses because of incomplete enantiomer separation. 
A more efficient way to separate enantiomers is the dynamic version of KR (DKR) as 
the desired product can then theoretically be isolated in quantitative yield and high ee’s.  
DKR is possible when the starting material racemizes, while the acylated enantiopure 
product is configurationally stable (Scheme 1).  There are many examples for DKR (e. g., 
Jacobsen’s hydrolytic DKR of epoxides10 and Bäckvall’s DKR via acyl transfer onto 
alcohols11) that have been developed in the last 20 years.12-15 
The desymmetrization of prochiral substrates or meso-compounds has become a 
powerful method in asymmetric synthesis because in theory 100% yield can be obtained 
(Scheme 1).16 
C = eeee+ ee´( )
100 S = ln 1!C 1+ ee´( )
"# $%
ln 1!C 1! ee´( )"# $%
S = ln 1!C( ) 1! ee( )
"# $%
ln 1!C( ) 1+ ee( )"# $%
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Scheme 1 
 
2.1 Synthesis of Esters via Acyl Transfer onto Alcohols 
2.1.1     Organocatalytic Synthesis of Esters 
2.1.1.1   N-Heterocyclic Carbenes as Catalysts for Acyl Transfer onto Alcohols 
 
The non-stereoselective synthesis of esters traditionally proceeds via Lewis / 
Brønsted base or Lewis / Brønsted acid catalysis.17  A problem of these approaches is the 
potential cleavage of acid sensitive functional groups such as commonly employed epoxides 
and acetals.  Furthermore, Lewis acid (e.g., Sc(OTf)3, TMSCl, La(OiPr)3) as well as base 
catalysts (e.g., phosphines) show low selectivity between primary and secondary alcohols.  
In 2003 Nolan18 as well as Hedrick19 reported almost simultaneously their transesterification 
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approaches utilizing NHC as catalysts.  Nolan and co-workers introduced a catalytic method 
for synthesizing various esters by using NHC’s or their precursor salts and base as catalysts.  
First they applied their NHC catalyst in the esterification of primary alcohols with vinyl acetate 
as the acyl source.  Almost quantitative yields were obtained even with unsaturated alcohols 
or alcohols bearing acid sensitive groups (Table 1).18  In the presence of primary and 
secondary alcohols in the reaction mixture, acylation of the primary alcohol is clearly favored 
(Equation 1). 
 
Table 1.  Acylation of primary alcohols with IMes 1 as catalyst. 
 
Entry Alcohol  Product (Ester)  t (min) Yield (%) 
1 
 
3 
 
4 60 99 
2 
 
5 
  
6 15 96 
3 
 
7 
 
8 15 100 
 
 
Under slightly modified conditions the transesterification of methyl esters with 
alcohols is possible (Table 2).  Secondary alcohols can be acylated, but the reaction requires 
higher catalyst loadings (3.5 mol%) due to their lower reactivity.  NHC’s are air and moisture 
sensitive and therefore Nolan and co-workers tested the in situ generation of the free 
carbene from a precursor salt by adding base to the reaction mixture.  The obtained yields 
were excellent (up to 100%) even at short reaction times (30 min).  The precursor salts for 
the in situ generation of the carbene are commercially available. 
 
R1-OH
0.5–1 mol% IMes 1
THF, r.t.
N N
1
O
O
+ R1-OAc
1.1 eq 2
OH OAc
OH OAc
O
O
OH O
O
OAc
OH HO+
1.0 eq 9 1.0 eq 10
0.5 eq IMes 1
THF, r.t., 5 min
AcO
AcO
+
ratio =          9                    :             1
(1)+ O
O
2.0 eq 2 11 12
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Table 2. Transesterification of methyl esters with primary and secondary alcohols mediated 
by NHC catalysts 13–15.a    
 
 
Entry Alcohol  Product (Ester)  Cat. 
(mol%) 
t (min) Yield (%) 
1 
 
9 
 
11 13 
(2.5) 
60 95 
2 
 
7 
 
8 13 
(2.5) 
30 90 
3 
 
10 
 
12 13 
(3.5) 
60 92 
4 
 
16 
 
17 13 
(3.5) 
60 96 
5d 
 
9 
 
11 14 
(3.0) 
30 93 
6d  9 
 
11 15 
(3.0) 
30 100 
7b  9 
 
18 13 
(2.5) 
15 96 
8c  9 
 
19 13 
(2.5) 
30 93 
 
 
R1 OMe
O
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2.5–3.5 mol% Cat. 
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O
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Entry Alcohol  Product (Ester)  Cat. 
(mol%) 
t (min) Yield (%) 
9b  9 
 
20 13 
(2.5) 
15 96 
a Reaction conditions: 1 mmol alcohol, 1 mL of methyl acetate, 0.5 g 4 Å MS, r.t.. b 1.5 mmol alcohol, 1 
mmol methyl ester, 1 mL THF, 0.5 g 4 Å MS. c 1 mmol alcohol, 1 mmol dimethyl carbonate, 1mL THF. 
d 1 mmol benzyl alcohol, 1 mL methyl acetate, 3 mol% imidazolium salt, 2.5 mol% KOtBu, 0.5 g 4 Å 
MS, r.t., 30 min. 
 
An advantage of the NHC-catalyzed esterification reactions is that these catalysts 
display broad functional group tolerance.  Esterification of substrates bearing amine, olefin, 
nitro, ether or thioether functions are feasible.  The esterification reactions mediated by 
NHCs require short reaction times, and excellent yields can be obtained. 
 
2.1.1.2   Asymmetric Acyl Transfer 
 
As mentioned before, acyl transfer is the most common group transfer reaction in 
organic synthesis.  Traditionally, the generation of enantiopure products from racemic 
alcohols utilizing enzymes was accomplished via selective acyl transfer (esterification) or 
selective hydrolysis of esters (ester hydrolysis)(Scheme 2).  
 
 
 
Scheme 2 
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While enzymes were successfully applied in the enantioselective esterification of 
various substrate classes and although they give high S-values, they do not present the 
optimal catalysts form a chemist’s point of view.  One drawback is the accessibility of one 
enantiomeric form of the enzyme and only one enantiomer of the substrate can be selectively 
acylated.  Furthermore, enzymes cannot be modified easily.  Small chiral organic molecules 
on the other hand can readily be synthesized in both enantiomeric forms, and therefore are 
capable of resolving both enantiomers in a given reaction.  Such organocatalysts are 
structurally more variable and can be further optimized to improve their selectivity.  The first 
part of the present chapter introduces various types of small organic molecules utilized for 
stereoselective acyl transfer.  The availability of the catalysts, the reaction conditions, the 
substrate scope, and the selectivities will be discussed and compared to other approaches.  
Some selected steps in natural product syntheses are presented to demonstrate the 
practicality of these methods. 
  
2.1.1.2.1  Enantioselective Acyl Transfer Using DMAP-Derivatives 
 
The first achiral acyl transfer onto alcohols utilizing DMAP (4-dimethylaminopyridine) 
as catalyst and acetic anhydride as acyl source was reported in the late 1960’s  by Steglich 
and Höfle.20  Independently, Litvinenko and Kirichenko found a rate acceleration for the 
benzoylation of m-choloroaniline by adding DMAP instead of pyridine as catalyst.21  It took 
nearly 30 years until the first asymmetric approach was introduced by Vedejs and co-workers 
in 1996.22 Experimental23-25 and theoretical26,27 studies support a nucleophilic mechanism for 
the DMAP-catalyzed acylation of alcohols.  In the first step the nucleophilic nitrogen of the 
pyridine ring attacks the electrophile (e.g., anhydride or acid halide) and forms an 
acylpyridinium salt.  The reactive intermediate transfers the acyl group onto the alcohol 
(Scheme 3).  Additional base is needed to neutralize the acid that is produced during the 
acylation process.  In some rare examples, additional base is not required, because of the 
weakness of the generated acid (e.g., acetic acid).28  Yet, the role of the base is not fully 
understood, because even in the latter case a rate acceleration is often observed, maybe 
due assisting by the proton abstraction from the alcohol.29  Additionally, the rate of the 
acylation is highly affected by the character of the anion and the solvent.30,31 
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Scheme 3 
 
The first enantioselective approach of Vedejs et al. required 1 eq of “catalyst” and two 
eq of a Lewis acid in the presence of base.  The KR of aryl alkyl alcohols could be achieved 
with S ≤ 45. 
In 1996 Fu introduced the new planar chiral ferrocenyl-DMAP derivative 28 as a 
catalyst for the KR of aryl alkyl carbinols.  In addition to 28 the same group also synthesized 
an analogous PPY-based (4-pyrrolidino pyridine) catalyst 29.32  Both 28 and 29 are 
commercially available or can be synthesized in eight steps from readily available starting 
materials (Scheme 4).33  These planar-chiral DMAP derivatives are discussed in connection 
with organocatalytic acyl transfer catalysts, because the nitrogen atom of the DMAP moiety 
is key.  The iron ion of the complex only functions as structure-forming element and 
supposedly does not influence the activity of the catalyst. 
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Scheme 4 
 
Catalyst (–)-28 was successfully applied in the KR of aryl alkyl carbinols (Table 
3).34,35,36  The ee’s and S-values (32–95) are excellent even at low catalyst loadings of 1 
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(–)-28(> 99% ee; 28%)
(+)-28(> 99% ee; 44%)
N
NMe2
27a'
+
N
N
+
27b''27b'
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mol% in t-amyl alcohol as solvent.  In contrast, in Et2O the selectivities ranged from 12–52 
even at a catalyst loading of 2 mol% at room temperature.  The ee’s provided by catalyst 28 
strongly depend on the solvent.  The selectivity increased as the steric demand of the alkyl 
moiety increases.  A big advantage of this method is the possible recovery of catalyst (–)-28, 
the low sensitivity of the catalyst towards moisture and oxygen and the absence of chemical 
by-products.  The S-values obtained by catalyst 29 were lower and will not be discussed 
further. 
 
Table 3. Efficiency of catalyst (–)-28 in the KR of aryl alkyl carbinols.36 
 
Entry Unreacted 
alcohol 
 Conv. (%) ee (%) of 
unreacted 
alcohol 
S-value 
1 
 
30 55 99 43 
2 
 
31 51 96 95 
3 
 
32 54 99 68 
4 
 
33 53 99 71 
5 
 
34 56 98 32 
6 
 
35 52 95 65 
 
Ar RAlkyl
OH
(±)
Ar RAlkyl
OH
Ar RAlkyl
OAc
0.6 eq Ac2O
1 mol% (–)-28
0.6 eq Et3N
t-amyl alcohol,
0 °C
+
(S) (R)
Me
OH
t-Bu
OH
Me
OH
F
Me
OH
Me
OH
Cl
Me
OH
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Fu also applied catalyst (–)-28 in the KR of racemic 1,5-diols as well as in the 
desymmetrization of meso-1,5-diols.  In both cases high selectivities could be achieved 
utilizing the same reaction conditions as for aryl alky alcohols (Equation 2 and 3).34,35,36 
 
 
In addition to Birman’s amidine catalyst 130 (S ≤ 32, Scheme 9 and Table 17), only 
catalyst (–)-28 is capable of resolving propargylic alcohols.37,38  The selectivities are in a 
range between 3.8 and 20 and therefore synthetically useful.  In contrast to aryl alkyl 
alcohols no additional base was employed, because the acylation of propargylic alcohols 
occurred under basic conditions in the absence of catalyst.  The selectivity for the KR 
decreases as the steric demand for the alkyl group of the substrate increases (Table 4).34,35,37 
Table 4. KR of propargylic alcohols by catalyst (–)-28.    
 
MeMe
MeMe
OHOH
(±)-36
 Ac2O
1 mol% (–)-28
 Et3N
t-amyl alcohol,
0 °C
MeMe
MeMe
OHOH
(S,S)-36
+ MeMe
MeMe
OAcOAc
37
Yield = 43%
ee = 98%
+ (16% mono-
    acetate 38)
Yield = 39%
ee = 99%
Kinetic resolution of racemic 1,5-diol 36
MeMe
MeMe
OHOH
meso-39
 Ac2O
1 mol% (–)-28
 Et3N
t-amyl alcohol,
0 °C
MeMe
MeMe
OAcOH
(S,R)-40
Yield = 91%
ee = 98%
Desymmetrization of meso-1,5-diol 39
(2)
(3)
R2
OH
(±)
R2
OH
R2
OAc
0.75 eq Ac2O
1 mol% (–)-28
t-amyl alcohol,
0 °C
+
R1 R1 R1(S) (R)
Entry Unreacted alcohol  
 
R  Conv. (%) ee (%) of 
unreacted 
alcohol 
S-value 
1 
 
 
Me 41 58 96 20 
2 Et 42 58 94 18 
      3 iPr 43 63 93 11 
4 tBu 44 86 95 3.8 
R
OH
Ph
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Catalyst (+)-28 was successfully applied the KR of allylic alcohols.  A large variety of 
substrates can be resolved with good to excellent enantioselectivities (Table 5).34,35,39  
 
Table 5. Efficiency of (+)-28 in the KR of allylic alcohols. 
 
 
Entry Unreacted 
alcohol  
 Conv. (%) ee (%) of 
alcohol 
S-value 
1 
 
51 75 92 5.4 
R4
OH
(±)
R4
OAc
R4
OH
0.6 eq Ac2O
1–2.5 mol% (+)-28
0.6 eq Et3N
t-amyl alcohol,
0 °C
+R3
R1 R2
R3
R1 R2
R3
R1 R2
(S) (R)
iPr
n-Pr
OH
Entry Unreacted alcohol  
 
R  Conv. (%) ee (%) of 
unreacted 
alcohol 
S-value 
      5 
 
OMe 45 60 94 14 
6 CF3 46 71 99 10 
7 F 47 65 97 13 
8 
 
- 48 64 95 12 
9 
 
- 49 66 95 10 
10 
 
- 50 69 94 7.9 
Me
OH
R
Me
OH
O
Me
Me
OH
n-Bu
Et
OH
Me
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Entry Unreacted 
alcohol  
 Conv. (%) ee (%) of 
alcohol 
S-value 
2 
 
52 54 99 64 
3 
 
53 63 92 10 
4 
 
54 77 90 4.7 
5 
 
55 60 97 18 
6 
  
56 66 97 12 
7 
 
57 55 94 25 
8 
 
58 59 99 29 
 
To illustrate the utility of this selective acyl transfer onto allylic alcohols, Fu applied 
catalyst (–)-28 to the KR of allylic alcohols, which serve as key intermediates in natural 
product syntheses.  The KR of a racemic allylic alcohol 59 was achieved with good 
selectivities ((–)-59: ee = 99.4%; (+)-60: ee = 74%)) and high yields ((–)-59: Yield = 40%; (+)-
60: Yield = 57%)).  Allylic alcohol (S)-(–)-59 served as a key intermediate in Brenna’s total 
synthesis of (–)-baclofen (Equation 4).35,39,40  
 
 
Me
Ph
OH
i-Pr
OH
Me
Me
n-pentyl
OH
Me
Me
i-Pr
Me
OH
Me
n-pentyl
Me
OH
Me
i-Pr
OH
n-Bu
Me
OH
Me
Me Me
Me
Me
OH
Cl
 Ac2O
1 mol% (–)-28
Et3N
t-amyl alcohol,
0 °C
(±)-59
Me
OH
Cl
(S)-59
Me
Cl
(R)-60
+
Yield = 40%
ee = 99%
Yield = 57%
ee = 74%
S = 37
(4)
OAc
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A second example is the KR of 61 mediated by (–)-28.  The selectivity realized with 
Fu’s catalyst is higher than that of an aldolase antibody (ee = 96%; S = 17) utilized by Sinha 
and Lerner in their total synthesis of epothilone (Equation 5).35,41  Examples of a small 
molecule catalyst being superior to an enzymatic approach are rare.  
 
In addition to Fu’s planar-chiral DMAP derivative various chiral DMAP- and PPY-
catalysts have been developed by other research groups and have been applied in KRs of 
various substrates.  In 1999 Spivey and co-workers employed a chiral DMAP derivative in 
the KR of a variety of substrates.34,42,43  Catalyst 63 can be synthesized in seven steps from 
commercially available 4-pyridone.  The selectivities for the KR of secondary alcohols are 
moderate to good but cannot compete with the selectivities achieved by Fu’s catalyst (Table 
6).  
 
Table 6. KR of aryl alkyl alcohols mediated by catalyst 63. 
 
Entry Ar R  Conv. 
(%) 
ee (%) of 
alcohol  
ee (%) of 
ester 
S-value 
1 1-Nap Me 35 17 19 89 21 
2b 1-Nap Me 35 22 26 91 29 
3 Ph Me 30 39 50 78 13 
4 2-Tol Me 33 41 61 86 25 
5 Ph t-Bu 31 18 19 89 20 
b Reaction conditions: 1.0 eq (iPrCO)2O 
OH
MeO
(±)-61
Me Et
O
Me
 Ac2O
1 mol% (–)-28
Et3N
t-amyl alcohol,
0 °C
OH
MeO
(R)-61
Me Et
O
Me
+
OAc
MeO
(S)-62
Me Et
O
Me
Yield = 47%
ee = 98%
Yield = 52%
ee = 92%
S = 107
(5)
Ar R
OH
(±)
1 mol% 63
2.0 eq (iPrCO)2O
0.75 eq Et3N
toluene, –78 °C Ar R
OH
Ar R
O
+
iPr
O
Ph N
NEt2
63
(S) (R)
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Spivey et al. tested a range of substrates (e.g., monosubstituted cyclic diols, a cyclic 
meso-diol and 2-bromo- and 2-phenylcyclohexanol) under optimized conditions.  The best 
selectivities were observed for monobenzoylated cyclic 1,2-diols (Table 7).44 
 
Table 7. Efficiency of catalyst 63 in the KR of various secondary alcohols.44 
 
Entry Substrate  Conv. 
(%) 
ee (%) of 
alcohol 
ee (%) 
of ester 
S-value Product/ 
enantiomer 
1 
 
64 11 8 67 6 (–)/1R,2S 
2 
 
65 96 85 39 6 (–)/1R,2S 
3 
 
66 18 18 86 16 (–)/1R,2S 
4 
 
67 64 98 65 20 (–)/1R,2S 
5 
 
68 51 75 73 14 (–)/1R,2S 
6 
 
69 54 61 53 6 (–)/1R,2S 
7 
 
70 16 14 78 9 (–)/1R,2S 
8 
 
30 34 37 71 8   (+)/ R 
9 
 
71 26 - 45 - (+)/1S,2R 
10 
 
72 20 - 78 - (–)/1R,2S 
Reaction conditions: 2.0 mmol (iPrCO)2O; 0.75 Et3N; 1 mol% (–)-63; –78 °C, 9 h 
OH
O
O
CN
OH
O
O
NO2
OH
O
O
NMe2
OH
O
O
OH
O
O
Br
OH
Ph
OH
OH
OH
OH
Ph
Ph
OH
OH
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In 1996 Fuji and Kawabata introduced a 4-PPY-derived chiral catalyst 73.34,35,45  On 
the basis of NMR studies, Fuji and co-workers proposed an “induced fit” mechanism for the 
acylation of secondary alcohols.  They examined 73 and the acylium ion adduct 74 in CDCl3 
by 1H-NMR (arrows in Scheme 5 denote the observed NOEs).  Catalyst 73 seems to adopt 
an “open conformation” in which the naphthalene ring and the pyridine ring are separated 
from each other.  In contrast, the naphthalene ring and pyridine ring of 74 are interacting (π-
π-stacking) and the catalyst adopts a “closed conformation” (Scheme 5). 
 
Scheme 5 
Fuji applied catalyst 73 in the KR of cyclic monobenzoylated 1,2-diols45 and 
monobenzoylated 2-aminoalcohols (Table 8).46  In general, the selectivities for the mono-
benzoylated 2-amino alcohols are higher (10–17) than those obtained for the mono-
benzoylated 1,2-diols (5.8–10.1).  The S-value for entry 6 can be increased to 54 by running 
the reaction at –40 °C. 
 
Table 8. KR of monobenzoylated 1,2-diols and monobenzoylated 2-aminoalcohols mediated 
by catalyst 73. 
 
 
Entry Substrate  t (h) Conv. 
(%) 
ee (%) 
of 
alcohol 
ee (%) 
of ester 
S-value 
1 
 
75 4 71 97 - 8.3 
NH
OH
N
HbHd
HaH
HH
Hc
73 (open conformation)
NH N
HbHd
HaH Hc
OH
O
Me
H Me
H
74 (closed conformation)
H2C
OH
XCOR
n
X = NH/O(±)
5 mol% 73
0.7 eq (iPrCO)2O
toluene, r.t.
for X = NH: 
1 eq collidine
H2C
OH
XCOR
n + H2C
O
XCOR
n
iPr
O
N
OH
HH
N
73
R = C6H4-p-NMe2
(R) (S)
OH
OCOR
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Entry Substrate  t (h) Conv. 
(%) 
ee (%) 
of 
alcohol 
ee (%) 
of ester 
S-value 
2 
 
66 3 72 99 - 10 
3 
 
76 4 70 92 - 7 
4 
 
77 5 73 92 - 6 
5 
 
78 9 69 99 44   >12 
6 
 
79 9 58 93 68 17 
7 
 
80 24 68 99 46 >13 
8 
 
81 3 64 99 56 17 
9 
 
82 9 69 97 46 10 
 
In the late 1990’s Yamada and his group reported a new acylating catalyst 83, which 
undergoes a conformational switch during the acylating step of the catalyst.34,35,47  They 
proposed a reaction model that could be confirmed by 1H-NMR measurements, X-ray 
analysis, and DFT computations.48  It has been suggested that the selectivities in the KRs of 
secondary alcohols are due to self-complexation of the acylated catalyst.  After the acyl 
transfer onto the substrate the catalyst adopts its “open conformation” again (Scheme 6). 
 
 
Scheme 6 
OH
OCOR
OH
OCOR
OH
OCOR
OH
NHCOR
OH
NHCOR
OH
NHCOR
OH
NHCOR
OH
NHCOR
N
NR2
N
O
S
S
R
R2COX
– R2COX NO
R2
NR2 N
O
S
R
S
"closed conformation""open conformation"
83 83-acylium ion
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Catalyst 83 can readily be prepared from 4-aminonicotinic acid and an auxiliary.  
Yamada utilized 83 in the KR of secondary alcohols with selectivities ranging from 2.2 to 9.6 
(Table 9).  High S-values were achieved for aryl alkyl alcohols, whereas secondary alkyl alkyl 
alcohols were resolved with much lower selectivities.49,50 
 
Table 9. KR of secondary alcohols with catalyst 83. 
 
Entry Substrate  Conv. (%) ee (%) of 
unreacted 
alcohol 
S-value 
1 
 
30 65 89 7.6 
2 
 
31 62 88a 9.6 
3 
 
85 65 94b 9.8 
4 
 
41 61 78b 6.6 
5 
 
86 52 31 2.3 
6 
 
87 48 25 2.2 
aReaction time 72 h; bTemperature –30 °C; 48 h 
 
Diols are important building block in organic synthesis and therefore methods for their 
enantioselective preparation are highly desirable.  Catalyst 84 was successfully applied in 
the KR of racemic 1,4-diol (88).  While substrates like aryl alkyl alcohols and cyclic meso as 
well as cyclic racemic 1,2- and 1,3-diols are often used as test substrates for 
R1 R2
OH
(±)
0.5 mol% 83
0.8 eq (iPrCO)2O
0.9 eq Et3N
t-BuOMe, r.t. R1 R2
OH
R1 R2
O
+
iPr
O
N
N
O
S
S
t-Bu
83
N
(S) (R)
OH
OH
OH
OH
OH
OH
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desymmetrizations and KRs mediated by various catalysts and successfully resolved, 
catalysts for KRs of racemic 1,4-diols are rare (Equation 6).  
 
 
 
In 2005 Connon and co-workers reported a PPY-derived catalyst 91 that can be 
easily synthesized in three steps from 3-carboxy-4-chloropyridine without the need for a 
resolution step.34,51  The catalyst design was inspired by the “induced fit” concept of Fuji’s 
catalyst 73 and Connon et al. tested catalyst 91 in the KR of various secondary alcohols 
(Table 10).52  The selectivities were moderate to good and ranged from 2.3 to 30.0.  Good 
selectivities were achieved for aryl alkyl alcohols and 2-phenylcyclohexanol, whereas N-
substituted aminoalcohols were poorly resolved.  The conversions were low for all examples 
in Table 10 except of entry 6 because the reactions were stopped after 6 h.  
 
Table 10. Efficiency of catalyst 91 in the KR of various secondary alcohols. 
 
 
Entry Substrate  Conv. (%) ee (%) of 
unreacted 
alcohol 
S-value 
1 
 
30 28 25 6 
OH
OH
5 mol% 84
Et3N, 0 °C, 3h
t-BuOMe
(±)-88
O
OH
(S,S)-89
iPr
O
+
1.5 eq (iPrCO)2O
O
O
iPr
O
iPr
O
(R,R)-90
Yield = 20%
ee = 92%
Yield = 53%
ee = 88%
(6)
OH
OH
(S,S)-88
Yield = 26%
ee = 99%
+
N
N
O
O
S
t-Bu
84
N
R1 R2
OH
(±)
1 mol% 91
0.75 eq (iPrCO)2O
0.75 eq Et3N
CH2Cl2,–78 °C,
6 h
R1 R2
OH
R1 R2
O
+
iPr
O
N
N
N
O
Ph
HO
Ph
91(R) (S)
OH
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Entry Substrate  Conv. (%) ee (%) of 
unreacted 
alcohol 
S-value 
2 
 
92 19 19 14 
3 
 
93 18 18 11 
4 
 
R = p-Me2N-
C6H4 
81 23 11 2 
5 
 
70 19 22 30 
6a 
 
R = p-Me2N-
C6H4 
66 77 >99 20 
a The reaction was stopped after 24 h; The phenyl groups of catalyst 91 were replaced by 3,5-CF3-
C6H3-groups. 
In 2007 Connon and co-workers also applied the slightly modified catalyst 91b in a 
one-pot-Baylis-Hillman reaction following an acylative KR.53  In this process DBU acts as the 
catalyst for the Baylis-Hillman reaction but does not promote acyl transfer.  The 
enantioselective acylation is mediated by catalyst 91b (Equation 7). 
 
 
OH
OH
OMe
OH
NHCOR
OH
Ph
OH
OCOR
OMe O O
OMe+
3.0 eq 94 1.0 eq 95
OMe
OMe
OOH
1) 1 eq DBU, r.t., 96 h
2) 1.5 eq (iPrOC)2O, CH2Cl2
     24 h, 5 mol% 91b, –78 °C
Yield = 25%
ee = 89%
Conv. = 66%
N
N
N
O
Ar
HO
Ar
Ar = 3,5-CF3-C6H3
91b
96a
(7)
OMe
OMe
OO
iPr
O
96b
Yield and ee
not given
+
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In 2003 Campbell and co-workers reported readily accessible PPY-derived catalyst 
97.54  The first step of the synthesis is the nucleophilic substitution of 4-chloropyridine with a-
methylproline.  The carboxylic acid group of the proline can be functionalized by various 
amines by standard peptide coupling agents (e.g., HATU).  Catalyst 97 was utilized for KRs 
of secondary alcohols.  The selectivities are poor for aryl alkyl alcohols and 2-phenyl 
cyclohexanol but are good for N-substituted amino alcohols (Table 11). 
 
Table 11. KR of various secondary alcohols mediated by catalyst 97.  
 
Entry Substrate  Conv. (%) ee (%) of 
recovered 
alcohol 
S-value 
1 
 
98 74 22 1.4 
2 
 
70 65 11 1.2 
3 
 
99 69 99 12.0 
4 
 
79 59 96 18.8 
5 
 
81 74 98 8 
R = p-Me2N-C6H4 
 
In conclusion, all chiral DMAP- or PPY-derived catalysts are capable of selective acyl 
transfer.  The best results for the KR of aryl alkyl alcohols were obtained by Fu’s catalyst 28 
with S-values in the range of 32–95.  The other catalysts resolve aryl alkyl alcohols with 
selectivities of 13–29 (Spivey 63), 9.6 (Yamada 83), 13.5 (Connon 91) and 1.4 (Campbell 
97).  KRs of allylic alcohols, propargylic alcohols, racemic 1,5-diols and the desymmetrization 
of meso-1,5-diols were achieved with catalyst 28 with good to excellent selectivities. 
R1 R2
OH
(±)
5 mol% 97
0.7 eq (iPrCO)2O
toluene, r.t.
3 h
R1 R2
OH
R1 R2
O
+
iPr
O
N
N
H
N
O
O
97
(S) (R)
OH
OH
Ph
NHCORHO
CO2Me
OH
NHCOR
OH
NHCOR
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Spivey’s catalyst 63 catalyzes KRs of monobenzoylated 1,2-diols with high 
selectivities under mild conditions.  The same substrates can be resolved by Connon’s 
catalyst 91  with excellent selectivities.  Catalyst 91 was the first catalyst utilized in a “one-
pot” Baylis-Hillman reaction followed by a KR.  The selective acyl transfer onto 2-phenyl 
cyclohexanol mediated by 91 produced high enantiomeric excesses.  Good selectivities for 
the KR of N-functionalized 1,2-aminoalcohols were reported for catalysts 73 (Fuji) and 
catalyst 97 (Campbell).  Yamada’s catalyst 83 is, to the best of our knowledge, the only chiral 
DMAP or PPY-derived catalyst capable of transferring an acyl moiety selectively onto 
racemic cyclic 1,4-diols. 
 
2.1.1.2.2 Phosphine and Phosphinite mediated Enantioselective Acyl Transfer 
 
Vedejs and Driver reported in 1993 the first acylation reaction mediated by 
tributylphosphines.55  They compared the catalytic efficiency of DMAP and tributylphosphine 
in the acylation reaction of alcohols and both catalyst product similar results.  The first chiral 
phosphines were published in 1996 but the selectivities were only moderate.22  In 1999 
Vedejs introduced catalysts 100a-c, which were successfully employed in the KR of racemic 
secondary alcohols (Table 12).34,35,56 
 
Table 12: KR of racemic secondary alcohols by phosphine catalyst 100a. 
 
 
 
Entry Substrate  mol% 
Cat. 
Solvent ee  (%) 
alcohol 
ee  (%) 
ester 
Conv. 
(%) 
S-
value 
1 
 
92 2.8 Heptane 84 95 47 100 
2 
 
31 4.9 Heptane 79 93 46 67 
R1 R2
OH
(±)
R1 R2
OH
R1 R2
O iPr
O
P
H
H
Ar
Ar = a: 3,5-tBu2C6H3
        b: Ph
        c: 3,5-Me2C6H3
100
2.5 eq (iPrCO)2O
Cat. 100a
–40 °C
+
(S) (R)
OH
OH
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Entry Substrate  mol% 
Cat. 
Solvent ee  (%) 
alcohol 
ee  (%) 
ester 
Conv. 
(%) 
S-
value 
3 
 
98 3.9 Heptane 41 97 30 99 
4 
 
101 12.1 Heptane 79 99 44 369 
5 
 
33 3.5 Heptane 95 95 50 145 
6 
 
102 5.0 Toluene 67 82 45 21 
7 
 
103 5.0 Toluene 90 88 50 49 
8 
 
104 5.0 Toluene 42 45 48 4 
 
Many other phosphine catalysts were employed in the KR of racemic secondary 
alcohols, but to date 100a is the most efficient catalyst for enantioselective acyl transfer in 
the field of phosphine catalysts.  In addition to catalysts 105a-c, 100a-c were also capable of 
transferring acyl moieties onto meso-71.  Phosphine 100b showed the highest enantiomeric 
excesses and conversions.  The ratio of 106 to meso-107 is 2.6:1, whereas catalyst 105c 
gave  87% ee and a ratio of 20:1 at 20% conversion (Table 13).  The high required catalyst 
loading of 35–41 mol%, and the low activity of phosphines 105a-c makes catalyst 100b 
preparatively more feasible.57 
 
Table 13: Desymmetrization of meso-71 by phosphine catalysts 105a-c and 100a-b. 
 
 
OH
OH
OH
Ph
OH
OH
OH
Ph
Ph
Ph
OH
OH
meso-71
Ph
Ph
O
OH
Ph
O
Ph
Ph
O
O
Ph
O
Ph
O106 meso-107
CH2Cl2
Cat.
(PhCO)2O
P
R
R
X
X
a: R = Me; X = Me
b: R = Me; X = tBu
c: R = Me; X = Ph
105a-c
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Entry Cat. Mol% t T (°C) Conv. 
(%) 
106/107 ee  (%) 
106 
1 105a 38 4 h r.t. 20 >20:1 78 
2 105b 41 1.5 h r.t. 20 >20:1 87 
3 105c 35 17 h r.t. 32 >20:1 87 
4 100a 4.1 5 min r.t. 64 5:1 61 
5 100b 10 22 h –30 97 2.6:1 94 
 
In 2003 Fujimoto and his group used a different approach to design a catalyst with a 
trivalent phosphorus center.58  They modified a cinchona alkaloid and synthesized an 
efficient bifunctional acylation catalyst, which combines a tertiary amino group with a trivalent 
phosphorus center.  The postulated reaction mechanism involves the activation of acyl 
chloride by the phosphinite moiety while the nitrogen atom of the quinuclidine abstracts a 
proton of the OH-group.  Catalyst 108 was successfully applied in the desymmetrization of 
meso-1,2-, meso-1,3- and meso-1,4-diols (Table 14).34,58,59 
 
Table 14: Desymmetrization of meso-1,2-, meso-1,3- and meso-1,4-diols with catalyst 108. 
 
Entry Substrate  t (h) T (°C) Solvent Yield (%) ee  (%) 
1 
 
109 4.0 –78 EtCN 99 86 
2 
 
71 1.5 –78 EtCN 98 91 
3 
 
110 3.5 –78 EtCN 80 93 
4 
 
111 4.5 –78 EtCN 80 76 
OH
meso
OH
OOH
Ph
O
(  )n(  )n
30 mol% Cat.
1 eq DiPEA
1.5 eq PhCOCl
N
OPPh2
N
108
OH
OH
Ph
Ph
OH
OH
OH
OH
O
OH
OH
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Entry Substrate  t (h) T (°C) Solvent Yield (%) ee  (%) 
5 
 
72 6.0 –78 EtCN 85 94 
6 
 
112 4.0 0 CH2Cl2 82 81 
7 
 
113 2.5 0 CH2Cl2 71 97 
8 
 
88 4.0 0 CH2Cl2 55 82 
9 
 
114 6.0 0 CH2Cl2 73 70 
 
The yields and enantiomeric excesses for all examples were very good.  Catalyst 108 
can be synthesized readily from cinchonidine in one step.  The broad substrate scope for the 
desymmetrization of diols by 108 and fast access to the catalyst makes 108 preparatively 
very useful.  A drawback might be the high susceptibility of the phosphinite moiety to 
oxidation and therefore the catalyst needs to be freshly prepared.  To solve this problem, 
Fujimoto et al. published an aminophosphinite catalyst in early 2012.  Catalyst 117 can be 
synthesized in two steps with high yield from commercially available aminoindanols (Scheme 
7).60 
  
Scheme 7 
This catalyst can be isolated and stored under argon in a refrigerator for several 
months.  The selectivities for the desymmetrization of meso-1,2-diols (Table 14, entry 1, 2, 5, 
8) are comparable to those with catalyst 108.  Consequently, Fujimoto et al. applied catalyst 
118 (i.e., catalyst 108 bearing a methoxy group) in the KR of chiral 1,2-diols (Table 15). 
OH
OH
OH
OH
OH
OH
OH
OH
OH
OTBS
HO
OH
NH2
20 eq HCOH
5 eq HCO2H
reflux
OH
NMe2
1 eq Ph2PCl
1 eq DiPEA
CH2Cl2, reflux
OPPh2
NMe2
(1S,2R)-aminoindanol
115
117116
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Table 15: KR of chiral 1,2-diols with bifunctional catalyst 118.  
 
Entry Substrate  Conv. (%) ee  (%) 
alcohol 
ee  (%) 
ester 
S-value 
1 
 
119 50 99 98 525 
2 
 
120 51 90 85 38 
3 
 
121 14 15 89 20 
4 
 
122 44 63 81 18 
5 
 
123 41 52 74 11 
6 
 
124 50 69 68 11 
 
The best selectivities utilizing 108 or 118 were obtained for racemic hydrobenzoin 
derivatives (S-values up to 525), for cyloalkyl-1,2-diols the enantiomeric excesses were good 
to moderate, while for cyclohexane-1,2-diol the conversion was low.  Hence, 118 would be 
the catalyst of choice for the KR of chiral hydrobenzoin derivatives, whereas Schreiner’s 
catalyst 238 (see Chapter 1.1.1.3.4) is more efficient in the KR of cycloalkane-1,2-diols. 
 
2.1.1.2.3 Amidines and Vicinal Diamines as Catalysts for Enantioselective Acyl 
Transfer 
 
In 2004 Birman reported the first KR of secondary allylic alcohols utilizing 2,3-
dihydroimidazo[1,2-a]pyridines as catalysts.61,35,34  This structural motif has been known 
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since 1936, but has not been used as a catalytic moiety for acylation reactions.  The acyl 
transfer was proposed62 to proceed via a nucleophilic mechanism, because Birman obtained 
the X-ray crystal structure of the N-acylated CF3-PIP hexafluoroantimonate.  Catalyst 127a 
can be easily synthesized from substituted amino alcohols in two steps and therefore various 
modifications of 127a are possible (Scheme 8).63 
 
 
 
Scheme 8 
Electron-withdrawing groups in the pyridine ring increase the selectivities and the best 
S-values were achieved by catalyst 127d.  Since the introduction of 127a-d in 2004 Birman 
and co-workers tested and optimized various amidine catalysts.61  The replacement of the 
pyridine moiety by a quinoline moiety (see 127 → 128 or 129 → 130) improved the 
performance of the catalysts in the KR of secondary alcohols.  Birman et al. proposed 
additional π-π-interactions as the reason of this observation.  Theoretical studies by Houk 
and co-workers62 confirmed the importance of the additional aromatic ring for the selectivity 
of the acyl transfer (Scheme 9). 
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Catalyst 130 showed the best results in the KR of secondary aryl alkyl alcohols; the 
selectivities for all substrates are very high.  Even substrates with two bulky moieties (Entry 
2) could be resolved with high S-values (S = 166).  One exception was mesityl methyl 
carbinol (Table 16, Entry 4).  In this case poor selectivity of only 2.5 was observed.  In 
contrast, catalyst 127d is capable of transferring an acyl moiety with a selectivity of S = 20 
onto mesityl methyl carbinol.  The highest S-value for this special substrate was obtained 
with Vedejs’ catalyst 100 (S = 369). 
 
Table 16. Efficiency of catalyst 130 in the KR of aryl alkyl alcohols. 
 
Entry Substrate  t (h) Conv. (%) S-value 
1 
 
30 33 49 80 
2 
 
31 48 51 166 
3 
 
33 33 50 209 
4 
 
101 24 20 3 
5 
 
88 10.5 50  108 
6 
 
35 8.5 49 128 
7 
 
85 32 36 23 
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While there are many nonenzymatic catalysts for the KRs of benzylic or allylic 
alcohols, the KR of propargylic alcohols was just recently achieved by Fu’s planar chiral 
DMAP-derivative catalyst 28 with selectivities up to 20.  Birman and his group applied their 
catalyst 130 in the KR of various propargylic alcohols as well;61,64 the selectivities ranged 
from 5.4 to 32.  Although the S-values were not as high as in the KR of aryl alkyl alcohols, 
they are the highest observed by a nonezymatic catalyst for this substrate class to date.  In 
addition to aryl and alkenyl moieties, amidine catalyst 130 is capable of selective acyl 
transfer onto alkynyl group bearing substrates (Table 17).  
 
Table 17. Efficiency of catalyst 130 in the KR of various propargylic alcohols. 
 
Entry Substrate  t (h) Conv. (%) S-value 
1a 
 
41 10.5 59 31 
2a 
 
44 10.5 43 10 
3b 
 
132 18 62 27 
4a 
 
48 1.5 55 32 
5c 
 
133 23 60 11 
6a 
 
49 2 52 32 
      
R2
OH
(±)
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R2
OH
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O
+
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O
R1 R1 R1
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OH
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O
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Entry Substrate  t (h) Conv. (%) S-value 
7c 
 
134 2.5 57 5 
aCatalyst loading: 4 mol% 130; b 10 mol% 130, 1.5 eq (EtCO)2O; c 10 mol% 130 
 
Superficially, it may seem as if new catalysts were synthesized in order to achieve the 
best possible selectivities in a particular test reaction, but the real motivation often is the 
synthesis of a catalysts for industrial applications.  Hence, test reactions are needed to 
determine the efficiency of a new catalyst system for asymmetric transformations (e.g., 
enantioselective acyl transfer).  Test reactions offer the possibility to compare selectivities of 
various catalysts.  An example of the utilization of a catalyst in total syntheses of a natural 
product is shown in Scheme 10.  Catalyst 130 was successfully applied in the 
desymmetrization of lobelanidine.  The desymmetrization step proceeds with high conversion 
and selectivity.65 
 
 
Scheme 10 
 
In 2008 Birman and co-workers extended the substrate scope by using aryl 
cycloalkanols in the KR mediated by catalyst 131.66  Good enantioselectivities were achieved 
for substrates with aromatic moieties, whereas the S-values decreased for substrates 
containing an –N3 or –OBz group in the 2-position of the alkyl ring.66 
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Table 18. KR of aryl cycloalkanols by catalyst 131. 
 
Entry Substrate  t (h) Conv. (%) S-value 
1 
 
70 10 51 107 
2 
 
140 7 51 66 
3 
 
141 10 44 44 
4 
 
142 12 46 28 
5 
 
143 10 28 5.6 
6 
 
144 10 26 10 
 
In 2007 Shiina and co-workers reported the KR of secondary benzylic alcohols 
mediated by catalyst 130.67  In contrast to Birman’s approach, where anhydrides were used 
as acyl source, Shiina used carboxylic acids as the acylation agents.   The reaction requires 
benzoic anhydride (PMBA, 145), which forms a mixed anhydride with the carboxylic acid 
catalyzed by 130 (Table 19).  In fact, the mixed anhydride presents the acyl source (similar to 
Scheme 11).  
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Table 19. KR of secondary benzylic alcohols with carboxylic acids catalyzed by 130. 
 
Entry R1  R2 ee (%) 
alcohol 
Yield (%) 
alcohol 
ee (%) 
ester 
Yield (%) 
ester 
S-value 
1 Et 146 Et 76 40 89 40 39 
2 Et 146 Ph(CH2)2 75 46 90 41 43 
3 Et 146 Ph(CH2)3 69 45 90 39 39 
4 Et 146 Me2CH(CH2)2 71 38 83 43 23 
5 Et 146 CH2=CH-(CH2)2 91 38 86 47 42 
6 Et 146 MeOCH2 38 51 82 32 15 
7 Et 146 Cy 51 40 76 53 12 
8 iPr 92 Et 81 43 90 39 47 
9 iPr 92 Ph(CH2)2 64 53 92 38 46 
10 tBu 31 Et 44 67 93 32 42 
11 tBu 31 Ph(CH2)2 58 54 96 36 88 
 
The KR of 2-hydroxyalkanoates can be achieved by using the same mixed anhydride 
technique.  In this case pivalic anhydride is utilized to generate the mixed anhydride 
catalyzed by (R)-benzotetramisol (BTM) 130.  Shiina and his group proposed following 
catalytic reaction mechanism: pivalic anhydride reacts with BTM and forms acylated species 
A.  The carboxylic acid attacks A and forms mixed anhydride B.  BTM activates mixed 
anhydride B and generates a second intermediate C, which transfers the acyl moiety (the 
former carboxylic acid) enantioselectively onto the racemic 2-hydroxyalkanoate (Scheme 11).  
Schreiner and co-workers reported a similar concept by generating the anhydride in situ from 
carboxylic acids by using substituted carbodiimides as coupling agents.  This led to the first 
enantioselective Steglich esterification.68  Approaches in which carboxylic acids are directly 
used as acyl source, are rare because of the need for water removal.  
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Scheme 11 
 
Shiina and co-workers applied their method to various 2-hydroxyalkanoates and 
excellent selectivities were observed with catalyst 130 (Table 20).  The KR of 2-
acyloxyalkanoates with other catalysts is not known and this approach is the first practical 
method to prepare enantiopure 2-hydroxyalkanoates and 2-acyloxyalkanoates.69 
 
Table 20. KR of 2-hydroxyalkanoates utilizing the mixed anhydride method and 
diphenylacetic acid as the acyl source. 
 
Entry R1  ee (%) 
alcohol 
Yield 
(%) 
alcohol 
ee (%) 
ester 
Yield (%) 
ester 
S-value 
1 Me 147 82 55 97 44 146 
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Entry R1  ee (%) 
alcohol 
Yield 
(%) 
alcohol 
ee (%) 
ester 
Yield (%) 
ester 
S-value 
2 Et 148 94 43 95 46 126 
3 nPr 149 97 48 95 50 171 
4 iPr 150 73 50 92 46 53 
5 nBu 151 88 51 96 47 128 
6 iBu 152 97 55 94 45 140 
7 Cy 153 75 53 91 43 47 
8 Ph(CH2)2 154 95 47 96 48 202 
9 TBSOCH2 155 87 50 93 47 80 
10 TBSO(CH2)2 156 87 52 96 45 146 
 
Consequently, Shiina and co-workers applied the mixed anhydride method to the KR 
of chiral carboxylic acids with achiral alcohols.70  The reaction conditions were similar to 
those used for the KR of chiral alcohols with achiral acids.67  The best results were obtained 
by utilizing bis(α-naphthyl)methanol, catalyst 157, and pivalic anhydride for the KR of various 
2-arylpropanoic acids (Table 21).71 
 
Table 21. KR of chiral carboxylic acids with bis(α-naphthyl)methanol mediated by catalyst 
157. 
 
Entry Substrate  ee (%) 
acid 
Yield (%) 
acid 
ee (%) 
ester 
Yield (%) 
ester 
S-value 
1 
 
158 59 51 92 45 44 
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Entry Substrate  ee (%) 
acid 
Yield (%) 
acid 
ee (%) 
ester 
Yield (%) 
ester 
S-value 
2 
 
159 73 30 89 48 193 
3 
 
160 67 42 87 46 29 
4 
 
161 99.5 43 98 40 484 
5 
 
162 73 38 98 47 235 
6 
 
163 46 35 75 45 11 
7 
 
164 39 47 88 37 24 
8 
 
165 82 41 96 48 136 
9 
 
166 86 49 98 48 361 
 
In summary, amidine based catalysts (e.g., 130, 131, and 157) are excellent catalyst 
for enantioselective acyl transfer reactions.  The synthesis of the catalysts can be achieved 
in a few steps from commercially available starting materials.  Various substrates like  aryl 
alkyl alcohols, propargylic alcohols and aryl cycloalkanols can be selectively acylated by 130 
and 131.  Shiina employed a mixed anhydride method and extended the substrate scope to 
2-hydroxyalkanoates and (chiral) carboxylic acids.  A big advantage of of Shiina’s and 
Schreiner’s68 methods is the possibility to use carboxylic acids as acyl equivalents.  
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In 1998 Oriyama reported the desymmetrization of meso alcohols with amine-based 
catalyst 167 and 168.35,72  The proline derived catalysts 167 and 168 showed similar 
selectivities at low catalyst loadings (0.5 mol%) with acyl chlorides as the acyl source (Table 
22).  KRs of secondary alcohols with catalyst 167 were also tested and produced S-values 
up to 160 for 2-phenylcyclohexanol at –78 °C. 
 
Table 22. Efficiency of catalyst 167 and 168 in the desymmetrizations of meso alcohols. 
 
Entry Substrate  Catalyst Yield (%) 
ester 
ee (%) ester 
1 
 
72 167 
168 
62 
83 
95 
96 
2 
 
169 167 
168 
78 
81 
96 
90 
3 
 
170 167 
168 
89 
89 
48 
66 
4 
 
71 167 
168 
68 
80 
64 
60 
5 
 
109 167 
168 
80 
85 
91 
94 
 
In 2010 Kawamata and Oriyama et al. accomplished the first non-enzymatic KR of 
racemic cyclic β-hydroxy sulfides.  Catalyst 167 catalyzed the acyl transfer with good to 
excellent selectivities (Table 23). 35,73 
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Table 23. Efficiency of catalyst 167 in the KR of β-hydroxy sulfides. 
 
Entry  Substrate  ee (%) 
alcohol 
Yield (%) 
alcohol 
ee (%) 
ester 
Yield 
(%) 
ester 
S-value 
1 
 
171 96 49 97 50 280 
2 
 
172 94 49 98 49 360 
3 
 
173 97 47 96 49 160 
4 
 
174 99 48 96 49 160 
5 
 
175 93 43 92 46 57 
6 
 
176 73 44 98 42 210 
7 
 
177 93 47 94 50 160 
8 
 
178 69 48 68 48 10 
9 
 
179 97 47 97 48 200 
10 
 
180 99 48 95 49 160 
11 
 
181 81 49 86 49 34 
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Non-enzymatic approaches for the KR of primary alcohols are rare.  Oriyama 
achieved the first KR of a primary alcohol with good selectivities.74  Primary alcohols are 
challenging substrates for desymmetrizations or KRs mediated by a small molecule catalyst 
owing to the fact that no functional group, which is usually required to achieve recognition by 
a catalyst, is close to the hydroxyl group.  Even enzyme-mediated enantioselective acyl 
transfer onto primary alcohols is rather rare and the selectivities are much lower than those 
for secondary alcohols.  The KR of (±)-182 with catalyst 168 under optimized conditions is 
shown in Equation 8.74 
 
 
 
In 2004 Kündig and co-workers reported the desymmetrization of a meso-Cr0-
complex utilizing chiral diamine catalysts 190 and 191.35,75  The synthesis of catalysts 190 
and 191 can be achieved in four steps starting with quinine or quinidine (Scheme 12).76 
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Scheme 12 
 
The selectivities for the desymmetrization of the meso-Cr0-complex are very good. 
Beside the chiral diamines 190 and 191, Kündig et al. also tested Oriyama’s catalyst 168 
under similar reaction conditions’ (Table 24).77 
 
Table 24. Efficiency of catalysts 168, 190, and 191 in the desymmetrization of meso-192. 
 
Entry Cat. t (h) Yield (%) 193 ee (%) 193  
1 168 22 78 95(–) 
2 190 23 80 94(+) 
3 191 22 76 99(–) 
 
Consequently, Kündig et al. tested catalyst 191 in the desymmetrization of meso-1,2-
diols.76  Oriyama et al. had already successfully applied catalyst 168 to the desymmetrization 
of the same substrates.  Kündig et al. used slightly modified conditions (2 mol% of catalyst 
191 instead of 0.5 mol% of 168; EtOAc as solvent) for his approach.  The selectivities 
achieved by catalyst 191 are comparable to those reported for 168.  Catalyst 191 showed 
1) H2CO/H2O
    HCO2H, reflux
2) Pd/C, H2, MeOH
1) H2CO/H2O
    HCO2H, reflux
2) Pd/C, H2, MeOH
NMe2N
N
Me2N
NH2N
N
H2N
190
191
188
189
Cr(CO)3
HO
OH
Cr(CO)3
HO
OBz
1.5 eq PhCOCl
10 mol% cat. 190, 191 
and 168
1.0 eq Et3N
4 Å-MS, CH2Cl2, –60 °C
meso-192 (–)-193 (shown) or (+)-193
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better results for substrate 72, whereas catalyst 168 performed better in the 
desymmetrization of substrates 71 and 169 (Table 25). 
 
Table 25. Efficiency of catalyst 191 in the desymmetrization of meso-1,2-diols compared with 
the results obtained by catalyst 168. 
 
Entry Substrate  Catalyst Yield (%) 
ester 
ee (%) ester 
1 
 
72 191 
168 
92 
83 
97 
96 
2 
 
169 191 
168 
79 
81 
84 
90 
3 
 
170 191 
168 
65 
89 
83 
66 
4 
 
71 191 
168 
82 
80 
13 
60 
5 
 
109 191 
168 
82 
85 
90 
94 
6 
 
110 191 87 78 
7 
 
111 191 84 77 
8 
 
194 191 86 77 
9 
 
195 191 51 93 
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In conclusion, chiral diamines like 167, 168, 190, and 191 are capable catalysts for 
enantioselective acyl transfer.  In particular, meso-1,2-diols can be resolved with high 
selectivities and good yields.  Catalyst 168 was also successfully utilized in the KR of β-
hydroxy sulfides and a glycerol-derivative bearing a primary alcohol moiety. 
 
2.1.1.2.4 Enantioselective Acyl Transfer via N-Alkylimidazoles 
 
As outlined in the Introduction, enantioselective acylation reactions are widely used in 
nature.  Enzymes are capable of transferring acyl moieties in a highly efficient and 
chemoselective way.  Although enzymes are used as catalysts in enantioselective acylation 
reactions, scientists were interested in the design of small organocatalysts with comparable 
properties but advantages such as ease of handling, availability and other reasons. 
Miller and co-workers synthesized small peptide-based catalysts containing a 
nucleophilic moiety to transfer acyl groups onto substrates.34,35,78,79  The peptide backbone 
should provide a chiral environment for selective substrate recognition.  In this context they 
discovered a D-Pro-Aib-β-turn motif as an excellent scaffold for the synthesis of highly 
selective catalysts.  After optimization of the peptides for the KR of 196 the highest 
enantioselectivities for the resolution of racemic trans-1,2-acetamidocyclohexanol were 
obtained using peptide 198.  A drawback of this catalyst may be its rather high molecular 
weight of 946 g·mol–1 and the narrow scope for monoprotected 1,2-aminoalcohols.80 
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Qu et al. modified the backbone of Miller’s tetrapeptide by introducing a thioamide 
instead of the amide in the β-hairpin-structure81 and the resulting catalyst 200 was compared 
with 199 in the KR reaction of 196; 200 provides a higher S-value (Table 26).81  A possible 
explanation might be the formation of a more constrained β-hairpin structure.  Qu succeeded 
in the synthesis of a smaller, highly efficient catalyst for the KR of 196, but the substrate 
scope is still limited to trans-1,2-acetamidocycloalkanols. 
 
Table 26: KR of trans-1,2-acetamidocycloalkanols with catalyst 199 and 200. 
 
 
Entry Substrate  Catalyst Conv. (%) S-value 
1 
 
2 
 
196 199 
 
200 
 
49 
 
50 
28 
 
109 
3 
 
4 
 
201 199 
 
200 
51 
 
48 
17 
 
75 
5 
 
6 
 
202 199 
 
200 
56 
 
44 
6 
 
9 
 
A big advantage of peptide catalysts is that they can be easily modified and the 
synthesis of a great number via SPPS (Solid Phase Peptide Synthesis) is possible in a rather 
short period of time.   A broad range of natural and non-natural amino acids are available 
and therefore a large number of combinations can be envisaged.   Peptide libraries can be 
prepared and their members tested for various substrates by using, e.g., fluorescence-based 
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assays for high-throughput identification of active catalysts.82,83   Miller and co-workers 
identified peptide 6 as an efficient catalyst for the KR of secondary alcohols by using such a 
screening method.82,84 
 
 
 
 
 
Equation 10 shows the high selectivity of 203 in the KR of (±)-30.  In contrast, 203 
was less efficient when substrates without an aryl moiety were used.  This study shows again 
the high chemoselectivity of peptide catalysts.   While the KR of secondary alcohols 
especially of rac-30 is widely known and can also accomplished with enzymes, examples for 
KRs of tertiary alcohols are rare.   Even enzyme-catalyzed reactions are not known.   Miller 
et al. achieved the KR of 209–212 with moderate to good selectivities.  Comparison of the S-
values generated with catalyst 207and 208 shows the large effect of small modifications on 
peptide catalyst systems (Equation 11, Table 27).  Simply replacing the π-methyl histidine 
residue of peptide 207 by a methylated β-methyl-π-methyl histidine moiety increased the 
selectivity.  A reason for this observation may be the restricted rotational freedom around the 
Cβ-Cγ bond of the β-branched π-methyl histidine moiety.  1H-NMR measurements exhibited 
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OH
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OH OH
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evidence for the restriction of the rotation for the Boc-protected β-methyl-π-methyl histidine, 
but did not show evidence for restriction of the rotation for the unprotected β-methyl-π-methyl 
histidine.  Hence, Miller proposed that either a remote steric effect or a hydrogen bonding 
interaction associated to the Boc-group is responsible for the dihedral angle restriction.79,85    
 
 
Table 27: Comparison of catalyst 207 and 208 in the KR of tertiary alcohols. 
Entry   Substrate  Catalyst Conv. (%) S-value 
1 
2 
R1 = Me 
R2 = Cy 
 
209 207 
208 
33 
53 
9 
>50 
3 
4 
R1 = Me 
R2 = p-NO2-Ph 
 
210 207 
208 
39 
60 
10 
24 
5 
6 
R1 = Me 
R2 = 
 
211 207 
208 
32 
65 
3 
18 
7 
8 
R1 = CO2Me 
R2 = Ph 
212 207 
208 
21 
43 
1.6 
2.8 
 
N
O
NH
O
N
H O
HN
Boc NH
ON
N
O
MeO
Ph
N
O
NH
O
N
H O
HN
Boc NH
ON
N
O
MeO
Ph
207 208
CH2Cl2/PhCH3
50 eq Ac2O
20 eq Et3N
10 mol% 207/208 +
(±)-209–212
(11)
R2 NHAc
R1 OH
R2 NHAc
R1 OAc
R2 NHAc
R1 OH
Ph
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The desymmetrization of meso compounds has become a powerful tool in asymmetric 
synthesis.  In contrast to KRs, desymmetrization reactions can achieve 100% theoretical 
yield.  Peptide 213, a modification of 207, enables the desymmetrization of meso glycerol 
derivative 214, which presents a formidable challenge.86  These examples show the manifold 
applications of small peptide catalysts, because primary, secondary, and tertiary OH-groups 
can be acylated. 
 
 
In 2006 Miller and co-workers found a catalyst that was effective in the 
enantioselective acylation of substrate 218.  This substrate was challenging because of the 
large distance between the two OH-groups (almost 10 Å) and also between the OH-group 
and the prostereogenic center (ca. 6 Å).  Enzymes seem to be the best choice to solve such 
a difficult problem, because their macromolecular structure generates a chiral environment, 
which provides the potential for enantioselective recognition even if the prostereogenic 
center and the enantiotopic phenol oxygens of the substrate are far away from each other.  
In this rare case a chemical method (catalyst 217) shows better results than enzymatic 
approaches.79,87,88  
 
N
O
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O
N
H O
HN
Boc NH
ON
N
O
MeO
Ph
213
OBn
O
OtBu
Y
X
Y
O
OHHO 1.8 eq Ac2O
2 eq DiPEA
10 mol% 213
PhCH3/CH2Cl2 (12:1)
–55 °C
Y
X
Y
O
OAcHO
+
Y
X
Y
O
OAcAcO
meso-214 (R)-215 216
X = H; Y = H
X = H; Y = OMe
Yield = 37; ee. = 91%
Yield = 34; ee. = 95%
215/216 ratio = 39:61
215/216 ratio = 37/63
(12)
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Site-selective functionalization of substrates containing more than one functional 
group is synthetically useful but difficult.  Hence, enzymatic approaches for chemo- and site-
selective transformations are known, but limited to a narrow substrate scope.  Miller et al. 
tested catalyst 220 and N-methylimidazole [NMI, (201)] in the site-selective acylation of the 
glucosamine derivative 222.  While achiral NMI produced a mixture of 223–225, catalyst 220 
achieved site selective acylation and 223 was obtained in 97% yield as the major 
product.79,89 
 
 
Glucoside 227 was then chosen as a more challenging substrate containing four 
unprotected OH-groups.  NMI 221 as catalyst achieved poor selectivities (three of the four 
possible products formed) and low conversion (14%).  Peptide 226 (a modification of 220) 
showed higher activity and provided mono acetate 229 in 58% yield; however, the 
chemoselectivity was moderate.79,89 
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Miller and co-workers achieved the selective acylation of a less reactive OH-group in 
the presence of more reactive OH-groups in erythromycin A (233) utilizing pentapeptide 
232.79,90  The most reactive hydroxyl-group (C2’) can be selectively acylated by simply using 
NMI (221) as catalyst and 1 eq of anhydride (product 234).  The next reactive position in the 
molecule is the C4’’ hydroxyl-group.  In the presence of 2 eq of anhydride the C2’ and C4’’ 
positions were acylated and addition of MeOH selectively cleaved the acetate in the C2’ 
position.  Under these conditions 235 is the major product.  A triacetate (C2’, C4’’ and C11 
acylated) forms after prolonged reaction time and even after 3 days less than 30% of 233 is 
converted to 235 and 237 (ratio = 4:1).  Tertiary hydroxyl groups do not react under these 
conditions. 
In contrast, peptide 232 is more reactive and a reversal of the inherent selectivity was 
observed; a ratio of 1:5 of 235 and 237 was estimated by NMR integration.  These three 
examples illustrate on the one hand the potential of small peptides as highly efficient and 
readily modified catalyst for site-selective natural product synthesis, but on the other hand 
the complexity and catalyst structure sensitivity for selectively transferring a moiety onto a 
certain functional group.  In order to identify a suitable peptide for the chemoselective 
transformation (see Equation 14), a peptide library containing 150 peptides was tested, and 
for transformation shown in Equation 15, a library including 36 peptides was tested.    
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Scheme 13 
 
Schreiner and co-workers introduced another approach for the design of peptide 
catalysts in 2008.28,35  They did not try to form a stable β-hairpin structure by using L-
proline/D-proline to generate secondary structure.  This approach introduced a rigid and 
lipophilic non-natural γ-adamantane amino acid as the structure forming building block in 
peptide catalyst 238.  The KRs of various trans-cycloalkane-1,2-diols were realized with S-
values >50 (Table 28).  In this rare case, the efficiency of a small organic catalyst is superior 
to enzymatic approaches.  Various Pseudomonas lipases were tested and displayed low 
activities and poor selectivities in the KR of trans-cyclohexan-1,2-diol (121).91  
Enantioselective monobenzoylation of the same substrate was accomplished by Cu(II)-
bisoxazoline-complexes,92-94 the obtained selectivities ranged from 14 to 22. Computations 
by Sunoj and co-workers95 confirmed the hypothesis of Schreiner et al. that it is not a 
secondary structure formed by the peptide, but hydrogen bond between a carboxyl group of 
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the peptide backbone and one hydrogen atom of the diol that is responsible for the observed 
selectivity.  Subsequently, catalyst 238 was utilized in the first enantioselective Steglich 
esterification protocol.68  Here, Schreiner and co-workers used carboxylic acids as 
electrophiles, which react in situ with a substituted carbodiimide to form the corresponding 
anhydride.  This method is superior when the chosen anhydride is not stable or not 
commercially available; the enantioselectivities were high. 
 
Table 28. KR of trans-1,2-cycloalkanediols with peptide catalyst 238. 
 
Entry n  ee  (%)  
alcohol 
ee  (%) 
ester 
Yield (%) 
alcohol 
S-value 
1 1 122 >85 49 37 >8 
2 2 121 >99 78 37 >50 
3 3 239 >99 79 41 >50 
4 4 240 >99 85 44 >50 
 
The desymmetrization of cis-cycloalkane-1,2-diols (meso-diols) was also successfully 
accomplished by peptide 238 (Table 29).96  A general drawback of this reaction is the 
configurationally lability of the monoacylated products via 1,2-acyl migration.  Racemization 
occurs during the work up and lowers the enantiomeric excesses of the isolated products.  
For this reasons Schreiner et al. devised a protocol for the in situ organocatalytic oxidation of 
the unacetylated hydroxy function to produce the corresponding α-acetoxy ketones as 
valuable chiral building blocks. 
 
(S,S) (R,R)
+
238 (1–2 mol%), 5.3 eq  Ac2O
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H O
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Table 29. Desymmetrization and direct oxidation of meso diols 241–244 under optimized 
conditions. 
 
Entry Product  Yield α-
acetoxy 
ketones (%) 
ee  α-
acetoxy 
alcohol (%) 
ee  α-
acetoxy 
ketones (%) 
1 
 
241 69 80 64 
2 
 
242 70 88 88 
3 
  
243 97 84 94 
4 
 
244 42 84 81 
 
Some enzymatic approaches for the desymmetrization of meso cyclohexane-1,2-diol 
(72) are known from the literature.  Pseudomonas lipase catalyzed this reaction with 
isopropenyl acetate as the electrophile.  An ee of 81% was observed and 81% of the product 
could be isolated.91 Porcine pancreas lipase catalyzed the desymmetrization of 72 with 
methyl acetate with an ee of 84%.97  In both cases catalyst 238 can compete with the 
enzymatic approaches.  Organocatalytic methods using chiral 4-pyrrolidinopyridine (PPY) 
analogues (65% ee, 61% conv., isobutyric anhydride), N,N-dimethylaminopyridine (DMAP)-
based atropisomeric biaryl derivatives (77% ee , 20% yield, isobutyric anhydride) or chiral 
phosphine (67% ee , 66% conv., acetic anhydride) led to lower enantioselectivities.  
Ishihara at al. (2004)98,99 as well as Qu and co-workers (2008)100 followed a non-
peptidic biomimetic acylation approach by introducing catalysts 245 and 246.   Both catalysts 
proved to be highly efficient in the KR of racemic monofunctionalized 1,2-diol and amino 
alcohols.  The only drawback of these reactions is that best selectivities were obtained in 
CCl4, which is highly toxic.  A variety of substrates is presented in Table 30.35  
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Table 30. Comparison of catalyst 245 with 246 in the KR of various racemic secondary 
alcohols.  
  
Entry Substrate  Cat. Conv. 
(%) 
ee  (%) 
alcohol 
ee  (%) 
ester 
S-value 
1 
 
247 245 
246 
52 
52 
97 
97 
90 
90 
87 
80 
2 
 
248 245 
246 
47 
44 
82 
68 
93 
86 
68 
28 
3 
 
249 245 49 80 82 25 
4 
 
250 245 39 51 80 15 
5 
 
251 245 50 88 86 39 
6 
 
252 246 53 88 76 23 
7 
 
253 246 52 98 88 91 
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One advantage of peptides or small molecules as catalysts is the possibility to modify 
them easily,  especially because peptides can be readily synthesized via automated SPPS. 
In all cases the catalysts are highly chemoselective and may therefore serve as catalysts for 
selective acylation of polyols.  Unfortunately, rational catalyst design of oligopeptides, which 
are capable of specific functionalizations, is difficult as the structures are far too complex to 
predict their selective recognition abilities of substrates.  Peptide libraries and fluorescence-
based assays can help identify active peptides for the acylation of substrates, but the 
preparation and testing of such libraries is time-consuming and a better conceptual 
understanding of these oligopeptides is highly desirable. 
 
2.1.1.2.5 N-Heterocyclic Carbenes as Catalysts for Enantioselective Acyl Transfer 
 
Wanzlick isolated the first NHC-dimer in 1960101,102 and eight years later the first 
metal-carbene-complex was synthesized by Öfele.103  In 1988 G. Bertrand reported the first 
stable phosphinocarbene.104  Three years later Arduengo introduced crystalline 1,3-
diadamantyl substituted imidazole-2-ylidene.105  The discovery of this first stable NHC (N-
heterocyclic carbene) caused a lot of excitement, because carbenes were no longer 
considered to be short-lived but could be employed as structural motifs with unique 
properties.  Now NHCs are widely used as ligands in organometallic complexes106 or as 
organocatalysts.107  In addition to the utility as catalysts for Umpolung reactions,108 NHC’s are 
also capable of transferring acyl groups.  Bakhtiar and Smith reported the first achiral acyl 
transfer reactions in 1994 (see Chapter 1.1.1.1 N-Heterocyclic Carbenes as Catalysts for 
Acyl Transfer onto Alcohols).109  Ten years later, Suzuki and co-workers published the first 
enantioselective KR mediated by NHCs.110  Carbenes 254–263 achieved only moderate 
selectivities (S ≤ 5) in the KR of sec. alcohols.111  Suzuki et al. proposed the following 
mechanism. 
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Scheme 14 
 
Selective acyl transfer mediated by NHCs seems to proceed via the same 
nucleophilic catalysis mechanism proposed for DMAP, DMAP-derivatives, N-alkyl imidazole-
derivatives, amidines, amines, phosphines, and phosphinites (vide supra).  Instead of a 
nucleophilic nitrogen or phosphorus atom, the in situ generated highly nucleophilic carbene 
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carbon atom attacks the acyl donor and transfers the acyl moiety onto the alcohol.  In 
addition to the properties of the nucleophile, the selectivity can also be affected by the 
chemical properties of the acyl source.  In 2005 Maruoka et al. increased the 
enantioselectivity of the acylation process by using vinyl diphenyl acetate as acylating 
agent.112  Under optimized conditions a variety of secondary alcohols were acylated (Table 
31). 
 
Table 31: Performance of 258 and 264 in the KR of sec. alcohols. 
 
Entry Substrate  Catalyst ee  (%) 
ester 
Yield (%) 
ester 
S-value 
1 
 
30 (R,R)-258 
(R,R)-264 
96 
93 
32 
33 
80 
46 
2 
 
146 (R,R)-258 92 33 38 
3 
 
32 (R,R)-258 
(R,R)-264 
91 
90 
39 
35 
42 
33 
4 
 
205 (R,R)-258 94 30 48 
5 
 
98 (R,R)-258 
(R,R)-264 
95 
93 
27 
35 
56 
46 
6 
 
35 (R,R)-258 94 29 47 
R1 R2
OH
R1 R2
O
R1 R2
OH
O
+
0.75 eq Ph2CHCO2CHCH2
5 mol% (R,R)-258/(R,R)-264
THF, –78 °C
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Ph
N N
CH3 CH3
N N
CH3 CH3
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(S) (R)
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OH
OH
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OH
MeO
OH
OH
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Entry Substrate  Catalyst ee  (%) 
ester 
Yield (%) 
ester 
S-value 
7 
 
85 (R,R)-264 84 27 16 
8 
 
102 (R,R)-264 87 33 22 
 
Allylic alcohols as well as aryl alkyl carbinols can be selectively acylated by catalysts 
258 and 264.  The selectivity is not affected by electron donating or electron-withdrawing 
groups on the aromatic ring.  In contrast to the KR of allylic sec. alcohols catalyzed by DMAP 
or N-alkylimidazole derivatives, no base is needed because vinyl acetates were used as acyl 
source instead of anhydrides or acyl chlorides.  The S-values were comparable to the S-
values achieved by Fu’s catalyst 28 (see Chapter 1.1.1.1.1) but the conversions 20% higher 
on average. 
In 2011 Studer and his group published the first KR of sec. alcohols by NHC-
catalyzed oxidative esterification using aldehydes as the acyl source.113  They applied an 
external organic oxidant for their resolution process.  Catalyst 265 achieved moderate 
selectivities in the KR of sec. allylic alcohols.  Various aromatic para-substituted electron-
poor aldehydes were tested.  Selectivities up to 60 for para-bromobenzaldehyde at 65% 
conversion were obtained.  The carbene was generated in situ from 265 using DBU as base. 
 
 
 
Studer and co-workers proposed following mechanism: In the first step the aldehyde 
reacts with the NHC and is oxidized by an external oxidation agent (266) to form a chiral acyl 
azolium ion.  The alcohol then attacks the acylazolium ion to form adduct A.  At the end of 
the process adduct A fragments into NHC and the product ester.  
OH
OH
HO 5 mol% 2651.1 eq DBU
1 eq 266
1 eq RCHO
THF, 2-12 h
R O
O
3 eq 35
O
t-But-Bu
O
t-But-Bu
266
N
NN
Ph
TBDPSO
BF4
265ee = 60%conv. = 65%
R = p-Br-C6H4
267
(16)
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Scheme 15 
An advantage compared to other KRs is the possibility to use simple aldehydes as 
acyl source instead of anhydrides, acid chlorides or vinyl acetates.  Drawbacks of this 
approach at present are the low ee’s and the necessity of having to use 1 eq of an external 
oxidizing agent.  Yashima and co-workers solved these problems by applying an NHC/flavin 
system (Table 32).114  The enantiomeric excesses were still moderate, but only 10 mol% of 
the oxidant is needed, because it can be regenerated by areobic oxidation. 
 
Table 32. Efficiency of a NHC/flavin system in the KR of sec. aryl alcohols. 
 
Entry Alcohol  R1 R3 Conv 
(%) 
ee  (%) 
alcohol 
S-value 
1 
 
30 Ph Ph 65 43 2.3 
2 
 
35 1-naphthyl Ph 55 44 3.2 
3 
 
98 2-naphthyl Ph 72 66 3.1 
4 
 
30 Ph 1-naphthyl 50 32 2.6 
5 
 
30 Ph 2-naphthyl 47 39 3.7 
6 
 
121  Ph 62 75 5.6 
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2.1.1.2.6 Enantioselective Ring Opening of Meso-Anhydrides Utilizing Cinchona 
Alkaloid-Derivatives  
 
The selective ring opening of meso anhydrides115 mediated by cinchona alkaloids was 
first reported by Oda in the 1980’s.116  Shortly thereafter, Aitken et al. reported the conversion 
of a meso-anhydride into a lactone mediated by quinine (57%, 76% ee).117,118   In 1999 Bolm 
and co-workers presented a method for the enantioselective ring opening of bi- and tricyclic 
meso anhydrides by commercially available quinidine (184) and quinine (185) (Scheme 
16).34,115,119  The desymmetrizations of various cyclic anhydrides utilizing catalysts 184 and 
185 proceeded with excellent enantiomeric excesses and high yields (Table 33).  
 
Scheme 16 
 
Table 33. Desymmetrization of meso anhydrides utilizing commercially available cinchona 
alkaloid 184 and 185.    
 
Enty Substrate  Catalyst Yield (%) of 
major 
enantiomer 
ee (%) of hemi 
ester (major 
enantiomer) 
1 
 
270 185 92 99 
2  184 98 99 
N
MeO
N
OH
185 (quinine)
N
MeO
NHO
H
184 (quinidine)
O
O
O
COOMe
COOH
COOH
COOMe
COOH
COOMe
COOMe
COOH
+
+
1.1 eq quinidine184
3.0 eq MeOH
toluene/CCl4 (1:1),
–55 °C, 60 h
1.1 eq quinine 185
3.0 eq MeOH
toluene/CCl4 (1:1),
–55 °C, 60 h
major enantiomer minor enantiomer
meso-270
271 ent-271
271ent-271
O
O
O
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Enty Substrate  Catalyst Yield (%) of 
major 
enantiomer 
ee (%) of hemi 
ester (major 
enantiomer) 
3 
 
272 185 94 93 
4  184 96 96 
5 
 
273 185 71 75 
6  184 61 93 
7 
 
274 185 96 92 
8  184 95 95 
9 
 
275 185 95 85 
10  184 96 85 
11 
 
276 185 99 93 
12  184 97 95 
13 
 
277 185 91 87 
14  184 98 93 
 
A drawback of this approach is the high “catalyst” loading of 110 mol%, and Bolm et 
al. investigated the ring opening by catalytic amounts of 184 and 185.34,120 They first tested 
the reaction under optimized conditions with just 10 mol% of quinidine (184) without 
additional base and the reaction stopped at 50% conversion (35% ee). Bolm and co-workers 
proposed following scenario: After the opening of the anhydride by 184 the resulting acid 
transfers its proton onto the alkaloid, afterwards the protonated alkaloid and the carboxylate 
of the hemi-ester form an acid-base complex.121 In addition, the protonated catalyst 184 
adopts the open(3)-conformation, which is catalytically active, but less selective.117,118,122  
They tested various auxiliary bases in order to avoid the protonation of 184 and identified 
pempidine (278, Table 34) as the base, which in combination with 184 showed the highest 
ee.  The selectivities and yields were still high (Table 34). A drawback of the method utilizing 
10 mol% of 184 is the long reaction time (6 d compared to 60 h) and that pempidine is more 
O
O
O
O
O
O
O
O
O
O
PhPh
O
O
O
O
O
O
O
O
O
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expensive than 184.  Though 184 and pempidine can be recovered, the latter method is not 
practical. 
 
Table 34. Efficiency of catalytic amounts of quinidine in the desymmetrization of meso 
anhydrides. 
 
Entry  Substrate  Yield (%) of 
hemi ester 
ee (%) of hemi 
ester 
1 
 
270 98 90 
2 
 
272 94 91 
3 
 
276 96 89 
 
Bolm’s group also reported a solvent-free approach under ball milling conditions.123  
Structure 184 (1.1 eq), the solid meso-anhydride (1.0 eq), and p-methyl benzyl alcohol (1.0 
eq) were added to a micro mill and were milled for 24 to 36 h (Equation 17).  The achieved 
selectivities were comparable to the selectivities observed in solution under otherwise similar 
conditions. 
 
 
O
O
O
COOH
COOMe
COOMe
COOH
+
0.1 eq quinidine 184
3.0 eq MeOH
1.0 eq pempidine
toluene/CCl4 (1:1),
–55 °C, 6 d
major enantiomer minor enantiomer
meso-270
271 ent-271
N
pempidine 278
O
O
O
O
O
O
O
O
O
1.1 eq quinidine 184
1.0 eq p-methyl benzyl 
           alcohol
ball milling, 24–36 h
Yield = 91%
ee = 61%meso-270 279
O
O
O
O
O
O
OH
(17)
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The enantiopure hemiesters, generated using 184 or 185, can be converted to 
enantiomerically enriched β-amino acids by Curtius degradation followed by hydrogenation 
(Scheme 17).34,124    
 
 
 
Scheme 17 
 
The enantioselective ring opening of meso anhydrides introduced by Bolm and his 
group enabled an improved synthesis of both enantiomers of trans-cyclohex-4-ene-1,2-
dicarboxylic acid accomplished by Bernardi and co-workers,125 and the synthesis of 
enantiopure alicyclic β-amino acids reported by Hamersăk.126  Furthermore, the 
enantioselective ring opening of cyclic meso anhydrides displays the key step in the 
enantioselective synthesis of the cyclopentyl core of axinellamines reported by Carreira et 
al..127  Hamersăk and his group applied the desymmetrization of meso anhydrides mediated 
by quinine in the synthesis of pregabalin.128  (S)-3-Aminomethyl-5-methylhexanoic acid 
(pregabalin) was designed as a potential drug for the treatment of epilepsy and neuropatic 
pain.129  Bolm’s method provided 72% ee with cinnamyl alcohol as nucleophile.  Further 
enantiomeric enrichment was achieved by classic salt formation with chiral amines.128  With 
the (S)-phenylethyl amine salt an ee of 97% was achieved.128  Enantioselective ring opening 
of meso anhydrides presents a powerful tool for the synthesis of enantiopure hemiesters and 
has been presented as a practical method in Organic Synthesis.130,34    
 
meso-272 (S)-280
O
O
O
O
O
OBn
1.1 eq quinidine 184
3.0 eq BnOH
toluene/CCl4 (1:1),
–55 °C, 60 h
OH
Yield = 95%
ee = 96%
NHCbz
O
OBn
Yield = 72%
ee = 93%
1) ClCOOEt, Et3N,
    THF, –20 °C
2) NaN3, –10 °C to r.t.
3) benzene, 80 °C
4) BnOH, Et3N, CH2Cl2,
    40 °C
(S)-281
Pd/C
1 atm. H2
NH2
O
OH
Yield = 97%
(S)-282
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Scheme 18 
In 2000 Deng and co-workers applied the commercially available “Sharpless-ligands” 
(DHQD)2AQN (289) and (DHQ)2AQN (290) in the desymmetrization of cyclic meso 
anhydrides.131  The selectivities obtained with 289 and 290 were excellent.34,131,132  The 
substrate scope ranges from monocyclic to tricyclic meso anhydrides.  A big advantage of 
cinchona alkaloid catalysts is the possibility to generate both enantiomers in good yields by 
choosing the quinidine or quinine-derived catalyst.  The catalysts can be quantitatively 
recovered, which makes this approach synthetically useful (Table 35).  Catalyst 290 is not 
shown but the selectivities are as good as those obtained with 289 (the product (R)-hemi 
ester is the major enantiomer). 
 
Table 35. Efficiency of catalyst 289 and 290 in the desymmetrization of cyclic meso-
anhydrides. 
 
 
Entry Substrate  Cat. (mol%) T (°C) Yield (%) ee (%) 
1 
 
291 8 (8) –30 99 (90) 95 (93) 
H2N
CN
O
O O
O
O
i)   H2O/CH2Cl2
     piperidine
ii)  HCl
iii) Ac2O
Yield = 65%
i) 185, cinnamyl alc.
   toluene, –30 °C, 24 h,
   72% ee
ii)(S)-phenylethyl amine
Yield = 72%
ee = 97%
O
COOH
O
O
HN
O
O
O
OH
O
NH2
283 284 285
286
287288
i) (PhO)2PON3,
   Et3N
ii)cinnamyl alc.
Pd(OAc)2, PPh3,
morpholine, EtOH
Yield = 62%
ee = 99.7%
pregabalin
OO
NN
OMeMeO
N
Et
OO
N
Et
(DHQD)2AQN 289
O
O
O
R
R
H
H
Cat. 289 (290)
10 eq MeOH
Et2O
R
R
O
OH
O
OMe
H
H
+
R
R
O
OMe
O
OH
H
H
meso (S) (R)
O
H
H
O
O
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Entry Substrate  Cat. (mol%) T (°C) Yield (%) ee (%) 
2 
 
292 5 (5) –20 97 (95) 97 (93) 
3 
 
293 15 (15) –20 88 (85) 96 (94) 
4 
 
270 10 (20) – 30 (–20) 82 (82) 95 (90) 
5 
 
294 5 (5) –20 93 (88) 98 (98) 
6 
 
295 30 (30) –40 (–35) 70 (56) 91 (82) 
The results in parenthesis are obtained with (DHQ)2AQN as catalyst.  The hemiesters were 
synthesized with the opposite absolute configuration. 
 
Deng performed the parallel KR of racemic 2-aryl and 2-alkyl succinic anhydrides 
utilizing catalyst 289 (Table 36).132,133  The best results were obtained with trifluoroethanol as 
the nucleophile.  The yields and selectivities obtained by catalyst 289 were excellent.  
Parallel KRs of 2-aryl-, as well as 2-alkyl-succinic anhydrides proceeded under mild 
conditions and the catalyst could be quantitatively recovered. 
Table 36. Parallel KR of 2-aryl- and 2-alkyl-succinic anhydrides mediated by catalyst 289.  
 
Entry R  Yield of (R)-
hemiester 
(%) 
Yield of (S)-
hemiester 
(%) 
ee of (R)-
hemiester 
(%) 
ee of (S)-
hemiester 
(%) 
1 Me 296 41 36 80 93 
O
H
H
O
O
O
O
O
O
O
O
O
O
O
O
O OO
O
O
O
R 15 mol% 28910 eq CF3CH2OH
Et2O, –24 °C
R
O
OH
O
OCH2CF3
+
R
O
OCH2CF3
O
OH
(±) (R) (S)
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Entry R  Yield of (R)-
hemiester 
(%) 
Yield of (S)-
hemiester 
(%) 
ee of (R)-
hemiester 
(%) 
ee of (S)-
hemiester 
(%) 
2 Et 297 50 38 70 91 
3 n-Octyl 298 41 38 66 98 
4 Allyl 299 49 40 82 96 
5a Ph 300 32 44 87 95 
6a m-MeO-
C6H4 
301 30 45 83 96 
7a p-Cl-C6H4 302 29 44 76 96 
a Yields obtained after the conversion of (R)-hemiester and (S)-hemiester into the β-aryl-γ-lactones.  
 
After Deng and co-workers successfully applied modified cinchona alkaloids in the 
desymmetrization of cyclic meso-anhydrides, and the KR of 2-aryl- and 2-alkyl succinic 
anhydrides, they were interested in the KR of urethane-protected α-amino acid-N-
carboxyanhydrides,134 which can be easily synthesized from racemic amino acids.  The 
reaction generates a carbamate-protected amino ester and the unreacted urethane-protected 
α-amino acid-N-carboxyanhydride enantiomer.  The latter can be hydrolyzed to the 
enantiomerically enriched protected amino acid.  The products and the catalyst can be 
separated through extraction.  This approach allows the preparation of enantiomerically 
enriched protected α-amino acids and the protected α-amino acid esters in high yields and 
excellent selectivities (Table 37).34,132,134 
 
Table 37. KR of urethane-protected α-amino acids-N-carboxyanhydrides utilizing catalyst 
289.    
 
PGN O
R
O
O
PGN O
R
O
O
+ R OMe
NHPG
O
H2O R OH
NHPG
O
(±) (S)-urethane-
protected !-
amino acid-N-
carboxyanhydride
(R)-urethane 
protected !-amino 
acid methyl ester
(S)-urethane 
protected !-amino 
acid
10 mol% 289
0.55 eq MeOH
Et2O, 4Å MS,
–60 °C, 17 h
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 Entry R PG  t (h) T (°C) Conv. 
(%) 
ee  %/ 
(% Yield) 
of amino 
acid ester 
ee  %/ 
(% Yield) 
of amino 
acid 
S-
value 
1 PhCH2 Cbz 303 17 –60 51 93 (48) 98 (48) 114 
2 4-F-
C6H4CH2 
Cbz 304 31 –78 50 92 (48) 93 (42) 79 
3 BnOCH2 Cbz 305 72 –78 52 89 (49) 96 (44) 69 
4 (CH3)2CH Cbz 306 22 0 59 67 (58) 96 (40) 19 
5 Ph Cbz 307 16 –78 46 97 (45) 84 (46) 170 
6 PhCH2 Fmoc 308 46 –78 51 92 (50) 96 (47) 93 
7 PhCH2 Boc 309 15 –40 59 67 (56) 98 (41) 19 
8 PhCH2 Alloc 310 15 –60 50 91 (45) 91 (45) 67 
 
As DKR can theoretically produce 100% of product, Deng and his group were 
interested in converting the KR of urethane protected α-amino acid-N-carboxyanhydrides into 
a dynamic KR (Table 38).  The racemization process needs to be faster than the selective 
transformation of the starting material.  Due to this requirement, Deng and co-workers 
increased the reaction temperature and utilized allyl alcohol in the alcoholysis.  The achieved 
selectivities and yields were high (yield up to 95% and S up to 92).34,132,135 
 
Table 38. Efficiency of 289 in a dynamic KR of urethane protected α-amino acids-N-
carboxyanhydride using allyl alcohol as nucleophile.  
    
 
 
 
PGN O
R
O
O
R O
NHPG
O
(±) (R)-urethane protected !-
amino acid ester
20 mol% 289 
1.2 eq allyl alcohol
Et2O, 4Å MS,
0.1 eq Pd(PPh3)4
10 eq morpholine
THF, 23 °C, 10 min
R OH
NHPG
O
(R)-urethane 
protected !-amino 
acid
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Entry R PG  t (h) T (°C)  Yield 
(%) of 
ester 
ee (%) 
of 
ester 
 Yield 
(%) of 
acid 
ee (%) 
of acid 
1 
 
Cbz 307 1 23 97 91 91 90 
2 
 
Cbz 311 1 23 96 90 93 90 
3 
 
Cbz 312 1 23 95 90 88 90 
4 
 
Cbz 313 2 –30 93 92 93 92 
5 
 
Cbz 314 0.5 23 98 91 86 89 
6 
 
Cbz 315 1.5 0 95 90 95 89 
7 
 
Fmoc 316 1 23 98 90 92 90 
 
The same strategy afforded the DKR of 5-aryl-1,3-dioxolane-2,4-diones to prepare 
optically pure α-hydroxy carboxylic acid derivatives in the range of 61–85% yield (Table 
39).136  The enantioselectivities obtained with catalyst 289 were good to excellent for 
substrates containing aromatic moieties substituted in para- or para and meta-position.  In 
contrast, enantioselectivities decreased for substrates bearing an ortho-substituted phenyl 
group.  
 
Table 39. Dynamic KR of 5-aryl-1,3-dioxolane-2,4-diones mediated by catalyst 289. 
 
 
 
F
F3C
S
O
N
Ts
O O
R'
O
O
R OR
OH
O
(±)
10 mol% 289 
1.5 eq ROH
Et2O
(R)
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Entry R’  R-OH t (h) T (°C) Yield (%) 
of ester 
ee (%) of 
ester 
1 
 
317 EtOH 24 –78 71 95 
2 
 
318 EtOH 24 –78 70 96 
3 
 
319 EtOH 24 –78 80 96 
4 
 
320 EtOH 24 –78 65 95 
5 
 
321 EtOH 24 –78 85 93 
6 
 
322 EtOH 8 –20 68 91 
7 
 
323 EtOH 24 –78 65 94 
8 
 
324 nPrOH 14 –40 74 91 
9 
 
325 EtOH 10 –60 66 62 
10 
 
326 EtOH 4 –20 61 60 
 
 
In order to demonstrate the practical utility of their approach, the synthesis of (+)-
biotin (333) was chosen as a test sequence.  Deng followed the approach of Sternbach and 
Goldberg and increased the selectivity by utilizing catalyst 327 for the enantioselective ring 
opening of 330.  High ee’s and excellent yields were obtained.137 
 
Cl
Br
F
F3C
F
F
Cl
Me
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Scheme 19.  
In 2008 Connon and co-workers introduced bifunctional cinchona alkaloid/thiourea-
derived catalyst 334138 and utilized it in the desymmetrization of meso or prochiral mono, bi 
and tricyclic anhydrides at room temperature at low catalyst loadings (1 mol%).138  They 
proposed that the thiourea moiety activates the anhydride by hydrogen-bonding while the 
cinchona moiety promotes general base catalysis.  The yields for various substrates range 
from 93% to 98% and the obtained selectivities were high (Table 40). 
 
Table 40. Desymmetrization of cyclic meso anhydrides utilizing bifunctional catalyst 334. 
 
N
OMe
OR
N
R =
DHQD-PHN 327
COOH
HOOC
3 steps
BnN NBn
COOHHOOC
O
Ac2O, reflux BnN NBn
O
O OO
BnN NBn
O
HOOC COOMe
(5S)(4R)
20 mol% 
DHQD-PHN 327,
MeOH, Et2O,
–40 °C
Yield = 100%
ee = 93%
BnN NBn
O
O O
Yield = 82%
ee = 91%
HN NH
O
S
COOH
4
4 steps
(+)-biotin 333
328 329 330
331332
N
OMe
NH
N
NHS
CF3F3C
334
O
O
O
R
R
1 mol%  334
10 eq MeOH
t-BuOMe, r.t.
R
R
O
OMe
O
OH
H
H
meso (R)
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Entry Substrate  t (h) Yield (%)  of 
hemi ester 
ee (%) of 
hemi ester 
1 
 
270 100 93 96 
2 
 
277 30 98 93 
3 
 
273 130 90 85 
4 
 
335 14 98 92 
5 
 
295 18 98 83 
 
The reaction mechanism of selective ring opening of cyclic anhydrides mediated by 
cinchona alkaloids was widely discussed in the literature.139  Nucleophilic catalysis or general 
base catalysis are theoretically possible, but most of the evidence supports the latter 
mechanism. 
Cinchona alkaloid-derived catalysts are capable of enantioselective ring opening of 
various cyclic anhydrides, 5-aryl-1,3-dioxolane-2,4-diones,136 urethane-protected α-amino 
acid-N-carboxyanhydrides,134 2-aryl- and 2-alkyl-succinic anhydrides.133  The selectivities and 
yields were consistently good to excellent.  Deng’s DKR is a powerful tool to generate 
enantioselectively enriched protected α-amino acid esters and protected α-amino acids from 
racemic α-amino acids.  An advantage of the methods introduced by Bolm, Deng, and 
Connon is the ability to recover the catalysts quantitatively.  All catalysts are commercially 
available or can be easily prepared from available starting materials.  In contrast to catalysts 
184 and 289, catalyst 334 gave excellent selectivities in the desymmetrization of cyclic meso 
anhydrides at room temperature and did not require cooling such as needed for 184 (–55 °C) 
and 289 (–40 °C to –20 °C). 
 
O
O
O
O
O
O
O
O
O
O
O
O
O
O OO
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2.1.2 Metal-Complex Mediated Enantioselective Synthesis of Esters 
 
The second part of the article will introduce on the one hand metal complexes, which 
are capable acyl transfer catalysts and on the other hand complexes that serve as 
racemization catalysts in order to accomplish DKRs.  
 
2.1.2.1   Cu(II)-Complex Mediated Acylation Reactions 
 
RajanBabu et al. introduced an yttrium-salen complex as a catalyst capable of 
selective acyl transfer onto secondary alcohols.140  The obtained S-values were poor and 
ranged from 1.5 to 4.8.  In 2003 Matsumura and co-workers reported the first synthetically 
useful KR of vicinal diols mediated by a Cu(II)-ion associated with a chiral (R,R)-Ph-box 
ligand 336.94  They proposed a coordination of the 1,2-diol with a metal-ion (Mn+) to form a 
reactive intermediate A.  In the next step A is transformed to a metal alkoxide B by a weak 
base and reacts with an acyl halide to form product C (Scheme 20).  In contrast to Fu’s 
planar chiral DMAP-ferrocene derived catalyst 28, in which the iron ion only acts as a 
structure-forming element, the copper ion of Matsumura’s catalyst is involved in the acyl 
transfer.   
 
  
Scheme 20 
 
 
 
R R
O O
Mn+
HH
R R
HO OH
R R
O O
Mn+
H
R R
HO OCOR2
A
B
C
Mn+
H+R2COX
Mn+ + X- +
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2.1.2.1.1 Kinetic Resolution Utilizing Cu-Complexes 
 
The first applications of catalyst 336·CuCl2 were in the KR of hydrobenzoin 
derivatives and racemic cyclic 1,2-diols (Table 41).94  The Cu-complex gave extraordinary 
high enantioselectivities for the hydrobenzoins (S-value > 645).  The selectivities for the 
cycloalkane 1,2-diols are good, but much lower compared to organocatalytic approaches 
(e.g., Schreiner’s catalyst 238 with S >50 for the enantioselective acylation). 
 
Table 41. KR of hydrobenzoins and cyclic 1,2-diols mediated by catalyst 336·CuCl2. 
 
Entry Substrate  Yield (%) of 
ester 
ee (%) of 
ester 
S-value 
1 
 
119 48 >99 >645 
2 
 
120 48 >99 >645 
3 
 
337 47 97 183 
4 
 
338 49 98 356 
5 
 
121 37 80 14 
      
R1 OH
OHR1
R1 OH
OBzR1
R1 OH
OHR1
+
5 mol% 336 . CuCl2
0.5 eq PhCOCl
1.0 eq DiPEA
CH2Cl2, 0 °C
(±) (S,S) (R,R)
N
O
N
O
CH3H3C
Ph PhCu
Cl Cl
(R,R)-Ph-box-CuCl2 
336 . CuCl2
Ph Ph
HO OH
HO OH
Cl Cl
HO OH
Me Me
HO OH
OMeMeO
OH
OH
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Entry Substrate  Yield (%) of 
ester 
ee (%) of 
ester 
S-value 
6 
 
239 49 84 28 
7 
 
339 44 77 14 
 
In 2005 Reiser et al. reported the KRs of racemic 1,2-diols, hydrobenzoin, and α-
hydroxycarbonyl compounds mediated by Cu(II)-aza-(bisoxazolines)-complexes (Table 42).93  
The yields and selectivities obtained for the substrates strongly depended on the type of 
ligand used in the reaction.  The yields and selectivities achieved by Reiser’s approach for 
hydrobenzoins and trans-cycloheptane-1,2-diol are comparable to those obtained by 
Matsumura.93  In contrast, the selectivities for the benzoylation of trans-cyclohexane-1,2-diol 
are higher. 
Table 42. Efficiency of  Cu(II)-aza-(bisoxazoline)-complexes in the KR of racemic cyclic 1,2-
diols and hydrobenzoin. 
 
Entry Ligand  Substrate  Yield (%) 
of ester 
ee (%) 
of ester 
Config. S-
value 
1a 
 
339 
 
121 46 83 S,S 22 
2b 
 
340 
 
239 46 82 R,R 21 
3a, c 
 
341 
 
119 49 99 R,R 751 
a Reaction time = 2 h; b reaction time = 3 h; c Catalyst loading: 0.5 mol% CuCl2/ligand 
OH
OH
Et Et
HO OH
R1 OH
OHR1
R1 OH
OBzR1
R1 OH
OHR1
+
5 mol% CuCl2/ligand
0.5 eq PhCOCl
CH2Cl2, 0 °C
(±)
N
O
H
N
N
O
Ph Ph
OH
OH
N
O
H
N
N
O
iPr iPr
OH
OH
N
O N
N
O
Bn Bn
Me
Ph Ph
HO OH
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Whereas the selectivities for substrates bearing two vicinal hydroxy groups obtained 
by Cu(II)-complexes (ligands: 339, 340, and 341) were good to excellent, for α-
hydroxycarbonyl compounds the achieved selectivities were only moderate (Equation 18). 
 
 
 
In 2006 Pfaltz and co-workers applied a Cu(II)-ion coordinated to a boron-bridged 
bisoxazoline (borabox) ligand as catalyst in the KR of  racemic hydrobenzoin (Equation 19), 
cyclohexane-1,2-diol (Equation 20), 1,2-phenylethanediol (Equation 21), and pyridyl alcohols 
(Table 43).92 
 
  
 
 
N
O
H
N
N
O
iPr iPr
Ph R
O
OH
Ph R
O
OBz
Ph R
O
OH
(R)-344/345 (S)-342/343
5 mol% CuCl2/ligand 340,
0.5 eq PhCOCl
CH2Cl2, 2–4 h, 0 °C
(±)
R = Ph; 342
R = OEt; 343
344) Yield = 43%; ee = 79%; S = 16
345) Yield = 45%; ee = 75%; S = 13
340
(18)
Ph Ph
HO OH
1 mol% CuCl2
1 mol% 346a
0.51 eq PhOCCl
1.0 eq iPrNEt2
CH2Cl2, 0 °C, 2 h Ph Ph
HO OH
Ph Ph
BzO OH
+
(±)-119 (R,R)-119 (S,S)-347Conv. = 51%
ee = 98% ee = 96%
S = 225
N
O B
N
O
RR
Bn BnH
R = 3,5-bis(trifluoromethyl)
      phenyl
346a
(19)
OH
OH
1 mol% CuCl2
1 mol% 346a
0.51 eq PhOCCl
1.0 eq iPrNEt2
CH2Cl2, 0 °C, 2 h
Conv. = 44%
OH
OH
OBz
OH
+
(±)-121 (R,R)-121 (S,S)-348
ee = 64% ee = 83%
S = 21
(20)
OH
Ph
HO
1 mol% CuCl2
1 mol% 346b
0.51 eq PhOCCl
1.0 eq iPrNEt2
CH2Cl2, 0 °C, 2 h
OH
Ph
HO OBz
Ph
HO OH
Ph
BzO
(±)-349 (S)-349 (R)-350 (R)-351
55%; 45% ee 37%; 48% ee 8%; 95% ee
N
O B
N
O
Bn BnH346b
(21)
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The selectivities for hydrobenzoin were excellent even at low catalyst loadings  
(1 mol%).  The results for the borabox ligand 346a and 346b are comparable to those 
obtained with box-ligands (336, 339, 340, and 341).  Pyridyl alcohols containing a phenyl 
moiety at the pyridine ring can be resolved with high selectivities by catalyst 346a.  
 
Table 43. Efficiency of catalyst 346a in the KR of pyridyl alcohols. 
 
Entry R n  Conv. 
(%) 
ee (%) of 
alcohol 
ee (%) of 
ester 
S-value 
1 H 1 352 46 5 5 1 
2 Ph 1 353 45 76 91 51 
3 H 2 354 52 83 76 19 
4 Ph 2 355 42 70 97 125 
5 Cl 2 356 47 58 65 8 
 
 
2.1.2.1.2 Desymmetrization of Meso-1,2-diols Mediated by a Cu(II)-complex 
 
Desymmetrization of meso-1,2-diols utilizing a copper(II)-ion coordinated by (R,R)-
Ph-box ligand 336·Cu(OTf)2 was achieved with moderate to good selectivities (Table 44).141  
A drawback of this method is the high catalyst loading of 10 mol%.  Organocatalytic 
approaches (e.g., Kündig’s diamine based catalyst 19176 or Oriyama’s catalyst 16872 
mediated the desymmetrization of similar substrates with higher ee’s (e.g., substrate 110; 
Yield = 87%, ee = 78% with cat. 191). 
 
 
 
1 mol% CuCl2
1 mol% 346a
0.51 eq PhOCCl
1.0 eq iPrNEt2
CH2Cl2, 0 °C, 2 hNR OH
n
NR
OH
n
NR
OBz
n
+
(±) (S) (R)
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Table 44. Desymmetrization of meso-1,2-diols utilizing catalyst 336·Cu(OTf)2. 
 
Entry Substrate  Yield (%) ee (%) 
1 
 
110 47 3 
2 
 
357 88 58 
3 
 
194 85 65 
4 
 
169 68 93 
5 
 
170 92 80 
6 
 
358 63 8 
7 
 
111 81 racemic 
8 
 
109 78 97 
9 
 
195 36 96 
 
Pfaltz applied the Cu(II)-borabox-derived catalyst 346a to the desymmetrization of 
meso-1,2-diols and obtained increased selectivities compared to the Cu(II)-(R,R)-Ph-box 
catalyst 336·Cu(OTf)2 (Table 45).142  The reaction proceeds at low catalyst loadings of 1 
mol% and with enantioselectivities up to 94%.  The ligands can be synthesized from readily 
R1 OH
OHR1
R1 OH
OBzR1
10 mol% (R,R)-Ph-box 336
10 mol% Cu(OTf)2
1.0 eq PhCOCl
1.5 eq K2CO3
CH2Cl2, r.t., 3 h
meso (1S, 2R)
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
S
HO
HO
O
HO
HO
OH
OH
OH
OH
BnO
BnO
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accessible oxazolines.  The borabox ligand structure can be assembled and varied by the 
reaction of metalated oxazoline with a diaryl or dialkylhaloborane.  
 
Table 45. Efficiency of catalyst 346a in the desymmetrization of cyclic meso diols. 
 
Entry Substrate  Yield (%) ee (%) 
1 
 
110 73 76 
2 
 
72 83 90 
3 
 
109 65 94 
 
 
2.1.2.2. Combination of Metal-Complexes and Enzymes in the Dynamic Kinetic 
Resolutions of Racemic Alcohols 
 
As mentioned in the Introduction the disadvantage of a KR is the limitation to 50% 
yield for the acylated substrate.  Desymmetrizations can produce a theoretical yield of 100%, 
but they require meso or prochiral compounds as starting materials.  To overcome the 
drawback of KR, fast racemization of one of the enantiomeric substrates is needed.  In DKR 
the starting material racemizes, while one enantiomer gets selectively acylated.  In a 
dynamic KR 100% theoretical yield is feasible (Scheme 21).  
 
1 mol% CuCl2
1 mol% 346a
1.0 eq PhOCCl
1.0 eq iPrNEt2
CH2Cl2, 0 °C to r.t.
R1 OH
OHR1
R1 OBz
OHR1
meso (1R, 2S)
OH
OH
OH
OH
OH
OH
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Scheme 21 
 
Examples for DKR utilizing just one catalyst (e.g., a chiral organic molecule, enzymes 
or metal complexes) are rare. More common is a combination of two catalysts.15  Possible 
racemization techniques were categorized by Zwanenburg et al.:143 base-catalyzed 
racemization, Schiff base-mediated racemization, acid-catalyzed racemization, enzyme-
mediated racemization as well as redox and radical induced racemization processes. 
Additionally, transition metals are also capable catalysts for the racemization of alcohols.  In 
combination with enzymes usually metal complexes or base are applied to the racemization 
of the substrate and enzymes provide the enantioselective transfer of the acyl moiety. In the 
case of the base-catalyzed racemization the substrate scope is mainly limited to molecules 
bearing an acidic proton at the stereogenic center.15 
 
2.1.2.2.1   Dynamic Kinetic Resolution of Alcohols Utilizing Ruthenium-Complexes for 
Racemization and Enzymes for Selective Acyl Transfer  
 
Iridium, rhodium, and ruthenium complexes are known to provide rapid racemization 
of secondary alcohols via hydrogen transfer, but just a few complexes are compatible with an 
enzymatic reaction.15,144,145 It has been proposed that metal hydrides are the reactive 
intermediates in the hydrogen transfer reaction between metal catalyst and alcohol (Scheme 
22). 
 
Scheme 22 
In 1996 Williams and co-workers were the first to use a combination of a rhodium-
catalyst and a lipase for the DKR of secondary alcohols.146  The obtained selectivities were, 
R1 R2
OH lipase, ROAc
fast R1 R2
OAc
R1 R2
OH lipase, ROAc
slow R1 R2
OAc
[M]
Acylation
Racemization
100% yield
O
R1 R2
H
H
M
R1 R2
O
+ M HH
O
R1 H
R2
H
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however, moderate.  In 1997 Bäckvall et al. reported a DKR of secondary alcohols mediated 
by a ruthenium catalyst and an immobilized lipase at 70 °C;11 in 2005 an improved method 
for the dynamic KR of sec. alcohols at room temperature and at short reaction times was 
published.147  The observed selectivities and yields were excellent and a wide range of 
secondary alcohols can be deracemized using this approach (Table 46).  They proposed the 
following ruthenium complex 359 catalyzed racemization mechanism (Scheme 23). 
 
 
Scheme 23 
 
 
 
 
 
Ru
PhPh
Ph
Ph
Ph
ClOC CO
359
Ru
PhPh
Ph
Ph
Ph
OtBuOC CO
360
t-BuOK   KCl
(S)-30
t-BuOH
Ph
OH
Ph
OH
Ru
PhPh
Ph
Ph
Ph
OOC CO Ph
Ru
Ph
Ph
Ph
Ph Ph
OOC
OC
Ph
H
Ru
PhPh
Ph
Ph
Ph
OOC CO Ph
(S)-30
rac-30
(i)
(ii)
(iii)
(iv)
(v)
A
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Table 46. Efficiency of catalyst 359 and CALB (Candida Antarctica lipase B) in the DKR of 
various secondary alcohols. 
 
Entry Substrate  t (h) Yield (%) ee (%) 
1 
 
30 3 95 >99 
2 
 
361 20 99 >99 
3 
 
146 17 92 >99 
4 
 
34 13 83 >99 
5 
 
362 6 85 97 
6 
 
363 6 98 >99 
7 
 
85 18 89 >99 
8 
 
364 72 92 98 
9 
 
86 17 98 >99 
10 
 
365 5 >99 99 
      
R1 R2
OH
R1 R2
OAc
5 mol% 359, CALB
1.5 eq
5–10 mol% t-BuOK
1 eq Na2CO3
OAc
toluene, r.t.
(±) (R)
OH
OH
O2N
OH
OH
Cl
OH
CN
S
OH
OH
OH
OH
N
OH
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Entry Substrate  t (h) Yield (%) ee (%) 
  11 
 
366 5 97 97 
 
Upscaling issues were addressed for the DKR of racemic 1-phenylethanol 30.148  At 1 
mol scale, applying 0.05 mol% of ruthenium catalyst 359 and small amounts of enzyme after 
20 h at 40 °C, 159 g (97% yield) of (R)-1-phenylethanol acetate (99% ee) were isolated.148  
The high efficiency was proved by carrying the reaction out at a 10 mol scale.  The catalysts 
loadings of the ruthenium-complex 359 (0.01 mol%) and the biocatalyst were lowered and 
the reaction was performed in a more highly concentrated reaction mixture.  After 21 days 
1.43 kg (87% yield) of the product were isolated in excellent enantiomeric purity (97% ee). 
Bäckvall et al. applied his approach to the DKR of various substrates like α- and β-
hydroxyphosphonates (Equations 22, 23)149 as well as β-azido alcohols (Equation 24).15,144  
The yields and selectivities for the α-hydroxyphosphonate and β-azido alcohol were high and 
the reactions were carried out under mild reaction conditions.  β-Azido alcohols can serve as 
precursors for the synthesis of enantiopure β-amino alcohols.  In the case of β-
hydroxyphosphonates keto-byproduct 372 formed.  Addition of 2,4-dimethyl-3-pentanol 
decreased the amount of 372, but did not increase the amount of product.  
  
 
 
 
Ph
N
Ph OH
Ru
Ph
Ph Ph
Ph
OC CO
Ru Ph
Ph
Ph
PhH
O OH
COCO
367
OH
P
O
OMe
OMe
(±)-368
OAc
P
O
OMe
OMe
4 mol% 367, CALB
3 eq p-Cl-C6H4OAc
toluene, 80 °C, 
24 h
(R)-369
Yield = 83%
ee > 99%
Dynamic kinetic resolution of racemic !-hydroxyphosphonates
P
OH O
OEt
OEt
4 mol% 367 CALB
3 eq p-Cl-C6H4OAc
0.5 eq 2,4-dimethyl-
3-pentanol
toluene, 70 °C, 
48 h
P
OAc O
OEt
OEt
P
O O
OEt
OEt
+
(±)-370 (R)-371 372
Yield = 69%
ee > 99%
Yield = 1%
Dynamic kinetic resolution of "-hydroxyphosphonates
(22)
(23)
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In order to broaden the substrate scope, Bäckvall and co-workers optimized the 
conditions to afford an efficient DKR of α-hydroxy acid esters.15,150  The best results were 
obtained utilizing catalyst 367 and Pseudomonas cepacia lipase applying 4-chlorophenyl 
acetate as acyl donor and cyclohexane as solvent.150  The selectivities were good and the 
yields were high for substrates bearing an aryl moiety or a secondary carbon atom in β-
position (Table 47).  In contrast, the selectivities for substrates with a primary carbon atom in 
β-position and without aromatic substituent were poor (ee = 30; entry 6). 
 
Table 47. Dynamic KR of α-hydroxy acid esters mediated by catalyst 367and PS-C. 
 
Entry Substrate  t (h) Yield (%) ee (%) 
1 
 
376 48 80 94 
2 
 
377 72 74 96 
3 
 
378 48 76 94 
4 
 
379 72 69 98 
5 
 
380 48 80 98 
Ph N3
OH 4 mol% 367, N-4353 eq p-Cl-C6H4OAc
toluene, 80 °C, 
24 h
Ph N3
OAc
Ph N3
O
+
(±)-373 (R)-374 375
Yield = 94%
ee > 99%
Yield = 6%
Dynamic kinetic resolution of !-azido alcohols
(24)
R1 CO2R2
OH
R1 CO2R2
OAc2 mol% 367, PS-C2 eq p-Cl-C6H4OAc
cyclohexane, 60 °C
(±) (S)
CO2Me
OH
CO2Et
OH
CO2Me
OH
MeO
CO2Me
OH
Br
CO2Me
OH
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Entry Substrate  t (h) Yield (%) ee (%) 
6 
 
381 48 62 30 
7 
 
382 24 60 80 
 
Subsequently, β-,151 γ-,152 and δ-hydroxy acid esters153 were deracemized.  The 
obtained selectivities were very good and the yields high.  For γ- and δ-hydroxy acid esters 
H2 as additional hydrogen source improved the yield (Equations 25, 26, and 27).15 
 
 
 
 
 
 
 
CO2Me
OH
Ph
CO2Me
OH
Ph CO2Et
OH
Ph CO2Et
OAc2 mol% 367, PS-C,p-Cl-C6H4OAc
cyclohexane, 60 °C
(±)-383 (R)-384
Yield = 70%
ee = 93%
Dynamic kinetic resolution of !-hydroxy acid esters
(25)
OtBu
O
OH
OtBu
O
OAc
OtBu
O
O
+
toluene, 60 °C,
24 h
6 mol% 367, PS-C,
1 bar H2,
3.9 eq p-Cl-C6H4OAc
Yield = 70%
ee = 94%
Yield = 3%
(±)-385 (R)-386 387
Dynamic kinetic resolution of !"hydroxy acid esters
(26)
Dynamic kinetic resolution of !-hydroxy acid esters
OtBu
O
toluene, 70 °C,
96 h
6 mol% 367, PS-C,
1 bar H2,
3 eq p-Cl-C6H4OAc
Yield = 89%
ee = 98%
(±)-388 (R)-389
OH
3
OtBu
OOAc
3 (27)
Acylation-type Reactions: Synthesis of Esters via Acyl Transfer 	  
	   	   97 
Bäckvall and co-workers used their approach for dynamic KRs of 1,3-, 1,4- and 1,5-
diols.15,154  In the case of 1,3-diols an intramolecular acyl transfer produced the undesired 
meso diacetate in 62% yield (Table 48; entry 3); 1,4- and especially 1,5-diols were obtained 
in good yields and high selectivities.  This approach offers advantages compared to KR, 
because the resolved diols are usually available as a mixture of the racemic and the meso 
forms of the substrates.  Hence, the theoretical yield of a KR would be 25% even under 
optimized reaction conditions.  
 
Table 48. Selective acylation of various diols coupled with a ruthenium-complex 367 
introduced isomerization. 
 
Entry   Substrate  Product  t (h) Yield 
(%) 
ee (%) 
(R,R/meso) 
1 
 
390 
 
397 48 63 >99 (86/14) 
2 
  
390 
 
398 1 47 >99 (96/4) 
3 
  
391 
 
399 24 90 >99 (38/62) 
4 
  
392 
 
400 24 63 97 (90/10) 
5 
  
393 
 
401 24 43 >99 (74/26) 
6 
  
394 
 
402 24 76 >99 (98/2) 
7 
  
395 
 
403 24 77 >99 (98/2) 
8 
  
396 
 
404 24 78 >99 (100/0) 
Reaction conditions: 4 mol% 367, 3 eq p-chlorophenyl acetate, CALB, toluene. 
 
R
OH
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OCOR
R
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OH
OCOR
OCOR
OH OH OAc OAc
OH OH OAc OAc
OH
OH
OAc
OAc
OH OH OAc OAc
OHHO OAcAcO
N
OH OH
N
OAc OAc
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1,4-Diols can be converted into γ-hydroxy ketones with good selectivities and in high 
yields also utilizing catalyst 367 and CALB under modified reaction conditions (Table 49).155  
In contrast to the reaction conditions (acyl donor = p-chlorophenyl acetate) used to generate 
acylated 1,4-diols, Bäckvall and co-workers utilized isopropenyl acetate as acyl donor in 
order to obtain γ-hydroxy ketones as products.  In the first step the enzyme acylates the less 
hindered alcohol function of the diol and acetone forms from isopropenol (keto-enol 
tautomerism), which is the leaving group of the acylation agent (isopropenyl acetate).  
Bäckvall proposed that the oxidation of the sterically more hindered OH group of the diol 
mainly occurs because acetone is reduced more rapidly by the ruthenium complex 367 than 
the hindered OH-function of the 1,4-diol and therefore the γ-hydroxy ketone accumulates in 
the system. 
 
Table 49. Dynamic kinetic asymmetric transformation of 1,4-diols into γ-hydroxy ketones 
utilizing a ruthenium complex 367 and lipase. 
  
Entry R  Acyl donor 
(eq) 
t (h) Yield (%) ee (%) 
1 Ph 405 10 20 75 84 
2 i-Pr 406 20 18 77 89 
3 Cy 407 20 17 73 90 
4 2-naphthyl 408 10 18 82 79 
5 p-F-C6H4- 409 10 36 75 86 
 
Allenes present a synthetically very useful class of axially chiral compounds.156  Yet, 
short synthetic routes for the enantioselective synthesis of axial, helical, and planar chiral 
allenyl derivatives are rare.  Deska and Bäckvall introduced the first DKR of allenols 
mediated by a palladium complex in combination with the enzyme PPL (porcine pancreatic 
lipase).157  The yields are good and the obtained ee’s ranged from 66–89% (Table 50).  
Enantioenrichment of the allenols can be achieved by enzymatic hydrolysis (ee = 99%;   
Yield = 91% for 411). 
 
R
OH
OH
R
O
OAc
2.5–5 mol% 367, CALB,
isopropenyl acetate
toluene, 70 °C
meso/(±) (R)
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Table 50. Efficiency of catalyst 410 and lipase (PPL) in the DKR of allenols. 
 
Entry R  t (h) Yield (%) ee (%) 
1 Ph 411 23 81 86 
2 3-tolyl 412 27 70 89 
3 4-chlorophenyl 413 24 83 89 
4 2-naphthyl 414 21 80 87 
5 n-pentyl 415 20 87 66 
 
Park and co-workers used ruthenium catalyst 367 in combination with lipase to 
deracemize mono-protected 1,2-diols via DKR.158  A trityl-protected diol acetate was obtained 
in excellent yield and ee = 99% (Equation 28).; 2,4-dimethyl-3-pentanol was added as to 
avoid the formation of the ketone byproduct.   
 
 
 
 
 
 
R • OH R
•
O
O
2 mol% [{(IPr)PdBr2}2] 410
5 eq vinyl butyrate
PPL on Celite
toluene, 50 °C
(±)
N NR R
Pd BrBr
Br Pd Br
N N RR
[{(NHC)PdBr2}2] 410
N N
iPr
iPriPr
iPr
IPr
(R)
OH
OTr
OAc
OTr
15 mol% 367, PCL,
p-Cl-C6H4OAc
0.5 eq 2,6-dimethyl-4-heptanol
toluene, 70 °C
Yield = 96%
ee > 99%
(±)-416 (R)-417
(28)
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2.1.2.2.2   Dynamic Kinetic Resolution of Alcohols Utilizing an Aluminum-Complex for 
Racemization and Enzymes for Selective Acyl Transfer 
 
In 2006 Berkessel and co-workers reported a new system for DKR of secondary 
alcohols.159  Instead of an expensive ruthenium-complex for the racemization of the alcohol, 
Berkessel utilized an in situ generated aluminum complex.  The enantioselective acylation of 
secondary alcohols was mediated by Novozym 435 and good to excellent ee’s were obtained 
(Table 51).  The aluminum complex was generated in situ from readily available substrates 
[e.g., AlMe3 (418), binol (419)].  The best yields and selectivities were obtained for AlMe3 with 
binol as ligand.  The reported substrate scope is limited to secondary aryl-alkyl and alkyl 
alcohols. 
 
Table 51. Efficiency of an in situ generated AlMe3/binol-complex in combination with 
Novozym 435 in the dynamic KR of secondary alcohols.    
 
Entry Substrate  AlMe3 (eq) t (h) Yield (%) ee (%) 
1 
 
30 0.1 3 96 96 
2 
 
146 0.1 18 99 98 
3 
 
86 0.2 19 97 99 
4 
 
87 0.2 18 93 80 
5 
 
420 0.2 18 95 95 
 
R1 R2
OH
R1 R2
O
OAlMe3 (418)/binol (419)
Novozym 435
1.2 eq enol acetate
toluene, r.t.
OH
OH
binol (419)(±) (S)
OH
OH
OH
OH
5
OH
5
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DKRs utilizing a ruthenium-complex/aluminum-complex for the racemization of 
alcohols and a lipase for the selective acyl transfer offer the opportunity to generate 
enantiomerically enriched products in high yields (100% theoretically yield). A broad 
substrate scope can be deracemized by these approaches.  Tolerating various functional 
groups (e.g., azides, halides, acid esters, and nitriles) DKR can serve as the key step for 
synthesizing complex enantiopure substrates (e.g., amino alcohols).  The ruthenium 
complexes 359 and 367 as well as the lipases Novozym 435 and PS-D are commercially 
available.  Catalysts 418/419 can be generated in situ by mixing commercially available 
reagents (binol and AlMe3). 
 
Conclusions and Outlook 
 
In the last 20 years various catalyst families for selective acyl transfer have been 
developed.  Today, metal complexes as well as organic molecules still can compete with 
enzymatic approaches in some asymmetric acylation reactions (e.g., Fu’s KR step in the total 
synthesis of epothilone,39 Deng’s enantioselective ring opening of a meso-anhydride in the 
synthesis of biotin,137 and Schreiner’s KR of cyclic trans-1,2 diols28).  Especially KRs or 
desymmetrizations of secondary alcohols are excellent entry points for producing 
stereochemically pure building blocks and many catalyst systems capable of enantioselective 
acyl transfer in this substrate class have been developed in the last decade.  In stark 
contrast, examples of KRs of primary and tertiary alcohols are rare (see Miller’s peptide 
catalyst for the acylation of a tertiary alcohol85 and Oriyama’s KR of a glycerol derivative74) 
and the identification of new catalysts for these substrate classes would be desirable.  
Although the identification of new catalysts for enantioselective or site-selective 
transformations is generally challenging, it still is a highly desirable goal.  The examples 
presented in this chapter show the potential of asymmetric acyl transfer as a tool for the 
synthesis of enantiopure substrates.  All catalysts are highly chemoselective and therefore 
their substrate scope is limited, yet this limitation offers applications as catalysts for late-key-
steps in natural product synthesis.  Examples for the successful utilization of small organic 
catalysts for enantioselective acyl transfer in natural product synthesis were reported by Fu 
(epothilone, (–)-baclofen), 39 Birman (lobeline),65 Hamersăk (pregabalin),128  and Deng 
(biotin).137  Miller and co-workers impressively demonstrated the potential of peptide catalysts 
in the site selective functionalization of substrates containing different OH-groups as present 
in  glucosamines, glucosides,89 and erythromycin A.90  Furthermore, peptides represent, to 
the best of our knowledge, the only catalyst family that was successfully utilized in the 
selective acyl transfer onto primary, secondary, and tertiary alcohols.  These examples give 
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hope that further investigations may lead to highly chemoselective catalysts capable of 
selective acylation of a specific OH-group in a polyol like vancomycin.  Nature uses enzymes 
for such complex problems.  Hence, the design of a chemoselective catalyst is maybe the 
biggest challenge in asymmetric synthesis, as enzymes are known to be complex 
macromolecules displaying secondary, tertiary, and quaternary structure.  
The combination of two catalysts is also a powerful tool for asymmetric acyl transfer 
reactions.  Bäckvall et al. showed the practical use of his approach (DKR via combination of 
Ru-catalyst and enzyme) by performing large-scale experiments (up to 10 mol).  The 
obtained selectivity (ee = 97%) and yield (87% = 1.43 kg) for (R)-1-phenylethanol acetate 
were still good on large scale.148 
To date catalysts are mostly identified through trial and error approaches or by using 
time consuming screening methods, but the investigation of processes for chemical 
recognition of the substrate by the catalyst have become more important.  In the cases of 
Birman’s amide-based catalysts 127/128 and Schreiner’s peptide catalyst 23895 
computations were able to shed some light onto the selective acyl transfer process.  While 
for 127/12862 π-π interactions seem to be responsible for the chemical recognition and the 
selective acylation, in peptide 238 hydrogen bonding as well as attractive dispersive 
interactions between the peptide backbone and the substrate seems responsible of the 
differentiation between the two enantiomers.  Other groups (e.g., Yamada et al., Fuji et al. 
and Connon et al.) investigated the conformational change of their free catalysts and the 
acylium ion adduct.  All three proposed an “induced fit” process for which NMR-experiments 
provided some evidence.45,50,51 
Though the first steps to a better understanding of the acyl transfer as well as the 
substrate recognition mechanism of the catalyst have been made, we are still far from 
rational catalyst design.  Much more work on the insights of these complex processes will be 
needed to achieve this goal.  Improved computational and analytical methods may prove 
critical in this endeavor. 
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ABSTRACT: In nature enantioselective acylations are performed by enzymes (acylases). 
Inspired by their extraordinary selectivity we envisioned the synthesis of a small peptidic 
catalyst for acylative kinetic resolution (KR)/desymmetrization of cyclic rac- and meso-
cycloalkane-1,2-diols. The entire optimization process from the theoretical concept to the 
final enantioselective catalyst is described and the scope of substrates and electrophiles is 
presented. Competition experiments with different alcohols and electrophiles were performed 
to show the full potential of the approach. Additionally we tried to shed some light on the 
forces responsible for the selectivity utilizing NMR- and IR-spectroscopic methods as well as 
computations. The catalyst system can be easily modified to a multicatalyst by simply adding 
other catalytically active amino acids to the peptide backbone and enables the synthesis of 
chiral and complex molecules from simple starting materials. 
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Introduction 
Enantioselective acylations of chiral or prochiral alcohols are common reactions in nature 
and in chemistry.  Enzymes can be used for the acylative resolution and desymmetrization of 
a broad range of secondary alcohols (e.g., cyclic meso-1,2- and 1,3-diols, 2,5-hexanediols, 
1,4-cyclooctanediols and acylation of natural products like vitamin C, alkaloids and 
hydrocortisone).1,2,3-5  Though enzymatic acylations are highly chemo- and enantioselective 
these approaches are often expensive, require stringent reaction conditions, long reaction 
times, and typically just one enantiomer of the product can be obtained. Also, there is a 
variety of substrates that cannot be effectively resolved by enzymes (e.g., trans-
cyclohexane-1,2-diol and primary alcohols).6 Hence, in the last 20 years various organic and 
organometallic catalysts (e.g., amidines,7 vicinal diamines,8,9 N-alkylimidazoles,10-14 
phosphines,15,16 phosphinites,17,18 Cu-complexes19-21 and 4-aminopyridine derivatives22,23)24,25 
were successfully applied in kinetic resolutions (KRs),26,27 desymmetrizations,28 and dynamic 
kinetic resolutions (DKR)29,30 of alcohols, amines, and thiols (Figure 1).   
 
 
Figure 1. Non-peptidic organocatalysts capable of selective acyl transfer. 
The application of short peptides as catalysts for enantioselective transformations has 
been neglected for a surprisingly long time, though many approaches were inspired by 
nature.31,32  Only at the end of the last century chemists realized the capacity of oligopeptides 
as active catalysts due to their high diversity and their well-established syntheses based on 
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the coupling of readily available enantiopure amino acids.31-33    Early prominent examples 
are the cyclic dipeptides (diketopiperazines) introduced by Inoue in 1981 for the 
enantioselective hydrocyanation of benzaldehydes34-38 and the homooligomers of Juliá and 
Colonna that proved to be highly efficient in epoxidation reactions.39-42     Remarkably, 
Wennemers et al. discovered that short proline containing oligopeptides display significantly 
higher reactivity at comparable enantioselectivities in aldol reactions compared to proline 
itself, which emphasizes the importance of the peptide backbone (Figure 2).43-45   
Acyl transfer as part of nature’s reaction portfolio is one of the most prominent examples 
for the use of short non-natural peptide catalysts for enantioselective transformations.24,25,31   
In 1998 Miller and coworkers introduced N-alkylimidazoles (π-methyl histidine derivatives 
performed best) containing peptides as acylation catalysts, which proved to be highly 
selective in various KRs and desymmetrizations.31,46-49  Especially the KR of racemic trans-2-
N-acetamidocyclohexanol using such peptides was intensively studied and led to the 
conclusion that a stable yet slightly flexible secondary structure based on intramolecular H-
bonding is responsible for the high enantioselectivities (Figure 2).31,46,49-51  Several attempts 
were made to improve the selectivities of these peptides by modifying the motifs that are 
responsible for the formation of a secondary structure (see the peptides of Toniolo52 and 
Qu53 in Figure 2).  Though non-peptidic catalysts were successfully utilized in natural product 
synthesis e.g., epothilone, (–)-baclofen (with Fu’s planar chiral ferrocenyl-DMAP 
derivative),54 lobeline (with Birman’s amidine based catalysts),55 and biotin (with Deng’s 
modified cinchona alkaloid catalyst),56 peptidic approaches may offer chemoselective 
acylations of complex polyols bearing compounds (e.g., vancomycin57 and erythromycin A58) 
and even carbohydrates.59  In 2008 our group introduced a highly efficient tetrapeptide 
catalyst for the KR of trans-cycloalkane-1,2-diols via acyl transfer (Figure 2).25,60  In contrast 
to the established peptide design concepts focusing on secondary structure formation our 
approach utilizes a highly lipophilic, structurally less flexible, non-natural adamantane γ-
amino acid (AGly in our shorthand notation) in the center of the peptide.  We envisioned that 
the more flexible amino acids at the N- and the C-terminus of the peptide would form a 
“dynamic pocket” like an active site in an enzyme and enable selective acyl transfer.  The 
incorporation of additional lipophilic amino acids would allow the use of nonpolar organic 
solvents. 
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Figure 2. Peptide based catalysts for enantioselective reactions. 
 
The KR of cyclic chiral trans-cycloalkane-1,2-diols via acyl transfer was chosen as the test 
reaction, because no synthetically useful approach for this class of substrates was reported. 
Additionally, natural products bearing vicinal diols are frequently found (e.g., in steroids, 
flavonoids, carbohydrates, and pharmaceuticals) and therefore a highly chemoselective 
peptide would be quite useful.61  Monoacetylation of trans-cycloalkane-1,2-diols utilizing 
enzymes (Pseudomonas lipases) displayed low activities as well as selectivities.6  In the 
case of metal catalytic approaches for the KR of trans-cycloalkane-1,2-diols only selective 
benzoyl transfer utilizing 0.5 eq of benzoyl chloride were reported by Onomura (2003),19 
Reiser (2005),20 and Pfaltz (2006).21,62  All three approaches utilize Cu(II)-complexes 
containing chiral C2-symmetric bisoxazolin ligands.  The catalyst loading ranged from 5 mol% 
(Onomura, Reiser) to 1 mol% (Pfaltz) and 1 eq of additional base was added by Pfaltz and 
Onomura.  The obtained S-values ranged from 14 to 2263 and the ee’s from 80% to 83% for 
the product.  Selective acyl transfer was not reported.  In contrast, our peptide based catalyst 
achieved a selectivity >50 and an ee of >99% for the remaining diol in the acylative KR.  
Additionally, our approach does not require the addition of a base, because the generated 
acetic acid (pKa = 4.74) is comparably weak and in equilibrium with the methylimidazolium 
ion (pKa = 7.3)64 always a small amount of unprotonated catalyst is available.  This is one of 
the rare cases where a chemical method is more efficient than an enzymatic approach.  
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Later the same peptide or similar peptidic catalysts were successfully applied to selective 
single- and multicatalytic transformations.25,65-70  
  The identification of such highly enantioselective catalysts is still a formidable challenge and 
mostly relies on trial and error or extensive screening experiments, because the chemical 
recognition processes of catalyst and substrate are usually hardly predictable.32  Here we 
report a full investigation of our oligopeptide catalyst platform including catalyst screenings, 
substrate scope, chemoselectivity, and present a structural mechanistic model for 
enantioselective acylations.  Additionally, the peptide catalyzed transfer of various other 
electrophiles to nucleophiles (e.g., alcohols) will be described.  
 
Results and Discussion 
Catalyst Screening Using the Acylative KR of trans-Cyclohexane-1,2-diol as Test 
Reaction  
A large variety of peptide catalysts was synthesized via automated solid phase peptide 
synthesis (SPPS) using an Fmoc-strategy; additionally, the chosen peptides were prepared 
in solution in larger quantities utilizing a Boc-strategy.  The crude peptides were initially 
characterized using ESI-MS; purified peptides were characterized by NMR, IR, ESI-MS, and 
ESI-HRMS (for detailed experimental procedures and analytical data see Experimental and 
Supplementary Information).   All peptide catalysts were tested in the KR of racemic trans-
cyclohexane-1,2-diol 1 (Scheme 1) with acetic anhydride, but without addition of base.  As 
mentioned in the introduction the KR through acetylation of rac-1 is a formidable challenge71 
and a difficult transformation due the lack of efficient enzymatic, metal-catalyzed, and 
organocatalytic approaches.6,72      
 
 
Scheme 1. KR of trans-cyclohexane-1,2-diol 1 as test reaction. 
 
We began our research for a new highly lipophilic peptide by using Boc-L-(π-Me)-histidine 
methylester 3 as a catalyst to determine whether the acyl transfer onto 1 under our chosen 
reaction conditions (in toluene; no auxiliary base) is generally possible.73  The ability to 
perform the KR in a non-polar solvent in the absence of base simplifies the purification of the 
product.  The ee’s and yields for our test reaction (Table 1) with 3 were low.  Additionally, we 
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tested 4 introduced by Snapper and Hoveyda in 2006 (4 showed excellent selectivities in the 
silylation of racemic and meso-1,2-diols) in the acylative KR of rac-1, but only low selectivity 
was observed.74  Our design concept focused on the AGly moiety as a sterically demanding 
and structure determining spacer that should lead to lipophilic peptides soluble in organic 
solvents.  At first we synthesized various tri-, tetra-, and pentapeptides and placed the rigid 
AGly in the center of the molecule.  We hoped separating the more flexible amino acids on 
the C- and N-terminus of the peptide would enable the formation of a chiral environment 
(e.g., “a pocket”).  All peptides included different catalytically active histidine moieties to 
identify the most active one: Boc-L-histidine for peptide 5; Boc-L-(τ-Bzl)-histidine for 7, 8, and 
9; and Boc-L-(π-Me)-histidine for 6, 10, 11, and 12 (Figure 3). 
 
Figure 3. Starting sequences for the search of a selective acyl transfer catalyst. 
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The results for 3–12a as applied to the KR of rac-1 are summarized in Table 1.  A 
comparison of the tripeptides 5–7 having the same peptidic backbone bearing a histidine-(5), 
π-methyl histidine (6) and a τ-benzyl-histidine moiety (7) shows that Boc-L-(π-Me)-histidine is 
the catalytically most active histidine derivative.  Tripeptidic and tetrapeptidic structures 
produced high yields but moderate selectivities; pentapeptides showed only low selectivities 
and activities and were not investigated further.  Peptide 12a was the most selective catalyst 
and used as model peptide for further modifications. 
 
Table 1. KR of trans-diol (±)-1 with peptide catalysts 3–12a. 
entrya cat. t (h) 
yield (%)c of 
(R, R)-2a 
erd of (R, R)-2a 
1b 3 15 2 46:54 
2e 4 4 11 44:56 
3 5 42 4 76:24 
4 6 18 48 69:31 
5 7 210 10 54:46 
6 8 210 10 58:42 
7b 9 210 5 53:47 
8b 10 15 1 75:25 
9 11 15 7 50:50 
10 12a 18 43 73:27 
aAll reactions were performed at 0 °C in a mixture of 2.25 mL toluene and 0.85 mL CHCl3 with 1 eq 
(43.6 mg, 0.375 mmol) of  racemic substrate 1, 0.5 eq of acetic anhydride, and 1 mol% of catalyst. 
bReaction was performed at –20 °C with 0.1 eq of acetic anhydride. Without catalyst no conversions 
could be observed. c,dYields and enantiomeric ratios were determined by chiral GC analysis using an 
internal calibration. eReaction was performed at 0 °C in 4.5 mL toluene with 1 eq of racemic substrate 
1 (0.025 mmol, 2.9 mg), 5.3 eq of acetic anhydride, and 2 mol% of catalyst in toluene. 
In contrast to enzymes, which often only exist in one enantiomeric form, we readily 
synthesized ent-12i (all amino acids D-configured) and, as expected, were able to acetylate 
S,S-1 with the same selectivity.   Switching the positions of L-Val and π-Me-His (13) or L-Val 
and AGly (17) lowered the selectivities for the KR of rac-1 than 12a.  Hence, it is important 
that AGly is in direct neighborhood to the catalytically active His-moiety. 
 
 
Lipophilic Oligopeptides for Chemo- and Enantioselective Acyl Transfer Reactions onto 
Alcohols 	  
	   	  115 
 
Figure 4. Variation of peptide catalysts; structural changes of the peptides compared to 12 
are drawn in red. 
Next we focused on changing the configuration of Val, Boc-(π-Me)-His (14 and 15) and of 
both amino acids (16).  The best er values were obtained for peptides containing 
homoconfigured Val and His amino acids (matched situation for 12a–l, ent-12, and 16).  The 
mismatched configuration of either Val or π-Me-His (14 and 15) decreases the selectivity for 
the KR of rac-1 dramatically (Figure 4). 
 
Table 2. Screening of the KR of (±)-1 with peptide catalysts 12a–l and 13–17. 
entrya cat. R 
yield (%)c of                      
(R, R)-2a 
erd of (R, R)-2a 
1 12ae Val 9.9 85:15 
2b 
12a-
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3f 
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entrya cat. R 
yield (%)c of                      
(R, R)-2a 
erd of (R, R)-2a 
5 14 – 9.8 60:40 
6 15 – 8.1 46:54 
7 16 – 10.5 21:79 
8 17 – 5.4 67:33 
9 12be AGly 8.6 67:33 
10 12ce Leu 10.8 86:14 
11 12de Ile 8.1 86:14 
12 12ee Pro 4.9 75:25 
13 12fe Ala 4.8 80:20 
14 12ge Phe 4.9 81:19 
15 12he AiB 4.1 71:29 
16 12ie Cha 8.3 88:12 
17 12je Ser 7.5 72:28 
18 12ke Gly 4.8 70:30 
19 12le Tyr 2.8 73:27 
aAll reactions were performed at –20 °C for 15 h in a mixture of toluene and CHCl3 with 1 eq of 
racemic substrate 1, 0.1 eq of acetic anhydride, and 1 mol% of catalyst (raw product, after resin 
cleavage and evaporating of the solvents; without further purification). Without catalyst no conversions 
were observed. b Reaction was performed for 24 h. c,d Yields and er values were determined by chiral 
GC analysis using an internal calibration. e Results taken from reference 60.60 f All reactions were 
performed at 0 °C in 4.5 mL toluene with 1 eq of racemic substrate 1 (0.025 mmol, 2.9 mg), 5.3 eq of 
acetic anhydride, and 2 mol% of catalyst. 
The catalytic efficiency of 12a and the results presented in Table 2 encouraged further 
variations.  Hence, L-Val was replaced by other L-configured amino acids at the i+2 position 
(Table 2, 12b–12l).  The use of Boc-L-(π-Me)-His-AGly-L-Cha-L-Phe-OMe (12i) as catalyst 
gave the highest ee in the KR of rac-1.  Indeed, 12i is the most efficient catalyst for the KR of 
trans-cycloalkane-1,2-diols to date.25,60  Though having identified a capable catalyst for the 
selective acylation of rac-1 the role of the C-terminal amino acid was investigated by using 
the Boc-L-(π-Me)-His-AGly-L-Leu-L-R motif (Figure 5) in order to obtain mechanistic insights 
of the substrate recognition process by the catalyst.  The results are summarized in Table 3. 
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Figure 5. Investigation of the role of the C-terminal amino acid. 
 
Table 3. Screening of the KR of (±)-1 with peptide catalysts 18–21 and 12c. 
entrya cat. yield (%)b of  (R, R)-2a erb of (R, R)-2a 
1 18 2.0 86:14 
2 19 1.6 84:16 
3 20 4.9 87:13 
4 21 5.1 89:11 
5 12c 12.7 86:14 
aAll reactions were performed at –20 °C for 15 h in a mixture of toluene and CHCl3 with 1 eq of 
racemic substrate 1, 0.1 eq of acetic anhydride, and 1 mol% of catalyst (raw product, after resin 
cleavage and evaporating of the solvents; without further purification) 18–21 and 12c.  Without 
catalyst no conversions were observed. bYields and enantiomer ratios were determined by chiral GC 
analysis using an internal calibration. 
 
Peptide catalyst 21 with C-terminal L-Cha proved to be the most selective but generally all 
tested peptides showed high selectivities.  This finding implies that the C-terminal amino acid 
in the tetrapeptide does not strongly affect the selectivity of the peptide.  
 
KR versus Desymmetrization 
The KR of rac-1 was achieved with catalyst 12i under optimized conditions (2 mol% 12i, 5.3 
eq Ac2O, 4.5 mL abs. toluene, 0 °C) with an ee of >99% for the starting material at a 
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conversion of 57%.  A general drawback of a KR is the limitation of the theoretical yield to 
50%, but in contrast to cyclic meso-cycloalkane-1,2-diols no racemization occurs, because 
the intramolecular acyl transfer yields in the same stereochemistry in the product.  
Additionally, the benzoylative desymmetrization of meso-22 has successfully been 
accomplished by chiral diamine76 and phosphinit-based18,77 catalysts.  Various (π-Me)-
histidine derived catalysts were utilized in the desymmetrization of meso-cyclohexane-1,2-
diol 22 (Scheme 2).  We also tested Snapper and Hoveyda’s catalyst 4 (highly effective in 
the desymmetrization of meso-1,2-diols via silyl-group transfer).74,78-80   
 
 
Scheme 2. Desymmetrization of cis-cyclohexane-1,2-diol 22 as test reaction. 
 
For the desymmetrizations of meso-22 with 12i high selectivity was observed.  To our 
surprise Hoveyda’s methylimidazole based catalyst 4 (Figure 3) proved to be catalytically 
inactive at low catalyst loadings (2 mol%) without addition of base (Table 4).74,78-80  Even at 
higher catalyst loadings and with added base only moderate selectivities at very low 
conversions could be achieved.  The desymmetrization with 12i is much faster and slightly 
more selective with base.  
 
Table 4. Desymmetrization of meso-22 with catalysts 12i and 4. 
entrya cat. t (h) C (%)c 
yield 
(%)c 
(R, S)-23 
er (%)d 
(R, S)-23 
1 12i 4 42 42 91:9 
2 12i 24 88 75 87:13 
3b 4 24 – – – 
aAll reactions were performed at 0 °C in 4.5 mL toluene with 1 eq of meso substrate 22 (0.025 
mmol, 2.9 mg), 5.3 eq of acetic anhydride, and 2 mol% of 12i.  Without catalyst there is no 
conversions. b Reaction performed at –20 °C with 20 mol% of 4 and 5.3 eq DiPEA. cConversions C 
and yields determined by GC-analysis. der values determined by chiral GC analysis.  
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Model for the Enantioselective Acylation with 12i 
The screening of the peptide catalysts identified some of the important structural 
requirements to produce high enantioselectivities in the acylative KR of rac-1 as reference 
substrate: 
• Tetrapeptides are most selective  
• The lipophilic and sterically demanding adamantyl amino acid needs to be located 
at the i+1 position  
• Homoconfigured (all three chiral α-amino acids have the same configuration) 
peptides show the highest selectivities 
• The i+3 position does not drastically affect the selectivity of the peptide  
 
For a better understanding of the chemical recognition process of the substrate by the 
catalyst responsible for the selectivity we attempted NMR polarization-transfer and IR studies 
with 12.  We measured NOE-spectra for the homoconfigured peptide 12a and the 
heteroconfigured peptide 14.  Unfortunately, the evaluation and comparison of the NOE-
spectra of 12a and 14 did not produce cross signals that could be assigned to a defined 
secondary structure for 12a.  Only NOE-signals for the vicinal amino acids were obtained.  
We also measured the chemical shift dependence of the NH groups in CDCl3 as a function of 
increasing the d6-DMSO concentration.81  In the absence of hydrogen bonds all NH groups 
should show significant downfield shifts.  In the case of 12i, for (Phe(NH), Val(NH), AGly(NH) 
and π-(Me)-His(NH)) we observed a downfield shift in the range of 0.4–1.4 ppm.  This 
indicates the absence of intramolecular hydrogen-bonds for 12i in CDCl3 at room 
temperature.   
Another useful method for the identification of intramolecular H-bonding is IR spectroscopy.  
Gellman has established IR spectroscopy as a tool for the determination of intramolecular 
amide-amide hydrogen bonds of peptides in CH2Cl2.82  Sharp bands in the N–H stretch 
region at 3460 – 3450 cm–1 were assigned to non-hydrogen bonded N–H, whereas broad 
bands at 3330 – 3300 cm–1 were assigned to internal hydrogen bonds. 
We performed IR experiments at various temperatures using a 13 mM solution of 12i in 
CDCl3.  In order to investigate H-bonding interactions we chose CDCl3 as solvent because of 
its moderate polarity and high solubility of 12i in this solvent.  In addition, the results of the IR 
experiments obtained in CDCl3 can be directly compared to those generated by NMR-
experiments.  At room temperature only one sharp band at 3460–3450 cm–1, assigned to 
non-hydrogen bonded NH groups, was observed.  While reducing the temperature in 10 K 
steps from 298 K to 233 K a new broad band at 3300 cm–1 appeared and the intensity 
increased as the temperature decreased (see SI).  This is an indication for an intramolecular 
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hydrogen bond at temperatures below 253 K).  Up to date we found no evidence for a 
secondary structure of 12a-l at r.t. or 0 °C through spectroscopic means (IR, NMR).   
We also investigated the possibility of a structure-forming element at the stage of the 
acylium ion.  NMR spectra of the acylium ion were measured at r.t. in CDCl3, but no unusual 
NOEs indicating a secondary structure were observed.  Hence, we utilized a molecular 
dynamics search for low-lying conformations of the catalyst/acylium ion adduct using the 
Merck Molecular Force Field (MMFF)83 and reoptimized the lowest-lying conformation at 
M06–2X/6–31+G(d,p).84,85  The conformational analysis of the acylium ion of 12i resulted in a 
folded structure as the energetically most favored conformation.  Irrespective of the starting 
geometry, the most favorable conformer always placed the cyclohexyl group in 12i in close 
proximity to the imidazole/acylium ion adduct (Figure 6, left).   We also applied a molecular 
dynamic search for catalyst/acylium ion adduct and (R,R)-1.  The acylated catalyst 12i 
generates a chiral environment around the substrate (Figure 6, middle and right). 
 
 
 
 
Figure 6. left; M06–2X/6–31+G(d,p) reoptimized structure of 12i;84,85 middle: M06–2X/6–
31+G(d,p) reoptimized structure for the enantioselective acylation of trans-cycloalkane-1,2-
diols in the “pocket” of the acylated catalyst. Hydrogen atoms on the catalyst are omitted for 
clarity. C gray, N blue, O red.86  right: Dispersion interactions of substrate and catalyst. 
The two geometrically nearest C=O groups apparently provide hydrogen bonding 
acceptors (Figure 6) needed for chiral recognition of the diols.  This arrangement helps 
rationalize why more hydrophobic R-groups provide higher ee values, as they enhance the 
London dispersion interactions with the substrate (Figure 6, right).87,88  The model also 
emphasizes that the AGly building block provides a scaffold that separates both ends of the 
peptide and also holds the centers governing recognition and stereochemistry in place.  It 
seems that rac-1, as well as the acylium ion adduct have to be present to structure the 
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“active site” of the peptide by dispersion (Figure 6, right) and hydrogen-bonding interactions 
in a rather dynamic binding event. 
 In 2009 Sunoj et al. independently performed ONIOM computations at the B3LYP/6-
31G(d):PM3 level that yielded transition structures for the 12i catalyzed acyl transfer onto 
(R,R)- and (S,S)-trans-cyclohexane-1,2-diol (Figure 7).89  These computations nicely 
confirmed our model and the energy difference of 4.5 kcal⋅mol–1 between the two transition 
states explained the observed high enantioselectivities.   
 
 
   
 
Figure 7. Optimized low-lying transition structures for the acyl transfer catalyzed by 12i (Moc 
instead of Boc) to (1R,2R)-1 (left) or to (1S,2S)-1 at ONIOM2(B3LYP/6-31G(d):PM3). Only 
selected hydrogens are shown for clarity. Parts in blue represent the higher (B3LYP) level 
and the non-framed part the lower (PM3) level in the ONIOM2 partitioning.86 
 
Substrate Scope for Peptide 12i Catalyzed Acylations  
We first utilized peptide 12i in the KR of cyclic trans-1,2-diols 24–26 and high 
enantioselectivities were observed.  The five-membered ring diol 27 with an S-value of 8 
proved to be an exception owing to its poor solubility in toluene and the required addition of 
CH2Cl2 (Scheme 3).  
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Scheme 3.  Enantioselective KR of trans-cycloalkane-1,2-diols with 12i.61 
 
Comparable selectivities were observed for the desymmetrization of cis-1,2-diols 22 and 30–
34 (Scheme 4).  Unfortunately, the enantiomerically enriched products are known to 
racemize easily, e.g., during the workup due to intramolecular acetyl transfer.90-92    Hence, 
we decided to oxidize the second OH-group directly after the desymmetrization in situ using 
a one-pot TEMPO catalyzed oxidation protocol.67   Nevertheless, enantiomeric ratios for the 
acetylated meso-diols 22, 30–34 can be readily determined by chiral GC.  
 
 
Scheme 4. Desymmetrization of meso-diols 22, 30–34 under optimized conditions.52 
 
In contrast to the selective esterification of 1,2-diols (the second OH-group is important as H-
bonding donor) other biomimetic approaches mostly require monoacetylated 1,2-diols or 
monoacetylated 1,2-aminoalcohols to achieve high selectivities.10-12,14,46  In these cases the 
additional H-bonding acceptor of the acyl group serves as a docking position.  Therefore 
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acylation catalyst 12i was tested in the KR of racemic 2, 23, and 40 (Figure 8).  The latter 
substrate was successfully used by Miller et al.;31,46,48,50  in our hands Miller’s catalyst led to 
excellent selectivities in the KR of rac-40 (90% ee for 40, 86% ee for the diacetylated 
aminoalcohol, S = 41 at C = 51%, 24 h at 0 °C)].60  As expected, 12i proved to be unselective 
in these three cases showing the complementarity to Miller’s catalyst.  Additionally, the 
inefficient KR of rac-23 was an important finding to show that the diacetylation occurring 
during the acylative desymmetrization of meso-22 does not affect the selectivity for the 
monoacetylated product.  
 
Figure 8. KR of the racemic monoacetylated substrates 2, 23, and 40. 
 
The enantioseparation of racemic secondary monoalcohols is another challenging field for 
acylative KRs.  The KR of racemic 1-phenylethanol 41 via organocatalytic acyl transfer is one 
of the most common test reactions in this area (efficient methods often take advantage of 
selective π–π-interactions between substrate and catalyst)24,25,93 and was therefore chosen 
as a test reaction for 12i as well.  Catalyst 12i promoted this reaction but showed no 
enantioselectivity (Figure 9).94  The KR of other racemic secondary alcohols like exo-
norborneol 42 and rac-43 via acylative KR with catalyst 12i also led to low selectivities 
(Figure 9).  Catalysts with additional H-bonding donor amino acids serine 12j and tryptophan 
12l in the i+2 position,60 were tested in the KR of rac-43 but were less efficient than 12i.  
Non-enzymatic examples of KR or desymmetrizations of primary alcohols are rare, because 
no second functional group, which is usually required to achieve chemical recognition by the 
catalyst, is close to the hydroxyl group.95,96  As expected the selectivity of 12i in the KR of 
racemic 44 was low (Scheme 9), despite significant activity.  This finding implicates that the 
second vicinal OH-group is necessary for the selectivity of the acylation.  
 
Figure 9. Testing the KR of the racemic monoalcohols 41–44 with catalyst 12i. 
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  Due to the inefficiency of 12i in the acylative KR of monoalcohols, a broader range of meso- 
and rac-1,2-diols 45, 47, 51, 54, and 57 (Scheme 5) was investigated.  
 
Scheme 5. Testing the KR of the racemic diols 45, 47, 51, 54, and 57 with catalyst 12i. 
 
Catalyst 12i showed good performance in the KR of the racemic diol 45 with an S-value of 
16; apparently 12i is not only efficient for cyclic vicinal diols but also for the non-cyclic 
analogues.  Landais et al. reported an efficient 10-step synthesis of aminocycloheptitols via 
desymmetrization/functionalization of 7-silylcycloheptatrienes. 97 Further functionalization of 
the 7-silylcycloheptatrienes gave racemic products.  Hence, we investigated the selective 
acetylation of rac-47 by 12i.  The KR of diol rac-47 is rather challenging due to the complex 
structure (five stereogenic centers) and the possible formation of two product regioisomers 
48 and 49.  In principle catalyst 12i is capable of differentiating between both enantiomeric 
forms by preferring the acylation of the R,R-enantiomer (configuration of the hydroxyl-
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groups).  The highest ee, but a rather low yield (yield = 15%) was observed for the 
monoacetylated regioisomer 49.  The selectivity for 48 was lower, but the yield was good 
(yield = 41%) (Scheme 5).  We suggest that the high selectivity but lower reactivity of 49 is 
because of the high steric demand of the dimethylphenylsilyl-group in proximity to the 
acetylated hydroxyl group.  Compared to all other KR experiments we found a large amount 
of diacetylated product 50.   
In contrast, 12i proved to be inactive and unselective for 51 and 57 and only moderately 
active but rather unselective in the desymmetrization experiments with the meso-diol 54 
(Scheme 5).  An explanation might be the rather rigid structure of 51, 54, and 57 and the 
steric demand of the substrates, as well as the absence of intramolecular hydrogen bonds of 
the diols.  
1,3-, 1,4- and 1,5-Diols are also preparatively useful substrates and were therefore tested in 
the acylative KR with 12i.  Racemic 1,3-diol rac-60 was only poorly resolved and after 24 h 
only 6% of 61 was observed.  Peptide 12i showed a higher activity for the desymmetrization 
of meso-1,3-diol 62 but provided no selectivity.  To our delight, moderate selectivities were 
achieved in the 12i catalyzed KR of non-vicinal 1,1′-binaphthyl-2,2′-diol rac-65 (S = 3; 
Scheme 6).  Enzymatic98 and chemical approaches99 were reported for the resolution of 1,1′-
binaphthyl-2,2′-diol rac-65; the non-enzymatic methods are based on inclusion complexes100 
or salt formation.101  Both enantiomers can be obtained in high yields and excellent ee´s 
(>99%).100,102  To the best of our knowledge no catalytic, non-enzymatic approaches for the 
acylative KR of rac-65 are known to date.  This is the first example for catalyst 12i displaying 
moderate selectivity for a substrate class different from 1,2-diols (Scheme 6).  It is also worth 
mentioning that the KR of 65 with catalyst 12i and acetic anhydride proceeded rapidly (4 h) 
under optimal conditions (5.3 eq Ac2O, 0 °C) and the diol was completely converted to the 
corresponding monoacetylated (64%) and diacetylated (36%) products.  Therefore the 
amount of acetic anhydride was reduced to 0.6 eq Ac2O, which led to a conversion of 43% to 
66 after 4 h (stirring over night yielded 60% of 66 with 33% ee); only the monoacetylated 
product was observed.  This indicates that the KR of rac-65 is even faster than for our 
reference diol 1.  
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Scheme 6. Efficiency of the KR of 60 and 65 as well as desymmetrization of meso-diols 62 
and 67 with catalyst 12i. 
 
Surprisingly, high activity and moderate selectivity was observed for the desymmetrization of 
1,5-diol 67.103  For an efficient KR or desymmetrization the substrate requires two hydroxyl 
groups with a proper spatial relationship. It is conceivable that an intramolecular hydrogen 
bond forms that increases the acidity of the second hydrogen and therefore promotes the 
acetylation.  This might be an explanation for the largely uneven conversions for, e.g., 
substrates 51 (5%) and 54 (> 90%).  While in substrate 54 an intramolecular hydrogen bond 
is possible, in 51 the two hydroxyl-groups are too far apart.  
 
Chemoselectivity of 12i  
The outstanding performance of catalyst 12i for vicinal diols implies high chemoselectivity, 
which underlines the close relationship to natural catalysts, e.g., enzymes.  Of course, high 
chemoselectivity is often undesirable in synthetic chemistry, which normally strives for broad 
substrate scope.  However, highly chemoselective catalytic processes are interesting for 
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one-pot reactions, wherein various chemicals are present in the reaction mixture.  This is 
typically the case for domino,104 tandem,104,105,106 or cascade105,106 reactions and becomes 
even more important for multicatalytic reactions.65,66,69,70,107  Additionally, this approach could 
be a useful tool for the site-selective acylation of, e.g., polyols. 
We performed competition experiments for the acetylation of chemically different alcohols 
with 12i to investigate the chemoselectivity of our best catalyst.  For reasons of comparison 
we performed the same experiments with 4-dimethylaminopyridine (DMAP) in parallel.  Initial 
studies showed that 12i is capable of transferring acyl groups selectively to the (R,R)-
enantiomer of trans-cycloalkane-1,2-diol 1 out of a mixture of alcohols 70–72 (Table 5).  We 
used the optimized standard reaction conditions for the KR.  The reaction was quenched 
after 1 h and analyzed by GC.  In the presence of 12i only esters 2 and 73 were observed.  
Ester 2 proved to be the main product; the er of the remaining diol (94% (S,S)-1 and 6% 
(R,R)-1) indicates that indeed (R,R)-1 is by far the most reactive compound in the mixture.  In 
contrast, DMAP led to the formation of the esters 2, 73, and 74 with 73 being the main 
product.  After 2 h all of the (R,R)-1 enantiomer had been acetylated by 12i and the catalyst 
showed higher activity towards 70 than to (S,S)-1. The reactivity for the acetylation of (S,S)-1 
and 72 by 12i  comparable.  
 
Table 5. Yields (via GC/MS) of 2, 73, 74, and 75 obtained in the competitive acetylation 
reaction. 
 
 
entry cat. t (h) yield (%) of 
2 
yield (%) of 
73 
yield (%) of 
74 
yield (%) of 
75 
1 12i 1 59 traces - - 
2 DMAP 1 traces 22 traces - 
3 12i 2 65 15 traces - 
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 0 °C, 
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entry cat. t (h) yield (%) of 
2 
yield (%) of 
73 
yield (%) of 
74 
yield (%) of 
75 
4 DMAP 2 31 36 13 - 
5 12i 5 72 32 traces - 
6 DMAP 5 59 68 20 - 
 
Catalyst 12i can also differentiate between cis and trans-cyclohexane-1,2-diol; the 
acetylation of a 1:1 mixture of 1 and 22 resulted in a ratio of 84:16 (2/23) after 3 h.  In 
contrast, DMAP proved to be less active and showed only a marginal preference for the 
trans-diol.  The results for 12i (Table 6) are remarkable because both diols should have 
comparable nucleophilicities and differ only in the configuration of the OH-groups.  We 
conclude that stronger hydrogen-bond interactions between (R,R)-1 and 12i compared to 
(S,S)-, (R,S)- and (S,R)-1 and the catalyst are responsible for its preferential acetylation.  
The structure of (R,R)-1 seems to fit perfectly into the “pocket” formed by 12i.  This 
extraordinary high chemo- and enantioselectivity is an astonishing feature for a small 
molecule. 
 
Table 6. Concurrent and competitive acetylation of trans-diol (±)-1 and meso-diol 22 with 
catalyst 12i and DMAP. 
 
entrya cat. t (h) C (%) to 2b erb 2 C (%) to 23b ratio 2:23b 
1 12i 1.5 23 94:6 3 87:13 
2 DMAP 1.5 5 50:50 4 56:44 
3 12i 3 31 91:9 6 84:16 
4 DMAP 3 9 50:50 7 56:44 
5b 12i 4.5 36 85:15 11 77:23 
6c DMAP 4.5 15 50:50 12 55:44 
6c 12i 7.5 38 80:20 15 72:28 
7b DMAP 22 20 50:50 16 55:44 
aReactions performed at –20 °C in 4.5 mL toluene with 1 eq of racemic substrate 1 (0.025 mmol, 2.9 
mg) and meso substrate 22 (0.025 mmol, 2.9 mg), 5.3 eq acetic anhydride, and 2 mol% 12i or DMAP. 
Without catalyst no conversions were observed. bConversions C, er values, and the 2:23 ratios were 
determined by chiral GC analysis. 
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Alternative Electrophiles in Group Transfer Reactions Catalyzed via Peptide 12i 
  
In addition to acetic anhydride we tested a wide range of electrophiles in KRs and 
desymmetrization experiments.  First of all, we investigated the role of the electrophile by 
determining the activity and selectivity of 12i in the KR of rac-1 using various acyl donors 
(Table 7).  All anhydrides reacted with 1 to give the corresponding monoesters in good 
yields; in contrast with vinyl acetate as electrophile (mainly used in combination with 
enzymes) no conversion was observed.  Acetyl chloride provided only 5% of the 
monoacetylated product after 4 h and resulted in no enantioselectivity neither for the starting 
material nor for the product (the background reaction led to similar conversions in the same 
time).  The finding that acyl chlorides, though they generally have higher carbonyl reactivities 
than anhydrides, are less reactive in acetyl transfer reactions catalyzed by the nucleophilic 
catalysts (DMAP) is common.108,109  Steglich et al. investigated the acetylation of 1-
ethinylcyclohexanol with DMAP and found that acetyl chloride reacted three times more 
slowly than acetic anhydride, though the equilibrium amount of the N-acetyl-pyridinium salt is 
significantly higher.110  This finding implies that the acetyl-transfer from the N-acetyl-DMAP 
salt onto a hydroxyl-group is highly affected by the counterion of the acylating agent and the 
auxiliary base.111  Albert et al. also reported the acetylation of 1-propanol with acetyl chloride 
and acetic anhydride catalyzed by DMAP in the presence of K2CO3 and pyridine as auxiliary 
base.112  With pyridine, acetyl chloride reacted very rapidly (t1/2 = 10 s), whereas acetic 
anhydride was significantly slower (t1/2 = 11 min).  In contrast utilizing K2CO3, which is 
insoluble in CHCl3, the reaction rates were reversed (acetyl chloride t1/2 = 35 min; acetic 
anhydride t1/2 = 3.2 min).  It was proposed that the reactivity can be contributed to the 
basicity of the generated counterion, which can act as a general base catalyst and 
deprotonate the nucleophile in the transition state.113,114  In the presence of a homogeneous 
base like pyridine, the auxiliary base or the counterion can perform the proton-transfer, 
whereas the insoluble K2CO3 does not take part in the deprotonation.  The importance of the 
counterion was also confirmed by computations utilized by Zipse et al. It was found that the 
counterion and its interaction with the catalytically active N-acetyl-pyridinium cation is 
important for the deprotonation of the substrate.111,113,114  Additionally, Lutz et al. investigated 
the structure of the N-acetyl-DMAP salt by X-ray, NMR- and IR-spectroscopy.111  Surprisingly 
no evidence for the formation of a “tight” ion pair for the N-acetyl-pyridinium chloride was 
found, but in the case of N-acetyl-pyridinium acetate the analysis of the X-ray data, as well 
as the computations confirmed a “tight” ion pair. The acetate seems to have hydrogen-bond 
interactions with the hydrogen at the C2 position of the pyridinium-ring and the hydrogen of 
the acetyl-group of the N-acetyl-moiety at the catalyst.111  Under our reaction conditions with 
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no additional base the proton transfer has to be accomplished by the counterion and 
therefore acetic anhydride reacts faster.  With acetyl chloride the catalysts is likely to be 
protonated by the in situ generated hydrogen chloride, but even with additional base (5.3 eq 
DiPEA) the reaction is much slower and rather unselective. The reaction with acetic or 
isobutyric anhydride proved to be fast compared to the sterically more hindered benzoic 
anhydride and pivalic anhydride (Table 7).  The use of acetic anhydride and isobutyric 
anhydride led to high selectivities (S >50 for acetic anhydride, S = 41 for isobutyric 
anhydride), whereas for benzoic anhydride (S = 8) and pivalic anhydride (S = 5) only 
moderate selectivities were observed.  
 
 
Table 7. KR of trans-diol (±)-1 with peptide catalyst 12i using various acyl donors. 
 
entrya electrophile ester C (%)b 
ee (%)c  
(R, R)-2 
ee (%)c  
(S, S)-1 
S b 
1 
 
2 57 75 >99 >50 
2 
 
2b 59 71 >99 41 
 
3 
  
2c 
 
2 
 
64 
 
2 
 
5 
4 
 
2d 5 76 4 8 
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2 5 – – 1 
6d  2 27 12 32 2.2 
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entrya electrophile ester C (%)b 
ee (%)c  
(R, R)-2 
ee (%)c  
(S, S)-1 
S b 
7 
 
2 – – – – 
aAll reactions were performed at 0 °C in 4.5 mL toluene, 1 eq of racemic substrate 1 (0.025 mmol, 
2.9 mg), 5.3 eq of the electrophile, and 2 mol% of catalyst (purified via HPLC) 12i. Without catalyst no 
conversions were observed. bS-values and conversions determined using the procedure of Kagan and 
Fiaud.63 cEe-values were determined by chiral GC analysis. d The reactions was performed at 0 °C in 
4.5 mL toluene, 1 eq of racemic substrate 1 (0.025 mmol, 2.9 mg), 5.3 eq of the electrophile, 2 mol% 
of catalyst 12i and 5.3 eq DiPEA. 
 
The direct use of acids as electrophiles in acylation reactions was realized by using peptide 
12i and carbodiimides (DI) for the activation and in situ formation of the anhydrides from 
carboxylic acid precursor.  This first enantioselective Steglich esterification protocol68 was 
successfully applied to a wide range of acids using trans-cycloalkane-1,2-diols 1 and 24–26 
(Scheme 7) as substrates and is a clear advantage, especially, when the corresponding 
anhydrides (as, for example, for formic acid) are not stable or not readily available (e.g., 
phenylacetic acid). 
 
 
 
Scheme 7. KR of cyclic trans-1,2-diols with acetic acid as electrophile. 
 
High selectivities and S-values >50 were observed for acetic acid 77, propionic acid 78, 
isobutyric acid 79, phenylacetic acid 82, and 86.  Accepting lower enantioselectivities and 
conversions this procedure is also applicable to the acids 76, 80, 81, 83, and 84 (Scheme 
8).68 
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Scheme 8. KR through enantioselective Steglich esterification of trans-cyclohexane-1,2-diols 
1 using various acids.69 	  
The steric demand of the electrophile affects the selectivity as well.  KR with acetic acid 77, 
propionic acid 78, isobutyric acid 79 and 3-pentenoic acid 86 catalyzed by 12i are highly 
selective, whereas the steric demand for pivalic acid 80 seems to be too high and the 
selectivity decreases.  Higher selectivity was found when the bulky moiety is in the β-position 
to the acid group (82), but a very bulky group like adamantyl (81) decreases the selectivity 
again.  The lowest selectivity was observed for benzoic acid (83, 84, and 85), because of 
higher stability of the imidazole/benzoylium ion intermediates.  
Other electrophiles such as di-tert-butyl dicarbonate (Boc2O), diphenylchlorophosphate and 
various benzenesulfonyl chlorides were used as electrophiles in the KR of (±)-1 with 12i.  
Miller et al. reported the selective sulfonylation (benzenesulfonyl chlorides)115 and 
phosphorylation (diphenylchlorophosphate)31,116,117 mediated by π-(Me)-histidine containing 
peptides and achieved for the phosphorylation of a meso-inositol derivative an ee of 98% in 
65% yield.  The selective sulfonylation of various functionalized meso-1,3-diols was 
accomplished in high yields and good selectivities (yield up to 76%; er up to 97:3).115  The 
reactivity of Boc2O towards alcohols and diols in the presence of 4-(dimethylamino)pyridine 
(DMAP) and N-methylimidazole (MeIm) has been reported by Hassner et al.118  The transfer 
of the Boc-group onto (±)-1 was tested utilizing 30 mol% DMAP (30 mol% N-
methylimidazole) and 1.2 eq of Boc2O (Scheme 9). 
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Scheme 9. Reaction of DMAP and MeIm with Boc2O with diol rac-1 leading to O-Boc-2e, 
O,O-di-Boc-product 88 and the cyclic carbonate 87. Yields were determined by GC-MS; 
isolated yields are given in parenthesis. 
 
While the monoacetylated diol (R,R)-2 is the only product of the acylation reaction, the 
reaction with Boc2O is more complex and three products were obtained by the DMAP and 
MeIm catalyzed reaction (Scheme 9).  Therefore the KR of (±)-1 with Boc2O required 
optimization (Table 8). 
 
Table 8. KR of trans-cyclohexane-1,2-diol 1 with Boc2O using various reaction conditions. 
 
 
entrya 
cat. 12i 
(mol%) 
t (h) C (%) 
Boc2O 
(eq) 
er 
(S,S)-1c 
er 
(R,R)-2ec 
er 
(R,R)-87e 
Sd 
1 2 58 30 1 80:20 15:85 17:83 10.3 
2 2 58 30 2 64:36 18:82 17:83 6.3 
3 2 36 60 5.3 95:5 18:82 22:78 11.7 
4 2 16 58 10 83:17 24:76 28:72 6.2 
5 5 16 50 5 80:20 20:80 20:80 7.2 
6 10 21 54 2 87:13 18:82 - 9.6 
7 5 102 50 2 86:14 14:86 - 12.8 
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entrya 
cat. 12i 
(mol%) 
t (h) C (%) 
Boc2O 
(eq) 
er 
(S,S)-1c 
er 
(R,R)-2ec 
er 
(R,R)-87e 
Sd 
8b 10 192 50 2 76:24 24:76 traces 5.2 
aAll reactions performed at room temperature in 4.5 mL dry toluene. b This reaction was carried out at 
0 °C in 4.5 mL dry toluene. c Yields and enantiomer ratios were determined by chiral GC analysis. d S-
values (selectivity factors) determined by the method of Kagan and Fiaud.63  
 
In principle, the enantioselective transfer of the Boc-group with 12i is possible but the 
reaction requires different conditions compared to the acylation reaction.  While the acylation 
reactions are most efficient using a large excess of Ac2O (5.3 eq) at low temperature (0 °C), 
the transfer of the Boc-group works best at room temperature, with 2 eq of Boc2O and 5 
mol% of  12i.  The use of a very large amount of Boc2O increases the yield of the undesired 
cyclic carbonate 87, whereas higher temperatures and higher catalysts loadings decrease 
the yield of 87.  
The generation of the O-Boc protected diol 2e is catalyzed by 12i, whereas the formation of 
the cyclic carbonate 87 only occurs in the presence of a strong base.  The reaction 
mechanism implies that the formation of the tert-butoxide during the catalytic cycle probably 
removes the proton from the second alcohol functionality and therefore promotes cyclization 
to the cyclic carbonate 87 (Figure 10).118    Evidence for this proposal comes from the finding 
that 2e does not cyclize to 87 in solution even in the presence of catalyst 12i.  In contrast, 
addition of Boc2O to the solution gives only the cyclic carbonate 87. 
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Figure 10. Proposed mechanism of the KR of trans-cyclohexane-1,2-diol with Boc2O and the 
reoptimized (M06–2X/6–31+G(d,p)) structure of the catalyst/tert-butoxycarbonylium-adduct. 
 
Using less Boc-anhydride minimized the formation of tert-butoxide and the rate of cyclization 
of 2e decreased.  A catalyst loading of 5 mol% and higher temperature accelerates the 
reaction and avoids the generation of 87. 
As peptide catalyst 12i is capable of transferring a variety of acyl anhydrides and Boc-
anhydride enantioselectively, we envisioned that the enantioselective transfer of other 
electrophiles such as diphenylchlorophosphate and various benzenesulfonyl chlorides would 
also be possible.  Although sulfonylation reactions are widely used in organic synthesis, 
catalytic asymmetric sulfonyl transfer reactions are rare.72,115  The KR of trans-cyclohexane-
1,2-diol with various benzenesulfonyl chlorides were therefore examined.  Much to our 
dismay, p-Cl- and p-CH3-benzenesulfonyl chlorides gave no reaction while p-
nitrobenzenesulfonyl chloride unselectively provided 14% of the monosulfonylated-trans-1,2-
cylohexanediol and 8% of the disulfonylated- trans-1,2-cylohexanediol after 24 h at r.t. 
Phosphoryl group transfer plays an important role in natural processes like cell signaling 
pathways.  Histidine containing kinases transfer the phosphoryl group to other nucleophiles. 
Miller et al. successfully applied a histidine containing peptide catalyst in the asymmetric 
phosphorylation of myo-Inositol.31,116,117  The phosphorylation of trans-cyclohexane-1,2-diol 
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mediated by 12i utilizing POCl(OPh)2 under optimized reaction conditions (10 mol% 12i, 1 eq 
POCl(OPh)2, 1 eq Et3N, r.t., PhCH3) unfortunately, unselectively yielded 32% of the 
monophosphorylated product. 
To test again chemoselectivity (this time for the electrophile), we performed a competition 
experiment using different electrophiles (Ac2O, POCl(OPh)2 or POCl(OEt)2 and p-NO2-
SO2Cl) for the functionalization of rac-1.  The progress of the reaction was monitored via GC-
MS and TLC.  For reasons of comparability 12i and DMAP were used as catalysts in parallel 
runs (Table 9). 
 
Table 9: Competitive functionalization of rac-1 with 12i and DMAP. 
 
entry Cat. t (h) C (%)c  er (%) of 1c er (%) of 2c S 
1a 12i 1 48 85:15 13:87 14 
2b DMAP 1 16 50:50 50:50 - 
3a 12i 2 50 86:14 14:86 13 
4b DMAP 2 18 50:50 50:50 - 
5a 12i 3 53 90:10 15:85 14 
6b DMAP 3 20 50:50 50:50 - 
7d 12i 1 51 93:7 8:92 32 
aS-values and conversions C determined using the procedure of Kagan and Fiaud.63 b Conversions 
were determined by GC-MS analysis. c Er values were determined by chiral GC analysis. d Reaction 
was performed with 5.3 eq Ac2O in absence of other electrophiles. 
After 1 h 12i nearly consumed all of (R,R)-1 (C = 48%).  The DMAP catalyzed reaction is 
slower and only provided 16% yield after 1 h.  Under optimized reaction conditions only 2 
was observed with both catalysts.  K2CO3 was used as base to avoid the protonation of the 
catalyst.  The selectivity of the competitive functionalization experiment (S = 14) is lower 
compared to the acylation experiment (S = 32), but still good.  These results show the 
capability of 12i to selectivelly acylate rac-1 in the presence of other electrophiles. 
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Multicatalytic approaches utilizing a modified peptide backbone of 12i 
Oligopeptides are excellent platforms for multicatalysts due to the acessability of various 
natural and non-natural amino acids bearing different functional groups.65  Therefore we also 
tested the selectivity for peptides with a second catalytically active amino acid (Figure 11). 
 
 
Figure 11. Catalysts 22–24 were synthesized to investigate the influence of a second 
catalytically active moiety on the selectivity for the KR of rac-1 . 
The incorporation of Asp (free carboxylic acid) in the i+2 position of the peptide lowered the 
selectivity of 96 drastically, while the functionalization of the C-terminus at the i+4 position 
(97) still yielded good ee’s. An explanation of this finding may be that the addition of CH2Cl2 
was required due to poor solubility of 96 in toluene. Additionally, the acidic moiety near the 
π-Me-His may affect the acyl transfer via interacting with the counterion of the acylating 
agent and however changing the transition state of the selective acyl transfer or by simple 
intramolecular ion-pairing.77  Its protected analog 95 in contrast showed a moderate S-value 
(Table 10; entry 1).  
 
Table 10. KR of (±)-1 with catalysts 95–97. 
entrya cat. t (h) C (%)d 
ee (%)d 
(R, R)-2a 
ee (%)d  
(S, S)-1 
Sc 
1 95 5 56 59 76 9 
2b,e 96 3 45 35 28 3 
3e 97 17 55 60 92 13 
aAll reactions were performed at 0 °C in 4.5 mL toluene with 1 eq of racemic substrate 1 (0.025 mmol, 
2.9 mg), 5.3 eq of acetic anhydride, and 2 mol% of 95–97 in toluene. Without catalyst no conversions 
could be observed. bCH2Cl2 was added because of the poor solibility of the catalyst. cS-values and 
conversions C determined using the procedure of Kagan and Fiaud.64 dEe values were determined by 
chiral GC analysis. eAdditionally 5.3 eq of iPr2EtN were added. 
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The finding that the amino acid at the i+3 position of the peptide does not highly affect the 
selectivity of the KR of rac-1 offered the application of multicatalytic approaches. First 
attempts were made by replacing the methyl ester C-terminus of the peptide by a TEMPO-
amide functionality.  Hence, the direct oxidation of the rapidly racemizing substrates 38–42 to 
the configurationally stable α-acetoxy-ketones were enabled (Figure 12). Multicatalyst 96 
showed remarkably high oxidation activity and therefore the amount of TEMPO, m-CPBA 
and tBu4NBr could be dramatically decreased compared to TEMPO itself (5 mol% vs. 60 
mol%; 3.0 eq vs. 8.0 eq and 5 mol% vs. 30 mol%).67,69 
 
Figure 12. Enantioselective one-pot acylation and oxidation of meso-1,2-diols. 
One of the most challenging topics in organic chemistry is the synthesis of complex 
molecules out of simple building blocks in few steps.  Hence, we added a β-aspartate moiety 
(as an epoxidation catalyst) at the i+4 position to peptide 12i and utilized symmetric alkenes 
as starting materials. The β-aspartate in combination with DIC and H2O2 forms the epoxide 
from the alkene, the addition of hydrazine sulfate forms a salt (113) and opens the epoxide to 
the trans-1,2-diol, which finally is selectively acetylated by (π-Me)-histidine.70  
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Table 11: Synthesis of monoacetylated diols from alkenes by a multicatalytic approach. 
 
entry alkene Yield (%) 
of diol 
Yield (%) 
of ester  
ee (%) of 
diol 
ee (%) of 
ester 
Sc 
1 
 
29 26 64 46 5 
2 
 
34 35 92 60 13 
3 
 
19 24 99 68 26 
4 
  
19 21 86 68 14 
aS-values and conversions C determined using the procedure of Kagan and Fiaud.63 c Ee values 
were determined by chiral GC analysis. 
These two examples show the high potential of multicatalytic approaches and that 
oligopeptides can serve as excellent platforms for the development of new multicatalysts in 
future. 
 
Conclusion and Outlook 
We identified the highly chemo- and enantioselective peptide catalyst 12i for acyl transfer 
onto racemic alkane-1,2-diols.  In contrast to common peptide design approaches 12i does 
not display a preferred secondary structure but instead recognizes the diols in a dynamic 
binding event of the acylium cation complex involving hydrogen bonding and dispersion 
interactions.   
Anhydrides proved to be the most efficient acyl source.  Hence, we introduced the first 
enantioselective Steglich esterification utilizing carboxylic acids as acylating agent from 
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which the anhydrides are generated in situ.  Competitive experiments for substrates and 
electrophiles show extraordinary chemoselectivity for cyclic trans-alkane-1,2-diols as the 
substrate and acetic anhydride as the electrophile.  Such a narrow substrate scope is usually 
only observed for enzymes or generally much larger molecules.  It is therefore a rather 
surprising finding that a short oligopeptide such as 12i mimics the behavior of structures that 
are typically by orders of magnitude more complex, but with the advantage that both 
substrate enantiomers can selectively be acetylated.   
Such exquisite chemoselectivity is the basis for multicatalytic approaches that are now 
being realized.  These provide high potential for rapidly reaching molecular complexity from 
simple starting materials in one pot, not requiring protective group chemistry.  In the future, 
we will attempt to directly address specific hydroxyl groups in polyols.  
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4. Investigation of a Secondary Structure of Boc-L-(π-Me)-His-AGly-L-Cha-L-
Phe-OMe (12i) via NMR- and IR-Spectroscopy 
 
Secondary structure plays an important role in the concept introduced by Miller. The use of 
proline enabled the formation of a β-hairpin structure, fixed by two intramolecular hydrogen 
bonds that seem to be responsible for the selectivity. NMR-titration-, IR- and NOE-
experiments were utilized and clear evidence for the existence of the proposed hydrogen 
bonds was found.46,48	   For the determination of a possible secondary structure of 12i we 
utilized the same spectroscopic methods. 
A useful method for the identification of intramolecular H-bonding is IR spectroscopy.  
Gellman has established IR-spectroscopy as a tool for the determination of intramolecular 
amide-amide hydrogen bonds of peptides in dichloromethane. Sharp signals in the N–H 
stretching region at 3460 – 3450 cm–1 were assigned to non-hydrogen bonded N–H, whereas 
broad signals at 3330 – 3300 cm–1 were assigned to internal hydrogen bonds.82 
We performed IR-experiments at various temperatures using a 13 mM solution of 12i in 
CDCl3. In order to investigate H-bonding interactions we chose CDCl3 as the solvent 
because of its moderate polarity and the high solubility of 12i. At r.t. only one sharp signal at 
3460–3450 cm–1, assigned to non-hydrogen bonded N–H groups, was observed.  While 
reducing the temperature from 298 K to 233 K in steps of 10 K, a new broad signal at 3300 
cm–1 appeared, its intensity increasing with decreasing temperatures (Figure 13).  This is an 
indication for an intramolecular hydrogen bond at temperatures below 253 K.  
  
 
Figure 13: IR-spectra of 12i in CDCl3 at different temperatures. 
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We measured NOE-NMR-spectra of the homoconfigured peptide 12i in d8-toluene and 
CDCl3, but only predictable NOE-signals for the vicinal amino acids were obtained.  We also 
measured the chemical shift dependence of the N–H groups in CDCl3 as a function of 
increasing the d6-DMSO concentration. In the absence of hydrogen bonds all N–H groups 
should show significant downfield shifts (Figure 14).  In the case of 12i, we observed a 
downfield shift in the range of 0.4–1.0 ppm for Phe(NH), Cha(NH), AGly(NH) and π-(Me)-
His(NH)).  This indicates the absence of intramolecular hydrogen bonds for 12i in CDCl3 at 
r.t.   
 
Figure 14: Chemical shifts for the NH-protons of 12i in CDCl3 at different concentrations of 
d6-DMSO. 
 
The selectivity for the KR of 1 utilizing 12i is highly influenced by the solvent (CH2Cl2, S = 
9.6; CH3CN, S = 2.4; PhCH3, S > 50)60 and therefore the low temperature IR-experiments 
were repeated in d8-toluene. Here, in contrast to CDCl3, a broad signal at 3300 cm–1 with a 
higher intensity than the signal at 3450 cm–1 was observed at r.t. Unfortunately, no low 
temperature IR-spectra could be measured because of the low solubility of the peptide 12i in 
d8-toluene.  The IR-intensity of hydrogen bond is affected by temperature and their strength 
decreases with increasing temperature. Hence, we measured an IR-spectrum at 313 K and, 
as expected, the intensity of the signal assigned to intramolecular hydrogen bonds 
decreased while the intensity for the signal at 3450 cm–1 (indicating free N–H-bonds) 
increased (Figure 15). These results show the presence of hydrogen bonds in d8-toluene at 
r.t. However, this method is not suitable to differentiate between intramolecular and 
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intermolecular hydrogen bonding. As mentioned before, 12i is only poorly soluble in d8-
toluene and aggregation of 12i in a non-polar solvent is possible.  
 
 
Figure 15: IR-spectra of 12i in d8-toluene at different temperatures. 
 
For that reason, we performed IR-measurements at different concentrations. Upon lowering 
the concentration from 30 mM over 15 mM to 7.5 mM, the intensity of both signals  
(3450 cm–1 and 3300 cm–1) decreased (Figure 16).  The loss of intensity for the signals 
assigned to intramolecular hydrogen bonds is more profound compared to the signal 
assigned to free N–H-bonds, but the respective signal does not disappear completely. In d8-
toluene a combination of intra- and intermolecular hydrogen bonds seems to be responsible 
for the high intensity of the signal at 3300 cm–1.  
 
Figure 16: IR-spectra of 12i in d8-toluene at different concentrations. 
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In order to verify this result, chemical shifts of the NH-protons of 12i (c = 26 mM) in d6-
benzene with different concentrations of d6-DMSO were measured. The NMR-solvent was 
changed from d8-toluene to d6-benzene as for d6-benzene only one signal is observed at  
δ = 7.27 ppm in the NMR-spectrum and overlap with shifting NH-protons can be minimized. 
The addition of 10% of d6-DMSO induced a downfield shift of 0.5 ppm for His-NH, of 0.15 
ppm for Phe-NH and of less than 0.1 ppm for Cha- and AGly-NH (Figure 17). The nearly 
invariant shifts of Cha-NH, Phe-NH and AGly-NH indicate hydrogen bonds, but the rigidity of 
the AGly makes hydrogen bonds between Cha-NH and AGly-NH with keto-groups of other 
amino acids unlikely. This finding may be explained by the rather high concentration of 12i  
(c = 26 mM) and the presence of intermolecular hydrogen bonds due to aggregation in non-
polar solvents. Up to date no clear evidence for a secondary structure was found.	  
	  
Figure 17: Chemical shifts for the NH-protons of 12i in d8-toluene at different concentrations 
of d6-DMSO. 
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5. Transfer of Different Electrophiles Utilizing Boc-L-(π-Me)-His-AGly-L-Cha-L-
Phe-OMe (12i) 
 
5.1 Asymmetric Phosphorylation- and Sulfonylation-Reactions Mediated by Boc-L-(π-
Me)-His-AGly-L-Cha-L-Phe-OMe (12i) 
 
The KR of rac-1 was tested under standard conditions (2 mol% 12i, 5.3 eq acylating agent, 
toluene, 0 °C) utilizing acetyl chloride as the acyl source. It is known from literature that the 
counterion can have a great influence on both the reaction rate and selectivity. Acetyl 
chloride provided only 5% of the monoacylated product after 4 h and resulted in no 
enantioselectivity neither for the starting material nor for the product (the background 
reaction led to similar conversions in the same time) in the absence of base, because the 
catalyst gets protonated by the generated HCl. Hence, the KR of rac-1 was repeated under 
the same conditions adding 5.3 eq DiPEA as homogeneous base to avoid the protonation of 
the catalytically active π-methyl histidine moiety. Even with base the acyl transfer (AcCl) is 
much slower and less selective (C = 27%; S = 2.2) compared to the reaction with Ac2O, 
because the background reaction cannot be fully suppressed under these reaction 
conditions.  The finding that acyl chloride, although it has higher carbonyl reactivity than 
acetic anhydride, is less reactive in acyl transfer reactions catalyzed by the nucleophilic 
catalysts (DMAP) is very common and is further discussed in the Chapter 3.  
As introductorily mentioned 12i is capable of enantioselective acyl transfer onto rac-1.25,60,68  
Thus, the selectivity towards phosphoryl- and sulfonyl-transfer was investigated and briefly 
discussed in Chapter 3. In this chapter the details on these reactions will be described. 
Miller et al. reported the selective sulfonylation (benzenesulfonyl chlorides)115 and 
phosphorylation (diphenylchlorophosphate)116,117 utilizing (π-Me)-histidine containing 
peptides and observed for the phosphorylation of a meso-inositol derivative 114 an ee of 
98% with 65% isolated yield of 115 (Scheme 10). The selective monosulfonylation of various 
functionalized meso-1,3-diols was accomplished in high yields and good selectivities (117 
yield up to 76%; er up to 97:3).115-117    
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Scheme 10: Selective phosphorylation and sulfonylation of the meso-inositol derivative 114 
reported by Miller et al. 
 
As peptide catalyst 12i is capable of transferring enantioselectively a variety of acyl-moieties 
utilizing anhydrides as acyl-source, we envisioned that the enantioselective transfer of other 
electrophiles such as diphenylchlorophosphate and various benzenesulfonyl chlorides would 
also be possible. Although sulfonylation reactions are widely used in organic synthesis, 
catalytic asymmetric sulfonyl-transfer reactions are rare.  The sulfonylation of rac-1 with 
various benzenesulfonyl chlorides was performed and optimized. Unfortunately, for p-Cl and 
p-CH3-benzenesulfonyl chlorides no reaction could be observed (Table 12). 
Other sulfonyl-based electrophiles like mesyl chloride and trifluoromethanesulfonic anhydride 
either reacted without addition of catalyst or various byproducts were observed and were 
therefore not further tested as sulfonylating agents.  
 
 
Table 12: Sulfonyl-transfer onto rac-1 mediated by DMAP with different bases. 
 
 
 
Entry  -R Base 93, 119–121 122–125 
1 -PhCH3 2,6-lutidine ✘ ✘ 
2 -PhCH3 K2CO3 ✘ ✘ 
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Entry  -R Base 93, 119–121 122–125 
3 -PhCl 2,6-lutidine ✘ ✘ 
4 -PhCl K2CO3 ✘ ✘ 
5 -CF3 2,6-lutidine ✘ ✘ 
6 -CF3 K2CO3 ✘ ✘ 
7 -PhNO2 2,6-lutidine ✔ ✔ 
8 -PhNO2 K2CO3 ✔ traces 
9 
 
– ✘ ✘ 
 
Hence, the reaction conditions for the p-nitrophenylsulfonyl-transfer were optimized. DiPEA 
and 2,6-lutidine were able to catalyze the sulfonyl- transfer and therefore K2CO3 was utilized 
in the KR of rac-1.  
 
Table 13: Sulfonyl-transfer onto rac-1 mediated by 12i with different bases. 
 
Entry Cat. Base 94 120 
1 12i 2,6-lutidine ✔ ✘ 
2 – 2,6-lutidine ✔ ✘ 
3 12i DiPEA ✔ ✘ 
4 – DiPEA ✔ ✘ 
5 12i K2CO3 ✔ ✘ 
6 – K2CO3 ✘ ✘ 
 
 
In the case of p-nitrobenzenesulfonyl chloride 90, 14% of monosulfonylated-trans-
cylohexane-1,2-diol 93 and 8% of disulfonylated-diol 122 were isolated after 24 h at r.t., but 
no ee was detected. 
Phosphoryl-group transfer plays an important role in natural processes such as cell signaling 
pathways. Histidine containing kinases transfer phosphoryl-group to other nucleophiles.  
The KR of rac-1 mediated by 12i utilizing POCl(OPh)2 under optimized reaction conditions 
(10 mol% 12i, 1 eq POCl(OPh)2, 1eq Et3N, r.t., PhCH3) yielded 32% monophosphorylated 
product (Scheme 11).  Unfortunately, no ee could be observed. 
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Scheme 11. KR of rac-1 with diphenylchlorophosphate and catalyst 12i under optimized 
conditions using 1 eq of Et3N as base. 
 
Aside from product 94-Ph, phenol was detected by GC/MS in all cases. An explanation might 
be the cyclization of 94-Ph to 126 (Scheme 11).  Unfortunately, 126 could not be isolated. A 
similar reaction of a monophosphorylated 1,2-diol was reported by Haché.119 
For further investigations of enantioselective phosphorylation reactions the use of 
POCl(OEt)2 would be more convenient as no cyclization was observed and 94-Et could be 
isolated in good yield (yield = 67%). 
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5.2  Enantioselective Ring Opening of Meso-Anhydrides Mediated by Boc-L-(π-Me)-
His-AGly-L-Cha-L-Phe-OMe (12i) 
 
The enantioselective ring opening of cyclic meso-anhydrides utilizing quinine/quinidine was 
reported by Bolm et al. (Introduction: Chapter 2.1.1.2.6).120-122 Catalyst 12i is capable of 
enantioselective acyl transfer onto rac-1 and meso-22 utilizing anhydrides as the acyl source. 
Hence, we tested 12i in the enantioselective ring opening of cyclic meso-anhydrides. Without 
catalyst, only traces of hemiesters 128/ent-128 were observed. 
 
Table 14: Ring opening of meso-anhydrides mediated by peptide 12i under different reaction 
conditions. 
 
Entry Cat. Base Solvent C (%) to hemiester 
128/ent-128 
1 – – toluene traces 
2 12i  – toluene 50 
3 12i 1 eq DBU toluene 50 
4 12i 1 eq MIm toluene 50 
5 12i – toluene/CCl4 (1:1) 50 
6 12i 1 eq Et3N toluene 50 
7 DMAP (30 
mol%) 
– toluene 50 
 
Variation of the reaction conditions afforded only 50% of to the hemiester 128/ent-128 as 
observed by GC-MS (Table 14).  A first hypothesis was that the catalyst is protonated by the 
generated acid moiety of the hemiester, therefore effectively halting the reaction.  Hence, 1 
eq of base was added to avoid the protonation of 12i, but none of the applied bases had any 
influence on the conversion to the hemiester. This finding was surprising, because Bolm et 
al. reported a catalytic approach (10 mol% quinine, 1 eq base) and observed full conversion 
to the hemiester 128/ent-128.122 The cyclic meso-anhydride 127 and the hemiester 128/ent-
128 seem to equilibrate, which is why we utilized a Steglich esterification to functionalize the 
second carboxylic group and enforce product formation. Additionally ester 129/ent-129 can 
be easily analyzed by chiral GC and is configurationally stable.  First, DMAP was used as 
catalyst to prove the practicability of this reaction sequence. The in-situ esterification of the 
second carboxylic acid worked well and 55% of 129/ent-129 and only 15% of 127 were 
O
O
O
COOH
COOMe
COOMe
COOH+
1 mol% 12i/DMAP
3 eq MeOH
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obtained. Additionally 130 mg (0.4 mmol; 15%) of 130/ent-130 were isolated. The side 
product was formed because N-acylureas were generated during the DIC-induced coupling 
due to an intramolecular acyl-transfer to the imino moiety, which competed with that to the 
alcohol.123	  In most cases DMAP is able to suppress this reaction. 
 
 
Scheme 12: Ring opening of meso-127 with DMAP and in-situ esterification of the second 
carboxylic acid via Steglich esterification conditions. 
 
The enantioselective ring opening and direct Steglich esterification was performed under 
similar conditions utilizing 3 mol% of 12i. Unfortunately, no selectivity was observed. 
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6. Exploring the Substrate Scope of Kinetic Resolutions Catalyzed by Boc-L-(π-
Me)-His-AGly-L-Cha-L-Phe-OMe (12i) 
Peptide 12i is capable of a selective acyl transfer onto rac-1 (S >50) and meso-22, whereas 
the cis-diol reacts slower than the trans-diol. An explanation might be the formation of an 
intramolecular hydrogen bond in case of the trans-diol, which acidifies the second hydroxyl 
group and facilitates the acyl-transfer. In order to prove this theory, structural similar 
substrates like trans-cyclohexane-1,2-dithiol, trans-2-mercaptocyclohexane-1-ol, trans-1,2-
diaminocyclohexane and trans-2-aminocyclohexane-1-ol were tested. 
 
6.1 Acylative Kinetic Resolution of trans-Cyclohexane-1,2-dithiol (133) and trans-2-
Mercaptocyclohexane-1-ol (134)  
 
While KRs and desymmetrizations are common methods for the separation of alcohols only 
a few examples for thiols are known from literature.124 Compared to rac-1, thiols are more 
acidic than alcohols and are not able to form strong hydrogen bonds. Thus, rac-133 and rac-
134 should be tested under optimized conditions in the acylative KR mediated by 12i. We 
propose that the chemical recognition of 1 by 12i is mainly based on hydrogen bonding. 
Therefore, the absence of hydrogen bond acceptors in the substrate may decrease the 
selectivity. Rac-133 and rac-134 were synthesized following literature procedures.125-128    
 
 
 
Scheme 13: Synthesis of racemic substrates 133 and 134. 
 
First, the KR of trans-cyclohexane-1,2-dithiol 133 was tested under standard conditions 
(2 mol% 12i, 5.3 eq Ac2O). In the absence of catalyst no acetylation was observed, but even 
with catalyst 12i the acetylation of 133 (C = 20 % after 5 h) was much slower compared to 
the acetylation of rac-1 (C = 50% after 4 h). An explanation might be that, even though the 
nucleophilicity of thiols is higher than that of alcohols, it is a “soft nucleophile” and prefers the 
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reaction with “soft electrophiles”. A C=O group as a “hard electrophile” in contrast reacts 
more likely with “hard nucleophiles” like alcohols. Unfortunately, no selectivity was observed.  
 
 
 
Scheme 14: KR of rac-133 and rac-134 utilizing 12i. 
 
Trans-2-mercaptocyclohexane-1-ol 134 offers the possibility of hydrogen bonding with 12i 
and therefore the interaction should increase. The reaction was carried out at r.t. in order to 
increase the conversion, but the acetylation of rac-134 was still slow (C = 48% after 24 h). 
For the KR of 134 no selectivity was observed and therefore the acetylated product was not 
isolated. It seems that both hydroxyl groups of the substrate rac-1 are necessary to generate 
any ee and to increase the reaction rate. 
 
 
6.2 Acylative Kinetic Resolution of trans-1,2-Diaminocyclohexane (140) and trans-2-
Aminocyclohexane-1-ol (143) 
 
Though amines play an important role in chemistry the examples for acylative KRs or 
desymmetrizations mediated by small organic catalysts are rare.25,129,130 A common method 
for separating the enantiomers of trans-1,2-diaminocyclohexane is the salt formation with 
enantiopure tartaric acid.131 
Contrary to thiols, amines can form hydrogen bonds, which yet are weaker compared to 
those formed by alcohols. For the KR of amines the reaction conditions have to be modified 
due to the high nucleophilicity of nitrogen. Hence, reactions are usually performed at low 
temperatures (–78 °C) to avoid non-catalyzed side reactions. Even at –40 °C the non-
catalyzed acylation of the amine-groups of rac-140 and rac-143 occurred.  
SH
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Scheme 15: Desymmetrization of a vic-diamine reported by Seidel et al. 
 
Seidel et al. reported a desymmetrization of the vicinal diamine 137 via cooperative catalysis 
of DMAP and a chiral thiourea catalyst 139 in 2011.129  
Based on Seidels findings, we tested the KR of trans-1,2-diaminocyclohexane rac-140 and 
trans-2-aminocyclohexane-1-ol rac-143 under modified conditions for the KR of rac-1 (–
78 °C, 0.5 eq ibutyric anhydride, toluene). The low amount of acylation agent is to avoid 
complete acylation and to halt the reaction at 50% conversion.  
 
 
Scheme 16: KR of rac-140 and rac-143 utilizing 12i. 
 
The separation of the enantiomers of rac-140, rac-143, monoacylated rac-141 and 
monoacylated rac-144 was not possible via chiral GC or chiral HPLC. The ee was detected 
by specific optical rotation. For reasons of comparability, the specific optical rotation of 
monoacylated (R,R)-1 was also measured at the same concentration (25 mg in 1 mL of 
CHCl3). A specific optical rotation of [α] = (–0.47 ± 0.16) °mL⋅dm–1⋅g–1 (measured at 22 °C at 
λ = 589 nm) for 141 was measured for the KR experiment catalyzed by 12i; for enantiopure 
141, a specific optical rotation of [α]= (–2.71 ± 0.35) °mL⋅dm–1⋅g–1 (measured at 22 °C at 
λ = 589 nm) was found. The optical purity can be easily calculated as: 
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!"#$%&'  !"#$%& % = [α]1α 2 ∙ 100 = 17.4   ± 8.3   α 1 = measured  specific  optical  rotation α 2 = maximal  specific  optical  rotation 
 
Horeau showed in 1969 that the ideal proportionality of optical purity and ee does not always 
hold, especially in rather non-polar solvents like CHCl3. The ee can hence not be determined 
exactly.132 
The specific optical rotation was also measured for 144, [α] = (–0.300 ± 0.122) °mL⋅dm–1⋅g–1 
(144 was synthesized by utilizing 12i as catalyst). The optical purity was not determined. 
Unfortunately, only low selectivity was observed for rac-141, but the error margin for the 
specific optical rotation and optical purity are quite high. This result implicates the importance 
of strong hydrogen bonding interactions between 12i and the substrate, because the 
selectivity for rac-1 is excellent, whereas the S-value of rac-141 is low and no selectivity was 
observed in the case of rac-133. Additionally, the low/no ee implies that both hydroxyl-groups 
(hydrogen bond donors) are necessary for the selectivity, because in the KR of rac-134 and 
rac-144, no ee could be observed. For rac-43 (see Chapter 3, Figure 9), bearing a hydroxyl-
group (hydrogen bond donor) vicinal to a keto-group (hydrogen bond acceptor), only low 
selectivity and activity were observed either.  
In future work, less reactive electrophiles (Boc2O) could be tested. The non-catalyzed mono-
Boc-protection of rac-140 was achieved with an excess of 140 at 0 °C (Boc-141). Catalyzed 
reactions at lower temperatures have not yet been conducted. 
In order to use chiral GC measurements for determining the ee, it could be helpful to 
functionalize the second amine function with highly reactive electrophiles like 1-
(trifluoroacetyl)imidazole. 
 
6.3  Acylative Kinetic Resolution of 1,1’-Bi-2,2’-naphthol 
 
The KR of BINOL 65 was tested under standard conditions (5.3 eq Ac2O, 0 °C) and after 4 h, 
64% of monoacylated BINOL 66 and 36% of diacylated BINOL were observed. The high 
activity of 12i towards BINOL was unexpected, because usually the reactivity for substrates 
not bearing two vicinal hydroxyl moieties is low. The reaction conditions were optimized and 
only 0.6 eq of Ac2O were used to avoid diacylation. 
Under optimized conditions, no diacylated product was observed. Surprisingly, moderate 
selectivities (S = 3) were detected and therefore the influences of temperature and the 
concentration of isobutyric anhydride on the selectivity were investigated. 
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Table 15: KR of BINOL 65 utilizing 12i and Ac2O/(iPrCO)2O 
 
 
Entry T (°C) Anhydride C (%) ee (%) (R)-
65 
ee (%) (S)-
66/145 
S-value 
1 –70 Ac2O 56 13.3 17.0 1.5 
2 –70 iBu2O 55 6.5 7.9 1.2 
3 –20 Ac2O 33 28.2 13.9 2.0 
4 –20 iBu2O 58 3.9 5.6 1.1 
5 0 Ac2O 42 39.4 28.4 3.0 
6 0 iBu2O 38 12.4 7.6 1.4 
7 25 Ac2O 46 43.1 37.2 3.6 
8 25 iBu2O 40 21.5 14.3 1.8 
9 35 Ac2O 42 39.8 28.9 3.0 
10 35 iBu2O 42 15.5 11.8 1.5 
 
For Ac2O and (iPrCO)2O, the best selectivities were achieved at r.t. Higher temperature 
(35	  °C) increased the selectivity, which may be due to decreased hydrogen bonding 
interactions. In contrast to this finding, lower temperatures do not increase the S-values. 
Usually, lower temperatures increase the selectivity, because weak forces like hydrogen 
bonding and dispersion interactions become more important. In the KR of rac-1, the 
selectivities for (iPrCO)2O are slightly higher than the selectivities for Ac2O, but the reaction is 
slower. In this case the reactivity is comparable, but the higher steric demand of the 
electrophile probably decreases the ee. 
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7. Synthesis of Adamantane Amino Acids as Building Blocks for Peptidic 
Catalysts 
 
7.1 Adamantane Cores in Nature, Chemistry and Pharmaceuticals 
 
Adamantane was first isolated from crude petroleum by Landa and Machacek133 in 1933 and 
eight years later, Prelog134 reported the first synthesis.  A more practical approach was 
reported in 1957 by Schleyer (Yield = 12–13%).135,136 Today, adamantane 146 and its higher 
analogues (diamandoids) 147 are used in chemistry (e.g. as bulky substituents), 
pharmaceutical industry (as building block for drugs) and in materials science.137,138 
Diamandoids exhibit remarkable physical properties (e.g., monolayers of functionalized 
diamondoids show monochromatic electron photoemission).139  
 
 
 
Scheme 17: Adamantane cores in nature, chemistry and pharmacy. 
 
Modified adamantane cores can be found in nature (Scheme 17), e.g., Tetrodotoxin (TTX) 
148, which is one of the strongest known toxins that contains a dioxoadamantane core.140,141 
Adamantane-bearing substances (e.g., Sampsonione I 149) were also isolated from 
Hypercum sampsonii, a plant being used in traditional chinese medicine.142,143  
Adamantane-amino-derivatives are known to be active drugs for the treatment of influenza 
and diseases related to the nervous system.144 Memantine® (1-amino-3,5-
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dimethyladamantane; 150) plays an important role for combating Alzheimer’s disease, 
Tromantadine (Viru-Merz®; 151)145 has anti Herpes simplex properties and Saxagliptin 
(Onglyza®; 152)146 was marketed in 2009 for the treatment of type 2 diabetes. Adapalene 
153 is used as a drug for the treatment of mild acne. 
Additionally, adamantane is a common building block in chemistry. The first stable, 
crystalline N-heterocyclic carbene (NHC) 154 contained two adamantane moieties and was 
synthesized by Arduengo in 1991.147 In 1994, Beller et al. utilized phosphine 155 successfully 
as a co-catalyst in a Suzuki coupling reaction.148 In peptide 12i, the unnatural adamantane 
amino acid (AGly) acts as a rigid spacer between the catalytically active Boc-(π-Me)-histidine 
moiety while the other amino acids generate a “pocket”, in which enantioselective acyl 
transfer reactions can occur (see Introduction).60,67,68 
The synthesis of various γ-amino adamantane carboxylic acids was reported by Schreiner et 
al.149 1-Aminoadamantane carboxylic acid 156 was successfully incorporated into the highly 
chemo- and enantioselective acylation catalyst 12i.60,149 Hence, we synthesized modified 
adamantane amino acids as building blocks for peptidic catalysts in order to determine how a 
more flexible spacer influences the selectivity.  
 
Scheme 18: Modified adamantane amino acids. 
 
In contrast to 156, the δ-adamantane amino acids 157 and 158 are both elongated (addition 
of a methylene group). The generation of an ε-adamantane amino acid (159) makes an 
elongation on both substituents necessary. The higher flexibility of 157, 158, and 159 
incorporated into a peptide may both broaden the substrate scope and enable the 
comparison of activities and selectivities with the model system. Thus, a better 
understanding of substrate recognition by 12i may be achieved. Other interesting 
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adamantane amino acids are 1,4-substituted 160 and 161 as well as rigid δ-adamantane 
amino acids. 
 
7.2 Synthesis of 3-[(9-Fluorenyl)methoxycarbonylamino]tricyclo[3.3.1.13.7]decane-1-
carboxylic acid (156) 
 
1-Aminoadamantanecarboxylic acid 156 can be easily prepared employing a literature 
procedure.149 
 
 
Scheme 19: Synthesis route for the preparation of 156. 
 
The direct C–H acetamidation of a tertiary carbon atom of adamantane carboxylic acid 
yielded 90% of pure 3-acetamidoadamantane-1-carboxylic acid. The formation of a radical 
cation generated by NO2+, which is an acceptor in single electron transfer (SET) reactions, is 
proposed as an intermediate in the acetamidation reaction.150 The yields for the hydrolysis of 
161 (Yield: 85%) and the Fmoc-protection of 162 (Yield: 55%) are comparable to those 
reported in the literature.149 
 
7.3 Synthesis of 1-[(9-Fluorenyl)methoxycarbonylamino]tricyclo[3.3.1.13.7]decane-3-
acetic acid (157) 
For the synthesis of 157, we followed a strategy similar to 156, but starting from adamantane 
acetic acid instead of 162. To functionalize adamantane at the tertiary carbon usually 
halogenated or hydroxylated adamantane precursors151 are used, because these derivatives 
are more active towards, e.g., Koch-Haaf152 and Ritter-type reactions.  Hence, the 
bromination of adamantane was the first step of the sequence. Bromine should be distilled 
prior to use to avoid multi-bromination due to metal traces.151,153  Adamantane was dissolved 
in distilled bromine at 0 °C and afterwards the mixture was refluxed for 1 h.  After work up, 1-
bromoadamantane was isolated almost quantitatively.  For generating the acetic acid moiety 
165 was suspended in conc. H2SO4 and oleum (20% SO3) at 0 °C and 1,1-dichloroethene 
was added.  The absence of a Lewis-acid (BF3) reduced the yield to 50%.  For the 
acetamidation of 166 the same conditions were applied as for 162, but only 65% of pure 
product could be isolated.  Acidic hydrolysis of 167 in aq. HCl unfortunately yielded only 35% 
of the desired product 168, because the formation of 1-chloroadamantane-3-acetic acid 169 
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is favored.151  Chlorinated adamantane carboxylic acid is also a byproduct in the hydrolysis of 
163, but a yield of only 15% is common.  Shorter reaction times (1 d) for the hydrolysis of the 
acetamide 167 did not increase the yield of 168. 
 
 
Scheme 20: Synthesis route for the preparation of 157 and its crystal structure (space group: 
monoclinic). 
 
The Fmoc-protection of 168 yielded a sufficient amount of 157, but 9-
fluorenylmethoxycarbonylamine was observed as a product if the reaction conditions was not 
strictly adhered to.  For the Boc-protection of 168 Boc-NH2 was also isolated in some cases.  
Especially the temperature should not rise over 25 °C at all stages of the reaction.  This 
observation is consistent with the higher amount of 1-chloroadamantane-3-acetic acid in the 
hydrolysis of 167 compared to the yield of 3-chloroadamantane-1-carboxylic acid in the 
hydrolysis of 163. Somehow the tendency of substitution of the amide function at the 
adamantane core is increased for 157 and 167.  
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Scheme 21: Distribution of products for the hydrolysis of 167 and the Fmoc-protection of 
168. 
 
Unfortunately, the structure of 170 could not be determined because the colorless solid was 
insoluble in various solvents (D2O, d8-toluene, d6-DMSO, and CDCl3) and no NMR-spectra 
could be obtained.  The high amount of 3-chloroadamantane-1-carboxylic acid in the 
hydrolysis may be due to the absence of an electron-withdrawing group at the adamantane 
unit.  The substitution on an electron-poor adamantane core (e.g., 3-acetamidoadamantane-
1-carboxylic acid 163) and, consequently, the formation of an adamantyl-cation, is less 
favored compared to an electron-rich core (1-acetamidoadamantane-3-acetic acid 167) due 
to hyperconjugation with the adamantane C-C σ-bonds.  In order to prove this hypothesis, 
the Fmoc-protection of the dialkylated 1-aminoadamantane-3-acetic acid was utilized as test 
reaction.  The two alkyl-groups at the adamantane should additionally stabilize an 
adamantyl-cation by hyperconjugation and a higher amount of substitution product should be 
obtained.  Additionally, the yields for the acidic hydrolyses of 164, 168, 172 and 173 were 
compared. 
 
 
Scheme 22: Comparison of the isolated yields for the hydrolysis products of adamantane 
cores with different electronic properties. 
  
The results are in accordance with the stability of the proposed intermediate carbocations.  
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of alkyl-groups decreases the yield of the hydrolysis product drastically. If no electron-
withdrawing groups are directly attached to the adamantane core, the influence of the 
increased hyperconjugation is low (168 vs. 173).  The Fmoc-protection of 168 yielded 58% of 
157 by following the literature procedure, while for 173 only 34% of the product could be 
isolated.   
In order to increase the yield of 168 a slightly modified synthesis route was tested and 
chloroacetonitrile was used as nucleophile in the acetamidation step (Ritter reaction).154  The 
reaction yielded 89% of pure 176.  The hydrolysis of 176 requires milder reaction conditions 
(AcOH, thiourea vs. HCl) and shorter reaction times (10 h vs. 3 d) and after work up, 74% of 
amino acid 177 were isolated.  A drawback of this route is that a hydroxyl group at the 
adamantane is required (175) to introduce the chloroacetamide substituent.  The hydroxyl 
group can be easily generated at r.t. by dissolving 174 in a 0.15 M NaOH solution.155  Two 
additional steps are necessary, but 174 and 175 can be synthesized in excellent yields and 
short time.  Much to our surprise, 174 could not be utilized for the preparation of 173.  By 
using the chloroacetonitrile route an overall yield of 56% of pure aminoadamantane acetic 
acid 177 compared to 23% overall yield for the acetonitrile route. 
  
 
Scheme 23: Preparation of 177 using chloroacetonitrile for the chloroacetamidation. 
 
The acetonitrile route was also tested for the synthesis of the free amino acid 180, but the 
yields are comparable to the ones obtained by utilizing the direct acetamidation route. 
Additionally one more step is required for the generation of 3-hydroxyadamantane-1-
carboxylic acid and therefore this route is less practically useful.  
 
Scheme 24: Synthesis route for the preparation of 180 using chloroacetonitrile for 
chloroacetamidation. 
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7.4  Syntheses of 3-[(9-Fluorenyl)methoxycarbonylmethylamino]tricyclo[3.3.1.13.7]-
decane-1-carboxylic acid (158) and 3-[(9-Fluorenyl)methoxycarbonylmethylamino]-
tricyclo[3.3.1.13.7]decane-1-acetic acid (159) 
 
For the synthesis of amino acids 158 and 159 a slightly modified procedure of the synthesis 
route described by Horvat et al. was utilized.156  In the first step the 3-hydroxyadamantane-1-
carboxylic acid 178 was generated.  Treatment of 178 with thionylbromide and ammonia gas 
yielded 77% of 182.  For the reduction of the amide 182 with BH3·DMS, only 35% of the 
amine hydrochloride salt 183 could be isolated.  This result is in accordance with the yields 
reported in literature.156 
 
 
 
 
Scheme 25: Synthetic route for the preparation of 158 and 159 (top); crystal structure of 158 
(bottom); space group: monoclinic. 
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Reduction with LiAlH4 did not produce larger amounts of 183.  In both cases, the starting 
material 182 could be recovered.  1-Bromo-3-methylaminoadamantane hydrochloride 183 
can be transformed into 184 by dissolving in H2SO4 and adding HCOOH.  After neutralization 
of the reaction mixture, the product precipitates within 3 h.  Standard conditions for the 
Fmoc-protection were applied and 158 could be isolated in 38% yield.  In the literature, 185 
was not isolated, but directly protected with Boc2O.  The results for the direct Boc-protection 
of 185 were not reproducible.  Hence, 185 was isolated after the neutralization from the 
reaction mixture.  
 
Scheme 26: Single crystal structure of 185 as zwitterion (left) and crystal packing (right); 
space group: orthorhombic. 
 
In contrast to the synthesis of 184, no precipitate was observed after several hours.  Hence, 
the neutralized reaction mixture was stored for 6 d, after which colorless crystals could be 
isolated.  However, the Fmoc-protection with Fmoc-Cl and Fmoc-OSu under standard 
conditions (acetone/H2O) did not produce 159. 
 
 
Scheme 27: Boc-protection of 185 with Boc-ON. 
 
The in-situ Boc-protection was not successful, which is why the Boc-protection of isolated 
185 was attempted.  Using Boc-ON [2-(tert-butoxycarbonyloxyimino)-2-phenylacetonitrile] as 
the protecting agent, 3-tert-butylcarbonylmethylaminotricyclo[3.3.1.13.7]decane-1-acetic acid 
Boc-159 could be isolated in good yield (74%). 
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7.5  Syntheses of 3-[(9-Fluorenyl)methoxycarbonylmethylamino]-5,7-dimethyl-
tricyclo[3.3.1.13.7]decane-1-carboxylic (190) and 3-[(9-
Fluorenyl)methoxycarbonylmethylamino]-5-methyltricyclo[3.3.1.13.7]decane-1-
carboxylic (196) 
 
The syntheses of (±)-190 (for the envisioned application a separation was not necessary) 
and 196 started from the mono- and dimethylated hydroxyadamantanes 186 and 192, 
respectively.151,157  The direct acetamidation of 187 and 193 produced slightly lower yields as 
described in literature.149  For acidic hydrolysis and Fmoc-protection, standard conditions (as 
mentioned in Scheme 19) were applied.  
 
 
 
 
Scheme 28: Preparation of (±)-190 and 196. 
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7.6 Synthesis of 4-tert-Butoxycarbonylmethylaminotricyclo[3.3.1.13.7]decane-1-
carboxylic acid (E-203) and (Z-203) 
 
Hydroxyadamantone 197 was synthesized according to the literature and a comparable yield 
was isolated.158  Linders et al. reported the synthesis of E- and Z-201 in 2006.159  The 
introduction of a N-benzyl substituent should offer the possibility of an easy HPLC 
separation.  The imine formation and reduction was reproducible, but unfortunately only the 
E-isomers of 200 could be separated via HPLC and column chromatography and Z-200 was 
not obtained.  E-200 was debenzylated under standard conditions (PdC/H2), but even after 2 
d only a mixture of 200 and 201 could be isolated.  Thus, the reaction mixture was treated 
with HCl in diethyl ether and 201 precipitated as the hydrochloride.  The carboxyl group was 
introduced under standard conditions (H2SO4, HCOOH), but after neutralization of the 
reaction mixture no adamantane amino acid 202 precipitated after 4 h.  A direct Boc-
protection with the reaction mixture of 202 was attempted, but no product could be isolated.  
A reason may be that only a small amount of 201•HCl was synthesized and the yield of 202 
was too low to be isolated. 
 
 
Scheme 29: Synthesis route for the preparation of E- and Z-202  
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8. Modification of Current Peptide Platform Boc-L-(π-Me)-His-AGly-L-Cha-L-
Phe-OMe (12i) 
8.1 Acylative Kinetic Resolution of trans-Cyclohexane-1,2-diol with Modified Peptides 
 
As mentioned in Chapter 3, peptide 12i shows characteristics of a small enzyme, such as 
high chemo- and enantioselectivities.  The substrate scope is limited to 1,2-diols like 1, 22 
and rac-45 and only anhydrides with moderate steric demand are tolerated.  We propose that 
a dynamic binding process in the non-polar solvent toluene accomplishes the chemical 
recognition of the 1,2-diol 1 by peptide 12i, because no evidence for a preferred secondary 
structure was found by NMR- or IR-spectroscopy.  
For a better understanding of this catalytic system, the peptide was modified at various 
positions and the influence of the structural changes was investigated by comparing the 
selectivities of the modified peptides in the KR of our model substrate rac-1 with the 
selectivities obtained by 12i.  Miller et al. compared the S-value of a flexible octapeptide 205, 
adopting a proline-induced β-hairpin structure stabilized by hydrogen bonding interactions, 
with octapeptide 206, in which the secondary structure is determined by a covalent bond 
(Scheme 30).48  The less flexible peptide showed a lower selectivity, which implicates that, a 
modicum of flexibility is necessary for a high ee. 
 
 
Scheme 30: Comparison of the KRs of rac-40 utilizing peptides 205 and 206. 
 
The flexibility of peptide 12i was increased by incorporating modified adamantane amino 
acids (Chapter 7) and methyl groups at the 3- and 3,5-positions of the adamantane core 
were added to investigate the influence on the structure. Adamantane becomes chiral by 
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bearing three different substituents, thereby decreasing the selectivity of the KR of rac-1. 
Hence, peptide 208 was tested, because the absence of an effect on the selectivity would 
probably allow immobilization at this position. 
 
 
Scheme 31: Modified peptides inspired by 12i incorporating different adamantane amino 
acids.  
 
The peptides were applied in the KR of rac-1 and their selectivities were compared.  
Elongation of the adamantane amino acids decreased the selectivity.  Although elongation at 
the C-terminus as in 210 has the smallest influence (S = 6.8) relative to 12i (S > 50), the 
overall loss of selectivity for all δ- and ε-adamantane amino acids is dramatic. Peptide 209, 
which has been elongated at the N-terminus, shows only low selectivity (S = 3.2).  The most 
flexible peptide 211 is also the most unselective catalyst (S = 2.9).  In contrast, substituents 
at the adamantane core itself have no pronounced effect on the selectivity, because the 
peptide backbone, which generates the chiral environment, is not affected.  Based on these 
findings, the immobilization of the catalyst at the adamantane core may be possible without 
loss of selectivity (see outlook). 
 
 
N
HNH
H
N
O
OO
Me
O
H
N
O
O
O-tBu
N N
N
H
H
N O-tBu
H
NN
H
O
O
O
O
N N
O OMe
N
H
H
N O-tBu
H
NN
H
O
O
O
O
N N
O OMe
H
NN
H O
OO
OMe
H
N N
HO
O-tBu
O
NN
H
N N
HNH
H
N
O
O-tBu
O
NN
O
OO
Me
O
N
H
H
N O-tBu
H
NN
H
O
O
O
O
N N
O OMe
!-adamantane amino acid
Additional substituents at the adamantane core
"- and #-adamantane amino acids
207 208
209 210
211
12i
Modification of Current Peptide Platform Boc-L-(π-Me)-His-AGly-L-Cha-L-Phe-OMe 	  
	  168 
Table 16: KR of rac-1 utilizing modified peptides 207–217. 
 
Entry Cat. t (h) C (%)a ee (%) 1 ee (%) 2 S-value a 
1 12i 2 54 99 85 >50 
2 207 2 55 99 78 >50 
3 208 2 57 99 74 48 
4 209 5 55 44 36 3.2 
5 210 2 50 60 58 6.8 
6 211 5 42 28 38 2.9 
a Conversions and S-values were determined following the procedure of Kagan and Fiaud.63 
 
In the next step, AGly was replaced by 3- and 4-aminobenzoic acid (212/213).  The planar 
aromatic ring may also be able to separate the catalytically active (π-Me)-histidine moiety 
from the rest of the peptide and generate some kind of catalytically active “pocket”.  Peptides 
212 and 213 were also tested in the KR of rac-1. 
 
 
Scheme 32: Modified peptides inspired by 12i incorporating 3- and- 4-aminobenzoic acid 
instead of adamantane amino acids at the i + 1 position.  
 
Table 17: KR of rac-1 utilizing modified peptides 212 and 213. 
  
 
Entry Cat. t (h) C (%)a ee (%) 1 ee (%) 2 S-value a 
1 212 6 44 32 40 3.1 
2 213 6 42 20 27 2.1 
a Conversion and S-value were determined following the procedure of Kagan and Fiaud.63 
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AGly seems to be essential for the selectivity, because with 3- and- 4-aminobenzoic acid as 
the structure-giving element, only low ee-values were detected.  Especially 213 was less 
reactive (only 20% conversion after 3 h) and rather unselective, which may be due to the 
planar spacer separating the two parts of the peptide chain.  Alternatively, the C- and N-
termini of the peptide are too far apart so that no “pocket” is formed.  In contrast, 3-
aminobenzoic acid (212) brings the C- and N-terminus of the peptide closer together, 
resulting in increased reactivity and selectivity (S = 3.5) compared to 213.  Again, high 
flexibility does not lead to high selectivity. 
 
In 2009, Sunoj et al. performed ONIOM computations at the B3LYP/6-31G(d):PM3 level that 
yielded transition structures for acyl transfer onto (R,R)- and (S,S)-1 catalyzed by 12i (Figure 
18).89 These computations confirm our model and the energy difference of 4.5 kcal⋅mol–1 
between the two transition states structures nicely explains the observed high 
enantioselectivities.  
 
   
 
Figure 18. Optimized low-lying transition structures for the acyl transfer catalyzed by 12i (Moc instead 
of Boc) to (1R,2R)-1 (left) and to (1S,2S)-1 at ONIOM2(B3LYP/6-31G(d):PM3). Only selected 
hydrogens are shown for clarity.  
 
In these computations, the carboxyl group of the cyclohexylalanine moiety seems to be 
responsible for the hydrogen bonding interaction, which is needed for the recognition of the 
substrate by the catalyst.  Hence, the i+2 position (Cha) was replaced by β-alanine (214) to 
shift the carboxyl group and to investigate the possibility of resolving cyclohexane-1,3-diol 
and other substrates.  In peptide 13, the positions for the catalytically active π-methyl 
histidine and cyclohexylalanine moieties were changed and the selectivity dropped 
dramatically to S = 1.5.  For the KR of rac-1 utilizing 214, only a low selectivity of S = 2.5 was 
observed (Table 18).  
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Scheme 33: Modified peptides inspired by 12i.  
 
The influence of the protecting groups at the L-Phe and π-methyl histidine should be 
investigated and peptides 215 and 216 were synthesized and tested.  Additional peptides 
incorporating amino acids with a high steric demand at the i + 2 position (217 and 218) were 
synthesized and tested, but the selectivity was not noticeably affected (Table 18).  
 
Table 18: KR of rac-1 utilizing modified peptides 13 and 214–218. 
 
 
Entry Cat. t (h) C (%)a ee (%) 1 ee (%) 2 S-valuea 
1 214 3 38 28 46 2.5 
2 13 5 33 8 16 1.5 
3 215 1 50 88 86 38 
4 216 2 46 82 94 >50 
5 217 1 67 99 48 19 
6 218 2 60 99 64 32 
a Conversion and S-value were determined following the procedure of Kagan and Fiaud.63 
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and a Bn– protecting group instead of a Me– group at Phe (216) only have a small influence 
on the S-value.  Elongation at the C-terminus of AGly had the lowest impact on the selectivity 
(S = 6.9; 210), but all modifications at the N- or C- terminus of the adamantane amino acids 
decreased the S-value to < 10. 
 
Scheme 34: The essential parts of the peptide 12i for the selectivity are drawn in red, the 
parts with moderate influence are colored in blue and the black moieties only have a small or 
negligible effect on the ee. 
 
It is no surprise that a catalyst with extraordinarily high selectivity can hardly be fine-tuned to 
perform even better, but the fact that it influences the system so dramatically is still 
remarkable.  The modified catalysts may be rather unselective in the KR of rac-1, but new 
substrates can possibly be resolved.   
Therefore, we chose three different model reactions: The acylative KR of rac-1-
phenylethanol, the KR of rac-cyclohexane-1,3-diol 60 and the KR of 1,1’-bi-2,2’-naphthol 
(BINOL) (±)-65.  The KR of 1-phenylethanol (±)-41 was chosen as test reaction, because it is 
one of the most common substrates for acylative KRs (see introduction).  The KR protocols 
for cyclic 1,3-diols are rare, but it contains the same structural features (two hydroxyl groups, 
cyclohexyl ring) as the resolvable 1,2-diols. Enantiopure BINOL is often used as a ligand or 
as a building block for chiral Lewis acid catalysts. Enzymatic and chemical approaches were 
reported for the resolution of 1,1′-binaphthyl-2,2′-diol (±)-65. The non-enzymatic methods are 
based on inclusion complexes or salt formation.100-102	  Both enantiomers can be obtained in 
high yields and with excellent ee (>99%).  To the best of our knowledge, no catalytic non-
enzymatic approaches for the acylative KR of (±)-65 are yet known. 
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Scheme 35: Test reactions for KR mediated by the modified peptides. 
 
 
8.2  Acylative Kinetic Resolution of Rac-1-Phenylethanol (41) Mediated by Modified 
Peptides  
 
The KR of 41 was tested under standard conditions (2 mol% catalyst, 5.3.eq Ac2O, toluene) 
utilizing 12i as a catalyst.  Unfortunately, only 16% of the racemic product could be obtained 
after 24 h.  In contrast to the KR of rac-1 were after 4 h 50% of the product formed, 12i 
showed only low reactivity.  
 
 
Scheme 36: KR of rac-41 mediated by 12i. 
 
A reason may be the absence of a second hydroxyl group for hydrogen bonding. 
Successfully used catalysts in the KR of rac-41 often have aromatic moieties for π-π-
interaction.  Hence, some other peptides with additional aromatic moieties were synthesized 
and tested, but all were unselective.  Only for 210, low selectivity was obtained. 
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Table 19: KR of rac-41 utilizing modified peptides 12g, 13, 209–213 and 217–218. 
Entry  Cat. t (h) C 
(%)a 
ee 
(%) 
41 
ee 
(%) 
219 
S-
valuea  
1 209 
 
24 50 6 6 1.2 
2 210 
 
24 50 38 20 2.1 
3 212 
 
24 50 10 10 1.3 
4 218 
 
24 ✘ 0 0 ✘ 
5 217 
 
24 62 10 6 1.2 
6 211 
 
24 50 6 6 1.2 
7 13 
 
24 42 6 8 1.2 
8 213 
 
24 50 6 6 1.2 
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24 ✘ 0 0 ✘ 
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Entry  Cat. t (h) C 
(%)a 
ee 
(%) 
41 
ee 
(%) 
219 
S-
valuea  
  10 214 
 
24 ✘ 0 0 ✘ 
a All yields and ee values were determined by chiral GC following the procedure by Kagan and 
Fiaud.63 
 
8.3 Acylative Kinetic Resolution of Rac-Trans-Cyclohexane-1,3-diol (60) Mediated by 
Modified Peptides  
 
The result for the KR of trans-cylohexane-1,3-diol utilizing 12i is rather disappointing, 
because only 6% of conversion was detected after 24 h at 0 °C. 
 
Scheme 37: KR of rac-60 mediated by 12i. 
 
This finding implicates that the chemical recognition of the peptide and the substrate is low, 
because the acyl transfer does not occur. Thus, various modified catalysts were tested at r.t. 
to increase the yield. 
 
Table 20: KR of rac-60 utilizing modified peptides 207–212, 214, 217 and 218. 
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Entry  Cat. t (h) C (%)a,b 
60 
ee (%) 
60 
3 211 
 
2.5 mol% 
5 10 0 
4 212 
 
2.5 mol% 
6 14 0 
5 208 
 
2.5 mol% 
7 12 0 
6 207 
 
2.5 
5 9 0 
7 217 
 
2.5 mol% 
5 19 0 
8 218 
 
2.5 mol% 
5 8 0 
9 214 
 
5 mol% 
2 43 0 
a All yields and ee values were determined by chiral GC following the procedure by Kagan and Fiaud. 
63 b All reactions were performed at r.t. 
 
All tested peptides were unselective and the acylation was slow even at r.t.  The only 
exception in terms of reactivity was peptide 214 bearing β-alanine at the i + 2 position.  For 
the KR of rac-60, 12i and the modified peptides 207–212, 214, 217 and 218 were not useful 
and other amino acid sequences should be tested.  
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8.4  Acylative Kinetic Resolution of 1,1’-Bi-2,2’-naphthol (65) Mediated by Modified 
Peptides 
 
For the KR of rac-65, moderate selectivity was observed using 12i as catalyst.  
Unfortunately, the S-value could not be increased by lowering the temperature or by using 
(iPrCO)2O as acyl source.  Hence, catalyst 210, 211 and 213 were tested.  We envisioned 
that the more flexible peptides 210 and 211 maybe increase the selectivity. For both 
catalysts, only lower selectivities (S = 1.3 and 1.5) compared to 12i (S = 3.5) could be 
observed.  Catalyst 213 was unreactive. 
  
Table 21: KR of rac-65 utilizing modified peptides 210, 211 and 213. 
 
 
 
Entry  Cat. C (%)a ee (%) 
65 
ee (%) 
66 
S-valuea 
1 213 
 
n.d. ✘ ✘ ✘ 
2 211 
 
16 18 4 1.5 
3 210 
 
35 9 5 1.3 
a All yields and ee values were determined by chiral GC following the procedure by Kagan and 
Fiaud.63 
 
In summary, the best selectivities for the KRs of rac-1 and rac-65 were obtained by peptide 
12i bearing the rigid adamantane amino acid 156.  Only 210 showed some selectivity (S = 
2.1) in the KR of rac-41, whereas for 12i, no selectivity was observed.  It seems that a certain 
degree of rigidity is necessary for high selectivity.  Therefore the synthesis and incorporation 
of Z-202 in a peptide might be promising. 
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9. NHC-Containing Peptides 
 
9.1 Syntheses of NHC-Precursor-Containing Peptides and Their Application as 
Catalyst in Benzoin Condensations 
 
Chiral NHCs are widely utilized in asymmetric benzoin condensations, Stetter reactions and 
other “Umpolung reactions”.160 In 2005 Miller et al. were the first to use a peptidic backbone 
for generating a chiral environment around the carbene.161,162 
 
 
 
Scheme 38: Carbene induced reactions reported by Miller et al. 
 
We envisioned the synthesis of a carbene precursor by simply methylating the second 
nitogen of the methylimidazole moiety of 12i.  The synthetic pathway was started by 
methylation of Boc-(π-Me)-histidine utilizing methyl iodide to generate Boc-dimethyl 
histidinium iodide.  The carbene precursor 234 could be isolated in 28% yield.  The peptide 
coupling with 234 was not possible, because of its poor solubility in CH2Cl2 (solvent for 
peptide synthesis in solution) and DMF (solvent for solid phase peptide synthesis (SPPS)).  
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Scheme 39: Synthesis of carbene precursors starting from histidine. 
 
We tried to isolate the free carbene derived from 233 by utilizing Arduengos approach (NaH, 
THF, DMSO), but no characteristic carbene signal in the 13C-NMR spectrum (expected 
around 215 ppm) was detected.163  The result does not confirm that the carbene was not 
isolated as 1,3-dimethyl-2-ylidenes are unstable towards air and moisture and decompose 
even at low temperatures. In order to avoid solubility problems of the amino acid salt 234, the 
tetrapeptides 12i and 236 were methylated directly, yielding about 50% of pure 235 and 237, 
respectively.  
 
 
 
Scheme 40: Synthesis of 235 and 237 via direct methylation of tetrapeptides 12i and 236. 
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All efforts to increase the yield of the methylation by utilizing Meerwein’s salt, methyl 
trifluoromethanesulfonate or methyl iodide under microwave conditions were not to avail.  In 
addition to peptide 235 bearing a dimethylimidazolium iodide moiety, the methylthiazolium 
iodide moiety containing peptide 237 was synthesized, because of the higher acidity.  
Thiamine, especially thiamine pyrophosphate (TPP), a naturally occurring thiazolium salt, is 
involved in many enzymatic transformations and cellular processes.164 The pKa values for the 
deprotonation of the N,N’-dimethylimidazolium iodide (pKa = 21.1) and N-methylthiazolium 
iodide (pKa = 14.5) differ significantly and milder reaction conditions may avoid 
decomposition of the peptidic backbone.165 
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Figure 20: Comparison of the 1H-NMR spectra of 12i/235 and 236/237. 
 
The benzoin condensation was chosen as test reaction due to the readily available 
substrates and the broad knowledge of NHCs as catalysts for this type of reaction.  
Additionally, we utilized a molecular dynamics search for the low-lying conformation of the 
Breslow intermediates of catalyst 235 and 237166,167  The model generated by the MMFF 
(Merck Molecular Force Field)83 for the enantioselective acylation of trans-cyclohexane-1,2-
diol by 12i helped to rationalize the mechanism and the influence of lipophilic amino acids on 
the selectivity.  
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Scheme 41: MMFF-model for the Breslow-intermediate of benzaldehyde and the 
thiazolylidene (left) and the dimethylimidazolylidene (right). Hydrogen atoms are omitted for 
clarity. 
 
In both conformations the Re-side of the intermediate seems to be blocked by the peptide 
backbone.  Hence, an asymmetric benzoin condensation may be possible.  In order to 
optimize the reaction conditions (base, solvent, temperature), N,N-dimethylimidazolium 
iodide (NDMI) 240 was chosen as small symmetric test catalyst.  The reaction conditions for 
the generation of the free carbene should be comparable for peptide 235 and the small 
model catalyst 240.168  The benzoin condensation of benzaldehyde and 241 was tested in 
different solvents. THF is the most common solvent for this reaction and 40% of benzoin 
could be isolated.  In toluene, DCM and 1,4-dioxane only traces of benzoin 239a could be 
observed.  In order to deprotonate 240, inorganic and organic bases were tested and only 
with NaH and potassium-tert-butoxide benzoin product formation was observed.  The 
deprotonation of N-methylthiazolium iodide 242 should be easier due to the higher acidity, 
but a benzoin condensation could only be achieved with NaH, potassium-tert-butoxide and 
DBU.  In the literature, Et3N is a common base for the in-situ generation of thiazolylidenes 
243, but we observed no benzoin condensation by utilizing 242 and Et3N.169  
.  
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Scheme 42: The deprotonation of 240 and 242 with different bases was tested indirectly by 
the detection of benzoin 239a. 
 
Potassium-tert-butoxide was applied as the base for further optimizations.  The influence of 
temperature on the benzoin condensation was tested.  As expected, the amount of benzoin 
increased with the temperature (Yield: 65% at 50 °C; 20% at 25 °C). Unfortunately, 
temperatures over 35 °C are not suitable for asymmetric benzoin condensations, because 
the structure of the peptide may become too flexible for a chiral induction.  At last, we tested 
various o- and p-substituted benzaldehydes at optimized reaction conditions (33 mol% N,N’-
dimethylimidazolium iodide; THF, r.t., 12 h).  
 
Table 22: Benzoin condensation with different aldehydes catalyzed by 240/KOtBu. 
 
Entry  R Yield (%) 
1 239a H 20a 
2 239b p-F 40a 
3 239c p-CF3 – 
4 239d p-MeO 4b 
5 239e p-NO2 – 
6 239f o-Cl 15b 
7 239g o-CH3 23b 
a Isolated product yields; b Yields were determined by GC-FID. 
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The best results were obtained for p-fluorobenzaldehyde 238b and o-methylbenzaldehyde 
238g, but again the yields were just moderate.  The low yields cannot only be rationalized by 
a low catalyst activity, but also a possible back reaction (retro-benzoin), which could also 
have a negative effect on the isolated yields.170  Retro-benzoin-reactions are usually utilized 
for the preparation of mixed benzoins.  By acylation of the free hydroxyl group of benzoin the 
equilibrium could be forced to shift to the product side. NHCs are also used as acylation 
catalysts and therefore, a benzoin-condensation with in-situ acylation was tested.  
 
Table 23: Benzoin condensation with in-situ acylation catalyzed by 240/KOtBu. 	  
 
Entry Product Cat.  R Yield (%) 
1 244a 240 H 70 
2 244b 240 p-F 47 
3 244a 235 H – 
4 244a 237 H 4 
 
The addition of an acylation catalyst (e.g., DMAP) was not necessary due to the acylation 
abilities of the free carbene. For the benzaldehyde 238a and p-fluorobenzaldehyde 238b, the 
yield could be increased utilizing 20 mol% of N,N’-dimethylimidazolium iodide 240, but for 
peptide 235 and 237 no effect on the yields were observed.	    Peptides 235 and 237 were 
tested with a catalyst loading of 30 mol% in the benzoin condensation. 
 
  
 
Scheme 43: Benzoin condensation catalyzed by 235 and 237 under optimized conditions. 
 
The benzoin condensation utilizing 237 yielded 20% of benzoin and 5% ee.  A reason for the 
low yield may be the lower pKa value (14.5 in DMSO) compared to 235 (21.1 in DMSO).  
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Prolonging the reaction time to 48 h did not increase the yield.  This finding was unexpected 
due to the fact that other chiral thiazolium-salt-based catalysts achieved quantitative yield in 
15 h with 5 mol% catalyst loading and Et3N as a base.169  In an intramolecular Stetter 
reaction, a dipeptide (222) with a thiazolium moiety also yielded 60–70% of pure product.  A 
reason for the low yields in the benzoin condensations may be the decomposition of the 
catalyst by the strong base KOtBu or by itself (vide infra). 
The fixation of CO2 by NHCs is known in the literature.171,172  While the inner salts are stable 
and can be used without precautions the CO2/NHC-adducts are labile in solution and are 
hence utilized as carbene precursors.  Taton et al. were able to synthesize an air-stable 
imidazolium hydrogen carbonate [NHC(H)][HCO3], which equilibrates in solution with its 
imidazolium carboxylate, the free carbene and H2CO3.173  The concept was tested by utilizing 
[IMes(H)][HCO3] 245a as catalyst in a benzoin-condensation (20 mol% [IMes(H)][HCO3], 
THF, 60 °C) and benzoin was obtained in 88% yield (determined by NMR).  A big advantage 
of the hydrogen carbonate NHC is that no additional base is required for carbene generation. 
 
Scheme 44: Equilibrium of [IMes(H)][HCO3] in H2O. 
 
We tested the formation of [IMe(H)][HCO3] and measured 1H-NMR and 13C-NMR spectra in a 
mixture of methanol-d4 and D2O (Figure 21). While in D2O the acidic proton could be 
observed, its peak intensity decreased in methanol-d4/D2O.  For 245, no peak was observed 
due to the rapid exchange with the deuterated solvent on the NMR time scale.  In the 13C-
NMR spectrum, a signal at 161.4 ppm appeared for 245, which could be assigned to HCO3–. 
The results are in accordance with those reported in literature.173 
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Figure 21: Comparison of the 1H- and 13C-spectra of 240 and 245. 
 
In contrast to literature reports, no signals indicating a NHC-CO2-adduct were found. A 
benzoin condensation under the reaction conditions described in the literature (20 mol% 
[IMe(H)][HCO3] , THF, 60°C, 24 h) was performed, but no product was observed.173  Hence, 
this concept was not pursued further for peptides 235 and 237. 
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9.2  Oxidative Esterification Reactions Utilizing Peptidic NHCs 
 
NHCs are capable catalysts for oxidative esterifications of alcohols and thioles using 
aldehydes as the acylating agent.174-176  For the oxidation an excess of external oxidant or an 
internal redox reaction is required.  It is proposed that, within the presence of a suitable 
oxidant, the in-situ-formed Breslow intermediate can be oxidized to give an acyl azolium ion.  
The nucleophilic alcohol attacks the acylating agent, generates the ester and regenerates the 
NHC catalyst.175-177  Different inorganic substrates like MnO2 and organic heterocycles can 
serve as the oxidant (Scheme 38).178  Only recently, biomimetic two-component 
organocatalysts with redox-active flavin derived from riboflavin (vitamin B2) has been 
reported.178  Kinetic resolutions and desymmetrizations of alcohols in the context of NHC-
catalysis are also known in literature.174,178,179 
 
 
 
Scheme 45: Proposed mechanism for the oxidative esterification of aldehydes mediated by 
carbenes. 
 
The asymmetric functionalization of cis-cyclohexane-1,2-diol rac-22 was investigated by 
Scheidt et al. and produced 250 in 58% yield and 80% ee.174 
 
Scheme 46: Oxidative desymmetrization of meso-22. 
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The structural similarity between catalyst 12i and 235 and 237 may enable a selective 
oxidative esterification of rac-1 using aldehydes as acylating agents.  We started with 
precursor 240 and tested MnO2 and phenazine 247 as oxidants.  MnO2 yielded only 4% of 
the monobenzoylated 2d, whereas by using the organic oxidant phenazine, full conversion 
and a 1:3 ratio of 2d:252 was detected via GC after 20 h. 
 
 
 
Scheme 47: Oxidative esterification of rac-1 with 235 and 240. 
 
Peptide 235 showed no conversion under similar reaction conditions. The reaction is 
possible, but the conditions need to be optimized.  The low activity of the peptidic catalysts 
235 and 237 in the benzoin condensation and esterification reactions disclose a general 
reactivity problem of NHCs with a peptidic backbone.  Based on this finding, the stability of a 
peptidic carbene precursor 237-V under standard conditions (THF, KOtBu, 4Å MS) was 
tested.  
 
 
 
Scheme 50: 237-V before and after the treatment with KOtBu under the reaction conditions 
used for the benzoin condensation. 
 
After 48 h, the solvent and the molecular sieve were removed and the residue was dissolved 
in MeOH.  The ESI-MS spectrum did neither show m/z = 724.2, nor an other particular mass. 
The reisolation of the catalyst was not possible either.  Therefore, the decomposition of the 
catalyst appears to be likely.  In contrast, the mass of 12i (m/z = 761 M+H) could be detected 
in the ESI-MS spectrum, after stirring the peptide in the presence of KOtBu in THF for 72 h at 
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r.t.  The decomposition of the peptide seems to be induced by the carbene.  Maybe shorter 
peptides (e.g., tripeptides) should be synthesized and tested in the benzoin condensation, 
because an intramolecular attack of the carbene is less favored in a shorter peptide. 
The decomposing may also be avoided by introducing bulkier substituents at the nitrogen 
atoms of the histidine imidazole-moiety of histidine.  In 2006 Guillen et al. reported a 
synthetic route to various π- and τ-substituted histidinium salts:180 
 
Scheme 51: Synthetic route for the preparation of various π- and τ-substituted histidinium 
salts. 
 
The higher steric demand of bigger substituents at the NHC may keep the other amino acids 
at distance, thereby preventing the attack of the nucleophilic carbene at the peptidic 
backbone.  
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10. Outlook 
 
10.1 Immobilization of Boc-L-(π-Me)-His-AGly-L-Cha-L-Phe-OMe 
Wang et al. immobilized MacMillan’s catalyst on periodic mesoporous organosilica spheres 
(PMO)181 by “click chemistry”.182  The heterogeneous catalyst system showed high activity 
and selectivity in an asymmetric Diels-Alder reaction.  The catalyst could be reused seven 
times without a significant loss of reactivity. 
 
Scheme 52: MacMillan’s immobilized catalyst on PMO (periodic mesoporous organosilica 
spheres). 
 
The KR of rac-1 was tested with 12a-resin (the peptide was not cleaved from the resin), but 
only a low selectivity was observed. Modifications of peptide 12i at the adamantane core 
(207 and 208) did not decrease the selectivity for the KR of rac-1 drastically and therefore an 
immobilization at this position might be possible.  Unfortunately 207 and 208 were only 
methylated and therefore it is not known whether bigger substituents at the adamantane core 
will also not decrease the selectivity.  The synthesis of an AGly bearing an additional alkine 
moiety would be necessary. The following synthesis route may be applicable, but 
unfortunately, nine synthetic steps are required for the Boc-protected amino acid with an 
additional alkine moiety.183  
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Scheme 53: Synthetic route for the preparation of AGly precursor with an additional alkine 
substituent for “click chemistry”.  
 
The immobilization would yield a mixture of 271a and 271b and the effect on the selectivity of 
the KR of rac-1 can hardly be predicted. However, the inversion of even one stereogenic 
center at the backbone of 12i usually has a negative effect on the ee (see chapter 3). 
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10.2 Dynamic KR of trans-Cycolhexane-1,2-diol via Combination of Boc-L-(π-Me)-His-
AGly-L-Cha-L-Phe-OMe and a Metal-Complex 
 
As mentioned introductorily metal complexes are capable of racemizing chiral alcohols. 
Bäckvall and coworkers successfully combined a ruthenium complex for the racemization 
with enzymes for selective acyl transfer (see Introduction) and hence increased the possible 
yield (dynamic KR with a theoretical yield of 100%).184,185  In 2012, Fu et al. reported the 
dynamic KR of rac-phenylethanol under modified conditions utilizing their planar-chiral 
DMAP-derivative and a racemization catalyst introduced by Bäckvall.186 
 
 
 
Scheme 55: Dynamic KR of rac-41 utilizing a metal complex for the racemization and an 
organocatalyst for the enantioselective acyl transfer. 
Probably a similar concept could be applied to our catalytic system and the yield of 2 could 
be increased.  In contrast to the system of Fu et al., peptide 12i shows the highest selectivity 
towards rac-1.  Hence, both steriogenic centers can be racemized by 273/274 and a mixture 
of, e.g., rac-1 and meso-1 could be generated.  In our case this should not be a problem, 
because (R,R)-1 reacts much faster than meso-1 and (S,S)-1, and is therefore the 
preferentially acetylated substrate.  A problem could occur if the reaction of the metal-
complex 272 with (R,R)-2 is as fast as the inversion of the steriogenic centers of meso-1, 
(SS)-1 and (RR)-1, because in this case, the enantiopure product may be transformed into 
(R,S)-2, which is not configurationally stable and will again racemize to rac-2.67  For that 
reason, this dynamic KR will only work, if the racemization of (R,R)-2 is slow due to a higher 
steric demand. 
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Scheme 56: From KR to DKR: Pro and contra. 
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11. Abstract 
 
In 2008/2009, a highly enantioselective tetrapeptide for the kinetic resolution (KR) and 
desymmetrization of cyclic rac- and meso-cycloalkane-1,2-diols was introduced by Schreiner 
et al.  The conceptual difference between Miller’s and Schreiner’s approaches is that Miller 
utilizes amino acids like proline to induce a β-turn and generate a secondary peptide 
structure.  The folded structure is fixed by hydrogen bonds and a “pocket” is formed in which 
enantioselective transformations (e.g., acetylations, sulfonylations and phosphorylations) can 
occur.  In contrast, Schreiner et al. use a rigid adamantane amino acid in the middle of the 
peptide as a rigid spacer to separate both sides of the peptide in order to generate a chiral 
environment. 
 
 
 
Miller mainly uses screening methods and peptide libraries for the identification of new 
enantioselective peptides, because catalyst/substrate interactions are hardly predictable due 
to their high complexity.  Thus, rational catalyst design is difficult. 
In this thesis, spectroscopic- and computational methods (NMR- and IR-spectroscopy as well 
as MMFF-computations) have been utilized to shed some light on the interactions 
(catalyst/substrate) responsible for the selectivity.  It has been shown that the solvent highly 
influences the structure of the catalyst, because in non-polar solvents (e.g., toluene) the 
peptide has a “tighter” structure and IR-signals at 3300 cm–1, which can be related to 
hydrogen bonding interactions, whereas no such signals are found at 3300 cm–1 in CDCl3 at 
r.t.  
In the second project, Schreiner’s catalyst was tested in KR-experiments with different 
electrophiles (e.g. Boc2O, AcCl, diphenylchlorophosphate, diethylchlorophosphate and 
various benzenesulfonylchlorides) to see the influence of the electrophile on the selectivity.  
It was found that the selectivity depends on the counterion of the electrophile as well as on 
the electrophile itself. For Ac2O and Boc2O, good selectivities could be observed, while 
sulfonylation-, phosphorylation and acetylation reactions (utilizing AcCl) were unselective. 
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The influence of hydrogen bonding interactions on the selectivity was also tested by using 
trans-1,2-diaminocyclohexane, trans-2-aminocyclohexane-1-ol, trans-cyclohexane-1,2-dithiol 
and trans-2-mercaptocyclohexane-1-ol as substrates in the KR.  For trans-cyclohexane-1,2-
dithiol, which can only form weak hydrogen bonds to the peptide, and trans-2-
mercaptocyclohexane-1-ol, which can only form one strong hydrogen bond, some activity, 
but no selectivity was observed.  Strong hydrogen bonding interactions seem to be 
responsible for the selectivity, because for the structural related amino alcohol, diamine, 
dithiol and mercoptoalcohol, some activity, but only low (diamine) or no selectivity (dithiol) 
was found.  
The third project dealt with the synthesis of modified adamantane amino acids (AAA), their 
incorporation into the model peptide and the utilization of the modified peptides in the KR of 
trans-cyclohexane-1,2-diol,  trans-cyclohexane-1,3-diol, 1-phenylethanol and BINOL. 
 
Unfortunately, all structural changes at the i + 1 position (more flexible AAAs or 3- and 4-
amino benzoic acid), a β-amino acid at the i +2 position decreased the ee for the KR of trans-
cyclohexane-1,2-diol.  In contrast, additional substituents at the adamantine core, new 
aromatic amino acids at the i +2 position and the replacement of the Boc-group by an acyl 
moiety only had a low impact on the selectivity.  For trans-cyclohexane-1,3-diol, no selectivity 
was observed, while a new peptide showed some selectivity for 1-phenylethanol.  For BINOL 
the best selectivities were observed with the unmodified catalyst.  
In the forth section, a novel catalytically active moiety (carbene precursor) was introduced 
into the standard catalyst.  
 
The synthesis of two different peptides bearing a dimethylimidazolium- or methylthiazolium-
salt-group is described.  The peptides as well as dimethylimidazolium iodide were tested in 
benzoin condensations, but in contrast to dimethylimidazolium iodide, only low product yields 
were observed.  Unfortunately, the catalyst decomposes under the reaction conditions 
utilized for the benzoin condensation. Hence, further investigations will be necessary.
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12. Experimental Part 
 
Chemicals 
Unless otherwise noted, all chemicals were purchased from Acros Organics, Alfa Aesar, 
Sigma Aldrich, Merck, Novabiochem, Fluka and TCI in the highest purity grade available. All 
solvents were distilled prior to use. All aldehydes were freshly distilled. Acetic anhydride, 
acetyl chloride, diphenylchlorophosphate, diethylchlorophosphate, chloroacetonitrile and 
trans-1,2-diaminocyclohexane were distilled and stored under argon. Potassium tert-butylate 
and K2CO3 were dried at 100 °C in vacuo and stored under argon. DBU, Et3N, and DiPEA 
were distilled and dried prior to use. All catalytic reactions were carried out under argon 
atmosphere (99.99%, Messer Griesheim) employing oven- and flame-dried glassware.  
 
Purification of the solvents 
All glassware was flame-dried and flushed with argon. 
Tetrahydrofuran: THF was stored over KOH for one day. After distillation the solvent was 
refluxed for several hours under argon with sodium and benzophenone until the solution 
turned blue. Anhydrous THF was stored over molecular sieve 4 Å under argon. 
Toluene: Toluene was refluxed under argon with sodium and benzophenone for several 
hours until the solution turned blue. Anhydrous toluene was stored over molecular sieve 4 Å 
under argon. 
Methanol: Methanol was refluxed under argon with pieces of magnesia for 3 h. 
Subsequently, MeOH was distilled off and stored over molecular sieve 3 Å. 
 
NMR 
1H- and 13C-NMR spectra were recorded on Bruker BioSpin Avance II AV600 (600 MHz), 
AV400 (400 MHz) or AV200 (200 MHz) spectrometers using TMS as an internal standard 
with chemical shifts given in ppm relative to TMS (δ = 0.00 ppm) or the respective residual 
solvent peaks. 1H-NMR data are reported as follows: chemical shifts (multiplicity [ppm], 
coupling constants [Hz], integration, classification). Multiplicity is recorded as s = singlet, 
bs = broadened singlet, d = doublet, t = triplet, q = quartet, m = multiplet, quin = quintuplet, 
sext = sextet and sept = septet. For 13C-NMR chemical shifts and partial assignments are 
reported.  
 
ESI-MS 
ESI mass spectra were recorded on a Finnigan LCQDuo spectrometer using methanol 
solutions of the respective compounds. 
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Column chromatography 
Flash column chromatography and filtration were performed using Merck silica gel 60 Å 
(0.040 – 0.063 mm mesh size). 
 
Thin-layer chromatography 
Analytical thin-layer chromatography (TLC) was performed using pre-coated polyester sheets 
Polygram® SIL G/UV254 Machery-Nagel, 0.2 mm silica gel with fluorescent indicator. 
Visualization was accomplished by irradiation with a UV lamp and/or molybdophosphoric 
acid solution (5% H3[P(Mo3O10)4] in ethanol). 
 
GC-FID 
GC analysis was performed utilizing a Hewlett Packard 5890 gas chromatograph combined 
with flame ionization detection. 
 
HPLC 
Chiral, analytical and normal phase HPLC was performed via a Spectra SP 8700 equipped 
with a UV detector (λ = 220 and 254 nm). 
 
Polarimetry: 
The specific optical rotation was measured on a Jasco P-2000 spectrometer utilizing a 1mL 
cell with d = 10 cm. 
 
HR-ESI:  
Accurate masses were measured on a Bruker microTOF LC. 
The mass accuracy of these measurement is in the range of 5 ppm. 
 
IR:  
Low temperature IR experiments: 
IR measurements were performed on a Bruker IFS 25 IR spectrometer. We utilized a 
variable temperature-measuring cell equipped with CaF2 windows. The solution was filled 
into the NaF2 cell (d = 0.1 mm) and cooled to the desired temperature by adding liquid 
nitrogen. The temperature varied less than 1 K during the process of data acquisition. The 
spectra  (30 scans) were obtained with 2 cm–1 resolution. Solvent subtraction was 
accomplished by utilizing reference spectra obtained at the same temperature as the sample 
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spectra. 
The IR measurements at different concentrations were performer on a Bruker Alpha IR 
spectrometer. We utilized a KBr cell (d = 0.5 mm) 
 
General procedures 
 
General procedure I: HBTU/HOBt mediated peptide coupling in solution 
All peptides were prepared employing standard solid phase peptide synthesis techniques 
(SPPS), utilizing Fmoc-protected amino acids. HBTU (2-(1H-benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate) was used as the coupling agent and HOBt (1-
hydroxybenzotriazole) as a racemization suppressant. Couplings were performed utilizing 
two times 2 eq of amino acid, 2 eq HOBt, 2eq HBTU and 4 eq DiPEA in DMF for 30 min. 
Fmoc-L-Phe-Wang resin was used as solid support and swollen in DMF for 30 min. prior first 
Fmoc-cleavage. 
 
General procedure II: Fmoc-cleavage on solid support 
Cleavage of N-terminal Fmoc-protective groups was accomplished by dissolving the solid 
phase supported peptide twice in 25% piperidine in DMF (25 min.). Prior the next coupling 
step the resin was washed five times with DMF, DCM and DMF. For storage, the resin 
should be washed five times with DMF, DCM and diethyl ether and be kept in a refrigerator 
until use. 
 
General procedure III: Peptide cleavage from the resin 
Peptides were cleaved from their resins as methyl esters by shaking the functionalized resin 
twice for 2 days with methanol/Et3N/THF (9 : 1 : 1). The resin was filtered off and washed 
several times with chloroform. The collected solutions were concentrated under reduced 
pressure and purified via silica flash gel chromatography eluting with chloroform/methanol 
(95 : 5). 
 
General procedure IV: Fmoc-protection of adamantane amino acids 
The adamantane amino acid hydrochlorides and 4.5 equiv. of Na2CO3  were suspended in 
water/acetone (1 : 1). During stirring and cooling in an ice bath, 1.1 equiv. of Fmoc-Cl (9-
fluorenylmethyl chloroformate) in acetone were added with an addition funnel. The mixture 
was stirred at r.t. for about 12 h. Acetone was evaporated under reduced pressure (the 
temperature of the water bath should not exceed 30 °C) and the mixture poured on ice and 
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extracted with diethyl ether. The aqueous phase was carefully acidified with conc. HCl (pH ≈ 
4) and the precipitate was three times extracted with ethyl acetate. The combined organic 
phases were washed with water, dried with Na2SO4 and the solvent was removed under 
reduced pressure. The residue was purified by recrystallization from nitromethane. The 
protected amino acids were dried in a desiccator over paraffin wax and P2O5 under reduced 
pressure. 
 
General procedure V: Boc-protection of adamantane amino acids 
The adamantane amino acid hydrochlorides and 1.0 equiv. NaOH were dissolved in water 
and refluxed for about 2 h. The adamantane amino acid was filtered off and dried in a 
desiccator over P2O5 under reduced pressure. 
The unprotected adamantane amino acid was suspended in water/acetone (1 : 1) and 1.5 eq 
of triethylamine were added. Then 1.0 eq of Boc-ON (2-(tert-butoxycarbonyloxyimino)-2-
phenylacetonitrile) was added and the reaction mixture was stirred for 24 h. Another 1.0 
equiv. of Boc-ON was added and after 24 h the mixture was poured on ice and 0.2 equiv. 
Na2CO3 were added. Acetone was evaporated under reduced pressure (the temperature of 
the water bath should not exceed 30 °C) and five times extracted with diethyl ether. The 
aqueous phase was carefully acidified with conc. HCl (pH ≈ 4) and the precipitates were 
three times extracted with EtOAc. The combined organic layers were washed with water, 
dried over Na2SO4 and concentrated. Drying in a desiccator over paraffin wax and P2O5 
under reduced pressure yielded the protected amino acids. 
 
General procedure VI: EDC/HOBt mediated peptide coupling in solution 
The same equivalents of N-protected amino acids or peptide fragments, 1.1 eq of EDC (1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride), 1.1 eq of HOBt and 1.1 eq of Et3N 
were dissolved in DCM and stirred for 12 h at r.t. The reaction mixture was diluted with 
EtOAc and extracted with 0.5 M citric acid (four times) and saturated NaHCO3-solution. The 
solvent was removed under reduced pressure and the crude product was dried in a 
desiccator over paraffin wax and P2O5. 
 
General procedure VII: Cleavage of the -OtBu-protecting group (Boc) 
The Boc-protected peptide was dissolved in a solution of HCl in 1,4-dioxane (4.0 M) and 
stirred for 1 h. The excess of HCl was removed by bubbling argon through the solution. After 
evaporation of the solvent under reduced pressure the deprotected peptide was coupled 
without further purification. 
Experimental Part 	  
	   199 
General procedure VIII: Methylation of the peptides 
100 mg of the tetrapeptide were dissolved in 2 mL acetonitrile and 1 ml of CH3I was added. 
The reaction mixture was heated to 90 °C and refluxed for 3 days. After one day 1 mL of 
CH3I was added. The solvent was removed under reduced pressure and the crude product 
was purified via column chromatography. Isolated products were characterized by 1H- and 
13C-NMR spectroscopy and ESI-MS. 
 
General procedure IX: Synthesis of adamantane amino acid hydrochlorides from their 
acetamides 
The precursor molecules were refluxed in a mixture of conc. hydrochloric acid and water. 
The hydrochloric acid was removed completely under reduced pressure and the product was 
dried in a desiccator. The crude hydrochloride was treated with an organic solvent and 
filtered off via suction filtration. Drying in a desiccator over paraffin wax and P2O5 under 
reduced pressure yielded the products. 
 
General procedure X: Enantioselective acylation of chiral alcohols, amino alcohols, 
dithiols and mercaptoalcohols 
0.025 mmol of the alcohol were dissolved in 4.45 mL of dry toluene. 2 mol% of the peptide-
catalyst and 13.5 µL (0.1325 mmol) of acetic acid anhydride were added and the mixture 
was stirred at r.t. or 0 °C. The conversion and enantiomeric excess were determined by 
chiral GC.  
 
trans-Cyclohexane-1,2-diol (1) 
 
Assay of enantiomeric purity. 
Enantiomers of the 1 were separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDM 
column (Macherey Nagel). 
T (Injector + Detector) = 250 °C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100-250 °C, 2 °C/min  
Retention times: R1 = 17.4 min; R2 = 18.0 min 
 
 
OH
OH
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trans-1-Acetoxycyclohexan-2-ol (2a): 
 
Proof of GC retention times: 
Racemic trans-cyclohexane-1,2-diol ((±)-1) (0.345 g, 3.0 mmol) was treated with acetic 
anhydride (371 µL, 4 mmol) in the presence of N,N-dimethylaminopyridine (0.073 g, 
0.6 mmol) in 20 mL DCM and the resulting solution was stirred for 6 h at r.t. DCM was then 
removed in vacuo, and the mono- and diacetylated product were purified via silica flash gel 
chromatography (EtOAc, Rf = 0.70; Rf = 0.81). Isolated racemic 2 was characterized and 
then subjected to the GC assay described above to verify the origin of the GC signals. 
1H NMR (400 MHz, CDCl3): δ/ppm = 4.87 – 4.73 (m, 2 H, CHOAc), 2.14 – 2.00 (m, 2 H, CH) 
2.03 (s, 6 H, CH3), 1.78 – 1.65 (m, 2 H, CH), 1.47 – 1.24 (m, 4 H, CH3). 
13C NMR (100 MHz, CDCl3): δ/ppm = 170.5 (C=O), 73.7, 30.1, 23.4, 21.2. 
HR-MS (EI): m/z = 201.114 [M+H]+ (calc. m/z = 201.113) 
The NMR data are in accordance with the literature.60 
 
Assay of enantiomeric purity. 
Enantiomers of 2 were separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDM 
column (Macherey Nagel). 
T (Injector + Detector) = 250°C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100-250 °C, 2 °C/min  
Retention times: R1 = 15.9 min; R2 = 16.2 min. 
(±)-1-Phenylethanol (41) 
 
Assay of enantiomeric purity. 
Enantiomers of 41 were separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDM 
column (Macherey Nagel).T (Injector + Detector) = 250°C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
OH
OAc
OH
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Conditions: 100-250 °C, 10 °C/min  
Retention times: R1 = 6.4 min; R2 = 6.6 min 
 
1-Phenyl-1-acetoxy-ethane (219) 
 
219 was purchased from Sigma Aldrich and used without further purification. 
Assay of enantiomeric purity. 
Enantiomers of 219 were separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDM 
column (Macherey Nagel). 
T (Injector + Detector) = 250°C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100-250 °C, 10 °C/min  
Retention times: R1 = 5.2 min; R2 = 5.5 min 
 
trans-Cyclohexane-1,3-diol (60) 
 
Assay of enantiomeric purity. 
Enantiomers of 60 were separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDAc 
column (Macherey Nagel). 
T (Injector + Detector) = 250°C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 120-250 °C, 5 °C/min  
Retention times: R1 = 26.5 min; R2 = 27.3 min 
 
 
 
 
 
 
OAc
OH
OH
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trans-3-Acetoxy-cyclohexan-1-ol (61): 
 
Assay of enantiomeric purity. 
Enantiomers of monoacetate 61 were separated by chiral GC employing a 30 m                          
FS-Hydrodex β-6TBDM column (Macherey Nagel). 
T (Injector + Detector) = 250°C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 60 °C isothermal for 2 min; then 60–140 °C, 1 °C/min  
Retention times: R1 = 51.1 min; R2 = 51.9 min 
 
Proof of GC retention times: 
Trans-diol 60 (0.118 g, 1.0 mmol) was treated with acetic anhydride (95 µL, 1.0 mmol) in the 
presence of DMAP (0.019 g, 0.15 mmol) in 10 mL DCM and the resulting solution was stirred 
overnight at r.t. DCM was removed in vacuo, and the monoacetylated product ((±)-61) was 
purified by silica flash gel chromatography (EtOAc, Rf (61) = 0.46). Isolated racemic ((±)-61) 
(0.082 g, 0.7 mmol, 70%) was characterized and then subjected to the GC assay described 
above to prove the origin of the GC signals. Additionally 0.035 g (0.18 mmol; 18%) of the 
diacylated diol 60 (EtOAc, Rf = 0.63) were obtained. 
1H NMR (400 MHz, CDCl3): δ/ppm = 5.20 – 5.10 (m, 1 H), 4.03 (sept., 1 H, J = 5.6 Hz), 2.04 
(s, 3 H), 1.97–1.37 (m, 8 H).  
13C NMR (100 MHz, CDCl3): δ/ppm = 170.5 (C=O), 70.3, 66.9, 38.9, 33.9, 30.1, 21.4, 21.4, 
19.1. 
The NMR data are in accordance with the literature.187 
 
[1,1'-Binaphthalene]-2,2'-diol (Binaphtol) (65): 
 
Racemic [1,1'-binaphthalene]-2,2'-diol (Binaphtol) 65 was purchased from Sigma Aldrich and 
used without further purification: 
 
OH
OAc
OH
OH
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Assay of enantiomeric purity. 
Enantiomers of diol 65 were separated by using HPLC employing a 25 cm, d = 0.46 cm 
Chiralpak IB column (Daicel). 
Eluent: Hexane/Isopropanol 95:5  
Flow = 1 mL/min 
UV-detector λ = 254 nm  
Retention times: R1 = 32.7 min; R2 = 35.0 min 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl acetate (66): 
 
Assay of enantiomeric purity. 
Enantiomers of acetate 66 were separated by HPLC employing a 25 cm, d = 0.46 cm 
Chiralpak IB column (Daicel). 
Eluent: Hexane/Isopropanol 95:5  
Flow = 1 mL/min 
UV-detector λ = 254 nm  
Retention times: R1 = 14.1 min; R2 = 16.0 min 
Proof of GC retention times: 
Product 66 was not isolated; a mixture of monoacylated (66) and diacylated product were 
synthesized via DMAP catalysis. The products were not separated because the HPLC-
signals could be assigned clearly. The NMR data can be found in literature.189 
 
2'-Hydroxy-[1,1'-binaphthalen]-2-yl isobutylate (145): 
 
 
Assay of enantiomeric purity. 
Enantiomers of diacetate 145 were separated by using HPLC employing a 25 cm, d = 0.46 
cm Chiralpak IB column (Daicel). 
OAc
OH
O
OH
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Eluent: Hexane/Isopropanol 95:5  
Flow = 1 mL/min 
UV-detector λ = 254 nm  
Retention times: R1 = 6.6 min; R2 = 7.3 min 
Proof of GC retention times: 
Product 70 was not isolated; a mixture of monoacylated (70) and 68 was synthesized via 
DMAP catalysis. The products were not separated because the HPLC-signals could be 
assigned clearly. 
 
General procedure for the KR of rac-65 with catalysts 12i, 210, 211 and 213 
 
100 mg (0.35 mmol) 65 and 2 mol% (0,007 mmol) catalyst were dissolved in 65 mL abs. 
toluene and cooled to a certan temperature. Then 0.5 eq. anhydride (Ac2O or (iPrCO)2O) 
were added and the mixture was stirred for 8 h. The conversion was monitored by TLC 
(CHCl3; Rf = 0.58 (diacylated product); Rf = 0.5 (145); Rf = 0.33 (65). The products were not 
isolated, because the HPLC-signals could be assigned clearly and the ee could be 
determined.  
 
Boc-protection of rac-1 
Proof of GC retention times using DMAP as catalyst: 
Trans-diol 1 (0.58 g, 5.0 mmol) was treated with Boc2O (1.26 mL, 5.5 mmol) in the presence 
of DMAP (0.182 g, 1.5 mmol) in 100 mL dry toluene and the resulting solution was stirred 
overnight at r.t. Toluene was then removed in vacuo, and the O-tert-butoxylated product ((±)-
2e), the O,O-di-tert-butoxylated product ((±)-88) and the cyclic carbonate ((±)-87) were 
purified by silica flash gel chromatography (DCM/MeOH (19:1), Rf (88) = 0.81; Rf (87) = 0.71; 
Rf (2e) = 0.62). Isolated racemic ((±)-2e) (0.842 g, 3.9 mmol; 78%; colorless solid) and ((±)-
88) (0.126 mg, 0.4 mmol, 8%, colorless solid) were characterized and then subjected to the 
GC assay described to prove the origin of the GC signals. ((±)-87) could only be isolated in 
traces and was therefore synthesized using different reaction conditions. The NMR data for 
((±)-2e) and ((±)-90) are in accordance with the literature.118 
 
Proof of GC retention times using N-methylimidazole as catalyst: 
Trans-diol 1 (0.58 g, 5.0 mmol) was treated with Boc2O (1.26 mL, 5.5 mmol) in the presence 
of N-methylimidazole (123,2 µL, 1.5 mmol) in 100 mL dry toluene and the resulting solution 
was stirred overnight at r.t. Toluene was then removed in vacuo, and the O-tert-butoxylated 
product ((±)-2e), the O,O-di-tert-butoxylated product ((±)-88) and the cyclic carbonate ((±)-
87) were purified by silica flash gel chromatography (DCM/MeOH (19:1), Rf (88) = 0.81; Rf 
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(87) = 0.71; Rf (2e) = 0.62). Isolated racemic ((±)-2e) (0.821 g, 3.8 mmol; 76%; colorless 
solid) and ((±)-88) (0.94 g, 0.3 mmol; 6%; colorless solid) were characterized and then 
subjected to the GC assay described to prove the origin of the GC signals. ((±)-87) could 
only be isolated in traces and therefore synthesized using different reaction conditions. The 
NMR data for ((±)-2e) and ((±)-88) are in accordance with the literature.118 
 
Description of the preparative kinetic resolution experiment of (±)-1 with Boc2O 
Catalyst 12i (38 mg, 0.05 mmol, 5 mol%) and diol (±)-1 (116.2 mg, 1 mmol) were dissolved in 
160 mL of dry toluene to produce a clear solution. 0.46 mL (2.0 mmol, 2.0 eq) Boc2O was 
added and the solution was allowed to stir for 48 h at r.t. The reaction mixture was quenched 
with 10 mL methanol and then filtered using 40 g silica gel suspended with DCM to remove 
the catalyst. The solvent was removed under reduced pressure. The crude product was 
directly purified via silica gel column chromatography (DCM/methanol (19:1)). 104.2 mg (0.48 
mmol, 48.1%) of 2e (Rf = 0.62) and 52.1 mg (0.45 mmol, 44%) of 1 (Rf = 0.71) were isolated 
and directly characterized by chiral GC and NMR spectroscopy. 
 
General procedure: Enantioselective Boc-protection of trans-1,2-cyclohexanediol 
2.9 mg (0.025 mmol) of rac-1 were dissolved in 4.45 mL of dry toluene. 1 mol%, 2 mol%, 
5 mol% or 10 mol% (0.38 mg, 0.76 mg, 1.9 mg or 3.8 mg) of 12i and 5.74 µL, 11.49 µL, 
28.88 µL or 54.7 (0.025 mmol, 0.05 mmol, 0.1325 mmol or 0.25 mmol) of Boc2O were added 
and the mixture was stirred at r.t. The conversion and ee were determined by chiral GC.  
A stock solution was prepared: 4 mg 12i in 800 µL of dry toluene.  
 
(3a, 7a)-Hexahydrobenzo-1,3-dioxo-2-one (87) 
 
Proof of GC retention times for the cyclic carbonate 87: 
Trans-diol 1 (0.50 g, 4.3 mmol) was treated with Boc2O (2.94 mL, 12.9 mmol) in the presence 
of DMAP (0.52 g, 4.3 mmol) in 10 mL of dry acetonitrile and the resulting solution was stirred 
overnight at r.t. (25 °C). Acetonitrile was then removed in vacuo, and the O,O-di-tert-
butoxylated product ((±)-88) and the cyclic carbonate ((±)-87) were purified by silica flash gel 
chromatography (hexane/EtOAc (3:1), Rf (88) = 0.52; Rf (87) = 0.26). Isolated racemic ((±)-
87) (0.421 g, 3.0 mmol; 70%; colorless solid) and ((±)-88) (0.145 mg, 0.46 mmol; 11%; 
colorless solid) were characterized and then subjected to the GC assay described above to 
prove the origin of the GC signals. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 3.96 (m, 2 H), 2.19 (m, 2 H), 1.92-1.80 (m, 2 H), 1.69-
1.55 (m, 2 H), 1.42-1.29 (m, 2 H).  
O
O
O
Experimental Part 	  
	  206 
13C-NMR (100 MHz, CDCl3): δ/ppm = 155.1 (C=O), 83.5, 28.2, 23.2. 
The NMR data are in accordance with the literature.118 
Assay of enantiomeric purity. 
Enantiomers of the cyclic carbonate 87 were separated by chiral GC employing a 30 m FS-
Hydrodex β-6TBDM column (Macherey Nagel). 
T (Injector + Detector) = 250°C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100-250 °C, 2 °C/min  
Retention times: R1 = 29.5 min; R2 = 29.7 min 
 
tert-Butyl-2-hydroxycyclohexyl carbonate (2e) 
 
1H-NMR (400 MHz, CDCl3): δ/ppm = 4.34 (dt, J = 15 Hz, 1 H), 3.57 (dt, J = 15 Hz, 1 H) 2.51 
(bs, 1 H), 2.19–2.06 (m, 2 H), 1.76–1.63 (m, 2 H), 1.55 (s, 9 H), 1.42-1.29 (m, 4 H)  
13C-NMR (100 MHz, CDCl3): δ/ppm = 153.3 (C=O), 82.1, 80.9, 72.4, 32.7, 29.8, 27.6, 23.7, 
23.6. 
The NMR data are in accordance with the literature.118 
Assay of enantiomeric purity. 
Enantiomers of the mono tert-butoxycarbonylated product 2e were separated by chiral GC 
employing a 30 m FS-Hydrodex β-6TBDM column (Macherey Nagel). 
T (Injector + Detector) = 250°C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100-250 °C, 2 °C/min  
Retention times: R1 = 27.6 min; R2 = 27.4 min 
 
 
tert-Butylcyclohexane-1,2-diyl dicarbonate (88) 
 
1H-NMR (400 MHz, CDCl3): δ/ppm = 4.70–4.60 (m, 2 H), 2.19–2.06 (m, 2 H), 1.76–1.63 (m, 2 
H), 1.52 (s, 18 H), 1.39-1.23 (m, 4 H)  
OBoc
OH
OBoc
OBoc
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13C-NMR (100 MHz, CDCl3): δ/ppm = 152.9 (C=O), 82.1, 76.4, 29.9, 27.8, 23.3. 
The NMR data are in accordance with the literature.118 
 
Assay of enantiomeric purity. 
Enantiomers of the di-tert-butoxycarbonylated product 88 were not separated by chiral GC 
employing a 30 m FS-Hydrodex β-6TBDM column (Macherey Nagel). 
T (Injector + Detector) = 250°C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100-250 °C, 2 °C/min 
Retention times: R1 = 39.6 min 
 
Sulfonylation of trans-1,2-cyclohexanediol using DMAP as catalyst (93) 
500 mg (4.3 mmol) of rac-1, 104 mg (20 mol%) of DMAP, 950 mg of (4.3 mmol) 4-
nitrobenzenesufonyl chloride and 763 µL of DiPEA were dissolved in 25 mL of dry DCM and 
stirred for 24 h. The products were purified via flash chromatography eluting with ethyl 
acetate/pentane (3 : 1). 120 mg of 93 (0.4 mmol; 9.3%; Rf = 0.52) and 130 mg of 122 
(0.26 mmol; 6.3%; Rf = 0.61) were isolated as yellowish crystals. 
 
trans-2-Hydroxycyclohexyl 4-nitrobenzenesulfonate (93) 
 
1H-NMR (400 MHz, CDCl3): δ/ppm = 8.33 (d, J = 12 Hz, 2 H), 8.08 (d, J = 12 Hz, 2 H), 4.36 
(m, 1 H), 3.52 (m, 1 H), 1.99 (t, J = 12 Hz, 2 H), 1.85 (s, 2 H), 1.65 (m, 2 H), 1.43 (m, 1 H), 
1.31–1.11 (m, 3 H) 
13C-NMR (100 MHz, CDCl3): δ/ppm = 150.3, 142.9, 129.1, 124.4, 87.9, 72.0, 32.6, 31.2, 
24.0, 23.3. 
IR (KBr): ν/cm-1 = 3538, 2939,1609, 1534, 1351, 1185, 1095, 1076, 981, 926. 
HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C12H15NO6SNa+ 324.0512; Found 324.0513. 
 
trans-Cyclohexane-1,2-diyl bis(4-nitrobenzenesulfonate) (122) 
 
1H-NMR (400 MHz, CDCl3): δ/ppm = 8.29 (d, J = 8 Hz, 4 H), 7.98 (d, J = 8 Hz, 4 H), 4.48 (m, 
2 H), 2.04–1.94 (m, 2 H), 1.62–1.55 (m, 2 H), 1.52–1.38 (m, 2 H), 1.28–1.12 (m, 2 H) 
13C-NMR (100 MHz, CDCl3): δ/ppm = 150.8, 142.4, 129.1, 124.5, 81.3, 31.0, 22.6. 
OH
OSO2Ph-p-NO2
OSO2Ph-p-NO2
OSO2Ph-p-NO2
Experimental Part 	  
	  208 
IR (KBr): ν/cm-1 =2950, 1610, 1538, 1351, 1186, 1094, 977, 919. 
HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C18H18N2O10S2Na+ 509.0295; Found 509.0300. 
 
Assay of enantiomeric purity. 
Enantiomers of the monosulfonylated diol 93 were separated by using HPLC employing a 25 
cm, d = 0.46 cm Chiralpak IB column (Daicel). 
Eluent: Hexane/Isopropanol 90:10 
Flow = 0.7 mL/min 
UV-detector λ = 254 nm  
Retention times: R1 = 27.8 min; R2 = 31.9 min 
 
Sulfonylation of rac-1 using 12i as catalyst: 
116.2 mg (1.0 mmol) of rac-1, 2 mol% (15.2 mg) of 12i, 288 mg of 4-nitrobenzenesufonyl 
chloride were dissolved in 5 mL of dry DCM and 2 mL of a saturated NaHCO3 solution were 
added. The mixture was stirred for 24 h. The products were purified via silica flash gel 
chromatography eluting with ethyl acetate/pentane (3 : 1). 42 mg (0.13 mmol, 14%) of 93 (Rf 
= 0.52), 39 mg (0.08 mmol, 8%) of 122 (Rf = 0.61) were isolated. The enantiomeric excess of 
1 was determined by chiral GC.  
 
Sulfonylation test reactions 
1) 11.6 mg (0,1 mmol) of rac-1 were dissolved in 4.5 mL of dry toluene. 5 mol% (3.8 mg) 
of 12i, 12.8 µL (0.11 mmol) of 2,6-lutidine and 20.96 mg (0.11 mmol) of tosyl chloride were 
added and the mixture was allowed to stir for 24 h. The conversion was determined by TLC 
using EtOAc/hexane as eluent.   
 
2) 11.6 mg (0,1 mmol) of rac-1 were dissolved in 4.5 mL of dry toluene. 5 mol% (3.8 mg) 
of 12i, 12.8 µL (0.11 mmol) of 2,6-lutidine and 21.1 mg (0.11 mmol) of 4-
chlorobenzenesulfonyl chloride were added and the mixture was allowed to stir for 24 h. The 
conversion was determined by TLC using EtOAc/hexane as eluent.   
 
3) 11.6 mg (0,1 mmol) of rac-1 were dissolved in 4.5 mL of dry toluene. 5 mol% (3.8 mg) 
of 12i, 12.8 µL (0.11 mmol) of 2,6-lutidine and 18.2 µL (0.11 mmol) of 
trifluoromethanesulfonic anhydride were added and the mixture was allowed to stir for 24 h. 
The conversion was determined by TLC using EtOAc/hexane as eluent.   
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trans-2-Hydroxycyclohexyl diphenyl phosphate (94-Ph) 
 
580 mg (5 mmol) of rac-1, 0.826 mL (5 mmol) of DIPEA and 183 mg (1.5 mmol) of DMAP 
were dissolved in dry toluene. 1.035 mL (5 mmol) of diphenylchlorophosphate were added 
and the mixture was stirred for 12 h at r.t. The solvent was removed under reduced pressure 
and the crude mixture was purified via silica gel chromatography utilizing EtOAc/hexane (3:2) 
as eluent. 578 mg (1.6 mmol, 33.2%; Rf = 0.35) of a colorless solid were isolated.  
 
The same reaction was accomplished using 22 mg (0.03 mmol) of 12c as catalyst. The 
reaction was stopped at a conversion of 50 %. The crude product was purified by preparative 
HPLC (eluent: TBME/Hexane 60:40; UV-detector λ = 254 nm, Emax = 2.56; refractometer; 
column l = 250 mm, d = 8 mm, LiChrosorb Diol (7 µm, Merck); 70 mg (0.2 mmol; 40%) of a 
colorless solid were isolated. The product seems to be sensitive towards acids. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.41–7.31 (m, 4 H, HAr (Phe)), 7.29–7.17 (m, 6 H, HAr 
(Phe)), 4.34 (m, 1 H, Hα (OP(OPh)2) ), 3.61 (m, 1 H, Hα (OH)), 2.95 (s, 1 H, OH), 2.17–2.09 
(m, 1 H), 2.08–2.00 (m, 1 H), 1.77–1.64 (s, 2 H), 1.49–1.40 (m, 1 H), 1.36–1.19 (m, 3 H). 
13C-NMR (100 MHz, CDCl3): δ/ppm = 150.6, 129.8, 125.5, 120.1, 85.3, 73.3, 32.4, 31.2, 
23.9, 23.5. 
HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C18H21O5PNa+ 371.1025; Found 371.1019. 
IR (KBr): ν/cm-1 = 3471.6, 2936.6, 1589.0, 1489.5, 1265.4, 1186.9, 1086.4, 1018.2, 955.4, 
774.0. 
Assay of enantiomeric purity. 
Enantiomers of the mono tert-butoxycarbonylated product 94-Ph were separated by chiral 
GC employing a 30 m FS-Hydrodex β-6TBDM column (Macherey Nagel). 
T (Injector + Detector) = 250°C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 140 °C isotherm 13 min 
140–250 °C, 2 °C/min  
250 °C isotherm 15 min 
Retention times: R1 = 37.5 min; R2 = 37.9 min (94-Ph) 
    R1 = 10.4 min; R2 = 10.9 min (1) 
 
OH
O P
O
OPh
OPh
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trans-2-Hydroxycyclohexyl diethyl phosphate (94-Et) 
 
290 mg (2.5 mmol) of rac-1, 0.35 mL (2.5 mmol) of DiPEA and 91.6 mg (0.75 mmol) of 
DMAP were dissolved in dry toluene. 0.36 mL (2.55 mmol) of diethylchlorophosphate were 
added and the mixture was stirred for 12 h at r.t. The solvent was removed under reduced 
pressure and the crude mixture was purified via Al2O3 gel chromatography utilizing 
acetonitrile as eluent. 425 mg (1.6 mmol, 67%; Rf = 0.49) of a colorless liquid were isolated.  
1H-NMR (400 MHz, CDCl3): δ/ppm = 4.13–4.01 (q, 4 H, J = 6.8 Hz, O-CH2-R), 4.00–3.96 (m, 
1 H, Hα (OP(OEt)2)), 3.63 (s, 1 H, OH), 3.53–3.47 (m, 1 H, Hα (OH)), 2.14–1.91 (m, 2 H), 
1.70–1.58 (m, 2 H), 1.40–1.12 (m, 4 H), 1.32–1.27 (t, 6 H, J = 7.0 Hz, CH3).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 83.2, 73.5, 64.1, 32.9 31.7, 24.0, 23.6, 16.1. 
IR (Film): ν/cm-1 = 3404.3, 2938.6, 1453.1, 1258.4, 1028.0. 
HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C10H21O5PNa+ 275.1022; Found 275.1019. 
 
(2R,3S)-3-endo-Methoxycarbonyl-bicyclo[2.2.1]hept-5-ene-2-endo-carboxylic acid (128) 
 
500 mg (3 mmol) of meso-127 were dissolved in 10 mL of dry toluene. 30 mol% (71µL, 
0.9 mmol) of methylimidazole and 3 mL of dry methanol were added and stirred for 7 d at r.t. 
The reaction mixture was concentrated to dryness in vacuo and the resulting residue was 
dissolved in ethyl acetate. The solution was washed with 2 M HCl and dried over Na2SO4. 
The crude product was purified by silica flash gel chromatography eluting with EtOAc (Rf = 
0.38).  294 mg (1.5 mmol; 50%) of the product were isolated as a colorless solid.  
1H-NMR (400 MHz, CDCl3): δ/ppm = 9.54 (bs, 1 H), 6.24 (m, 1 H), 6.14 (m, 1 H), 3.52 (s, 3 
H), 3.23 (dq, J = 10 Hz, 2 H), 3.10 (d, J = 13 Hz, 2 H), 1.41 (td, J = 9 Hz, 1 H), 1.27 (d, J = 9 
Hz, 1 H)   
13C-NMR (100 MHz, CDCl3): δ/ppm = 178.5, 172.9, 135.7, 134.3, 51.5, 48.8, 48.3, 47.9, 
46.5, 46.0 
The NMR-data are in accordance with the literature.122 
 
 
 
 
 
OH
O P
O
OEt
OEt
COOMe
COOH
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2-tert-Butyl-3-methyl bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate (129) 
 
507 mg (2.6 mmol) of 128, 30 mg (0.25 mmol) of DMAP, 1 mL (6.0 mmol) of DIC and 0.5 mL 
(5.2 mmol) of tert-butanol were dissolved in 5 mL of dry DCM and stirred for 1 d at r.t. The 
precipitates were filtered off and the solution was concentrated to dryness in vacuo. The 
resulting residue was dissolved in DCM and the precipitates were filtered off again. The 
solution was washed with 0.5 M HCl, NaHCO3 solution and water, dried over Na2SO4 and the 
solvent was removed under reduced pressure. The crude product was purified by silica flash 
gel chromatography eluting with ethyl acetate/pentane (1 : 1) (Rf = 0.63).  360 mg (1.4 mmol; 
55%) of the product were isolated. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 6.20 (m, 1 H), 5.89 (m, 1 H), 3.57 (s, 3 H), 3.27 (t, J = 4 
Hz, 1 H), 3.16 (m, 1 H), 3.00 (m, 1 H), 2.51 (dd, J = 4.8 Hz, 1 H), 1.54 (m, 1 H), 1.39 (s, 9 H), 
1.35 (m, 1 H)   
13C-NMR (100 MHz, CDCl3): δ/ppm = 174.1, 173.7, 137.8, 135.1, 80.5, 51.9, 48.5, 48.1, 
47.9, 47.3, 45.7, 28.2. 
GC-MS m/z: [M]+ calcd for C14H20O4•+ 252; Found 252. 
 
Assay of enantiomeric purity. 
Enantiomers of the 3-endo-Methoxycarbonyl-bicyclo[2.2.1]hept-5-ene-2-endo-tert-butylester 
were separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDM column (Macherey 
Nagel). 
T (Injector + Detector) = 250°C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 110 isotherm (60 min) 
110-250 °C, 15 °C/min  
Retention times: R1 = 61.5 min; R2 = 62.0 min 
 
Methyl-3-(isopropyl(isopropylcarbamyl)carbamyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (130) 
 
Compound 129 was isolated as a byproduct in the synthesis of 128. The crude product was 
COOtBu
COOMe
CON–CONHiPr
COOMe
iPr
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purified by silica flash gel chromatography eluting with ethyl acetate/pentane (1 : 1) (Rf = 
0.43) and yielded 130 mg (0.4 mmol; 15%) of a colorless product. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.25 (bs, 1 H, NH), 6.31 (dd, J = 2.8 Hz, 1 H), 6.15 (dd, 
J = 2.8 Hz, 1 H), 4.35 (sept, J = 7.0 Hz, 1 H), 3.94 (sept, J = 7.2 Hz, 1 H), 3.57 (s, 3 H), 3.28 
(dd, J = 7.2, 2.6 Hz, 1 H), 3.20 (dd, J = 7.2, 2.6 Hz, 1 H), 3.10 (s, 1 H), 2.99 (s, 1 H), 1.40 (d, 
J = 8 Hz, 1 H), 1.28–1.19 (m, 7 H), 1.36 (q, J = 4.2 Hz, 6 H)   
13C-NMR (100 MHz, CDCl3): δ/ppm = 173.9, 154.4, 136.4, 133.4, 52.1, 51.4, 49.2, 48.9, 
47.6, 46.8, 45.7, 42.8, 22.6, 22.2, 21.4, 20.1 
 
Competition Experiment with different electrophiles 
 
2.9 mg (0.025 mmol) of trans-cyclohexane-1,2-diol 1, 13.5 µL of (0.1325 mmol) Ac2O, 27 mg 
(0.1325 mmol) of 4-nitrobenzenesulfonyl chloride, 19 µL (0.1325 mmol) of POCl(OEt)2 and 
80 mg (0.58 mmol) of K2CO3 were dissolved in 4.5 mL of abs. toluene and cooled to 0 °C. 2 
mol% of peptide 12i was added and the reaction monitored via GC and TLC  (the 
sulfonylated product cannot be detected via GC) and chiral GC. 
For reasons of comparability the same reaction was run with 2 mol% of DMAP as catalyst. 
Assay of product formation: 
All signals were detected by GC-FID employing a 30 m 5890_V UP5 (Machery Nagel). 
T (Injector + Detector) = 250 °C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100 °C – 250 °C, 15 °C/min 
Retention times: R = 9.8 min 
trans-Cyclohexane-1,2-diol 1: 6.9 min. 
Acylated product 2a: 8.8 min. 
POCl(OEt)2: 6.7 min. 
POCl(OPh)2: 15.2 min. 
DMAP: 9.5 min. 
 
TLC: 
EtOAc = eluent 
Rac-1  Rf = 0.15 n.f. 
93 Rf  = 0.6 f. 
94-Ph Rf  = 0.5 f. 
94-Et Rf  = 0.3 n.f. 
2  Rf  = 0.6 n.f. 
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POCl(OPh)2 Rf  = 0.7  f. 
SO2ClPh-p-NO2 Rf  = 0.65 f. 
f. = shows fluorescence 
n.f. = shows no fluorescence 
The spots were first detected under UV-light and then by phosphomolybdic acid. 
 
Assay of enantiomeric purity. 
See rac-1 and 2. 
 
trans-Cyclohexane-1,2-diyl diethanethioate 
 
1H-NMR (400 MHz, CDCl3): δ/ppm = 3.47 (m, 2 H), 2.25 (s, 6 H), 2.06–1.96 (m, 2 H), 1.66-
1.56 (m, 2 H), 1.56–1.44 (m, 2 H), 1.43–1.31 (m, 2 H) 
13C-NMR (100 MHz, CDCl3): δ/ppm = 194.6, 46.2, 33.1, 30.5, 24.9. 
 
Assay of enantiomeric purity. 
Enantiomers of trans-cyclohexane-1,2-diyl diethanethioate 
were separated by chiral GC employing a 30 m FS-Hydrodex β-6TBDM column (Macherey 
Nagel). 
T (Injector + Detector) = 250 °C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100-250 °C, 2 °C/min  
Retention times: R1 = 35.1 min; R2 = 35.6 min 
 
trans-	  (3a,7a)-Hexahydrobenzo[1,3]dithiole-2-thione (132)128 
 
3.5 g (62 mmol) of KOH were dissolved in 15 mL of dry methanol under argon. 5.7 g 
(74 mmol) of CS2 were added and the solution stirred for 30 min. Afterwards 2.45 g (25 
mmol) cyclohexene oxide were added and the mixture was allowed to stand for 20 h at r.t. 
The excess CS2 was distilled off, the yellow crystals separated via suction filtration, washed 
with water and dried in a desiccator under reduced pressure. 3.7 g (19.5 mmol; 78%) of the 
product were isolated as yellow crystals. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 4.12–3.9 (m, 2 H), 2.19–2.05 (m, 2 H), 1.95–1.81 (m, 2 
SAc
SAc
S
S
S
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H) 1.80–1.31 (m, 4 H)  
13C-NMR (100 MHz, CDCl3): δ/ppm = 64.53, 29.10, 24.89 
 
trans-Cyclohexane-1,2-dithiol (133)125 
 
3.7 g (19.5 mmol) of 133 were dissolved in 25 mL of dry THF, added to a suspension of 1,2 g 
(31.6 mmol) LiAlH4 in 50 mL of dry THF and the mixture was stirred for 1 h. The suspension 
was cooled in an ice-bath, 30 mL of water were added and the solution was acidified with 
2 M HCl. After extraction with diethyl ether and drying over Na2SO4, the solvent was removed 
under reduced pressure. The crude product was distilled (25 mbar, b.p. = 106 °C) to afford 
2.5 g (16.9 mmol; 87%) of the dithiol as a colorless liquid. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 3.31–2.95 (m, 2 H), 2.61–2.32 (m, 1 H), 2.21–1.95 (m, 2 
H), 1.85–1.55 (m, 2 H), 1.45 (m, 1 H) 1.45–1.15 (m, 4 H). 
13C-NMR (100 MHz, CDCl3): δ/ppm = 48.3, 36.9, 26.45 
 
Assay of enantiomeric purity. 
Enantiomers of  trans-cyclohexane-1,2-diol 133 were separated by chiral GC employing a 30 
m FS-Hydrodex β-6TBDAc column (Macherey Nagel). 
T (Injector + Detector) = 250 °C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100-220 °C, 2 °C/min  
           220-250 °C, 20 °C/min  
Retention times: R1 = 15.3 min; R2 = 15.8 min 
 
trans-2-Mercaptocyclohexan-1-ol (134)127 
 
To 0.52 mL (5.1 mmol) of 131 and 1.33 g (7.45 mmol) of hexamethyldisilathiane (HMDST)  in 
0.5 mL of dry THF under argon, 1.3 mL of tetrabutyl ammonium fluoride (TBAF, 1 M solution 
in THF) were added and the solution was stirred for several minutes at r.t. After the addition 
of 50% citric acid and additional stirring for 30 min, the reaction mixture was washed with a 
citric acid-solution, diluted with diethyl ether and dried over Na2SO4. The solvent was 
evaporated. 482 mg (3.6 mmol; 71%) of a colorless liquid were obtained. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 2.71 (m, 2 H), 2.19–2.01 (m, 2 H), 1.95 (m, 2 H), 1.65 
SH
SH
SH
OH
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(m, 2 H), 1.45–1.21 (m, 4 H). 
13C-NMR (100 MHz, CDCl3): δ/ppm = 47.36, 36.18, 34.28, 26.30, 24.06 
 
Assay of enantiomeric purity. 
Enantiomers of trans-2-mercaptocyclohexane-1-ol 134 were separated by chiral GC 
employing a 30 m FS-Hydrodex β-6TBDM column (Macherey Nagel). 
T (Injector + Detector) = 250 °C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100-170 °C, 2 °C/min 
  170-250 °C , 20 °C/min 
Retention times: R1 = 16.9 min; R2 = 17.8 min 
 
trans-	  2-Mercaptocyclohexyl ethanethioate (135) 
 
Assay of enantiomeric purity. 
Enantiomers of 135 could not be separated by chiral GC employing a 30 m FS-Hydrodex β-
6TBDM column (Macherey Nagel). 
T (Injector + Detector) = 250 °C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100-250 °C, 2 °C/min  
Retention times: R1 = 25.1 
The monoacylated product was not isolated because no selectivity for 133 was observed and 
the signals could be assigned clearly. 
 
trans-2-Hydroxycyclohexyl ethanethioate or trans-mercaptocyclohexyl acetate 
(136a/136b)	   
 
Assay of enantiomeric purity. 
Enantiomers of 136a/136b could not be separated by chiral GC employing a 30 m FS-
Hydrodex β-6TBDM column (Macherey Nagel). 
T (Injector + Detector) = 250 °C 
SH
SAc
SAc
OH
SH
OAc
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Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100-170 °C, 2 °C/min 
  170-250 °C , 20 °C/min 
Retention times: R1 = 27.9 min 
The product was not isolated, because no selectivity for the KR of 134 was observed. 
 
trans-tert-Butyl-2-aminocyclohexylcarbamate (Boc-141) 
 
2.5 mL (20.8 mmol) of rac-140 were dissolved in 13 mL of toluene and cooled to 0 °C in an 
ice bath. 1.5 g (7.0 mmol) of Boc2O were dissolved in 13 mL of toluene, added dropwise via 
an addition funnel within 1 h, and the reaction mixture was stirred for 24 h at r.t. 10 mL of 
H2O and toluene were added and the layers were separated. The organic layer was 
concentrated under reduced pressure and the residue was dissolved in 15 mL H2O and 
15 mL of Et2O and acidified with an HCl solution to pH = 5. The bis-protected amine was 
extracted with Et2O. The aqueous phase was adjusted to pH = 10.5 with NaOH-solution and 
extracted with EtOAc (5 x 15 mL). The organic layers were dried over Na2SO4, and then 
evaporated under reduced pressure to yield 849 mg (4 mmol; 56.6% based on Boc2O) of the 
colorless solid monoboc-protected amine and 313 mg (1 mmol, 28% based on Boc2O) of the 
diboc-protected amine. The NMR data are in accordance with the literature.118 
 
trans-N-(2-Aminocyclohexyl)-isobutyramide (141) 
 
2.5 mL (20.8 mmol) of rac-140 were dissolved in 12.5 mL of DCM and cooled to 0 °C in an 
ice bath. 1.1 g (7.0 mmol) of (iPrCO)2O were dissolved in 13 mL of DCM, added drop 
wise via an addition funnel within 1 h, and the reaction mixture was stirred for 16 h at r.t. 10 
mL of H2O and DCM each were added and the layers were separated. The organic layer was 
concentrated under reduced pressure and the residue was dissolved in 15 mL H2O and 
15 mL DCM and acidified with a HCl solution to pH = 5. The bis-protected amine was 
extracted with DCM. The aqueous phase was adjusted to pH = 10.5 with a NaOH-solution 
and extracted with EtOAc (5 x 15 mL). The organic layers were dried over Na2SO4, and then 
evaporated under reduced pressure to yield 405 mg (2.2 mmol; 31% based on (iPrCO)2O) of 
monoboc-protected amine as a yellowish solid and 608 mg (2.4 mmol; 69% based on 
NHBoc
NHBoc
NH2
NHBoc
NH2
N
H
O
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(iPrCO)2O) of the bis-protected amine (colorless solid).  
1H-NMR (400 MHz, CDCl3): δ/ppm = 5.42 (d, 1 H, J = 7.7 Hz, NH); 3.51–3.41 (m, 1 H); 2.38–
2.24 (m, 2 H); 1.96–1.86 (m, 2 H); 1.81 (s, 2 H); 1.70–1.60 (m, 2 H); 1.32–0.99 (m, 10H);  
13C-NMR (100 MHz, CDCl3): δ/ppm = 177.4 (C=O), 55.6, 55.5, 35.9, 35.2, 32.6, 25.1, 25.0, 
19.7. 
HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C10H20N2ONa+ 207.1468; Found 207.1462. 
 
trans-Cyclohexyl-1,2-isobutyramide (142) 
 
1H-NMR (400 MHz, CDCl3): δ/ppm = 6.12 (s, 2 H, NH), 3.51–3.41 (m, 2 H, CH), 2.38–2.18 
(m, 2 H), 1.99–1.88 (m, 2 H), 1.78–1.60 (m, 2 H), 1.32–1.10 (m, 4H), 1.08–0.99 (m, 12 H). 
13C-NMR (100 MHz, CDCl3): δ/ppm = 177.6 (C=O), 53.4, 35.6, 32.3, 24.7, 19.5. 
HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C14H26N2O2Na+ 277.1886; Found 277.1884. 
 
Catalytic acylation of rac-140 with (iPrCO)2O at –78 °C 
 
87.5 µL (0.53 mmol) of (iPrCO)2O and 15 mg (2 mol%; 0.02 mmol) of 12i were dissolved in 
160 mL of abs. toluene and cooled to –82°C in an ethylacetate/liquid nitrogen bath. 105 µL 
(0.875 mmol) of rac-140 were added and the reaction mixture was allowed to stir for 10 h at 
–82°C. The solvent was removed under reduced pressure and 30 mL of H2O and 30 mL of 
DCM were added and the layers were separated. Another 30 mL of H2O and were added 
and the aqueous layer was acidified to pH = 5 with a HCl solution. The bis-protected amine 
was extracted with DCM. The aqueous layer was adjusted to pH = 10.5 with a NaOH-
solution and extracted with EtOAc (3 x 30 mL). The organic layers were dried with Na2SO4, 
and then evaporated under reduced pressure to yield 60.7 mg (0.33 mmol; 38%) of the 
monoboc-protected amine (141) as a yellowish solid and 12 mg (0.05 mmol; 6%) of the bis-
protected amine (142, colorless solid). 
1H-NMR (400 MHz, CDCl3): δ/ppm = 5.42 (d, 1 H, J = 7.7 Hz, NH); 3.51–3.41 (m, 1 H); 2.38–
2.24 (m, 2 H); 1.96–1.86 (m, 2 H); 1.81 (s, 2 H); 1.70–1.60 (m, 2 H); 1.32–0.99 (m, 10H);  
13C-NMR (100 MHz, CDCl3): δ/ppm = 177.4 (C=O), 55.6, 55.5, 35.9, 35.2, 32.6, 25.1, 25.0, 
19.7. 
HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C10H20N2ONa+ 207.1468; Found 207.1462. 
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trans-N-(2-Hydroxycyclohexyl)isobutyramide (144) 
 
645 mg (5.6 mmol) of rac-143 were dissolved in 20 mL of DCM and cooled to 0°C in an ice 
bath. 975 (6.16 mmol) of (iPrCO)2O were added and the mixture was stirred for 40 h at r.t. 
The solvent was removed under reduced pressure and the crude product was purified via 
silica flash gel column chromatography CH3Cl/MeOH (10:1). 90% (5 mmol) of a colorless 
solid were isolated (Rf = 0.3). 
1H-NMR (200 MHz, CDCl3): δ/ppm = 5.68 (s, 1 H, NH); 4.18 (bs, 1 H, OH); 3.71–3.44 (m, 1 
H, CHOH); 3.42–3.18 (m, 1 H, CHNH); 2.51–2.29 (quin, 1H, J = 7 Hz, CH(CH3)2); 2.13–1.89 
(m, 2 H); 1.79–1.63 (m, 2 H); 1.46–0.99 (m, 10 H). 
13C-NMR (50 MHz, CDCl3): δ/ppm = 179.1 (C=O), 75.6, 55.6, 35.6, 34.5, 31.5, 24.6, 24.0, 
19.6. 
HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C10H19NO2Na+ 208.1308; Found 208.1304. 
 
Catalytic acylation of 143 with (iPrCO)2O at –78 °C 
 
87.5 µL (0.53 mmol) of (iPrCO)2O and 15 mg (2 mol%; 0.02 mmol) of 12i were dissolved in 
160 mL of abs. toluene and cooled to –82°C in an ethylacetate/liquid nitrogen bath. 100 mg 
(0.875 mmol) of rac-143 were added and the reaction mixture was allowed to stir for 10 h at 
–82 °C. The solvent was removed under reduced pressure and the crude product was 
purified via silica flash gel column chromatography CH3Cl/MeOH (10:1). 90.7 mg (0.47 mmol; 
54%) of 144 were isolated (Rf = 0.34) as a colorless solid. Product 143 was isolated by drying 
the silica gel and subsequent extraction with MeOH. 41.2 mg (0.36 mmol; 41%) of the amino 
alcohol could be recoverd. 
1H-NMR (200 MHz, CDCl3): δ/ppm = 5.68 (s, 1 H, NH); 4.18 (bs, 1 H, OH); 3.71–3.44 (m, 1 
H, CHOH); 3.42–3.18 (m, 1 H, CHNH); 2.51–2.29 (m, 1H, CH(CH3)2); 2.13–1.89 (m, 2 H); 
1.79–1.63 (m, 2 H); 1.46–0.99 (m, 10 H). 
13C-NMR (50 MHz, CDCl3): δ/ppm = 179.1 (C=O), 75.6, 55.6, 35.6, 34.5, 31.5, 24.6, 24.0, 
19.6, 18.9. 
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Adamantane Amino Acids 
 
3-[(tert-Butoxycarbonyl)amino]tricyclo[3.3.1.13.7]decane-1-carboxylic acid (Boc-156) 
 
1.0 g (5.1 mmol) of 3-aminoadamantane-1-carboxyclic acid 180 were suspended in 50 mL of 
H2O and 50 mL of acetone. 1.1 mL (7.65 mmol) of Et3N were added. Then, 1.3 g (5.1 mmol) 
of Boc-ON were added and the reaction mixture was stirred overnight. Another 1.3 g 
(5.1 mmol) Boc-ON were added and after stirring for 24 h, the reaction mixture was poured 
over 200 g of crushed ice and 113 mg of Na2CO3 were added. After evaporation of acetone, 
the aqueous layer was extracted with diethyl ether (5 x 50 mL) and acidified to pH=2 by 
dropwise addition of HCl. A white solid precipitated, which was extracted with ethyl acetate (3 
x 50 mL). The combined organic layers were washed with water (3 x 25 mL) and dried over 
Na2SO4. The solvent was evaporated under reduced pressure and the remaining solid was 
dried over P2O5 and paraffin wax in a vacuum desiccator. 420 mg (1.4 mmol, 27%) of a 
colorless solid were obtained. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.11 (bs, 1H, CO2H); 6.52 (bs, 1 H, NH); 2.10-1.98 
(m, 2 H, adamantane), 1.98–1.69 (m, 6 H), 1.69–1.47 (m, 6H), 1.26 (s, 9 H). 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 177.7 (C=O); 154.3 (C=O); 77.3, 50.1, 42.3, 41.7, 
40.5, 37.8, 35.3, 28.5, 28.3. 
The NMR data are in accordance with the literature.149 
Crystallographic data: 
 
Identification code shre203p 
Empirical formula C16H25NO4 
Formula weight 295.31 g mol–1 
Temperature 293(2) K 
Wavelength 0.71073 Å 
COOH
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Crystal system, space group Triclinic P –1 
Unit cell dimensions a = 6.5642(10) Å α = 88.685(18) deg. 
 b = 9.9774(16) Å β = 84.354(18) deg. 
 c = 12.5043(19) Å γ = 80.554(18) deg. 
Volume 803.9(2) Å3 
Z, Calculated density 4, 1.746 Mg/m3 
Absorption coefficient 0.117 mm–1 
F(000) 464 
Crystal size 1.10 mm x 1.00 mm x 1.50 mm 
Theta range for data collection 2.63 to 28.13 deg. 
Limiting indices –8 ≤ h ≤ 8, –13 ≤ k ≤ 13, –16 ≤ l ≤ 14 
Reflections collected / unique 7239 / 3546 [R(int) = 0.0514] 
Completeness to theta = 28.13 ° 90.3 % 
Absorption correction None 
Refinement method Full-matrix least-squared on F2 
Data / restraints / parameter 3546 / 0 / 290 
Goodness-of-fit on F2 1.388 
Final R indices [I > 2 σ(I)] R1 = 0.0639 wR2 = 0.1886 
R indices (all data) R1 = 0.0782 wR2 = 0.1964 
Largest diff. peak and hole 0.38 and -0.45 e Å–3 
 
The same reaction was also carried using ultrasonic sound due to the poor solubility of the 
free adamantine amino acid, but the yield did not increase. 
 
3-(9-Fluorenyl)methoxycarbonylaminotricyclo[3.3.1.13.7]decane-1-carboxylic acid (156) 
 
2.317 g (10 mmol) of 164 were dissolved in 120 mL of acetone/water (1/1). The procedure is 
in accordance with the general procedure IV. During work up, the reaction mixture should not 
get warmer than 40 °C. The crude product was recrystallized from nitromethane. 2.68 g (6.4 
mmol; 64.2%) of a slightly yellowish product were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.11 (bs, 1H, CO2H), 7.88 (d, J = 7,6 Hz, 2H), 7.72 
(d, J = 7,2 Hz, 2H), 7.41 (t, J = 7,4 Hz, 2H), 7.34 (t, J = 7,6 Hz, 2H), 7.12 (s, 1H, NH), 4.20 
(m, 3H), 2.10–1.55 (m, 14 H, adamantane) 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 177.7 (C=O); 154.3 (C=O); 144.0, 140.7, 127.6, 
127.0, 125.2, 120.1, 64.8 (Fmoc-CH2), 50.2 (Cq), 46.7, 42.3, 41.5, 40.2 (Cq), 37.6, 34.9, 28.2 
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IR (KBr): ν/cm-1 = 3315, 3065, 3040, 2911, 2853, 1718, 1675, 1555, 1448, 1263, 1089, 732 
The NMR data are in accordance with the literature.149 
 
1-(9-Fluorenyl)methoxycarbonylaminotricyclo[3.3.1.13.7]decane-3-methylcarboxylic 
acid (157) 
 
0.25 g (1 mmol) of 168 were dissolved in 30 mL of acetone/water (1/1). The procedure is in 
accordance with the general procedure IV. For this synthesis it is important to look carefully 
after the temperature. During work up, the reaction mixture should not get warmer than 30 
°C. The crude product was recrystallized from nitromethane. 0.250 g (0.58 mmol; 58%) of a 
light yellow product were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.03 (bs, 1H, CO2H); 7.94 (d, J = 7.6 Hz, 2 H); 7.77 
(d, J = 7.2 Hz, 2 H); 7.46 (t, J = 7.5 Hz, 2 H); 7.39 (t, J = 7.6 Hz, 2 H); 7.13 (s, 1H, NH); 4.24 
(m, 3H); 2.20–0.96 (m, 16 H, adamantane) 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 172.4 (C=O), 154.1 (C=O), 144.1, 140.7, 127.5, 
127.0, 125.3, 120.0, 64.8 (Fmoc-CH2), 50.5 (Cq), 47.7, 46.7, 45.6, 40.7, 40.2, 35.3 (Cq), 33.7, 
28.8 
IR (KBr): ν/cm-1 = 3327,3288, 2898, 2853, 1687, 1439, 1333, 742 
Elem. Anal.: C27H29NO4 (431.52): calcd. C 75.15, H 6.77, N 3.25; found: C 75.21, H 6.80, N 
3.32 
Crystallographic data: 
 
Identification code shre249p 
Empirical formula C27H29NO4 
Formula weight 431.52 g mol–1 
Temperature 293(2) K 
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Wavelength 0.71073 Å 
Crystal system, space group Monoclinic P 21/c 
Unit cell dimensions a = 8.7479(6) Å α = 90.0(0) deg. 
 b = 16.2356(11) Å β = 96.257(7) deg. 
 c = 31.6541(18) Å γ = 90.0(0) deg. 
Volume 4469.0(5) Å3 
Z, Calculated density 8, 1.283 Mg/m3 
Absorption coefficient 0.086 mm–1 
F(000) 1840 
Crystal size 1.15 mm x 0.95 mm x 0.12 mm 
Theta range for data collection 1.80 to 23.30 deg. 
Limiting indices –9 ≤ h ≤ 9, –17 ≤ k ≤ 17, –35 ≤ l ≤ 34 
Reflections collected / unique 23490 / 6364 [R(int) = 0.0783] 
Completeness to theta = 23.30 ° 98.4 % 
Absorption correction None 
Refinement method Full-matrix least-squared on F2 
Data / restraints / parameter 6364 / 0 / 809 
Goodness-of-fit on F2 0.632 
Final R indices [I > 2 σ(I)] R1 = 0.0404 wR2 = 0.0952 
R indices (all data) R1 = 0.0893 wR2 = 0.1181 
Largest diff. peak and hole 0.64 and -0.18 e Å–3 
 
 
3-(9-Fluorenyl)methoxycarbonylmethylaminotricyclo[3.3.1.13.7]decane-1-carboxylic 
acid (158) 
 
0.35 g (1.65 mmol) of 184 were dissolved in 40 mL of acetone/water (1/1). The procedure is 
in accordance with the general procedure IV. 
For this synthesis it is important to look carefully after the temperature. During work up, the 
reaction mixture should not get warmer than 30 °C. The crude product was recrystallized 
from nitromethane. 0.275 g (0.63 mmol; 38%) of a light yellow product were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm 12.03 (bs, 1 H), 7.89 (d, J = 6.8 Hz, 2 H), 7.72 (d, J = 
8 Hz, 2 H), 7.41 (t, J = 6.0 Hz, 2H); 7.32 (t, J = 6.0 Hz, 2H), 4.28 (m, 3 H), 2.10–1.95 (m, 2 
H), 1.83–1.15 (m, 14 H) 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 178.4(C=O), 156.6 (C=O), 144.9, 140.7, 140.78, 
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127.6, 127.0, 125.3, 120.1, 65.1 (Fmoc-CH2), 51.6 (Cq), 46.8, 41.1, 38.8, 38.1, 35.5, 
34.1(Cq), 27.5 
IR (KBr): ν/cm-1 = 3318, 3250, 3098, 2934, 2901, 2848, 1700, 1656, 1553, 1478, 1452, 
1213, 1129, 733 
Elem. Anal.: C27H29NO4 (431.52): calcd. C 75.15, H 6.77, N 3.25; found: C 75.03, H 6.72, N 
3.53 
Crystallographic data: 
 
Identification code shre217p 
Empirical formula C27H29NO4 
Formula weight 431.52 g mol–1 
Temperature 293(2) K 
Wavelength 0.71073 Å 
Crystal system, space group Monoclinic P –1 
Unit cell dimensions a = 12.9727(27) Å α = 90.00(0) deg. 
 b = 12.1817(17) Å β = 93.31(2) deg. 
 c = 13.8644(24) Å γ = 90.00(0) deg. 
Volume 2187.3(3) Å3 
Z, Calculated density 4, 1.213 Mg/m3 
Absorption coefficient 0.076 mm–1 
F(000) 856 
Crystal size 0.90 mm x 0.15 mm x 1.00 mm 
Theta range for data collection 2.68 to 28.21 deg. 
Limiting indices –17 ≤ h ≤ 17, –16 ≤ k ≤ 14, –18 ≤ l ≤ 18 
Reflections collected / unique 20039 / 9835 [R(int) = 0.1914] 
Completeness to theta = 27.05 ° 91.1 % 
Absorption correction None 
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Refinement method Full-matrix least-squared on F2 
Data / restraints / parameter 9835 / 0 / 809 
Goodness-of-fit on F2 0.608 
Final R indices [I > 2 σ(I)] R1 = 0.0603 wR2 = 0.1309 
R indices (all data) R1 = 0.2581 wR2 = 0.2335 
Largest diff. peak and hole 0.25 and -0.23 e Å–3 
 
3-(9-Fluorenyl)methoxycarbonylmethyltricyclo[3.3.1.13.7]decane-1-methylcarboxylic 
acid (159) 
 
1.0 g (3.7 mmol) of 185 were added to a stirred and cooled (ice bath) mixture of 15 mL conc. 
sulfuric acid and 0.75 mL conc. nitric acid. Afterwards, 15 mL of 1,1-dichloroethane were 
added and the reaction mixture was stirred for another 1 h at 0 °C. Stirring was continued 
overnight at r.t. The solution was poured on ice and extracted with diethyl ether. The 
aqueous layer was alkalized to pH = 9 with saturated NaOH. 75 mL of acetone and 2.8 g 
(11 mmol) of Fmoc-Cl were added and the mixture was again stirred overnight. 
The procedure is in accordance with the general procedure IV. For this synthesis it is 
important to look carefully after the temperature. During work up, the reaction mixture should 
not get warmer than 30 °C. Only 0.07g (0.16 mmol; 4%) of a yellowish, highly viscous oil 
were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.03 (bs, 1H, CO2H); 7.77 (d, J = 7,6 Hz, 2 H); 7.61 
(d, J = 7,2 Hz, 2 H), 7.42–7.02 (m, 4H); 4.19 (m, 3H); 2.13–0.94 (m, 18 H, adamantane) 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 172.5 (C=O), 156.6 (C=O), 143.6, 140.8, 127.7, 
126.6, 125.4, 120.0, 65.3 (Fmoc-CH2), 51.7 (Cq), 48.3, 47.1, 44.5, 41.5, 38.9 (Cq), 34.7, 32.2, 
28.0, 21.2 
MS (ESI): m/z = 468.2 [M + Na]+; (calc. 468.2) 
 
3-[(tert-Butoxycarbonyl)methylamino]tricyclo[3.3.1.13.7]decane-1-methylcarboxylic acid 
(Boc-159) 
 
724 mg (3.2 mmol) of 185, 985.1 mg (4 mmol) Boc-ON (2-(tert-butoxycarbonyloxyimino)-2-
phenylacetonitrile) and 0.5 mL (4.0 mmol) of Et3N were dissolved in 80 mL of acetone and 80 
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mL of H2O and stirred for 18 h at r.t. The reaction mixture was poured on ice and 65 mg of 
Na2CO3 (0.6 mmol) were added. Acetone was removed under reduced pressure and the 
aqueous solution was extracted with Et2O. The aqueous layer was acidified to pH = 2 with 
conc. HCl and extracted with EtOAc (3 x). The organic layer was dried over Na2SO4 and the 
solvent removed under reduced pressure. 739.3 mg (2.4 mmol; 74%) of the product were 
isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 4.55 (bs, 1 H, NH), 2.81–2.72 (m, 2 H), 2.21–1.91 
(m, 4 H), 1.68–1.38 (m, 21 H)  
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 177.3 (C=O), 156.4, 79.1, 51.4, 48.2, 44.7, 41.6, 
39.2, 36.0, 34.8, 33.0, 28.5, 28.4  
MS (ESI): m/z = 468.2 [M + Na]+; (calc. 468.2) 
The NMR-data are in accordance with the literature.156 
 
3-Acetamidotricyclo[3.3.1.13.7]decane-1-carboxylic acid (163)149 
 
25 g (138.9 mmol) of 162 were suspended in 20 mL of conc. nitric acid and cooled to 0 °C in 
an ice bath. In the course of 1 h. 150 mL of conc. sulfuric acid were added to the suspension. 
After stirring for 2 h at 0 °C, 100 mL of acetonitrile were added within 3 h at the same 
temperature. The reaction mixture was poured on ice, the colorless precipitates collected via 
suction filtration, washed with water and recrystallized from acetic acid/water/acetone (5 : 5 : 
2 ). The product was dried in a desiccator under reduced pressure and 27.82 g (117.2 mmol; 
84.4%) of the acetamide were obtained as colorless crystals. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 11.17 (bs, 1H, CO2H); 7.43 (bs, 1H, NH); 2.08 (m, 
2H); 1.98 (s, 2H); 1.85 (m, 4H); 1.76 (s, 3H, CH3); 1.69 (d, J = 2,8 Hz, 4H); 1.55 (bs, 2H) 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 177.6 (C=O), 168.8 (C=O), 50.8, 42.1, 41.4, 40.0, 
37.6, 35.0, 28.6, 28.5, 23.6. 
The NMR-data are in accordance with the literature. 
 
3-Aminotricyclo[3.3.1.13.7]decane-1-carcoxylic acid hydrochloride (164)149 
 
23.3 g (98.2 mmol) of 163 were refluxed in 270 mL of conc. HCl and 150 mL of water for 3 d. 
The crude product was treated with acetone. 18.69g (80.7 mmol; 82.2%) of product were 
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obtained as a colorless solid.  
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.36 (bs, 1H, CO2H); 8.33 (bs, 3H, NH3Cl); 7.37 (t, 
1H, J(15NH) =50.6 Hz) 2.15 (m, 2H); 1.88 (m, 2H); 1.76–1.73 (m, 6H); 1.64–1.49 (m, 4H);  
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 177.1 (C=O), 168.8 (C=O), 51.4, 41.5, 41.2, 39.2, 
37.2, 34.3, 28.3. 
The NMR-data are in accordance with the literature. 
 
Tricyclo[3.3.1.13.7]decane-1-methylcarboxylic acid (166)155 
  
50 g (232 mmol) of 165 were suspended in 550 mL conc. sulfuric acid, which was cooled to 
0 °C in an ice bath. While stirring, 100 mL of Oleum (20% SO3) and afterwards, 44 mL of 1,1-
dichloroethene were added. The reaction mixture was stirred for additional 2 h at r.t. and 
poured on ice. The precipitates were filtered of via suction filtration. The crude product was 
dissolved in a 5%-solution of NaOH at 60-70 °C, the impurities were filtered off and the 
solution was acidified with conc. HCl (pH = 4-6) to precipitate the methylcarboxylic acid. The 
product was filtered off via suction filtration, washed with water and dried in a desiccator over 
paraffin wax and P2O5 under reduced pressure. 22.6 g (115.5 mmol; 49%) of a colorless 
solid were isolated.  
1H-NMR (200 MHz, d6-DMSO): δ/ppm = 11.09 (s, 1 H), 2.20-1.77 (m, 5 H), 1.77-1.23 (m, 11 
H) 
13C-NMR (50 MHz, d6-DMSO): δ/ppm = 172.0 (C=O), 47.8, 41.4, 35.7, 31.2, 27.6.  
 
1-Acetamidotricyclo[3.3.1.13.7]decane-3-methylcarboxylic acid (167) 
 
12 g (61.9 mmol) of 166 were suspended in 10 mL conc. nitric acid and cooled to 0 °C in an 
ice bath. Then during 1 h, 64 mL of conc. sulfuric acid were added to the suspension and 
after 2 h stirring at 0 °C, 44 mL of acetonitrile were added within 3 h at the same 
temperature. After another 3 h of stirring the reaction mixture was poured on ice. After 
standing in the refrigerator for 1 d the product was filtered off via suction filtration and dried in 
a desiccator under reduced pressure. 11.10 g (44.6 mmol; 72%) of the acetamide were 
obtained as colorless crystals. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 11.71 (bs, 1H, CO2H); 7.41 (bs, 1H, NH); 2.08–1.95 
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(m, 6 H); 1.90–1.67 (m, 9 H), 1.59–1.39 (m, 6 H) 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 172.3 (C=O), 168.7 (C=O), 51.4, 47.7, 45.5, 40.8, 
40.2, 35.2, 33.6, 28.8, 23.6. 
The procedure is in accordance with that reported in literature.149 
 
1-Aminotricyclo[3.3.1.13.7]decane-3-methylcarboxylic acid hydrochloride (168) 
 
11.1 g (44.2 mmol) of 1-acetamidoadamantane-3-methylcarboxylic acid  were refluxed in 80 
mL of conc. HCl and 80 mL of water for 1 d. The crude product was treated with acetone. 3.8 
g  (15.5 mmol; 35%) of the hydrochloride were obtained as a colorless solid.  
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 11.52 (bs, 1H, CO2H), 8.20 (t, 1H, J(15NH) =50.6 
Hz), 7.37 (bs, 3vH, NH3Cl),  2.19–2.00 (m, 4 H), 1.80–1.62 (m, 5 H), 1.59–1.39 (m, 5 H). 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 172.3 (C=O), 51.5, 47.3, 44.0, 39.1, 34.5, 33.3,  
28.2. 
 
3-(9-Fluorenyl)methoxycarbonylamine (171) 
 
3-(9-Fluorenyl)methoxycarbonylamine was isolated as the main product when the reaction 
conditions (especially temperature) of the general procedure IV were not kept constant 
during the Fmoc-protection of 168 . 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 7.94 (d, J = 7.6 Hz, 2 H), 7.77 (d, J = 7.2 Hz, 2 H), 
7.46 (t, J = 7.5 Hz, 2 H), 7.39 (t, J = 7.6 Hz, 2 H), 4.39–4.20 (m, 3H). 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 156.6, 144.0, 140.7, 127.5, 126.7, 125.3, 120.3, 
65.0, 46.7. 
IR (KBr): ν/cm-1 = 3427, 3327, 3263, 3205, 3018, 2970, 2900, 1683, 1614, 1424, 1337. 
MS (ESI): m/z = 262.1 [M + Na]+; (calc. 262.1). 
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1-Amino-5,7-dimethyltricyclo[3.3.1.13.7]decane-3-methylcarboxylic acid hydrochloride 
(173) 
 
1.55 g (5.5 mmol) of 1-acetamido-5,7-dimethyladamantane-3-methylcarboxylic acid were 
refluxed in 24 mL of conc. HCl and 12 mL of water for 1 d. The crude product was treated 
with acetone. 0.506 g  (1.8 mmol; 33%) of the product were obtained as a colorless solid.  
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.12 (bs, 1H, CO2H), 8.38 (bs, 3H, NH3Cl), 7.45 (t, 
1H, J(15NH) =50.6 Hz), 2.10 (s, 2 H), 1.55 (s, 2 H), 1.38 (m, 4H), 1,21 (m, 4 H), 1.08 (s, 2 H), 
0.88 (s, 6 H)  
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 172.1 (C=O), 52.8, 48.8, 46.4, 45.1, 42.7, 40.1, 
34.7, 32.2, 31.2,  
 
1-(9-Fluorenyl)methoxycarbonylamino-5,7-dimethyltricyclo[3.3.1.13.7]decane-3-
methylcarboxylic acid (173-Fmoc) 
 
0.25 g (1 mmol) of 173 were dissolved in 12 mL of acetone/water (1/1). The procedure is in 
accordance with the general procedure IV. During work up, the reaction mixture should not 
get warmer than 30 °C. 528 mg (0.14 mmol; 34%) of the product were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.06 (bs, 1H, CO2H), 7.96 (d, J = 7.6 Hz, 2 H), 7.77 
(d, J = 7.2 Hz, 2 H), 7.46 (t, J = 7.5 Hz, 2 H), 7.39 (t, J = 7.6 Hz, 2 H), 7.13 (s, 1H, NH), 4.26 
(m, 3H), 2.20–0.96 (m, 14 H, adamantane + CH2), 0.87 (s, 6 H). 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 172.4 (C=O), 154.1 (C=O), 144.1, 140.7, 127.7, 
127.0, 125.3, 120.0, 64.9 (Fmoc-CH2), 52.6, 48.9, 46.6, 46.4, 45.1, 42.7, 40.1, 34.7, 32.2, 
31.2. 
 
1-Bromotricyclo[3.3.1.13.7]decane-3-methylcarboxylic acid (174) 
 
1.0 g (5.1 mmol) of 166 and 3 mL of Br2 were stirred for 18 h at r.t. and afterwards refluxed 
for 6 h. The excess of Br2 was distilled off and the residue was washed with NaHSO3-
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solution, the product was filtered off and dried in a desiccator over paraffin wax and P2O5. 
1.21 g (4.5 mmol; 88%) of the colorless product were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 11.99 (bs, 1H, CO2H), 4.47 (s, 1H), 2.15 (s, 2H), 
2.06 (s, 2H), 1.72–1.40 (m, 12 H) 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 172.7, 66.7, 49.6, 47.6, 44.5, 41.0, 35.2, 34.9, 29.8. 
 
1-Hydroxytricyclo[3.3.1.13.7]decane-3-methylcarboxylic acid (175) 
 
1.21 g (4.4 mmol) of 174 were dissolved in 70 mL of 0.15 M NaOH and the solution was 
allowed to stand for 20 h. The mixture was acidified with H2SO4 and extracted with diethyl 
ether, dried over Na2SO4 and the solvent was evaporated under reduced pressure. 0.878 g 
(4.18 mmol; 95%) of the product were isolated as a colorless solid. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 11.93 (bs, 1H, CO2H), 2.31-2.15 (m, 6H), 2.14–2.07 
(m, 2H), 2.05 (s, 2H), 1.68–1.50 (m, 6H) 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 172.1, 67.7, 52.9, 48.1, 46.91, 36.8, 34.0, 31.9. 
 
1-Chloroacetamidotricyclo[3.3.1.13.7]decane-3-methylcarboxylic acid (176)154 
 
596 mg (2.8 mmol) of 175, 1.13 g (15 mmol) of chloroacetonitrile and 1.3 mL (22.5 mmol) of 
acetic acid were mixed and cooled to 0–3 °C in an ice bath. 1.2 mL (22.5 mmol) conc. H2SO4 
were added dropwise, keeping the temperature below 10 °C. The reaction mixture was 
stirred for 20 h at r.t. and poured on ice. The precipitates were filtered off, washed with water 
and dried in a desiccator over paraffin wax and P2O5. 668 mg (2.5 mmol; 89%) of the 
colorless product were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 8.35 (bs, 1H, CO2H), 7.61 (s, 1 H, NH), 3.87 (s, 2 
H), 2.02–1.82 (m, 4 H), 1.82–1.52 (m, 6 H), 1.52–1.31 (m, 6 H) 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 172.3 (C=O), 164.8 (C=O), 51.8, 47.5, 44.9, 43.41, 
40.7, 39.9, 35.1, 33.6, 28.8. 
IR (KBr): ν/cm-1 = 3316, 2911, 2847, 2623, 1696, 1651, 1563, 1447, 1319, 631. 
MS (ESI): m/z = 308.1 [M + Na]+; (calc. 308.1). 
 
 
COOH
OH
COOH
N
H
O Cl
Experimental Part 	  
	  230 
1-Aminotricyclo[3.3.1.13.7]decane-3-methylcarboxylic acid (177)154 
 
629 mg (2.33 mmol) of 176, 214 mg (2.8 mmol) of thiourea and 0.93 mL of AcOH were 
refluxed in 5 mL of dry EtOH for 8 h. The solvent was removed under reduced pressure and 
the crude product was dissolved in H2O. The mixture was neutralized with NaOH and the 
precipitates were filtered off. 360 mg (1.7 mmol; 74%) of the colorless solid were isolated. 
1H-NMR (400 MHz, D2O): δ/ppm = 1.97–1.90 (m, 2 H), 1.85 (s, 2 H), 1.44–1.21 (m, 12 H) 
13C-NMR (100 MHz, D2O): δ/ppm = 181.3 (C=O), 52.2, 49.6, 47.3, 43.4, 40.8, 35.0, 33.8, 
29.1. 
IR (KBr): ν/cm-1 = 2917, 2633, 2229, 1645, 1548, 1394, 1361. 
MS (ESI): m/z = 210.1 [M + Na]+; (calc. 210.1). 
 
3-Hydroxytricyclo[3.3.1.13.7]decane-1-carboxylic acid (178)188 
 
7.21 g (40 mmol) of 162 were suspended in 4 mL of conc. nitric acid at 0 °C. 50 mL of conc. 
sulfuric acid were added within 2 h at 0 °C. The reaction mixture was stirred for another 3 h 
and afterwards poured on ice. The colorless precipitates were filtered off via suction filtration, 
washed with water and dried under high vacuum over P2O5 in a desiccator. 5.65 g (28.8 
mmol; 72%) of the product were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 5.64 (bs, 2 H, CO2H and OH), 2.19–2.09 (m, 2 H, 
adamantane), 1.70–1.41 (m 12 H, adamantane)  
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 177.9 (C=O), 66.4 (C-OH), 46.4, 44.5, 42.4, 37.3, 
35.2, 29.6. 
Crystallographic data: 
 
Identification code shre214p 
Empirical formula C11H16O3 
COOH
NH2
COOH
OH
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Formula weight 196.24 g mol–1 
Temperature 293(2) K 
Wavelength 0.71073 Å 
Crystal system, space group Monoclinic P 21/c  
Unit cell dimensions a = 6.7002(10) Å α = 90.000(0) deg. 
 b = 20.7848(29) Å β = 106.002(16) deg. 
 c = 7.1773(11) Å γ = 90.000(0) deg. 
Volume 960.80(46) Å3 
Z, Calculated density 4, 1.600 Mg/m3 
Absorption coefficient 0.110 mm–1 
F(000) 524 
Crystal size 0.25 mm x 0.60 mm x 0.15 mm 
Theta range for data collection 3.11 to 27.05 deg. 
Limiting indices –8 ≤ h ≤ 8, –26 ≤ k ≤ 26, –9 ≤ l ≤ 9 
Reflections collected / unique 7503 / 2056 [R(int) = 0.0625] 
Completeness to theta = 27.05 ° 97.3 % 
Absorption correction None 
Refinement method Full-matrix least-squared on F2 
Data / restraints / parameter 2056 / 0 / 192 
Goodness-of-fit on F2 0.812 
Final R indices [I > 2 σ(I)] R1 = 0.0414 wR2 = 0.1131 
R indices (all data) R1 = 0.0704 wR2 = 0.1295 
Largest diff. peak and hole 0.32 and -0.29 e Å–3 
 
3-Chloroacetamidotricyclo[3.3.1.13.7]decane-1-carboxylic acid (179)154 
 
492 mg (2.5 mmol) of 178, 1.13 g (15 mmol) of chloroacetonitrile and 1.2 mL (19.8 mmol) of 
acetic acid were mixed and cooled to 0-3 °C in an ice bath. 1.2 mL (22.5 mmol) of conc. 
H2SO4 were added dropwise keeping the temperature below 10 °C. The reaction mixture was 
stirred for 20 h at r.t. and poured on ice. The precipitate was filtered off, washed with water 
and dried in a desiccator over paraffin wax and P2O5. 644 mg (2.37 mmol; 95%) of the 
colorless product were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.03 (bs, 1H, CO2H), 7.77 (s, 1 H), 3.95 (s, 2 H, 
2.11 (s, 2H), 2.00 (s, 2H), 1.94–1.79 (m, 4H), 1.77–1.64 (m, 4H), 1.57 (s, 2H) 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 177.9, 165.0, 51.5, 43.1, 41.3, 39.8, 37.8, 34.9, 
COOH
N
H
O Cl
Experimental Part 	  
	  232 
28.2. 
IR (KBr): ν/cm-1 = 3316, 3092, 2911, 2847, 262, 1696, 1650, 1563, 1447, 1282, 1155, 615 
 
3-Aminotricyclo[3.3.1.13.7]decane-1-carboxylic acid (180)154 
 
0.64 g (2.4 mmol) of 179, 0.23 g (3 mmol) of thiourea and 1 mL of acetic acid were dissolved 
in 5 mL of ethanol and refluxed for 14 h. To isolate the adamantane amino acid the mixture 
was evaporated to dryness and afterwards 10 mL of H2O were added. The solution was 
acidified with conc. HCl to pH∼1 and filtered. The solution was neutralized with a 20% aq. 
NaOH-solution. The precipitate was filtered off, washed with water and dried in a desiccator 
over paraffin wax and P2O5. 0.448 g (2.1 mmol; 86%) of the free adamantane amino acid 
were isolated as a colorless solid.	  	  
The NMR data are in accordance with the literature.149 
 
1-Bromotricyclo[3.3.1.13.7]decane-3-carboxamide (181)156 
 
2.6 g (13.3 mmol) of 178 were dissolved in 5 mL of freshly distilled thionyl bromide and 
heated to 65 °C for 1 h. The excess thionyl bromide was distilled off under reduced pressure. 
The residue was dissolved in 30 mL of dry DCM and NH3 gas was bubbled through  the 
solution for about 2 h. The precipitates were filtered off via suction filtration and washed with 
water. The crude product was purified by recrystallization from acetone/cyclohexane (1:1, 
v/v). 2.82 g (10.9 mmol; 82%) of a colorless product were isolated. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 6.31 (bs 1H, NH2), 5.77 (bs 1H, NH2), 2.38 (s, 2 H), 
2.31–2.13 (m, 6 H), 1.80 (m, 4 H), 1.64 (m, 2 H) 
13C-NMR (100 MHz, CDCl3): δ/ppm = 178.5 (CONH2), 63.4 (C-Br), 49.9, 48.3, 44.8, 37.5, 
34.9, 31.7. 
 
1-Bromo-3-(methylamino)tricyclo[3.3.1.13.7]decane hydrochloride (183)156 
 
11.0 g (43 mmol) 182 in 100 mL of dry diethyl ether were added to a solution of 3.3 g 
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(86 mmol) of LiAlH4 in 200 mL of dry diethyl ether. The suspension was refluxed for 15 h. 
12.9 mL of a 4%-NaOH-solution were added, the precipitates were filtered off and the solvent 
was removed under reduced pressure. The product was precipitated by adding HCl⋅diethyl 
ether to the solution. The hydrochloride was filtered off via suction filtration and recrystallized 
from 2-propanol to yield 5.8 g (20.6 mmol; 48%) of the colorless product.  
BH3·DMS can also be used for the reduction. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm 8.12 (bs, 3 H), 2.64 (s, 2 H), 2.39–2.16 (m, 8 H), 1.81–
1.55 (m, 6 H))  
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 66.7 (C-Br), 50.1, 48.5, 47.6, 44.3, 36.6, 33.8, 31.5 
 
3-(Methylamino)tricyclo[3.3.1.13.7]decane-1-carboxylic acid (184)156 
 
0.53 g (1.9 mmol) of 183 were dissolved in 10 mL of conc. H2SO4 and the resulting mixture 
was stirred and cooled in an ice bath. At the same temperature, 1.1 mL of HCOOH was 
added during 2 h. Stirring was continued for about 1 h and the mixture poured on ice. The 
solution was neutralized with saturated aqueous NaOH. After about 10 h the product 
precipitated as colorless crystals. The crude yield was too high because of impurities of 
inorganic impurities. The crude product was recrystallized from water to yield in 0.223 g (1 
mmol; 55%) of the free amino acid. 
1H-NMR (400 MHz, D2O): δ/ppm 2.65 (s, 2 H), 2.05 (s, 2 H), 1.92–1.30 (m, 12 H) 
13C-NMR (100 MHz, D2O): δ/ppm = 182.2 (-COOH), 49.9, 40.7, 39.8, 37.5, 37.2, 34.6, 31.8, 
27.3 
IR (KBr): ν/cm-1 = 3453, 3047, 2925, 2848, 1713, 1602, 1513, 1203, 1107, 619. 
MS (ESI): m/z = 210.1 [M + Na]+; (calc. 210.1). 
 
 
3-Methylaminotricyclo[3.3.1.13.7]decane-1-methylcarboxylic acid (185) 
 
1.0 g (3.7 mmol) of 183 were added to a stirred and cooled (ice bath) mixture of 15 mL conc. 
sulfuric acid and 0.75 mL of conc. nitric acid. Afterwards 15 mL of 1,1-dichloroethane were 
added and the reaction mixture was stirred for an additional 1 h at 0 °C and then overnight at 
r.t. The solution was poured on ice and extracted with diethyl ether. The aqueous layer was 
COOH
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neutralized with a saturated NaOH-solution and some of the solvent was evaporated under 
reduced pressure. Inorganic salt precipitated after a few days and was filtered off. After 
another 6 d the product precipitated as colorless crystals. 724 mg (3.3 mmol; 86%) were 
isolated. 
1H-NMR (400 MHz, D2O): δ/ppm = 2.64 (s, 2 H), 2.02 (m, 4 H), 1.88 (s, 1 H), 1.60–1.22 (m, 
11 H) 
13C-NMR (100 MHz, D2O): δ/ppm = 178.5 (C=O); 50.5, 49.9, 43.7, 41.0, 38.1, 34.7, 32.2, 
28.1, 21.8 
IR (KBr): ν/cm-1 = 3444, 3033, 2911, 2858, 2619, 1618, 1504, 1390, 683 
MS (ESI): m/z = 224.0 [M + H]+; (calc. 223.16) 
Crystallographic data: 
 
Identification code shre241p 
Empirical formula C13H21NO2 
Formula weight 233.31 g mol–1 
Temperature 293(2) K 
Wavelength 0.71073 Å 
Crystal system, space group Orthorhombic P 21 21 21 
Unit cell dimensions a = 6.7306(11) Å α = 90.0(0) deg. 
 b = 11.8326(14) Å β = 90.0(0) deg. 
 c = 14.8911(19) Å γ = 90.0(0) deg. 
Volume 1185.93(3) Å3 
Z, Calculated density 4, 1.245 Mg/m3 
Absorption coefficient 0.083 mm–1 
F(000) 484 
Crystal size 0.60 mm x 0.90 mm x 0.15 mm 
Theta range for data collection 2.74 to 28.18 deg. 
Limiting indices –8 ≤ h ≤ 8, –13 ≤ k ≤ 15, –19 ≤ l ≤ 19 
Reflections collected / unique 9568 / 2877 [R(int) = 0.0862] 
Completeness to theta = 28.18 ° 99.2 % 
Absorption correction None 
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Refinement method Full-matrix least-squared on F2 
Data / restraints / parameter 2877 / 0 / 229 
Goodness-of-fit on F2 0.633 
Final R indices [I > 2 σ(I)] R1 = 0.0431 wR2 = 0.0990 
R indices (all data) R1 = 0.0968 wR2 = 0.1301 
Largest diff. peak and hole 0.18 and -0.18 e Å–3 
 
3-Acetamido-5-methyltricyclo[3.3.1.13.7]decan-1-carboxylic acid ((±)-188)149 
 
The acetamidation of 187 was achieved by the procedure described in the literature. 
1.46 g (5.8 mmol; 88%) of the product were isolated as a colorless solid. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.12 (bs, 1H, CO2H); 7.43 (bs, 1H, NH); 2.11 (s, 
1H); 1.95–1.87 (m, 2H); 1.87–1.69 (m, 5H); 1.69–1.51 (m, 4 H), 1.48–1.39 (m, 2H), 1.36–
1.21 (m, 2H), 0.85 (s, 3 H)  
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 177.6 (C=O), 168.7, 51.6, 46.9, 44.5, 42.1, 42.1, 
41.5, 40.1, 37.0, 31.4, 30.0, 28.9, 23.7. 
The NMR data are in accordance with the literature.	   
 
3-Amino-5-methyltricyclo[3.3.1.13.7]decane-1-carboxylic acid hydrochloride (±)-189 
 
1.46 g (5.8 mmol) of 188 were refluxed in 20 mL of conc. HCl and 9 mL of water for 3 d. The 
crude product was treated with acetone to remove by-product 3-chloro-5-methyladamantane-
1-carboxylic acid. The crude product was treated with acetone. 1.06 g  (4.3 mmol; 75%) of 
the product were obtained as a colorless solid.  
1H-NMR (400 MHz, d6--DMSO): δ/ppm = 12.36 (bs, 1H, CO2H); 8.35 (bs, 3H, NH3Cl); 7.45 (t, 
1H, J(15NH) = 50.6 Hz) 2.21 (s, 1H); 1.92–1.77 (m, 2H); 1.77–1.56 (m, 4H); 1.56-1.44 (m, 2 
H), 1.44–1.24 (m, 4H), 0.85 (s, 3 H)  
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 176.8 (C=O), 168.8, 51.9, 45.8, 43.9, 42.0, 41.20, 
40.4, 38.2, 36.3, 31.5, 29.4, 28.5 
The NMR data are in accordance with the literature.149 
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3-(9-Fluorenyl)methoxycarbonylamino-5-methyltricyclo[3.3.1.13.7]decane-1-carboxylic 
acid (190) 
 
0.25 g (1 mmol) of 189 were dissolved in 30 mL acetone/ water (1/1, v/v). The procedure is in 
accordance with the general procedure IV. During the whole work up, the reaction mixture 
should not get warmer than 30 °C. The crude product was recrystallized from nitromethane. 
0.230 g (0.54 mmol; 54%) of a colorless solid were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.13 (bs, 1H, CO2H), 7.93 (d, J = 8.0 Hz, 2H), 7.76 
(d, J = 8.0 Hz, 2H), 7.46 (t, J = 8.0 Hz, 2H), 7.37 (t, J = 7,6 Hz, 2H), 7.20 (s, 1H, NH), 4.24 
(m, 3H), 2.24–1.25 (m, 14 H, adamantane), 0.89 (s, 3H, CH3). 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 177.6 (C=O); 154.2 (C=O); 144.0, 140.7, 127.5, 
127.0, 125.3, 120.1, 64.8 (Fmoc-CH2); 50.9 (Cq); 47.0, 46.7, 42.2 (Cq), 42.0, 41.6, 39.5, 37.0, 
31.4 (Cq), 29.9, 28.9. 
IR (KBr): ν/cm-1 = 3315, 3065, 3040, 2911, 2853, 1718, 1675, 1555, 1448, 1263, 1089, 732. 
Elem. Anal.: C27H29NO4 (431.52): calcd. C 75.15, H 6.77, N 3.25; found: C 75.33, H 6.77, N 
3.43. 
The NMR data are in accordance with the literature.149 
 
3-Acetamido-5,7-dimethyltricyclo[3.3.1.13.7]decane-1-carboxylic acid (194)149 
 
The acetamidation of 193 was achieved by the procedure described in literature. 
1.25 g (4.7 mmol; 87%) of the product were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.10 (bs, 1H, CO2H); 7.43 (bs, 1H, NH); 1.85 (m, 
2H); 1.78 (m, 3H); 1.62–1.44 (m, 4 H), 1.46–1.32 (m, 4H), 1.12–1.01 (m, 2H), 0.85 (s, 6 H).  
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 177.7 (C=O), 168.8, 52.4, 49.3, 46.2, 43.9, 42.8, 
40.8, 40.1, 38.4, 31.9, 29.6, 23.7. 
The NMR data are in accordance with the literature.	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3-Amino-5,7-dimethyltricyclo[3.3.1.13.7]decane-1-carboxylic acid hydrochloride (195) 
 
1.25 g (4.7 mmol) of 194 were refluxed in 20 mL of conc. HCl and 9 mL of water for 3 d. 
Aqueous HCl was removed under reduced pressure. The crude product was treated with 
acetone to remove by-product 3-chloro-5,7-dimethyladamantane-1-carboxylic acid. 0.69 g  
(2.7 mmol; 55%) of the product were obtained as a colorless solid.  
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.36 (bs, 1H, CO2H), 8.39 (bs, 3H, NH3Cl), 7.38 (t, 
1H, J(15NH) = 50.6 Hz), 1.82–1.77 (m, 2H), 1.52–1.31 (m, 8H), 1.21–1.03 (m, 2 H), 0.85 (s, 6 
H).  
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 176.7 (C=O), 52.5, 48.5, 45.0, 43.3, 42.7, 32.1, 
29.0. 
The NMR data are in accordance with the literature.149 
 
3-(9-Fluorenyl)methoxycarbonylamino-5,7-dimethyltricyclo[3.3.1.13.7]decane-1-
carboxylic acid (196)149 
 
 
0.256 g (0.98 mmol) of 195 were dissolved in 30 mL of acetone/water (1/1, v/v). The 
procedure is in accordance with the general procedure IV. During the whole work up, the 
reaction mixture should not get warmer than 30 °C. The crude product was recrystallized 
from nitromethane. 282 mg (0.63 mmol; 64%) of a colorless solid were isolated. 
1H-NMR (400 MHz, d6-DMSO): δ/ppm = 12.11 (bs, 1H, CO2H), 7.93 (d, J = 8.0 Hz, 2H), 7.75 
(d, J = 8.0 Hz, 2H), 7.38 (t, J = 7,4 Hz, 2H), 7.34 (t, J = 7,6 Hz, 2H), 7.21 (s, 1H, NH), 4.24 
(m, 3H), 1.97– 1.78 (m, 2H), 1.68–0.51 (m, 12 H, adamantane), 0.90 (s, 6H, 2X CH3). 
13C-NMR (100 MHz, d6-DMSO): δ/ppm = 177.5 (C=O); 154.2 (C=O); 143.9, 140.7, 127.6, 
127.0, 125.3, 120.1, 64.8 (Fmoc-CH2); 51.7 (Cq); 49.2, 46.7, 46.3, 43.8, 42.8 (Cq), 41.0, 
32.00 (Cq), 29.50. 
IR (KBr): ν/cm-1 = 3324,3041, 2940, 2915, 2861, 1694, 1539, 1450, 1273, 1252,1128, 738 
Elem. Anal.: C28H31NO4 (445.55): calcd. C 75.48, H 7.01, N 3.14; found: C 75.13, H 7.02, N 
3.60. 
The NMR data are in accordance with the literature.149	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5-Hydroxy-2-tricyclo[3.3.1.13.7]decanone (198)158 
 
12 g (80 mmol) of 197 were added to 100 mL of 100% nitric acid cooled in an ice bath. The 
mixture was allowed to stand at r.t. for 3 d and was then heated at 60 °C for 90 min. Nitric 
acid was distilled off under reduced pressure. 40 mL of water and 15 mL of conc. sulfuric 
acid were added to the residue and the mixture heated to 60 °C for 1 h. The solution was 
cooled and extracted with a 2:1 mixture of pentane/diethyl ether. The acidic aqueous layer 
was neutralized with a saturated NaOH-solution and extracted with chloroform. The organic 
layer was washed with brine, dried over Na2SO4 and the solvent was removed under 
reduced pressure. The crude product was dissolved in DCM, and pentane was added until 
no more precipitate formed. The product was filtered off via suction filtration and dried in a 
desiccator over paraffin wax and P2O5 under reduced pressure to yield 8.64 g (52 mmol; 
65%) of the product as a colorless solid. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 2.71–2.42 (m, 3 H), 2.24 (d, 1H), 2.17–1.79 (m, 9 H). 
13C-NMR (100 MHz, CDCl3): δ/ppm = 216.8 (C=O); 67.1, 46.9, 44.9, 44.1, 38.1, 29.8. 
 
5-(S)-α-Methylbenzyliminotricyclo[3.3.1.13.7]decane-2-ol (199)159 
 
(S)-α-methylbenzylamine (2.54 g, 20 mmol) and  198 (3.32 g, 20 mmol) and were dissolved 
in 100 mL dry ethanol and refluxed for 64 h in an argon atmosphere.  The reaction mixture 
was concentrated and the crude imine (5.20 g, 98%) was used without purification in the next 
step.  
 
E- + Z- 5-(S)-α-Methylbenzylaminotricyclo[3.3.1.13.7]decane-2-ol (200)159 
 
5.20 g (19 mmol) of 199 were dissolved in 100 mL of dry THF under argon atmosphere and 
cooled to 0 oC.  880 mg (24 mmol) of solid sodium borohydride and 4 mL (68 mmol) of acetic 
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acid were added, and the reaction mixture was stirred at 0 oC for 2h.  The reaction mixture 
was diluted with DCM, and washed with saturated NaHCO3-solution (2 x 20 mL).  The 
organic layer was dried over Na2SO4 and evaporated under reduced pressure. Isomer E-200 
was obtained in pure form by chromatography over silica gel using ethyl acetate as the 
eluent. 1.77 g (7.5 mmol, 34%) of the colorless solid were isolated. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.26–7.18 (m, 4 H), 7.18–7.09 (m, 1 H), 3.75 (q, J = 4 
Hz, 1 H), 2.52 (t, 1 H), 2.01–1.94 (m, 2 H), 1.88–1.72 (m, 3 H), 1.65–1.46 (m, 7 H), 1.32–1.17 
(m, 5 H). 
13C-NMR (100 MHz, CDCl3): δ/ppm = 146.1, 128.1, 126.6, 126.4, 67.8, 57.63, 54.8, 45.4, 
44.7, 44.4, 34.6, 32.8, 29.9, 29.8, 29.7, 24.8. 
Melting point: 105 °C 
The obtained data for E-200 are in accordance with the literature. Unfortunately, no pure Z-
200 could be isolated via silica gel chromatography and HPLC. 
HPLC-Method 
E-isomer 200 was purified by using HPLC employing a 25 cm, d = 0.46 cm NH2-phase 
Eluent: TBME/hexane (1:4) 
Flow = 5 mL/min 
UV-detector λ = 254 nm  
Retention times: R1 = 40 min. 
 
E-5-aminotricyclo[3.3.1.13.7]decane-2-ol hydrochloride (201 ·HCl)159 
 
200 mg (0.74 mmol) of E-200 and 30 mg of 10 % Pd/C were suspended in 1 mL of methanol 
and the mixture was hydrogenated for 72 h. The Pd/C was filtered off, the solvent removed 
under reduced pressure and the crude product dried in a desiccator over P5O10. 
Unfortunately, debenzylation was not complete. The mixture of 201 and 200 was dissolved in 
Et2O/MeOH and HCl in Et2O was added. Product 201·HCl precipitated and was filtered off. 
82 mg (0.4 mmol, 55%) of the hydrochloride were isolated as a colorless solid. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 8.21 (s, 3 H, NH3), 3.21 (s, 1 H, OH), 2.11 (s, 2 H), 2.01 
(s, 1 H), 1.91 (d, J = 14 Hz, 2 H), 1.74–1.53 (m, 7 H), 1.37 (d, J = 14 Hz, 2 H). 
13C-NMR (100 MHz, CDCl3): δ/ppm = 65.1, 53.8, 48.6, 45.1, 43.6, 31.9, 28.8, 28.4.  
 
 
 
NH3Cl
HO
H
Experimental Part 	  
	  240 
Peptides: 
Boc-L- (π-Me)-His-AGly-L-Cha-L-Phe-OMe (12i) 
 
The peptide was synthesized on a solid support using 
commercially available Fmoc-Phe-Wang resin. 
461.5 mg (0.3 mmol) of the preloaded resin was swollen 
in DMF for 30 min. The Fmoc-cleavage was performed by shaking the resin twice in 25% 
piperidine in DMF (v/v) for 25 min. The resin was washed five times with DMF, DCM and 
DMF. Chain elongation was achieved by a double coupling procedure (1 h shaking per 
coupling step) using Fmoc-Cha-OH (0.237 g, 0.6 mmol), HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol) per coupling step. 
After washing and cleavage of the Fmoc-group the peptide was elongated using Fmoc-AGly-
OH 154 (0.250 g, 0.6 mmol), coupling agents and the base were used in the same 
stoichiometric amounts as given above. The peptide was washed again and the protection 
group was cleaved. For the last double coupling step the reaction time was increased to 2 h. 
Boc-L-(π-Me)-His-OH (0.121 g, 0.45 mmol), HBTU (0.228 g, 0.6 mmol), HOBt⋅H2O (0.092 g, 
0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol) were used for coupling. The peptide 
was washed five times with DMF, DCM and diethyl ether and afterwards cleaved from the 
solid support by shaking it twice for 2 days in methanol/THF and triethylamine (9 : 1 : 1, v/v). 
The resin was filtered off and washed twice with chloroform. The collected solutions were 
concentrated under reduced pressure and purified by silica flash gel chromatography eluting 
with chloroform/methanol (9 : 1), Rf= 0.48. 
1H-NMR (600 MHz, CDCl3): δ/ppm = 7.40 (s, 1 H, HAr, CH (His)), 7.24–7.15 (m, 3 H, HAr 
(Phe)), 7.10 (d, 2 H, J= 9 Hz, HAr (Phe)), 6.84 (s, 1 H, HAr, CH (His)), 6.55 (d, 1 H, J= 12 Hz, 
NH (Phe)), 6,0 (d, 1 H, J= 9 Hz, NH (Cha)), 5.77 (s, 1 H, NH (AGly)), 5.18 (d, 1 H, J= 8,4 Hz, 
NH (His)), 4.8 (q, 1 H, J= 7,2 Hz, Hα (Phe)), 4.4 (q, 1 H, J= 7,2 Hz, Hα (Cha)), 4.16 (s, 1 H, Hα 
(His)), 3.70 (s, 3 H, OCH3), 3.60 (s, 3 H, NCH3), 3.14–3.04 (m, 2 H, Hβ (Phe)), 3.09–2.98 (m, 
2 H, Hβ (His)), 2.21-2.17 (m, 2 H, adamantane), 1.93–1,80 (m, 6 H, adamantane + Cha), 
1,74–1,58 (m, 12 H, adamantane + Cha), 1,4 (s, 9 H, C(CH3)), 1.31 (t, 1 H, Cha), 1.27–1.09 
(m, 4 H, Cha), 0.97–0.80 (m, 2 H, Cha). 
13C-NMR (150 MHz, CDCl3): δ/ppm = 176.4 (C=O); 171.9 (C=O), 171.6 (C=O), 169.8 (C=O), 
155.0 (C=O), 138.2, 135.5, 129.6, 128.8, 128.2 127.2, 126.9, 80.3, 54.5, 53.2, 52.3, 50.7, 
42.5, 42.2, 40.4, 40.2, 39.5, 38.3, 38.1, 37.9, 35.1, 34.2, 33.5, 32.7, 31.5, 29.1, 28.3, 26.8, 
26.3, 26.1, 26.1. 
MS (ESI): m/z =  761.5 [M+H]+ (calc. m/z = 761.5); m/z = 783.4 [M+Na]+ (calc. m/z = 783.4); 
m/z = 1521.3 [2M+H]+ (calc. m/z = 1521.9). 
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HRMS (ESI-TOF) m/z: [M+H]+ calcd for C42H61N6O7+ 761.4596; Found 761.4557. 
The NMR data are in accordance with the literature.60 
 
Boc-L-(π-Me)-His-A Gly-L-Phe-L-Phe-OMe (12g)60 
 
The peptide was synthesized by Dr. Christian. E. Müller. The ESI-MS data are in accordance 
with the literature. 
 
Boc-L-Cha-AGly-L-(π-Me)-His-L-Phe-OMe (13) 
 
Solid support: 461.5 mg (0.3 mmol) Fmoc-Phe-Wang resin 
1. Double coupling: 117.3 mg (0.3 mmol) Fmoc-(π-Me)-His-OH, HBTU (0.228 g, 0.6 
mmol), HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
2.      Double coupling: 250 mg (0.6 mmol) Fmoc-A Gly-OH 154, HBTU (0.228 g, 0.6 mmol),    
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
3. Double coupling: 271.2 mg (0.6 mmol) Boc-L-Cha-OH·DCHA, HBTU (0.228 g, 
0.6 mmol), HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
Washing: 5X DMF, 5X DCM, 5X DMF 
Fmoc-cleavage: 25% piperidine in DMF 
Cleavage from the resin: methanol/THF/triethylamine (9 : 1 : 1). 
The crude peptide was purified via column chromatography utilizing silica flash gel and 
CH3Cl/MeOH (10:1: Rf = 0.35). Overall, 136 mg (0.18 mmol; 60%) of the pure peptide were 
isolated. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.58 (s, 1 H, HAr, CH (His)), 7.25–7.13 (m, 3 H, HAr 
(Phe)), 7.00 (d, 2 H, J= 8 Hz, HAr (Phe)), 6.82 (s, 1 H, HAr, CH (His)), 6.39 (d, 1 H, J= 8 Hz, 
NH (Phe)), 5.89 (s, 1 H, NH (Cha)), 4.88 (s, 1 H, NH (AGly)), 4.65 (q, 1 H, J= 7,2 Hz, Hα 
(Phe)), 4.51 (q, 1 H, J= 7,2 Hz, Hα (Cha)), 3.98–3.89 (m, 2 H, Hα (His) + NH (His)), 3.64 (s, 3 
H, OCH3), 3.60 (s, 3 H, NCH3), 3.10–3.01 (m, 1 H, Hβ (Phe)), 3.00–2.91 (m, 3 H, Hβ (His) + 
Hβ (Phe)), 2.17–2.09 (m, 2 H, adamantane), 2.03–1.78 (m, 7 H, adamantane + Cha), 1.75–
1.50 (m, 12 H, adamantane + Cha), 1.38 (s, 9 H, C(CH3)), 1.27–1.01 (m, 4 H, Cha), 0.97–
0.74 (m, 2 H, Cha). 
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13C-NMR (100 MHz, CDCl3): δ/ppm = 176.7 (C=O); 171.9 (C=O); 171.5 (C=O); 170.2 (C=O); 
155.8 (C=O); 137.9, 135.8, 129.1, 128.6, 127.6, 127.1, 77.2, 53.8, 52.5, 52.0, 51.7, 42.6, 
42.4, 40.5, 40.3, 39.9, 38.1, 37.9, 37.5, 35.2, 34.1, 33.7, 32.7, 32.0, 39.1, 28.3, 26.6, 26.4, 
26.3, 26.1. 
MS (ESI): m/z = 761.3 [M+H]+ (calc. m/z = 761,5) 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C42H61N6O7+ 761.4596; Found 761.4575. 
 
Boc-L-(π-Me)-His-5,7-Me2-AGly-L-Cha-L-Phe-OMe (207) 
 
 
Solid support: 492.5 mg (0.3 mmol) Fmoc-Phe-Wang resin 
1. Double coupling: 235.89 mg (0.6 mmol) Fmoc-L-Cha-OH, HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
2. Double coupling: 200.9 mg (0.45 mmol) 196, HBTU (0.228 g, 0.6 mmol), HOBt⋅H2O 
(0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol) 
3. Double coupling: 121.25 mg (0.45 mmol) Boc-L-(π-Me)-histidine, HBTU (0.228 g, 
0.6 mmol), HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
Washing: 5 X DMF, 5 X DCM, 5 X DMF 
Fmoc-cleavage: 25% piperidine in DMF. 
Cleavage from the resin: methanol/THF/triethylamine (9 : 1 : 1). 
The crude peptide was purified via column chromatography utilizing silica flash gel and 
CH3Cl/MeOH (10:1: Rf = 0.45). Overall, 145 mg (0.2 mmol; 65%) of the pure peptide were 
isolated. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.53 (s, 1 H, HAr, CH (His)), 7.26–7.13 (m, 3 H, HAr 
(Phe)), 7.03 (d, 2 H, J= 7.2 Hz, HAr (Phe)), 6.81 (s, 1 H, HAr, CH (His)), 6.60 (d, 1 H, J= 10 
Hz, NH (Phe)), 6.14 (s, 1 H, NH (Cha)), 6.03 (s, 1 H, J = 9 Hz, NH (AGly)), 5.27 (d, 1 H, J= 
8,4 Hz, NH (His)), 4.73 (q, 1 H, J= 7,2 Hz, Hα (Phe)), 4.38 (q, 1 H, J= 7,2 Hz, Hα (Cha)) 4.17 
(s, 1 H, Hα (His)), 3.63 (s, 3 H, OCH3), 3.56 (s, 3 H, NCH3), 3.10–2.88 (m, 4 H, Hβ (Phe) + Hβ 
(His)), 1.88–1.70 (m, 3 H, adamantane), 1.68–0.96(m, 22 H, adamantane + Cha), 1.36 (s, 9 
H, C(CH3)),  0.91–0.73 (m, 7 H, CH3-Ad + Cha). 
13C-NMR (150 MHz, CDCl3): δ/ppm = 176.2 (C=O); 172.0 (C=O); 171.7 (C=O); 169.8 (C=O); 
137.8; 135.8; 129.2; 128.6; 127.2; 127,21; 80.4; 77.2; 53.9; 53.3; 52.6; 52.3; 50.7; 49.5; 46.3, 
44.4, 44.3, 43.9, 40.9, 39.6, 37.8, 31.1, 33.4, 32.8, 32.7, 31.8, 29.6, 28.3, 27.0, 26.3, 26.1, 
26.1 
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MS (ESI): m/z = 789.4 [M+H]+ (calc. m/z = 789.5) 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C44H65N6O7+ 789.4909; Found 789.4902. 
 
Boc-L- (π-Me)-His-5-Me-AGly-L-Cha-L-Phe-OMe (208) 
 
 
Solid support: 492,5 mg (0.3 mmol) Fmoc-Phe-Wang resin 
1. Double coupling: 235.89 mg (0.6 mmol) Fmoc-L-Cha-OH, HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
2. Double coupling: 194.9 mg (0.45 mmol) 190, HBTU (0.228 g, 0.6 mmol), HOBt⋅H2O 
(0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol) 
3.  Double coupling: 121.25 mg (0.45 mmol) Boc-L-(π-Me)-histidine, HBTU (0.228 g, 
0.6 mmol), HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
Washing: 5X DMF, 5X DCM, 5X DMF 
Fmoc-cleavage: 25% piperidine in DMF. 
Cleavage from the resin: methanol/THF/triethylamine (9 : 1 : 1). 
The crude peptide was purified via column chromatography utilizing silica flash gel and 
CH3Cl/MeOH (10:1: Rf = 0.45). Overall, 138 mg (0.18 mmol; 62%) of the pure peptide were 
isolated. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.53 (s, 1 H, HAr, CH (His)), 7.25–7.12 (m, 3 H, HAr 
(Phe)), 7.04 (d, 2 H, J= 9 Hz, HAr (Phe)), 6.82 (s, 1 H, HAr, CH (His)), 6.55 (m, 1 H, NH 
(Phe)), 6.13 (s, 1 H, NH (Cha)), 6.01 (s, 1 H, NH (AGly)), 5.28 (s, 1 H, NH (His)), 4.73 (q, 1 H, 
J= 7,2 Hz, Hα (Phe)), 4.37 (q, 1 H, J= 7,2 Hz, Hα (Cha)), 4.17 (s, 1 H, Hα (His)), 3.63 (s, 3 H, 
OCH3), 3.60 (s, 3 H, NCH3), 3.10–2.87 (m, 4 H, Hβ (Phe) + Hβ (His)), 2.21–2.09 (m, 1 H, 
adamantane), 1.93–1.68 (m, 5 H, adamantane + Cha), 1.68–1.47 (m, 9 H, adamantane + 
Cha), 1.47–1.24 (m, 15 H, C(CH3) + adamantane), 1.23–0.96 (m, 4 H, Cha), 0.92–0.73 (m, 5 
H, CH3-Ad + Cha). 
13C-NMR (100 MHz, CDCl3): δ/ppm = 176.3 (C=O); 172.0 (C=O); 171.7 (C=O); 169.7(C=O); 
137.8; 135.8; 129.2; 128.6; 127.2; 80.5; 77.2; 53.3; 53.2; 52.3; 50.7; 44.9; 43.2; 42.2; 41.5; 
39.6; 37.8; 37.6; 37.4; 34.1; 33.4; 32.8; 32.1; 29.9; 29.5; 28.3; 27.0; 26.3; 26.2; 26.0. 
MS (ESI): m/z = 775.3 [M+H]+ (calc. m/z = 775.5) 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C43H63N6O7+ 775.4753; Found 775.4742. 
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Boc-L-(π-Me)-His-MAACA-L-Cha-L-Phe-OMe (209) 
 
Solid support: 461.5 mg (0.3 mmol) Fmoc-Phe-Wang resin 
1. Double coupling: 235.89 mg (0.6 mmol) Fmoc-L-Cha-OH, HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
2. Double coupling: 193.9 mg (0.45 mmol) 158, HBTU (0.228 g, 0.6 mmol), HOBt⋅H2O 
(0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol) 
3.  Double coupling: 121.25 mg (0.45 mmol) Boc-L-(π-Me)-histidine, HBTU (0.228 g, 
0.6 mmol), HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
Washing: 5X DMF, 5X DCM, 5X DMF 
Fmoc-cleavage: 25% piperidine in DMF 
Cleavage from the resin: methanol/THF/triethylamine (9 : 1 : 1). 
The crude peptide was purified via column chromatography utilizing silica flash gel and 
CH3Cl/MeOH (10:1: Rf = 0.45). Overall, 178 mg (0.23 mmol; 76%) of the pure peptide were 
isolated. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.37 (s, 1 H, HAr, CH (His)), 7.24-7.12 (m, 3 H, HAr 
(Phe)), 7.03 (d, 2 H, J= 8 Hz, HAr (Phe)), 6.78 (d, 1 H, J = 7.2 Hz, HAr, CH (His)), 6.36–6.24 
(m, 2 H, NH (Phe) + NH (Cha)), 5.26 (m, 2 H, J = 7.2 Hz, NH (AGly) + (His)), 4.74 (q, 1 H, J= 
7,2 Hz, Hα (Phe)), 4.37 (q, 1 H, J= 7,2 Hz, Hα (Cha)), 4.23 (q, 1 H, J = 6 Hz, Hα (His)), 3.64 
(s, 3 H, OCH3), 3.53 (s, 3 H, NCH3), 3.12–2.89 (m, 5 H, Hβ (Phe) + Hβ (Cha)), 2.78–2.74 (m, 
1 H), 2.01 (s, 2 H, Hβ (His)), 1.71-1.44 (m, 14 H, adamantane), 1.33–0.99 (m, 9 H, 
adamantane + Cha), 1,34 (s, 9 H, C(CH3)), 0.94-0.71 (m, 2 H, Cha). 
13C-NMR (100 MHz, CDCl3): δ/ppm = 177.1 (C=O); 172.3 (C=O); 172.0 (C=O); 170.9 (C=O); 
155.4 (C=O); 138.2; 135.9, 129.3, 128.6, 127.6, 127.1, 80.4, 77.2, 53.2, 52.4, 51.1, 50.5, 
41.2, 41.0, 39.2, 39.0, 38.4, 37.8, 35.7, 34.4, 33.5, 32.6, 31.6, 28.4, 28.1, 26.9, 26.4, 26.2, 
26.0 
MS (ESI): m/z = 775.5 [M+H]+ (calc. m/z = 775.5). 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C43H63N6O7+ 775.4753; Found 775.4717. 
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Boc-L-(π-Me)-His-AAMCA-L-Cha-L-Phe-OMe (210) 
 
Solid support: 461.5 mg (0.3 mmol) Fmoc-Phe-Wang resin 
1. Double coupling: 235.89 mg (0.6 mmol) Fmoc-L-Cha-OH, HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
2. Double coupling: 258.6 mg (0.6 mmol) 157, HBTU (0.228 g, 0.6 mmol), HOBt⋅H2O 
(0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol) 
3.  Double coupling: 121.25 mg (0.45 mmol) Boc-L-(π-Me)-histidine, HBTU (0.228 g, 
0.6 mmol), HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
Washing: 5X DMF, 5X DCM, 5X DMF 
Fmoc-cleavage: 25% piperidine in DMF 
Cleavage from the resin: methanol/THF/triethylamine (9 : 1 : 1). 
The crude peptide was purified via column chromatography utilizing silica flash gel and 
CH3Cl/MeOH (10:1: Rf = 0.45). Overall, 163 mg (0.21 mmol; 70%) of the pure peptide were 
isolated as a colorless solid. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.36 (s, 1 H, HAr, CH (His)), 7.24–7.12 (m, 3 H, HAr 
(Phe)), 7.04 (d, 2 H, J= 8 Hz, HAr (Phe)), 6.77 (s, 1 H, HAr, CH (His)), 6.72 (d, 1 H, J= 12 Hz, 
NH (Phe)), 6.07 (d, 1 H, J= 9 Hz, NH (Cha)), 5.77 (s, 1 H, NH (AGly)), 5.20 (d, 1 H, J= 8.4 Hz, 
NH (His)), 4.73 (q, 1 H, J= 7.2 Hz, Hα (Phe)), 4.38 (q, 1 H, J = 7.2 Hz); 4.09 (m, 1 H, Hα 
(His)), 3.63 (s, 3 H, OCH3), 3.53 (s, 3 H, NCH3), 3.09-2.95 (m, 2 H, Hβ (Phe)), 2.90 (d, 2 H), 
2.08–2.02 (m, 2 H, adamantane), 1.95–1.80 (m, 4 H, adamantane + Cha), 1.78–1.38 (m, 16 
H, adamantane + Cha), 1.35 (s, 9 H, C(CH3)), 1.31 (t, 1 H, Cha),1.27–1.09 (m, 4 H, Cha), 
0.94–0.68 (m, 2 H, Cha). 
13C-NMR (100 MHz, CDCl3): δ/ppm = 171.96 (C=O), 171.73 (C=O), 170.65 (C=O), 169.45 
(C=O), 155.32 (C=O), 138.10, 135.80, 129.27, 128.55, 127.79, 127.38, 127.09, 80.32, 54.36, 
53.32, 52.67, 52.32, 50.90, 50.28, 46.23, 41.05, 40.47, 39.33, 37.84, 35.25; 34.64, 34.00, 
33.53, 32.54, 31.49, 29.45, 28.29, 27.00, 26.33, 26.19, 26.01. 
MS (ESI): m/z = 775.5 [M+H]+ (calc. m/z = 775.5); 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C43H63N6O7+ 775.4753; Found 775.4700. 
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Boc-L- (π-Me)-His-MAAMCA-L-Cha-L-Phe-OMe (211) 
 
 
All peptide couplings are in accordance with the general procedures VI and VII. 
1. HOBt/EDC mediated peptide coupling: 
 
H-Phe-OMe · HCl:    0.269 g (1.250 mmol) 
Boc-Cha-OH · (C6H11)2NH:   0.566 g (1.250 mmol) 
EDC · HCl:      0.263 g (1.375 mmol) 
HOBt:       0.210 g (1.375 mmol) 
Et3N:       0.19 mL (1.375 mmol) 
DCM:      8.0 mL 
 
2. Cleavage of the Boc-group with HCl · 1,4-dioxane. 
3. HOBt/EDC mediated peptide coupling: 
 
H-Cha-Phe-OMe · HCl:   0.472 g (1.10 mmol) 
Boc-181:      0.342 g (1.10 mmol) 
EDC · HCl:      0.232 g (1.21 mmol) 
HOBt:       0.185 g (1.21 mmol) 
Et3N:       0.17 mL (1.21 mmol) 
DCM:      10.0 mL 
 
4. Cleavage of the Boc-group with HCl · 1,4-dioxane. 
5. HOBt/EDC mediated peptide coupling: 
 
Boc-MAAMCA-H-Cha-Phe-OMe · HCl:  0.446 g (0.70 mmol) 
Boc-π-Me-His-OH:     0.188 g (0.70 mmol) 
EDC · HCl:       0.148 g (0.77 mmol) 
HOBt:        0.104 g (0.77 mmol) 
Et3N:        0.1 mL (0.77 mmol) 
DCM:       8.0 mL 
 
The crude peptide was purified by silica flash gel column chromatography eluating with 
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CHCl3/MeOH 10:1 (Rf = 0.4) and 209 mg (0.26 mmol; 21%) of the peptide were isolated as a 
colorless solid. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.43 (s, 1 H, HAr, CH (His)), 7.26–7.13 (m, 3 H, HAr 
(Phe)), 7.03 (d, 2 H, J= 7.2 Hz, HAr (Phe)), 6.81 (s, 1 H, HAr, CH (His)), 6.76 (d, 1 H, J= 10 
Hz, NH (Phe)), 6.50 (d, 1 H, J= 10 Hz, NH (Cha)), 6.20(s, 1 H, NH (AGly)), 5.41 (d, 1 H, J= 
8,4 Hz, NH (His)), 4.75 (q, 1 H, J= 7,2 Hz, Hα (Phe)), 4.37 (q, 1 H, J= 7,2 Hz, Hα (Cha)), 4.24 
(s, 1 H, Hα (His)); 3.63 (s, 3 H, OCH3); 3.56 (s, 3 H, NCH3); 3.13–2.74 (m, 4 H, Hβ (Phe) + Hβ 
(His)), 2.03–1.83 (m, 4 H, adamantane), 1.72–1.4 (m, 14 H, adamantane + Cha), 1.37 (s, 9 
H, C(CH3)),  1.32–0.97 ( m, 12 H, Cha + adamantane), 0.97–0.68 (m, 2 H, Cha). 
13C-NMR (150 MHz, CDCl3): δ/ppm = 172.3 (C=O); 171.8 (C=O); 171.1 (C=O); 170.7 (C=O); 
137.9, 135.8, 129.4, 128.6, 127.1, 77.2, 55.32, 52.3, 51.3, 50.7, 44.5, 42.2, 41.5, 39.4, 37.9, 
35.8, 34.4, 34.0, 33.6, 33.3, 31.6, 28.3, 26.3, 26.0. 
MS (ESI): m/z = 789.4 [M+H]+ (calc. m/z = 789.5). 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C44H65N6O7+ 789.4909; Found 789.4902. 
 
Boc-L-(π-Me)-His-3-Abz-L-Cha-L-Phe-OMe (212) 
 
Solid support: 461.5 mg (0.3 mmol) Fmoc-Phe-Wang resin 
1. Double coupling: 235.85 mg (0.6 mmol) Fmoc-L-Cha-OH, HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
2.  Double coupling: 216 mg (0.6 mmol) Fmoc-3-Abz-OH, HBTU (0.228 g, 0.6 mmol),    
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol) 
3.  Double coupling: 121.25 mg (0.45 mmol) Boc-L-(π-Me)-histidine, HBTU (0.228 g,     
0.6 mmol), HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
Washing: 5X DMF, 5X DCM, 5X DMF 
Fmoc-cleavage: 25% piperidine in DMF 
Cleavage from the resin: methanol/THF/triethylamine (9 : 1 : 1). 
The crude product was purified via silica flash gel column chromatography utilizing 
CH3Cl/MeOH (10:1; Rf = 0.4). Overall, 120 mg (0.17 mmol; 57%) of the pure peptide were 
isolated as a colorless solid. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.81 (s, 1 H, HAr, CH (His)), 7.63–6.88 (m, 12 H, HAr 
(Phe) + (Abz) + NH (Phe)+ NH (Cha)), 6,84 (s, 1 H, HAr, CH (His)), 5.85 (s, 1 H, NH (AGly)), 
4.86–4.55 (m, 3 H, NH (His) + Hα (Phe) + Hα (His)), 3.53 (s, 3 H, OCH3), 3.49 (s, 3 H, NCH3), 
3.11–2.86 (m, 4 H, Hβ (Phe) + Hβ (His)), 1.71–1.41 (m, 8 H, adamantane + Cha), 1.30 (s, 9 
H, C(CH3)), 1,27–1,09 (m, 4 H, Cha), 0.91–0,69 (m, 2 H, Cha), 
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13C-NMR (100 MHz, CDCl3): δ/ppm = 173.0 (C=O); 172.0 (C=O); 170.4 (C=O); 167.4(C=O); 
155.8 (C=O); 138.2; 137.8; 135.9; 134.6, 129.1, 128.4, 128.0, 127.1, 123.4, 123.0, 118.4, 
80.6, 54.5, 53.7, 52.2, 51.9, 39.7, 37.8, 34.1, 33.5, 32.7, 31.5, 28.4, 27.3, 26.3, 26.1, 26.0 
MS (ESI): m/z = 703.3 [M+H]+ (calc. m/z = 703.4); m/z = 725.3 [M+Na]+ (calc. m/z = 725.4). 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C38H51N6O7+ 703.3814; Found 703.3765. 
 
Boc-L-(π-Me)-His-4-Abz-L-Cha-L-Phe-OMe (213) 
 
Solid support: 461.5 mg (0.3 mmol) Fmoc-Phe-Wang resin 
1. Double coupling: 235.85 mg (0.6 mmol) Fmoc-L-Cha-OH, HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
2.      Double coupling: 216 mg (0.6 mmol) Fmoc-4-Abz-OH, HBTU (0.228 g, 0.6 mmol),    
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
3. Double coupling: 121.25 mg (0.45 mmol) Boc-L-(π-Me)-histidine, HBTU (0.228 g,       
0.6 mmol), HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
Washing: 5X DMF, 5X DCM, 5X DMF 
Fmoc-cleavage: 25% piperidine in DMF 
Cleavage from the resin: methanol/THF/triethylamine (9 : 1 : 1) 
The crude product was purified via silica flash gel column chromatography utilizing 
CH3Cl/MeOH as eluent (10:1; Rf = 0.45). Overall, 112 mg (0.17 mmol; 56%) of the pure 
peptide were isolated as a colorless solid. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 8.01 (s, 1 H, HAr, CH (His)), 7.81 (s, 2 H, HAr (Abz), 
7.43–7.18 (m, 4 H, HAr (Phe) + (Abz)), 7.18–6.98 (m, 5 H, HAr (Phe) + (Abz)), 6.93 (s, 1 H, 
HAr, CH (His)), 5.62 (s, 1 H, NH (AGly)), 4.91–4.66 (m, 3 H, NH (His) + Hα (Phe) + Hα (His)), 
3.64 (s, 3 H, OCH3), 3.47 (s, 3 H, NCH3), 3.17–2.88 (m, 4 H, Hβ (Phe) + Hβ (His)), 2.17 (s, 1 
H), 1.86–1.50 (m, 7 H, Cha), 1.49–1.26 (m, 10 H, C(CH3) + H (Cha)), 1,27–1,09 (m, 3 H, 
Cha), 0.91–0,69 (m, 2 H, Cha) 
13C-NMR (100 MHz, CDCl3): δ/ppm = 174.0 (C=O); 171.6 (C=O); 170.6 (C=O); 166.5(C=O); 
155.9 (C=O); 141.3,138.4, 135.9, 129.0, 128.5, 128.3, 126.9, 126.6, 118.9, 80.6, 54.2, 53.9, 
52.2, 51.7, 45.9, 39.2, 37.9, 34.1, 33.5, 32.4, 31.3, 29.7, 28.2, 26.8, 26.3, 26.1, 26.0 
MS (ESI): m/z = 703.3 [M+H]+ (calc. m/z = 703.4); m/z = 725.3 [M+Na]+ (calc. m/z = 725.4). 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C38H51N6O7+ 703.3814; Found 703.3760. 
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Boc-L-(π-Me)-His-AGly-L-β-Ala-L-Phe-OMe (214) 
 
Solid support: 461.5 mg (0.3 mmol) Fmoc-Phe-Wang resin 
1. Double coupling: 185.7 mg (0.6 mmol) Fmoc-β-Ala-OH, HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol) 
2.  Double coupling: 250 mg (0.6 mmol) Fmoc-A Gly-OH, HBTU (0.228 g, 0.6 mmol),    
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol) 
3. Double coupling: 121.25 mg (0.45 mmol) Boc-L-(π-Me)-histidine, HBTU (0.228 g, 
0.6 mmol), HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
Washing: 5X DMF, 5X DCM, 5X DMF 
Fmoc-cleavage: 25% piperidine in DMF 
Cleavage from the resin: methanol/THF/triethylamine (9 : 1 : 1) 
The crude product was purified via silica flash gel column chromatography utilizing 
CH3Cl/MeOH as eluent (10:1; Rf = 0.40). Overall, 94 mg (0.14 mmol; 46%) of the pure 
peptide were isolated as a colorless solid. 
1H-NMR (600 MHz, CDCl3): δ/ppm = 7.63 (s, 1 H, HAr, CH (His)), 7.26–7.10 (m, 3 H, HAr 
(Phe)), 7.05 (d, 2 H, J= 7.2 Hz, HAr (Phe)), 6.86 (s, 1 H, HAr, CH (His)), 6.55 (d, 1 H, J= 6 Hz, 
NH (Phe)), 6.48(d, 1 H, J= 7.6 Hz, NH (β-Ala)), 6.09 (s, 1 H, NH (AGly)), 5.34 (d, 1 H, J= 7.6 
Hz, NH (His)), 4.76 (q, 1 H, J= 6.8 Hz, Hα (Phe)), 4.20–4.12 (m, 1 H, Hα (His)), 3.67 (s, 3 H, 
OCH3), 3.60 (s, 3 H, NCH3), 3,14–3,04 (m, 2 H, Hβ (Phe)), 3.48–3.26 (m, 2 H, β-Ala), 3.12– 
2.89 (m, 4 H, Hβ (His) + (β-Ala)), 2.34–2.27 (m, 2 H, adamantane), 2.13–2.05 (m, 2 H, 
adamantane), 1.96–1.43 (m, 8 H, adamantane), 1.34 (s, 9 H, C(CH3)). 
13C-NMR (150 MHz, CDCl3): δ/ppm = 176.7 (C=O); 172.1 (C=O); 171.7 (C=O); 169.5 (C=O); 
137.7, 135.9,129.2, 128,6, 127.2, 77.2, 53.4, 52.4,42.6, 42.4, 40.2, 37.9, 37.7, 35.4, 35.1, 
31.9, 29.2, 28.2, 26.9. 
MS (ESI): m/z = 679.3 [M+H]+ (calc. m/z = 679.4). 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C36H51N6O7+ 679.3814; Found 679.3793. 
 
Ac-L-(π-Me)-His-A Gly-L-Phg-L-Phe-OMe (215) 
 
This peptide was synthesized by M.Sc. Raffael C. Wende. The synthesis can be found in 
literature.70 
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Boc-L-(π-Me)-His-A Gly-L-Phg-L-Phe-OBn (216) 
 
All peptide couplings are in accordance to the general procedure VI and VII. 
1. HOBt/EDC mediated peptide coupling: 
 
H-Phe-OBn · HCl:     0.319 g (1.250 mmol) 
Boc-Cha-OH · (C6H11)2NH:    0.566 g (1.250 mmol) 
EDC · HCl:       0.263 g (1.375 mmol) 
HOBt:        0.210 g (1.375 mmol) 
Et3N:        0.19 mL (1.375 mmol) 
DCM:       8.0 mL 
 
2. Cleavage of the Boc-group with HCl · 1,4-dioxane. 
3. HOBt/EDC mediated peptide coupling: 
 
H-Cha-Phe-OMe · HCl:    0.472 g (1.10 mmol) 
Boc-3-methylaminoadamantan- 
1-methylcarboxylic acid:    0.313 g (1.10 mmol) 
EDC · HCl:       0.232 g (1.21 mmol) 
HOBt:        0.185 g (1.21 mmol) 
Et3N:        0.17 mL (1.21 mmol) 
DCM:       8.0 mL 
 
4. Cleavage of the Boc-group with HCl · 1,4-dioxane. 
5. HOBt/EDC mediated peptide coupling: 
 
Boc-MAAMCA-H-Cha-Phe-OMe · HCl:  0.650 g (0.95mmol) 
Boc-(π-Me)-His-OH :     0.269 g (0.95 mmol) 
EDC · HCl:       0.382 g (2.00 mmol) 
HOBt:        0.270 g (2.00 mmol) 
Et3N:        0.15 mL (2.00 mmol) 
DCM:       6.0 mL 
 
The crude peptide was purified by silica flash gel column chromatography eluating with 
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CHCl3/MeOH 10:1 (Rf = 0.4) and 523 mg (0.68 mmol; 54%) of a colorless solid were isolated. 
1H-NMR (600 MHz, CDCl3): δ/ppm = 7.40 (s, 1 H, HAr, CH (His)), 7.38–7.32 (m, 3 H, Har 
(Phe) + Ph), 7.30–7.23 (m, 5 H, Har (Phe) + Ph), 7.25–7.19 (m, 2 H, Har (Phe)),), 6.87 (s, 1 H, 
HAr, CH (His)), 6.52 (d, 1 H, J= 12 Hz, NH (Phe)), 6,0 (d, 1 H, J= 9 Hz, NH (Cha)), 5.78 (s, 1 
H, NH (AGly)), 5.18 – 5.08 (m, 3 H, CH2 + NH (His)), 4.8 (q, 1 H, J= 7,2 Hz, Hα (Phe)), 4.4 (q, 
1 H, J= 7,2 Hz, Hα (Cha)), 4.16 (s, 1 H, Hα (His)), 3.60 (s, 3 H, NCH3), 3.14–3.04 (m, 2 H, Hβ 
(Phe)), 3.09–2.98 (m, 2 H, Hβ (His)), 2.21-2.17 (m, 2 H, adamantane), 1.93–1,80 (m, 6 H, 
adamantane + Cha), 1,74–1,58 (m, 12 H, adamantane + Cha), 1,4 (s, 9 H, C(CH3)), 1.31 (t, 1 
H, Cha), 1.27–1.09 (m, 4 H, Cha), 0.97–0.80 (m, 2 H, Cha) 
13C-NMR (150 MHz, CDCl3): δ/ppm = 176.4 (C=O); 171.9 (C=O), 171.6 (C=O), 169.8 (C=O), 
155.0 (C=O), 138.2, 135.5, 135.0, 129.6, 129.0, 128.8, 128.4, 128.2 127.2, 126.9, 80.3, 67.1, 
53.2, 52.3, 50.7, 42.5, 42.2, 40.4, 40.2, 39.5, 38.3, 38.1, 37.9, 35.1, 34.2, 33.5, 32.7, 31.5, 
29.1, 28.3, 26.8, 26.3, 26.1, 26.1. 
MS (ESI): m/z = 763.4 [M+H]+ (calc. m/z = 763.4). 
 
Boc-L-(π-Me)-His-A Gly-L-Phg-L-Phe-OMe (217) 
 
Solid support: 461.5 mg (0.3 mmol) Fmoc-Phe-Wang resin 
1. Double coupling: 224.42 mg (0.6 mmol) Fmoc-L-Phg-OH, HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
2. Double coupling: 250 mg (0.6 mmol) Fmoc-AGly-OH 154, HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
3. Double coupling: 121.25 mg (0.45 mmol) Boc-L-(π-Me)-histidine, HBTU (0.228 g, 
0.6 mmol), HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
Washing: 5X DMF, 5X DCM, 5X DMF 
Fmoc-cleavage: 25% piperidine in DMF 
Cleavage from the resin: methanol/THF/triethylamine (9 : 1 : 1). 
The crude peptide was purified via column chromatography utilizing silica flash gel and 
CH3Cl/MeOH (10:1: Rf = 0.35). Overall, 224 mg (0.22 mmol; 76%) of the pure peptide were 
isolated as a colorless solid. 
1H-NMR (600 MHz, CDCl3): δ/ppm = 7.66 (s, 1 H, HAr, CH (His)), 7.38–7.20 (m, 8 H, HAr 
(Phe) + (Phe-Gly)), 7.13–6.97 (m, 2 H, HAr (Phe)), 6.89 (s, 1 H, HAr, CH (His)), 6.63 (d, 1 H, 
J= 7.8 Hz, NH (Phe)), 6.40 (d, 1 H, J= 9 Hz, NH (Phe-Gly)), 6.15 (s, 1 H, NH (AGly)), 5.44–
5.28 (m, 1 H, NH (His)), 4.85 (q, 1 H, J= 7,2 Hz, Hα (Phe)), 4.75 (q, 1 H, J= 7,2 Hz, Hα (Phe-
N
H
H
N O-tBu
H
NN
H
O
O
O
O
N N
O OMe
Experimental Part 	  
	  252 
Gly)), 4.23 (s, 1 H, Hα (His)), 3,70 (s, 3 H, OCH3), 3,60 (s, 3 H, NCH3), 3.16–2.88 (m, 4 H, Hβ 
(Phe) + Hβ (His)), 2.22–2.11 (m, 2 H, adamantane), 2.05–1.46 (m, 12 H, adamantane), 1,4 
(s, 9 H, C(CH3)).  
13C-NMR (150 MHz, CDCl3): δ/ppm = 175.9 (C=O); 171.3 (C=O); 171.2 (C=O); 169.7(C=O); 
155.4 (C=O); 137.5; 135.5; 129.16; 129.0, 128.7, 128.4, 127.1, 127.1, 127.0, 80.4, 56.8, 
53.7, 53.2, 52.4, 52.3, 42.5, 42.1, 40.2, 38.0, 37.6, 35.1, 31.9, 29.1, 28.3, 27.6, 26.9 25.6. 
MS (ESI): m/z = 741.3 [M+H]+ (calc. m/z = 741.4) 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C41H53N6O7+ 741.3970; Found 741.3938. 
 
Boc-L-(π-Me)-His-A Gly-L-His(Trt)-L-Phe-OMe (218) 
 
Solid support: 461,5 mg (0.3 mmol) Fmoc-Phe-Wang resin 
1. Double coupling: 371.8 mg (0.6 mmol) Fmoc-L-His(Trt)-OH, HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol) 
2. Double coupling: 250 mg (0.6 mmol) Fmoc-A Gly-OH, HBTU (0.228 g, 0.6 mmol), 
HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol) 
3. Double coupling: 121.25 mg (0.45 mmol) Boc-L-(π-Me)-histidine, HBTU (0.228 g, 
0.6 mmol), HOBt⋅H2O (0.092 g, 0.6 mmol), and DiPEA (0.155 g, 204.1 µL, 1.2 mmol). 
Washing: 5X DMF, 5X DCM, 5X DMF 
Fmoc-cleavage: 25% piperidine in DMF 
Cleavage from the resin: methanol/THF/triethylamine (9 : 1 : 1). 
The crude peptide was purified via column chromatography utilizing silica flash gel and 
CH3Cl/MeOH (10:1: Rf = 0.35). Overall, 224 mg (0.22 mmol; 76%) of the pure peptide were 
isolated as a colorless solid. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.99–7.86 (m, 1 H, HAr, CH (His)), 7,64–7.60 (m, 1 H, 
HAr (His)), 7,54 (s, 1 H, HAr (His)), 7.31 (s, 1 H, HAr, CH (His)), 7.29–7.19 (m, 9 H, HAr (Phe)), 
7.17–7.07 (m, 3 H, HAr (Phe)); 7.06–7.00 (m, 6 H, HAr (Phe)); 6.94–6.88 (m, 2 H, HAr (Phe)); 
6.81 (s, 1 H, NH (Phe), 6.63 (s, 1 H, NH (His)), 5.96 (s, 1 H, NH (AGly)), 5.24 (d, 1 H, J= 8.4 
Hz, NH (His)), 4.69 (q, 1 H, J= 7.6 Hz, Hα (Phe)), 4.56 (q, 1 H, J= 7.6 Hz, Hα (His)), 4.11 (bs, 
1 H , Hα (His)), 3.55 (s, 6 H, OCH3 + NCH3), 3.08–2.76 (m, 6 H, Hβ (Phe)) + (His)),  2.21-2.17 
(m, 2 H, adamantane), 1.98–1.45 (m, 12 H, adamantane), 1.34 (s, 9 H, C(CH3)). 
13C-NMR (150 MHz, CDCl3): δ/ppm = 176.8 (C=O); 171.5 (C=O); 170.9 (C=O); 169.4(C=O); 
155.2 (C=O); 142.1, 138.1, 137.8, 136.9, 135.9, 129.7, 129.3, 128.5, 128.0, 127.7, 126.9, 
126.6, 119.7, 75.4, 54.3, 53.4, 52.9, 52.4, 42.5, 52.4, 42.5, 42.1, 40.1, 40.0, 38.0, 37.8, 35.1, 
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31.8, 30.3, 29.4, 29.0, 28.3, 26.9 
MS (ESI): m/z = 987.2 [M+H]+ (calc. m/z = 987.5), m/z =1009.3 [M+Na]+ (calc. m/z = 1009.5). 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C58H67N8O7+ 987.5127; Found 987.5054. 
 
Boc-L-(π, τ-Dime-His)I-L-AGly-L-Cha-L-Phe-OMe (235) 
 
 
According to the general procedure 100 mg (0.13 mmol) of the tetrapeptide 12i were 
methylated. The crude product was purified by silica flash gel column chromatography using 
DCM/MeOH 4:1 (Rf = 0.2) and 50 mg (0.055 mmol, 39%) of the peptide (pale yellow solid) 
were obtained. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 9.20 (s, 1 H, CH-imidazole (His)), 7.32–7.22 (m, 3 H, 
HAr (Phe)), 7.17 (s, 1 H, CH-imidazole (His)), 7.15–7.11 (m, 2 H, HAr (Phe)), 6.92 (s, 1 H, NH 
(His)), 6.69 (d, J = 10.7, 1 H, NH (Phe)), 6.17 (d, J = 9, 1 H, NH (Cha)), 5.88 (d, J = 8.9, 1 H, 
NH (AGly)), 4.79–4.76 (m, 1 H, Hα (Phe)), 4.49–4.44 (m, 1 H, Hα (Cha)), 4.44–4.40 (m, 1 H, 
Hα (His)), 3.99 (s, 3 H, NCH3), 3.90 (s, 3 H, NCH3), 3.69 (s, 3 H, OCH3), 3.21–3.06 (m, 4 H, 
Hβ (Phe) + Hβ (His), 2.23–2.07 (m, 6 H, adamantane + Cha), 1.99–1.94 (m, 2 H, adamantane 
+ Cha), 1.86–1.64 (m, 12 H, adamantane + Cha), 1.58–1.50 (m, 1 H, Cha), 1.42 (s, 9 H, 
C(CH3)3), 1.25–1.07 (m, 4 H, Cha), 1.06–0.96 (m, 2 H, Cha).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 176.9 (C=O), 172.2 (C=O), 171.75 (C=O), 168.2 
(C=O), 136.6, 135.9, 132.3, 129.3, 128.7, 128.4, 127.2, 103.1, 67.4, 67.0, 53.4, 53.2, 52.4, 
42.6, 42.2, 40.2, 39.2, 38.3, 38.0, 37.8, 36.6, 34.9, 34.2, 33.5, 32.6, 29.1, 28.3, 27.2, 26.4, 
26.1, 26.1, 23.5.  
MS (ESI): m/z = 775.3 [M]+ (calcd: 775.5). 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C43H63N8O7+ 775.4753; Found 775.4717. 
 
Boc-β-(4-Taz)-AGly-L-Cha-L-Phe-OMe (236) 
 
1. Coupling: 
1.08 g (5 mmol) H-L-Phe-OMe⋅HCl, 2.26 g (5 mmol) Boc-L-Cha-OH⋅(C6H11)2NH , 0.84 g (5.5 
mmol) HOBt⋅H2O, 1.06 g (5.5 mmol) EDC ⋅HCl and 0.75 mL ( 5.5 mmol) Et3N in 25 mL DCM. 
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After evaporation of the solvent, 2.00 g of the dipeptide Boc-L-Cha-L-Phe-OMe were 
obtained as a colorless solid (4.6 mmol, 92%). 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.25–7.13 (m, 3 H, HAr (Phe)), 7.06–7.00 (m, 2 H, HAr 
(Phe)), 6.47 (d, J = 7.8, 1 H, NH (Phe)), 4.86–4.70 (m, 2 H, NH (Cha + Hα (Phe)), 4.13–3.99 
(m, 1 H, Hα (Cha)), 3.63 (s, 3 H, OCH3), 3.04 (dq, J = 6.2 Hz, J = 14.4, 2 H, Hβ (Phe)), 1.74–
1.47 (m, 6 H, Cha), 1.37 (s, 9 H, C(CH3)3), 1.29–0.98 (m, 5 H, (Cha)), 0.94–0.72 (m, 2 H, 
(Cha)).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 172.2 (C=O), 171.6 (C=O), 155.5 (C=O), 135.7 (Car), 
129.3 (Car), 128.7 (Car), 127.1 (Car), 80.0, 53.1, 52.4, 52.2, 39.8, 37.9, 33.9, 33.6, 32.5, 28.2 
(C(CH3)3), 26.3, 26.1, 26.0. ESI: m/z = 455.1 [M + Na]+ (calcd: m/z = 455.2). 
The Boc-group was cleaved under standard conditions. 
2. Coupling: 
1.53 g (4.6 mmol) H-L-Cha-L-Phe-OMe⋅HCl, 1.36 g (4.6 mmol) Boc-L-AGly-OH, 0.7 g 
(5.06 mmol) HOBt⋅H2O, 0.97 g (5.06 mmol) EDC ⋅HCl and 0.7 mL (5.06 mmol) Et3N in 25 mL 
DCM. After removal of the solvent 2.414 g of the tripeptide Boc-AGly-L-Cha-L-Phe-OMe were 
obtained as a colorless solid (3.96 mmol, 86%). 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.25–7.14 (m, 3 H, HAr (Phe)), 7.06–7.00 (m, 2 H, HAr 
(Phe)), 6.48 (d, J = 6.9 Hz, 1 H, NH (Phe)), 5.85 (d, J = 8.0 Hz, 1 H, NH (Cha)), 4.74–4.70 
(m, 1 H, Hα (Phe)), 4.43–4.34 (m, 2 NH (AGly) + Hα (Cha)), 3.64 (s, 3 H, OCH3), 3.03 (dq, J = 
6.1 Hz, J = 14.3 Hz, 2 H, Hβ (Phe)), 2.17–2.08 (m, 2 H, adamantane), 1.92–1.80 (m, 6 H, 
Cha + adamantane), 1.67–1.52 (m, 12 H, Cha + adamantane), 1.43–1.38 (m, 1 H, Cha), 1.36 
(s, 9 H, C(CH3)3), 1.22–1.03 (m, 5 H, Cha), 0.9–0.72 (m, 2 H, Cha).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 176.6 (C=O), 172.1 (C=O), 171.8 (C=O), 154.5 (C=O), 
135.8, 129.2, 128.6, 127.1, 79.0, 53.2, 52.3, 50.8, 50.6, 42.6, 40.9, 39.3, 38.1, 37.8, 35.3, 
34.2, 33.5, 32.7, 29.3, 28.5 (C(CH3)3), 26.3, 26.1, 26.1. ESI: m/z = 632.3 [M + Na]+ (calcd: 
m/z = 632.4), 648.1 [M + K]+ (calcd: m/z = 648.3), 1241.2 [2 M + Na]+ (calcd: m/z = 1241.7).  
The Boc-group was cleaved under standard conditions. 
3. Coupling: 
1.85 g (3.63 mmol) H-AGly-L-Cha-L-Phe-OMe · HCl, 988 mg (3.63 mmol) Boc-L-Taz-OH, 
619 mg (3.99 mmol) EDC·HCl, 539 mg (3.99 mmol) HOBt, 0.5 mL (3.99 mmol) Et3N in 50 ml 
DCM. The crude product was purified via silica gel column chromatography eluating with 
DCM/MeOH 10:1 (Rf = 0.3). After evaporation of the solvents under reduced pressure 2.09 g 
(2.73 mmol, 75%) of the tetrapeptide Boc-L-Taz-AGly-L-Cha-L-Phe-OMe were isolated as a 
colorless solid. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 8.70 (s, 1 H, CH (Taz)), 7.25–7.14 (m, 3 H, HAr (Phe)), 
7.10–7.00 (m, 3 H, HAr (Phe) + CH (Taz)), 6.48–6.38 (m, 1 H, NH (Phe)), 6.10 (bs, 1 H,) 5.90 
(d, 1 H, J = 9.6 Hz), NH (Cha)), 5.84 (d, 1 H, J = 8 Hz, NH (Taz)), 4.78–4.68 (m, 1 H, Hα 
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(Phe)), 4.41–4.30 (m, 2 H, Hα (Cha) + NH (AGly)), 3.64 (s, 3 H, OCH3), 3.63–3.57 (s, 1 H, Hβ 
(Taz)), 3.15–2.94 (m, 4 H, Hβ (Phe) + Hβ (Taz)), 2.15–2.04 (m, 2 H, adamantane), 1.89–1.72 
(m 6 H, Cha + adamantane), 1.66 – 1.53 (m, 13 H, Cha + adamantane), 1.38 (s, 9 H, 
C(CH3)), 1.20–1.00 (m, 5 H, Cha), 0.92–0.77 (m, 2 H, Cha). 
13C-NMR (150 MHz, CDCl3): δ/ppm = 176.4 (C=O); 171.9 (C=O); 171.6 (C=O); 169.8 (C=O); 
155.0 (C=O); 138.2; 135.5; 129.6; 128.8; 128.2; 127.2; 127.0; 80.3; 54.5; 53.2; 52.3; 50.7; 
42.5; 42.1; 40.4; 40.2; 39.5; 38.3; 38.1; 37.9; 35.1; 34.2; 33.5; 32.7; 31.5; 29.1; 28.3; 26.8; 
26.8; 26.3; 26.1 
MS (ESI): m/z = 786.3 [M + Na]+ (calcd: 786.4), 802.2 [M + K]+ (calcd: 802.4). 
HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C41H57N5O7SNa+ 786.3871; Found 786.3862. 
 
Boc-β-(4-MeTaz)I-AGly-L-Cha-L-Phe-OMe (237) 
 
According to the general procedure 100 mg (0.13 mmol) of the tetrapeptide 236 were 
methylated. The crude product was purified by silica flash gel column chromatography using 
DCM/MeOH 4:1 (Rf = 0.2) and 55 mg (0.06 mmol, 43%) of the peptide (pale yellow solid) 
were obtained. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 10.32 (s, 1 H, CH-thiazolyl (Taz)), 7.97 (s, 1 H, CH-
thiazolyl (Taz)), 7.28–7.15 (m, 3 H, HAr (Phe)), 7.15–7.08 (m, 3 H, HAr (Phe + NH (Taz)), 6.93 
(s, 1 H, NH (Phe)), 6.33 (s, 1 H, NH (Cha)), 5.92 (s, 1 H, NH (AGly)), 4.73–4.66 (m, 2 H, Hα 
(Phe)), 4.62–4.56 (m, 1 H, Hα (Cha)), 4.38 (s, 3 H, NCH3), 4.37–4.30 (m, 1 H, Hα (Taz)), 3.62 
(s, 3 H, OCH3), 3.50–3.38 (m, 1 H, Hβ (Taz)), 3.32–3.23 (m, 1 H, Hβ (Taz)), 3.11–3.03 (m, 2 
H, Hβ (Phe)), 2.02–1.88 (m, 8 H, adamantane + Cha), 1.83–1.50 (m, 13 H, adamantane + 
Cha), 1.31 (s, 9 H, C(CH3)3), 1.20–1.03 (m, 4 H, Cha) 0.91–0.73 (m, 2 H, Cha).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 177.2 (C=O), 172.6 (C=O), 171.9 (C=O), 168.5 (C=O), 
159.1, 155.3, 146.4, 135.9, 129.2, 128.5, 127.0, 123.5, 80.2, 53.2, 52.5, 51.5, 42.5, 42.1, 
41.9, 40.3, 40.1, 39.1, 37.9, 37.8, 37.5, 35.0, 34.0, 33.3, 32.5, 31.3, 29.6, 28.3 (C(CH3)3), 
26.2, 26.0, 25.9.  
MS (ESI): m/z =  778.3 [M]+ (calcd: m/z = 778.4) 
HRMS (ESI-TOF) m/z: [M]+ calcd for C42H60N5O7S+ 778.4202; Found 778.4201. 
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Boc-β-(4-Taz)-AGly-L-Val-L-Phe-OMe (236-V) 
 
 
1. Coupling: 
431 mg (2 mmol) of H-L-Phe-OMe ⋅HCl, 543 mg (2 mmol) Boc-L-Val-OH, 297 mg (2.2 mmol) 
of HOBt⋅H2O, 421 mg (2.2 mmol) of EDC⋅HCl and 0.31 mL (2.2 mmol) of Et3N in 10 mL 
DCM. After evaporation of the solvent 558 mg (1.47 mmol, 73%) of the dipeptide Boc-L-Val-
L-Phe-OMe were obtained as a colorless solid.  
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.34–7.23 (m, 3 H, HAr (Phe)), 7.15–7.08 (m, 2 H, HAr 
(Phe)), 6.43–6.28 (m, 1 H, NH (Phe)), 5.09–4.98 (m, 1 H, NH (Val)), 4.93–4.84 (m, 1 H, Hα 
(Phe)), 3.96–3.85 (m, 1 H, Hα (Val)), 3.72 (s, 3 H, OCH3), 3.18–3.06 (m, 2 H, Hβ (Phe)), 
2.14–2.04 (m, 1 H, CH), 1.46 (s, 9 H, C(CH3)3), 1.02–0.8 (m, 6 H, CH3 (Val)).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 171.7 (C=O), 171.2 (C=O), 155.7, 135.7, 129.3, 128.6, 
127.2, 79.9, 59.9, 53.1, 52.3, 38.0, 30.9, 28.3 (C(CH3)3), 19.2, 17.6.  
MS (ESI): m/z = 401.1 (calcd: m/z = 401.2). 
The Boc-group was cleaved under standard conditions. 
2. Coupling: 
408 mg (1.47 mmol) of H-L-Val-L-Phe-OMe ⋅HCl, 434 mg (1.47 mmol) of Boc-L-AGly-OH, 
218 mg (1.62 mmol) of HOBt⋅H2O, 310 mg (1.62 mmol) of EDC ⋅HCl and 0.25 mL (1.62 
mmol) of Et3N in 10 mL DCM. After removal of the solvent 611 mg (1.1 mmol, 75%) of the 
tripeptide Boc-AGly-L-Val-L-Phe-OMe were obtained as a colorless solid.  
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.32–7.21 (m, 3 H, HAr (Phe)), 7.12–7.08 (m, 2 H, HAr 
(Phe)), 6.40–6.32 (m, 1 H, NH (Phe)), 6.20–6.14 (m, 1 H, NH (AGly)), 4.87–4.81 (m, 1 H, 
NH (Val)), 4.49–4.44 (m, 1 H, Hα(Phe)), 4.29–4.21 (m, 1 H, Hα(Val)), 3.71 (s, 3 H, OCH3), 
3.16–3.05 (m, 2 H, Hβ (Phe)), 2.25–2.19 (m, 2 H, adamantane), 2.12–2.04 (m, 1 H, CH), 
2.03–1.99 (m, 2 H, adamantane), 1.96–1.89 (m, 4 H, adamantane), 1.82–1.74 (m, 4 H, 
adamantane), 1.69–1.59 (m, 2 H, adamantane), 1.43 (s, 9 H, C(CH3)3), 0.95–0.86 (m, 6 H, 
CH3 (Val)).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 176.6 (C=O), 171.6 (C=O), 170.9 (C=O), 135.6, 129.2, 
128.7, 127.2, 120.2, 78.9, 57.8, 53.1, 52.3, 50.8, 42.8, 40.9, 38.3, 37.8, 35.3, 31.1, 29.2, 28.5 
(C(CH3)3), 19.1, 18.1.  
MS (ESI): m/z = 578.3 [M + Na]+ (calcd: m/z = 578.3). 
The Boc-group was cleaved under standard conditions. 
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3. Coupling: 
300 mg (0.6 mmol) of H-AGly-L-Val-L-Phe-OMe·HCl, 147 mg (0.6 mmol) of Boc-L-Taz-OH, 
113 mg (0.66 mmol) of EDC·HCl, 80 mg (0.66 mmol) of HOBt, 0.08 ml (0.66 mmol) of Et3N in 
10 mL DCM. The crude product was purified via silica gel column chromatography eluting 
with DCM/MeOH 10:1 (Rf = 0.3). After evaporation of the solvents under reduced pressure 
297 mg (0.42 mmol, 42%) of the tetrapeptide Boc-L-Taz-AGly-L-Val-L-Phe-OMe was isolated 
as a colorless solid. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 8.77 (s, 1 H, CH-thiazolyl (Taz)), 7.31 – 7.24 (m, 3 H, 
HAr (Phe)), 7.14 – 7.08 (m, 3 H, HAr + CH-thiazolyl (Taz)), 6.37 – 6.28 (m, 1 H, NH (Taz)), 
6.22 – 6.16 (m, 1 H, NH (Phe)), 6.00 – 5.94 (m, 1 H, NH (AGly)), 4.88 – 4.80 (m, 1 H, NH 
(Val)), 4.27 – 4.18 (m, 1 H, Hα (Phe)), 4.16 – 4.08 (m, 1 H, Hα (Val)), 3.77 – 3.60 (m, 4 H, 
OCH3 + Hα (Taz)), 3.38 – 3.29 (m, 1 H, Hβ (Taz)), 3.19 – 3.06 (m, 3 H, Hβ (Phe) + Hβ (Taz)), 
2.11 – 2.01 (m, 3 H, adamantane), 1.98 – 1.71 (m, 10 H, adamantane + CH (Val)), 1.68 – 
1.55 (m, 2 H, adamantane), 1.44 (s, 9 H, C(CH3)3), 0.95 – 0.84 (m, 6 H, CH3 Val)).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 176.4 (C=O), 141.6 (C=O), 171.2 (C=O), 170.9 (C=O), 
170.2 (C=O), 155.5, 153.3, 152.9, 135.5, 130.9, 129.2, 128.8, 128.7, 127.3, 115.9, 80.0, 
60.4, 57.8, 54.6, 53.1, 52.3, 51.9, 42.7, 42.4, 40.2, 40.1, 38.2, 38.0, 37.8, 35.1, 35.7, 31.1, 
29.1, 28.9, 28.7, 28.3 (C(CH3)3), 21.1, 19.1, 18.1, 14.2, 14.1.  
MS (ESI): m/z = 732.3 [M + Na]+ (calcd: m/z = 732.3), m/z = 4114.3 [2 M + Na]+ (calcd: m/z = 
1441.7). 
 
Boc-L-(N-Me-Taz)I-L-AGly-L-Val-L-Phe-OMe (237-V) 
 
 
According to the general procedure 100 mg (0.14 mmol) of the tetrapeptide 236-V were 
methylated. The crude product was purified by silica flash gel column chromatography using 
DCM/MeOH 4:1 (Rf = 0.2) and 296 mg (0.42 mmol, 77%) of the peptide (pale yellow solid) 
were obtained. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 10.37 (s, 1 H, CH-thiazolyl (Taz)), 8.02 (s, 1 H, CH-
thiazolyl (Taz)), 7.34–7.14 (m, 5 H, Har (Phe)), 7.14–7.04 (m, 1 H, NH (Taz)), 6.60–6.50 (m, 1 
H, NH (Phe)), 6.04–5.94 (m, 1 H, NH (AGly)), 4.83–4.74 (m, 1 H, NH (Val)), 4.73–4.61 (m, 1 
H, Hα (Phe)) 4.47 (s, 3 H, NCH3 (Taz)), 4.26–4.18 (m, 1 H, Hα (Val)), 3.69 (s, 4 H, OCH3 + Hα 
(Taz)), 3.56–3.44 (m, 1 H, Hβ (Taz)), 3.44–3.31 (m, 1 H, Hβ (Taz)), 3.19–3.12 (m, 2 H, Hβ 
(Phe)), 2.67–1.95 (m, 9 H, adamantane), 1.92–1.59 (m, 6 H, adamantane + CH (Val)), 1.38 
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(s, 9 H, C(CH3)3), 0.96–0.77 (m, 6 H, CH3 (Val).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 172.0 (C=O), 171.8 (C=O), 159.2, 136.0, 129.3, 128.7, 
127.2, 53.7, 53.4, 52.55, 42.7, 42.2, 37.5, 30.9, 29.1, 28.4 (C(CH3)3), 19.1, 18.4.  
MS (ESI): m/z = 724.3 [M]+ (calcd: m/z = 724.4). 
HRMS (ESI-TOF) m/z: [M+H]+ calcd for C38H54N5O7S+ 724.3738; Found 724.3740. 
 
 
Carbene-precursors 
 
L-Histidinedihydrochloride methyl ester (228) 
 
50 g (0.322 mol) of 227 were dissolved in 1 L dry methanol and HCl gas was introduced. A 
small amount of bubbling should be seen in the gas trap filled with basic solution for about 6 
h. The reaction vessel should be monitored all the time. The reaction vessel was sealed and 
allowed to stir overnight. The product was separated by filtration and washed with water. The 
product was dried separately in a desiccator over paraffin wax and P2O5 under reduced 
pressure.  67 g (0.28 mol; 86%) of the colorless solid were isolated. 
1H-NMR (400 MHz, D2O): δ/ppm 3.46–3.24 (m, 2H), 3.73 (s, 3H), 4.39 (t, 1H), 7.35 (s, 1H), 
8.64 (s, 1H). 
13C-NMR (100 MHz, D2O): δ/ppm 24.5, 51.8, 53.9, 117.9, 126.2, 134.3, 168.9. 
 
L-Dibenzoylhistidine methylester (229) 
 
To a solution of 62.0 g (0.256 mol) 228 in 900 mL water, 91.8 g (0.870 mol) of Na2CO3 were 
added. Afterwards 900 mL of THF were added and the transparent solution became opaque. 
144.0 g (0.636 mol) of benzoic anhydride were added and allowed to stir. After one hour a 
second portion of 75 g (0.331 mol) were added and the solution stirred for another 2 h. THF 
was removed in vacuo and 700 mL of DCM were added. The reaction mixture was washed 
with saturated NaHCO3 solution (three times), citric acid (10%, two times) and brine. The 
organic layer was dried with Na2SO4 and the solvent was evaporated under reduced 
pressure. Diethyl ether (400 mL) were added and the product appeared as a withe solid. The 
product was separated by filtration and dried under high vacuum over paraffin wax and P2O5 
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in a desiccator. Overall, 82 g (0.21 mol; 85%) of the pure product were isolated as a 
colorless solid. 
1H-NMR (400 MHz, CDCl3): δ/ppm 3.24–3.10 (m, 2H), 3.67 (s, 3H), 5.04–4.97 (m, 1H), 7.25–
8.10 (m, 12H) 
13C-NMR (100 MHz, CDCl3): δ/ppm 171.6, 167.0, 165.9, 139.5, 138.0, 134.5, 133.78, 131.7, 
130.5, 129.7, 128.9, 128.4, 127.1, 115.5, 52.5, 29.5. 
 
L-benzoyl methyl histidine methyl ester (230) 
 
39 g (0.103 mol) of 229 were dissolved in 180 mL of nitromethane and 20 g (0.135 mol) of 
Meerwein’s salt dissolved in 90 mL of nitromethane, were added via an addition funnel over 
25 min. After 4 h the solvent was removed under reduced pressure to give an orange oil. 
500 mL of water were added and the reaction mixture was allowed to stir overnight. The 
reaction mixture was transferred to a separating funnel and extracted with diethyl ether. The 
pH of the aqueous layer was adjusted to eight with a saturated NaHCO3 solution, the product 
extracted with DCM and dried over Na2SO4. The solvent was removed and the product dried 
in vacuo. Overall, 23.9 g (83 mmol; 81%) of the colorless solid were obtained. 
1H-NMR (400 MHz, CDCl3): δ/ppm 3.26 (m, 2H), 3.55 (s, 3H), 3.78 (s, 3H), 5.00 (m, 1H), 
6.80 (s, 1H), 7.18–7.94 (m, 7H) 
13C-NMR (100 MHz, CDCl3): δ/ppm 171.6, 167.3, 138.7, 133.6, 132.1, 128.9, 127.7, 126.8, 
52.9, 51.8, 31.6, 25.9  
 
L-π-Methylhistidine dihydrochloride (231) 
 
24.5 g (0.0852 mol) of the 230 were dissolved in 1.4 L of 6 M HCl and refluxed for 6–8 h. 
While cooling a colorless solid precipitated. The reaction mixture was extracted with diethyl 
ether and the aqueous layer was concentrated to give a yellow oily residue. The crude 
product was dissolved in warm methanol and diethyl ether was added until the product 
crystallized. The product was separated by filtration and dried in vacuo. Overall, 13.3 g (55.2 
mmol; 65%) of the product were isolated. 
1H-NMR (400 MHz, D2O): δ/ppm 3.42–3.13 (m, 2H), 3.73 (s, 3H), 4.20 (t, 1H), 7.31 (s, 1H), 
COOMe
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8.58 (s, 1H) 
13C-NMR (100 MHz, D2O): δ/ppm 135.9, 118.7, 51.3, 48.7, 33.2, 23.8 
 
Boc-L-(π-Me)-histidine (232) 
 
20.47 g (0.0852 mol) of the 231 were dissolved in 615 mL of THF and 615 mL of water. 
Then, 29.7 mL (0.170 mol) of DiPEA and 46.51 g (0.213 mol) of Boc-anhydride were added 
and the reaction mixture was allowed to stir at r.t. for 24 h. The solvent was removed in 
vacuo and the crude product was dissolved in 1.5 L NH3(aq) (1.25 M). The solution was 
washed with DCM and the aqueous layer was concentrated. The colorless solid was dried in 
vacuo. The crude product was then extracted with DCM and filtered off. The solvent was 
removed under reduced pressure to yield 14.2 g (52.7 mmol; 62%) of a yellowish solid. 
1H-NMR (200 MHz, D2O): δ/ppm 1.26 (s, 9H), 3.02–2.76 (q, 1H), 3.24–3.02 (q, 1H), 3.74 (s, 
3H), 4.10 (s, 1H), 7.13 (s, 1H), 8.46 (s, 1H) 
13C-NMR (50 MHz, D2O): δ/ppm 177.1, 157.1, 135.1, 131.4, 118.4, 80.6, 54.3, 33.1, 27.9, 
26.8. 
 
L-Benzoyl-N,N’-dimethyl histidine methyl ester iodide (233) 
 
1 g (3.5 mmol) of 230 was dissolved in 5 mL of acetonitrile, then 2 mL of methyl iodide were 
added and the solution was warmed to 60 °C for 5 h. The excess methyl iodide was distilled 
off and the solvent was evaporated under reduced pressure. The crude product was purified 
via silica flash gel column chromatography eluting with DCM/methanol (9/1), Rf = 0.32.  The 
product (0.89 g, 2.1 mmol; 60%) was isolated as a yellowish solid. 
1H-NMR (400 MHz, D2O): δ/ppm 3.21–3.41 (m, 2 H), 3.75 (s, 3 H), 3.85 (s, 3 H), 3.88 (s, 3 
H), 4.86 (m, 1 H), 7.49–7.70 (m, 4 H), 7.87 (m, 1 H), 9.04 (m, 1 H) 
13C-NMR (100 MHz, D2O): δ/ppm 170.8, 166.9, 136.8, 133.8,131.9, 131.3, 128.5, 127.4, 
121.4, 52.5, 50.8, 35.8, 33.4, 24.5. 
HRMS (ESI-TOF) m/z: [M+]+ calcd for C16H20N3O3+ 302.1499; Found 302.1498. 
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Boc-L-N,N’-Dimethylhistidine iodide (234) 
 
1 g (3.6 mmol) of Boc-L-(π-Me)-histidine 232 was dissolved in 5 mL of DCM, then 2 mL of 
methyl iodide were added and the mixture was stirred for 1 day at r.t. The crude product was 
purified via silica flash gel column chromatography eluting with ethanol/NH3 (aq) (7 / 3), Rf = 
0.57. 0.42 g (1.0 mmol; 28%) of the product was isolated as a colorless solid. 
1H-NMR (400 MHz, D2O): δ/ppm 1.37 (s, 9H), 2.98 (q, 1H), 3.21 (q, 1H), 3.81 (2 x s, 6H), 
4.19 (s, 1H), 7.23 (s, 1H), 8.61 (s, 1H) 
13C-NMR (100 MHz, D2O): δ/ppm 176.6, 157.0, 136.3, 131.9, 121.6, 81.1, 54.1, 35.4, 33.1, 
27.5, 26.6. 
HRMS (ESI-TOF) m/z: [M]+ calcd for C13H22N3O4+ 284.1605; Found 284.1609. 
 
2-Hydroxy-1,2-diphenylethanon (239a) 
 
In a flame-dried vessel under an argon atmosphere, 22 mg of 240 (0.1 mmol, 10 mol%) were 
dissolved in 3 mL of dry THF at r.t. Subsequently, 11 mg of KOtBu (0.11 mmol, 11 mol%) 
were added and the solution was allowed to stir for 30 min. Subsequently, 101 µL of 
benzaldehyde (1 mmol) were added. After 24 h, the reaction mixture was quenched with 
3 mL of a saturated NaCl solution. The organic layer was extracted with dichloromethane 
and dried over MgSO4. After evaporation of the solvent, the crude product was purified by 
silica flash gel column chromatography (EtOAc/hexane, 2:8). Overall, 138 mg (0.65 mmol, 
65%) of colorless crystals were obtained. The racemic product was subjected to the HPLC 
assay to prove the origin of signals. 
1H-NMR (200 MHz, CDCl3): δ/ppm = 7.99–7.86 (m, 2 H, HAr), 7.61–7.47 (m, 1 H, HAr), 7.46–
7.20 (m, 7 H, HAr), 5.96 (d, J = 5.8 Hz, 1 H, CH), 4.56 (d, 1 H, J = 5.8 Hz, OH).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 198.9 (C=O), 139.0, 133.9, 133.4, 129.2, 128.7, 128.6, 
127.8, 76.2 (CH).  
ESI: m/z = 235.0 [M + Na]+ (calcd: m/z = 235.1), m/z = 251.0 [M + K]+ (calcd: m/z = 251.3). 
1H-NMR-data are in accordance with the data reported from Sigma Aldrich. 
Assay of product formation: 
Racemic 239a was detected by GC-FID employing a 30 m 5890_V UP5 (Machery Nagel). 
T (Injector + Detector) = 250 °C 
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Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100 °C – 250 °C, 15 °C/min 
Retention times: R = 9.8 min 
 
Assay of enantiomeric purity: 
Enantiomers of 2-hydroxy-1,2-diphenylethanon were separated by chiral HPLC employing a 
Chiralpak IB column (Daicel) 
Eluent: Hexane/2-Propanol 95:5 
Flow: 1 mL/min 
UV-detector: λ = 254 nm and refractometer 
Retention times: R1 = 12.9 min, R2 = 16.1 min 
 
1,2-Bis(4-Fluorophenyl)-2-hydroxyethanone (239b) 
 
In a flame-dried vessel under an argon atmosphere, 20 mg of 240 (0.1 mmol, 10 mol%) were 
dissolved in 3 mL of dry THF at r.t. Subsequently, 11 mg of KOtBu (0.11 mmol, 11 mol%) 
were added and the solution was allowed to stir for 30 min. Then 107 mL of p-
fluorobenzaldehyde (1 mmol) were added. After 24 h, the reaction mixture was quenched 
with 3 mL of a saturated NaCl solution. The organic layer was extracted with 
dichloromethane and dried over MgSO4. After evaporation of the solvent, the crude product 
was purified via column chromatography (EtOAc/hexane, 2:8). 81 mg (0.33 mmol, 33%) of 
colorless crystals were obtained. The racemic product was subjected to the HPLC assay to 
prove the origin of signals. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 8.03–7.86 (m, 2 H, HAr), 7.42–7.23 (m, 2 H, HAr), 7.18–
6.98 (m, 4 H, HAr), 5.9 (d, J = 5.6, 1 H, CH), 4.52 (d, J = 5.2, 1 H, OH).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 197.2 (C=O), 167.4 (d, JC-19F = 256), 162.8 (d, JC-19F = 
243), 134.8 (d, JC-19F = 4), 131.9 (d, JC-19F = 10), 129.7 (d, JC-19F = 3), 129.6 (d, JC-19F = 8), 
116.3 (d, JC-19F = 22, 2 x C), 116.1 (d, JC-19F = 22, 2 x C), 75.4.  
ESI: m/z = 277.1 [M + Na]+ (calcd: m/z = 277.1). 
The NMR-data are in accordance with the literature.190 
 
Assay of product formation: 
Racemic 239b was detected by GC-FID employing a 30 m 5890_V UP5 (Machery Nagel). 
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T (Injector + Detector) = 250 °C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100 °C – 250 °C, 15 °C/min 
Retention times: R = 9.1 min 
 
N-N’-Dimethylimidazolium iodide (240) 
 
1 mL of N-methylimidazole (12.5 mmol) was dissolved in 2 mL of acetonitrile and 1 mL of 
methyl iodide was added dropwise. The solution was refluxed overnight at 90 °C. The 
precipitates were filtered off and washed three times with acetonitrile and dried over P2O5 
and paraffin wax in vacuo. Overall, 2.46 g of pale yellow crystals (11 mmol, 88%) could be 
obtained. 
1H-NMR (400 MHz, D2O): δ/ppm = 8.61 (s, 1 H, CH), 7.37 (s, 2 H, CH), 3.85 (s, 6 H, CH3).  
13C-NMR (100 MHz, D2O): δ/ppm = 136.6 (CH), 123.4 (2 x CH), 35.9 (2 x CH3). 
 
N-Methylthiazolium iodide (242) 
 
1 mL of N-methylimidazole (14 mmol) was dissolved in 2 mL of acetonitrile and 1 mL of 
methyl iodide was added dropwise. The solution was refluxed overnight at 90 °C. The 
precipitates were filtered off and washed three times with acetonitrile and dried over P2O5 
and paraffin wax in vacuo. Overall, 2.22 g pale yellow crystals (9.8 mmol, 70%) could be 
obtained. 
1H-NMR (400 MHz, D2O): δ/ppm = 8.61 (s, 1 H, CH), 7.37 (s, 2 H, CH), 3.85 (s, 6 H, CH3). 
13C-NMR (100 MHz, D2O): δ/ppm = 136.6 (CH), 123.4 (2 x CH), 35.9 (2 x CH3). 
 
General procedure for the in-situ acylation of benzoin 
In a flame-dried vessel under an argon atmosphere, precatalyst 240 (22 mg, 0.1 mmol, 
33 mol%) and KOtBu (11 mg, 0.11 mmol) were degassed for 30 min, suspended in 
anhydrous THF and stirred for 15 min at r.t. Then, benzaldehyde (30 µL, 0.3 mmol) was 
added via an Eppendorf pipette to the carbene solution. Subsequently, acetic anhydride 
(36 mL, 1.2 eq.) was added and the solution was stirred for 12 h. After quenching the 
reaction mixture with water, a GC-FID analysis was performed.. 
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2-Oxo-1,2-diphenylethyl acetate (244a) 
 
Racemic 2-hydroxy-1,2-diphenylethanon (80 mg, 0.38 mmol) were dissolved in 3 mL DCM. 
Subsequently, 40 µL Ac2O (0.42 mmol), 4.5 mg DMAP (0.04 mmol, 10 mol%) and 53 µL 
Et3N (0.42 mmol) were added and the solution was stirred for 12 h at r.t. (25 °C). The solvent 
was evaporated under reduced pressure and the acylated product was directly purified via 
silica flash gel column chromatography and eluated with DCM/MeOH 8:2 (Rf = 0.4). 83 mg of 
2-Oxo-1,2-diphenylethyl acetate (0.34 mmol, 89%) could be obtained. The racemic product 
was subjected to the HPLC assay to prove the origin of signals. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.96–7.90 (m, 2 H, HAr), 7.56–7.45 (m, 3 H, HAr), 7.44–
7.32 (m, 5 H, HAr), 6.87 (s, 1 H, CH), 2.21 (s, 3 H, CH3).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 193.7 (C=O), 170.5 (C=O), 134.6 (CAr), 133.6 (CAr), 
133.5 (CAr), 129.4 (CAr), 129.2 (CAr), 128.8 (CAr), 128.7 (2 x CAr), 128.6 (2 x CAr), 77.7 (CH), 
80.8 (CH3). 
The NMR-data are in accordance with the literature.190 
 
Assay of product formation: 
Racemic 244a was detected by GC-FID employing a 30 m 5890_V UP5 (Machery Nagel). 
T (Injector + Detector) = 250 °C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100 °C – 250 °C, 15 °C/min 
Retention times: R = 10.9 min. 
 
Assay of enantiomeric purity: 
Enantiomers of 2-oxo-1,2-diphenylethyl acetate were separated by chiral HPLC employing a 
Chiralpak IB column (Daicel) 
Eluent: Hexane/2-Propanol 95:5 
Flow: 1 mL/min 
UV-detector: λ = 254 nm and refractomter 
Retention times: R1 = 7.6 min, R2 = 11.1 min 
 
 
 
 
O
OAc
Experimental Part 	  
	   265 
1,2-Bis(4-fluorophenyl)-2-oxoethyl acetate (244b) 
 
Racemic 1,2-bis(4-fluorophenyl)-2-hydroxyethanone (67 mg, 0.27 mmol) were dissolved in 
3 mL of DCM. Subsequently, 28 µL of Ac2O (0.30 mmol), 3.7 mg of DMAP (0.03 mmol, 
10 mol%) and 41 µL triethylamine (0.3 mmol) were added and the solution was stirred for 
12 h at r.t. (25 °C). The solvent was evaporated under reduced pressure and the acylated 
product was directly purified via silica flash gel column chromatography and eluated with 
DCM/MeOH 8:2 (Rf = 0.8). 60 mg of 1,2-bis(4-fluorophenyl)-2-oxoethyl acetate (0.21 mmol, 
77%) could be obtained. The racemic product was subjected to the HPLC assay to prove the 
origin of signals. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 7.92–7.84 (m, 2 H, HAr), 7.39–7.33 (m, 2 H, HAr), 7.05–
6:95 (m, 4 H, HAr), 6.72 (s, 1 H, CH), 2.13 (s, 3 H, CH3).  
13C-NMR (100 MHz, CDCl3): δ/ppm = 192.1 (C=O), 170.4 (C=O), 167.2 (d, JC-15F = 225), 
163.2 (d, JC-15F = 248), 131.5 (d, JC-15F = 10), 130.8 (d, JC-15F = 2.3), 130.5 (d, JC-15F = 8.8), 
129.3 (d, JC-15F = 3), 116.3 (d, JC-15F = 22), 116.0 (d, JC-15F = 22), 76.6 (CH), 20.7 (CH3). 
The NMR-data are in accordance with the literature.190 
 
Assay of product formation: 
Racemic 244b was detected by GC-FID employing a 30 m 5890_V UP5 (Machery Nagel). 
T (Injector + Detector) = 250 °C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 100 °C – 250 °C, 15 °C/min 
Retention times: R = 10.3 min 
 
Assay of enantiomeric purity: 
Enantiomers of 1,2-bis(4-fluorophenyl)-2-oxoethyl acetate were separated by chiral HPLC 
employing a Chiralpak IB column (Daicel) 
Eluent: Hexane/2-Propanol 95:5 
Flow: 1 mL/min 
UV-detector: λ = 254 nm and refractomter 
Retention times: R1 = 7.6 min, R2 = 11.1 min 
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Synthesis of N-N’-Dimethylimidazolium Hydrogen Carbonate (245a)173 
 
A mixture of 240 (500 mg, 2.23 mmol) and 1.05 eq. of KHCO3 (25 mg, 0.24 mmol) was dried 
at 60 °C in vacuo for 20 h. 5 mL of dry MeOH were added at r.t. and the resulting suspension 
was stirred for 48 h. After filtration of the suspension over Celite to remove KCl, the solvent 
was evaporated in vacuo to yield a yellow solid. Trituration of the solid with acetone and 
drying in vacuo yielded 286 mg of N-N’-dimethylimidazolium hydrogen carbonate 
(1.81 mmol, 81%) as a colorless solid. 
1H-NMR (400 MHz, D2O): δ/ppm = 7.53 (s, 2 H, CH), 3.89 (s, 6 H, 2 x CH3). The N2CH and 
HCO3– protons could not be observed due to their rapid exchange with the deuterated 
solvents on the NMR time scale.  
13C-NMR (400 MHz, D2O): δ/ppm = 161.4 (HCO3-), 138.8 (Cq), 124.8 (2 x CH), 36.6 (2 X 
CH3). 
 
Benzoin condensation with 245a as catalyst 
N-N’-Dimethylimidazolium hydrogen carbonate (50 mg, 0.31 mmol) and molecular sieve 3 Å 
were introduced into a Schlenk tube and subjected to vacuum for 30 min. Subsequently, 
2 mL of dry THF were added and the solution was stirred for 10 min. Then, 30 mL 
benzaldehyde (0.3 mmol) were added and the reaction mixture was stirred overnight. After 
quenching the reaction mixture with water, a GC-FID analysis was performed. 
 
2-Hydroxycyclohexylbenzoate (2d) 
 
Racemic 1 (232 mg, 2.0 mmol) was treated with EDC·HCl (420 mg, 2.2 mmol), Et3N (310 µL, 
2.2 mmol) and benzoic acid (244 mg, 2.2 mmol) in the presence of N,N’-
dimethylaminopyridine (12 mg, 0.01 mmol, 0.5 mol%) in 10 mL of DCM and stirred for 18 h at 
r.t. The solvent was removed in vacuo and the crude product was purified by silica gel flash 
chromatography with EtOAc/hexane (1:1), Rf = 0.35. Isolated racemic monobenzoate 
(206 mg; 0.9 mmol; 45%) was characterized and subjected to the GC assay to prove the 
origin of signals. Additionally, 91 mg (0.3 mmol; 15%; Rf = 0.5) of the dibenzoylated product 
252 were obtained. 
1H-NMR (400 MHz, CDCl3): δ/ppm = 8.11–8.03 (m, 2 H, o-HAr), 7.61–7.53 (m, 1 H, p-HAr), 
7.47–7.42 (m, 2 H, m-HAr), 4.90–4.81 (m, 1 H, CH), 3.80–3.68 (m, 1 H, CH), 2.36–2.29 (m, 1 
H, OH), 2.21–2.07 (m, 1 H), 1.80–1.72 (m, 2 H), 1.52–1.27 (m, 4 H).  
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13C-NMR (100 MHz, CDCl3): δ/ppm = 166.7 (C=O), 133.1 (CAr), 130.3 (CAr), 129.7 (2 x CAr), 
128.4 (2 x CAr), 78.7, 72.8 (C-OH), 33.0, 30.0, 23.9, 23.7. 
The NMR-data are in accordance with the literature.68 
 
Assay of enantiomeric purity: 
Enantiomers of 2d were separated by chiral GC employing a 30 m FS-Hydrodex βTBDAc 
column (Machery Nagel). 
T(Injector + Detector) = 250 °C 
Splitflow = 80 mL/min 
Precolumn pressure = 0.8 bar 
Conditions: 160 °C isothermal 
Retention times: R1 = 84.6 min, R2 = 86.2 min. 
 
Enantiomers of 2d were separated by chiral HPLC employing a Chiralpak IC column (Daicel) 
Eluent: Hexane/2-Propanol 9:1 
Flow: 1 mL/min 
UV-detector: λ = 220 nm and refractomter 
Retention times: R1 = 14.6 min, R2 = 16.2 min 
 
trans-Cyclohexyl-1,2-dibenzoate (252) 
 
1H NMR (400 MHz, CDCl3): δ/ppm = 8.11–8.03 (m, 4 H, HAr), 7.51–7.42 (m, 2 H, HAr), 7.42– 
7.30 (m, 4 H, HAr), 5.35–5.22 (m, 2 H, CH), 2.31–2.18 (m, 2 H, CH), 1.90–1.81 (m, 2 H, CH), 
2.21–2.07 (m, 1 H), 1.69–1.42 (m, 4 H). 
13C NMR (100 MHz, CDCl3): δ/ppm = 166.0 (C=O), 132.9 (CAr), 130.2 (CAr), 129.7 (2 x CAr), 
128.2 (CAr), 74.2 (C-OH), 30.2, 23.5. 
 
Oxidative Esterification 
A flame-dried vessel was charged with 240 or 12i (10 mmol, 30 mol%), KOtBu (13 mmol, 
11 mol%), 1 (38 mmol, 1.1 eq) and phenazine (0.33 mmol, 1.2 eq.) and degassed for 30 min. 
3 mL of dry THF were added and the mixture was stirred for 10 min. Subsequently, 
benzaldehyde (30 µL, 0.3 mmol) was added via an Eppendorf pipette. The reaction mixture 
was allowed to stir at r.t. for 12 h. After quenching the mixture with water, the product ee was 
determined by chiral GC and chiral HPLC.  
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Theoretical section 
For the molecular dynamics search for low-lying conformations of catalyst/acylium ion 
adduct, catalyst/tert-butoxycarbonylium adduct and catalyst/acylium ion adduct with (R,R)-1 
we utilized the Merck Molecular Force Field (MMFF).83 The lowest-lying conformation was 
reoptimized at the M06-2X/6–31+G(d,p) level of theory.84,85 
 
Catalyst/acylium ion adduct 
 
 6                     0.58105   2.61741  -0.38197  
 6                     2.71439   3.89563  -0.23696  
 6                     0.67328   4.68387   1.02144  
 6                     1.93441   5.12634   0.26034  
 6                    -0.22398   3.85138   0.0947  
 6                     1.82293   3.06146  -1.16609  
 6                    -0.62315   4.69848  -1.13073  
 6                     1.41468   3.9226   -2.37348  
 6                     1.52849   5.98949  -0.94189  
 6                     0.64238   5.15702  -1.8773  
 1                     2.31897   4.22944  -2.91331  
 1                     0.79959   3.33318  -3.05833  
 1                     0.34476   5.76061  -2.74117  
 1                    -1.21134   5.56494  -0.80562  
 1                     0.98721   6.87936  -0.59908  
 1                     2.41826   6.33709  -1.48052  
 1                     2.57689   5.70353   0.934  
 1                     3.61535   4.21248  -0.77888  
 1                     3.02554   3.27915   0.61572  
 1                     0.12334   5.56125   1.38256  
 1                     0.9333    4.08132   1.89644  
 1                     0.90091   2.03072   0.49464  
 1                    -1.24275   4.12796  -1.83472  
 1                    -0.03743   1.97293  -1.01857  
 7                     2.56536   1.85605  -1.57022  
 1                     3.41807   1.65224  -1.06203  
 6                     2.05086   0.87554  -2.34592  
 8                     1.01104   0.97109  -2.98708  
 6                     2.87262  -0.42302  -2.39628  
 7                     3.22018  -0.84373  -1.05035  
 1                     3.8071   -0.22079  -2.93546  
 6                     2.1298   -1.50396  -3.19519  
 1                     2.82162  -2.33696  -3.34831  
 1                     1.88955  -1.09217  -4.17725  
 6                     0.85567  -2.00001  -2.58601  
 6                    -0.49864  -3.35441  -1.45557  
 6                    -0.42743  -1.59624  -2.79781  
 1                    -0.78953  -0.75239  -3.36212  
 7                     0.7728   -3.10566  -1.73028  
 1                    -0.87874  -4.12144  -0.79799  
 6                     1.88517  -3.84668  -1.13064  
 1                     2.72713  -3.86858  -1.82305  
 1                     1.55328  -4.86323  -0.92251  
 1                     2.18362  -3.35751  -0.20086  
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 1                     2.74501  -0.46279  -0.23956  
 6                     4.23636  -1.74105  -0.86217  
 8                     4.85991  -2.23552  -1.78175  
 8                     4.39454  -1.99888   0.44257  
 6                     5.46498  -2.89372   0.91073  
 6                     6.82018  -2.31804   0.51717  
 6                     5.27717  -2.86905   2.42224  
 6                     5.24626  -4.29988   0.36211  
 1                     5.38251  -1.85193   2.81007  
 1                     4.28637  -3.24561   2.69406  
 1                     6.02997  -3.50229   2.89823  
 1                     5.97532  -4.9762    0.81701  
 1                     5.37195  -4.33138  -0.72093  
 1                     6.96545  -2.34008  -0.56358  
 1                     4.2472   -4.6599    0.63087  
 1                     6.9104   -1.28758   0.87472  
 1                     7.61023  -2.90912   0.98862  
 6                    -1.38391   3.22575   0.86241  
 8                    -1.34383   3.03247   2.07235  
 7                    -2.40491   2.73213   0.09552  
 1                    -2.30327   2.80194  -0.90829  
 6                    -3.18822   1.59224   0.56226  
 1                    -3.49834   1.80311   1.58925  
 6                    -4.40018   1.38732  -0.34166  
 6                    -5.19024   0.09787  -0.09908  
 6                    -6.41179  -1.37997   1.54577  
 6                    -7.24694  -1.20594  -0.81981  
 6                    -7.64868  -1.38603   0.64576  
 6                    -6.4292    0.07371  -1.00265  
 6                    -5.58943  -0.0995    1.36898  
 1                    -4.06224   1.3993   -1.3878  
 1                    -5.05613   2.2571   -0.21024  
 1                    -4.6951   -0.15193   2.00415  
 1                    -6.17662   0.7678    1.70704  
 1                    -4.5519   -0.75561  -0.37502  
 1                    -6.12637   0.19224  -2.05202  
 1                    -7.06051   0.94208  -0.763  
 1                    -8.31869  -0.56712   0.94111  
 1                    -8.13303  -1.18334  -1.46214  
 1                    -6.64547  -2.07194  -1.134  
 1                    -8.20904  -2.3173    0.77631  
 1                    -6.69774  -1.50427   2.59571  
 1                    -5.78129  -2.23963   1.27681  
 6                    -2.25656   0.37415   0.5484  
 8                    -2.11144  -0.33738  -0.44776  
 7                    -1.55261   0.15186   1.67594  
 1                    -1.57401   0.85485   2.40818  
 6                    -0.65157  -0.97123   1.74605  
 1                     0.01654  -0.96573   0.87272  
 6                     0.18795  -0.92379   3.035  
 6                     1.30266   0.09034   2.956  
 6                     3.4372    1.90279   2.80479  
 6                     2.49404  -0.26198   2.30999  
 6                     1.18637   1.365     3.51152  
 6                     2.25301   2.2632    3.44367  
 6                     3.5536    0.63828   2.22347  
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 1                     0.61692  -1.91839   3.19081  
 1                    -0.47525  -0.71818   3.88313  
 1                     0.26905   1.66184   4.01365  
 1                     2.61273  -1.26725   1.90778  
 1                     4.47588   0.33358   1.73452  
 1                     4.27028   2.59839   2.7705  
 1                     2.15867   3.24224   3.90316  
 6                    -1.37768  -2.31208   1.68064  
 8                    -0.81183  -3.31897   1.30177  
 8                    -2.61574  -2.27714   2.14171  
 6                    -3.30923  -3.53742   2.17584  
 1                    -2.71469  -4.27212   2.72101  
 1                    -3.48901  -3.87996   1.15557  
 1                    -4.24576  -3.33658   2.69088  
 7                    -1.25534  -2.45696  -2.09866  
 6                    -2.70714  -2.43937  -1.96776  
 8                    -3.19936  -3.19858  -1.18278  
 6                    -3.42044  -1.5029   -2.88752  
 1                    -3.14854  -0.47644  -2.62736  
 1                    -3.14555  -1.7025   -3.92732  
 1                    -4.49195  -1.64655  -2.751 
 
E[M06–2X] = – 2643.9664535 
 
 
 
 
 
Catalyst/acylium ion adduct with (R,R)-1 
 
 6                     0.44138  -1.34633  -3.8584  
 6                    -1.31039   0.062    -2.75184  
 6                     0.41991  -1.1115   -1.36201  
 6                    -1.0479   -0.65726  -1.40731  
 6                     0.71266  -2.06895  -2.53016  
 6                    -1.02317  -0.89666  -3.91665  
 6                    -1.93842  -2.12581  -3.80844  
 6                    -1.96293  -1.90053  -1.3101  
 6                    -1.66552  -2.85041  -2.48258  
 6                    -0.19708  -3.30442  -2.43229  
 7                     2.14076  -2.42323  -2.52873  
 6                     2.7837   -3.06537  -1.5305  
 8                     2.23885  -3.71232  -0.64633  
 6                     4.32923  -3.01562  -1.59357  
 7                     4.84251  -1.79181  -2.18617  
 1                     4.62648  -3.81468  -2.28172  
 6                     4.94941  -3.40116  -0.23147  
 6                     4.46334  -2.70469   1.00331  
 7                     5.07891  -1.60214   1.59458  
 6                     6.21776  -0.84196   1.07938  
 1                     7.13602  -1.17112   1.56886  
 1                     6.03108   0.21653   1.27038  
 1                     6.29122  -1.00475   0.00539  
 6                     3.4351   -3.0461    1.82629  
 7                     3.45339  -2.17463   2.89643  
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 6                     2.49345  -2.05258   3.98583  
 8                     2.77407  -1.31815   4.88831  
 6                     1.27483  -2.90673   3.85428  
 1                     0.78607  -2.70559   2.89854  
 1                     1.54593  -3.96583   3.90904  
 1                     0.60461  -2.66202   4.67631  
 6                     4.44719  -1.29754   2.71951  
 1                     4.65983  -0.46054   3.36722  
 1                     2.69757  -3.82158   1.70599  
 1                     4.7427   -4.46326  -0.0834  
 1                     6.03557  -3.30006  -0.317  
 6                     4.41684  -0.55633  -1.77533  
 8                     3.79803  -0.39784  -0.73462  
 8                     4.76245   0.37058  -2.66181  
 6                     4.59943   1.81222  -2.39923  
 6                     3.13785   2.14913  -2.1224  
 6                     5.51475   2.21273  -1.24951  
 6                     5.05888   2.43376  -3.71165  
 1                     5.00299   3.52276  -3.64159  
 1                     5.52146   3.30329  -1.16311  
 1                     6.09219   2.15139  -3.9292  
 1                     4.423     2.10418  -4.53777  
 1                     5.33931  -1.83265  -3.06517  
 1                     2.49407   1.73699  -2.90733  
 1                     2.80594   1.77627  -1.15194  
 1                     3.02552   3.23758  -2.13008  
 1                     6.53895   1.8828   -1.4507  
 1                     5.1618    1.81131  -0.29743  
 1                     0.0234   -3.98161  -3.26705  
 1                     1.10536  -0.47268  -3.94131  
 1                     0.66775  -2.02126  -4.69393  
 1                    -2.98834  -1.81364  -3.85667  
 1                     0.01054  -3.84037  -1.50291  
 1                     0.63358  -1.617    -0.41309  
 1                     1.08908  -0.24326  -1.41903  
 1                    -1.79547  -2.40905  -0.35191  
 1                    -3.02049  -1.60583  -1.33783  
 1                    -1.20443  -0.37789  -4.8643  
 1                    -0.67319   0.95486  -2.82076  
 1                    -2.35312   0.39909  -2.81384  
 6                    -1.309     0.29378  -0.24138  
 8                    -0.43853   0.57943   0.5861  
 7                    -2.55735   0.80285  -0.15532  
 6                    -2.95811   1.79354   0.83548  
 6                    -4.24634   1.33982   1.54231  
 8                    -5.07573   2.13977   1.9467  
 7                    -4.37935  -0.00274   1.67854  
 6                    -5.64769  -0.6179    1.99515  
 6                    -5.42122  -2.12078   1.9541  
 8                    -4.40671  -2.64904   1.55543  
 8                    -6.49007  -2.78816   2.38293  
 6                    -6.38597  -4.21824   2.35743  
 1                    -6.21804  -4.56329   1.33522  
 1                    -7.33498  -4.58666   2.73979  
 1                    -3.22533   0.59626  -0.8927  
 1                    -3.7013   -0.61077   1.23432  
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 1                    -2.16071   1.8122    1.58628  
 6                    -3.13439   3.18261   0.21161  
 6                    -1.89717   3.68283  -0.53536  
 6                    -0.98781   5.45132  -2.10624  
 6                     0.53317   4.35502  -0.41769  
 6                     0.23801   5.6325   -1.20698  
 6                    -0.68831   3.89973   0.38402  
 6                    -2.20254   4.97331  -1.30572  
 1                    -3.41608   3.87938   1.0086  
 1                    -3.05795   4.81614  -1.97426  
 1                    -1.61483   2.91983  -1.28057  
 1                    -0.75683   4.70736  -2.88264  
 1                     0.80642   3.548    -1.11468  
 1                    -1.22098   6.38662  -2.62536  
 1                     1.10833   5.92495  -1.8052  
 1                     0.04977   6.45275  -0.50083  
 1                    -2.50078   5.75316  -0.58977  
 1                    -3.98836   3.1458   -0.47848  
 1                    -0.44686   2.97669   0.92185  
 1                     1.39598   4.50369   0.24452  
 1                    -0.94768   4.66269   1.13467  
 1                    -5.9681   -0.34625   3.00688  
 6                    -6.7787   -0.20612   1.00572  
 6                    -6.30462  -0.22638  -0.42644  
 6                    -5.2916   -0.24217  -3.0491  
 6                    -6.14858  -1.42877  -1.12521  
 6                    -5.95616   0.96934  -1.06573  
 6                    -5.45016   0.96451  -2.36642  
 6                    -5.64713  -1.43905  -2.42616  
 1                    -7.09627   0.80238   1.27633  
 1                    -7.62437  -0.88326   1.15652  
 1                    -6.09147   1.90909  -0.53516  
 1                    -6.43189  -2.36684  -0.65236  
 1                    -5.54167  -2.38127  -2.95641  
 1                    -5.19754   1.90355  -2.85162  
 1                    -4.91556  -0.24639  -4.06816  
 1                     2.71591  -1.89182  -3.16912  
 1                    -1.75823  -2.80302  -4.65214  
 1                    -2.31445  -3.7291   -2.40052  
 8                     1.57572  -0.21972   2.30696  
 6                     1.87979   1.00783   2.95701  
 6                     2.97622   3.25208   2.68931  
 6                     1.05531   2.95725   4.3089  
 6                     1.76118   3.91567   3.34466  
 6                     0.6602    1.65801   3.60074  
 6                     2.58583   1.95713   1.99321  
 8                     3.76347   1.34022   1.48192  
 1                     3.49285   0.6467    0.85911  
 1                    -5.55853  -4.54392   2.98985  
 1                     0.86744  -0.05405   1.65604  
 1                     2.60007   0.75561   3.74957  
 1                    -0.08262   1.86374   2.81805  
 1                     0.20838   0.9461    4.30028  
 1                     1.0518    4.22585   2.5657  
 1                     1.72724   2.72322   5.1458  
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 1                     0.17001   3.43492   4.73968  
 1                     2.07164   4.82477   3.86876  
 1                     3.45166   3.92059   1.96299  
 1                     1.89339   2.1789    1.16029  
 1                     3.73199   3.01657   3.45189  
 
 E[M06–2X] = –3030.1604445 
 
 
 
Catalyst/tert-butoxycarbonylium ion adduct	   
 
 6                    -3.11171   2.97032  -1.16495  
 6                    -1.09869   3.76819  -2.43162  
 6                    -0.82322   2.23345  -0.4663  
 6                    -0.19338   3.41728  -1.23969  
 6                    -2.22531   2.6122    0.03704  
 6                    -2.49749   4.15276  -1.9307  
 6                    -2.39298   5.37058  -1.0016  
 6                    -0.0963    4.62985  -0.29201  
 6                    -1.50494   5.01328   0.1974  
 6                    -2.12347   3.83441   0.96751  
 7                    -2.82675   1.45317   0.70745  
 6                    -2.33375   0.87887   1.8205  
 8                    -1.37396   1.30191   2.46105  
 6                    -3.00707  -0.43292   2.28119  
 7                    -4.45834  -0.37743   2.37146  
 1                    -2.65055  -0.56685   3.30578  
 6                    -2.54228  -1.63922   1.44265  
 6                    -1.07907  -1.93197   1.56552  
 7                    -0.53518  -3.07237   0.96799  
 6                    -1.26222  -4.02477   0.12818  
 1                    -2.03382  -4.51683   0.72309  
 1                    -0.55006  -4.75146  -0.25694  
 1                    -1.71127  -3.4905   -0.71028  
 6                    -0.05492  -1.31924   2.2254  
 7                     1.06884  -2.1025    2.0262  
 6                     2.41055  -1.90711   2.53305  
 8                     3.2704   -2.69121   2.2473  
 6                     0.75371  -3.1494    1.25929  
 1                     1.44951  -3.90319   0.92522  
 1                    -0.02438  -0.39849   2.78736  
 1                    -3.10705  -2.51333   1.79114  
 1                    -2.8091   -1.49281   0.3911  
 6                    -5.31375  -0.40647   1.3118  
 8                    -4.94092  -0.42279   0.14182  
 8                    -6.574    -0.41244   1.73212  
 6                    -7.69869  -0.35032   0.78466  
 6                    -7.70488  -1.59876  -0.09065  
 6                    -8.90743  -0.33194   1.71127  
 6                    -7.61919   0.93659  -0.02972  
 1                    -8.53984   1.04568  -0.60974  
 1                    -8.93159  -1.23394   2.32828  
 1                    -7.53377   1.80044   0.63637  
 1                    -6.77416   0.92456  -0.71936  
 1                    -4.87957  -0.28593   3.2846  
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 1                    -7.68157  -2.49738   0.53288  
 1                    -8.62724  -1.61617  -0.6779  
 1                    -6.85623  -1.60986  -0.7757  
 1                    -9.82459  -0.28959   1.1186  
 1                    -8.87489   0.54188   2.36719  
 1                    -3.12884   4.09645   1.32012  
 1                    -3.2041    2.09796  -1.82842  
 1                    -4.11898   3.22398  -0.80908  
 1                    -1.96941   6.22144  -1.54842  
 1                    -1.51673   3.58262   1.8413  
 1                    -0.20307   1.94473   0.39069  
 1                    -0.90279   1.35929  -1.1298  
 1                     0.36722   5.47321  -0.81766  
 1                     0.53127   4.40439   0.58014  
 1                    -3.1344    4.39139  -2.78887  
 1                    -1.15089   2.91112  -3.1115  
 1                    -0.65481   4.59377  -2.99988  
 6                     1.14739   2.89523  -1.74671  
 8                     1.30077   2.52659  -2.90762  
 7                     2.13325   2.73283  -0.81386  
 6                     3.21981   1.78203  -1.04793  
 6                     2.60235   0.38765  -0.83941  
 8                     2.579    -0.1881    0.24564  
 7                     1.97475  -0.08505  -1.94419  
 6                     1.02613  -1.17187  -1.88873  
 6                     1.68906  -2.53839  -2.02488  
 8                     1.31041  -3.52989  -1.43461  
 8                     2.67521  -2.53743  -2.91111  
 6                     3.3282   -3.79686  -3.13037  
 1                     4.08598  -3.604    -3.88597  
 1                     2.60694  -4.53727  -3.48111  
 1                     3.78515  -4.14308  -2.20182  
 1                     1.90535   2.91941   0.15454  
 1                     1.9476    0.5284   -2.75355  
 1                     3.50928   1.89614  -2.09553  
 6                     4.40541   2.06507  -0.14048  
 6                     5.55537   1.05941  -0.26942  
 6                     7.17731  -0.14828  -1.79676  
 6                     7.91234   0.5377    0.51523  
 6                     8.35337   0.31125  -0.93259  
 6                     6.74702   1.52629   0.57592  
 6                     5.99976   0.82945  -1.72074  
 1                     4.06111   2.08759   0.90293  
 1                     5.17063   0.43637  -2.32268  
 1                     5.21054   0.09209   0.1274  
 1                     6.8402   -1.13513  -1.44868  
 1                     7.59808  -0.42015   0.95436  
 1                     7.49344  -0.27081  -2.83792  
 1                     9.16472  -0.4225   -0.97575  
 1                     8.75346   1.25125  -1.33694  
 1                     6.28948   1.79382  -2.16577  
 1                     4.76717   3.073    -0.38071  
 1                     6.42902   1.68644   1.61349  
 1                     8.75015   0.90378   1.11765  
 1                     7.08303   2.50336   0.19751  
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 1                     0.52318  -1.16243  -0.91204  
 6                    -0.00742  -0.97615  -3.02238  
 6                    -1.21722  -1.87011  -2.91638  
 6                    -3.49851  -3.4995   -2.74615  
 6                    -2.37053  -1.42067  -2.26299  
 6                    -1.22185  -3.15074  -3.47881  
 6                    -2.35196  -3.9623   -3.39302  
 6                    -3.50797  -2.22469  -2.17954  
 1                     0.49947  -1.1285   -3.98258  
 1                    -0.31941   0.07396  -2.98856  
 1                    -0.33867  -3.51034  -4.00199  
 1                    -2.38765  -0.42049  -1.82975  
 1                    -4.39058  -1.84619  -1.67285  
 1                    -2.34232  -4.94933  -3.84434  
 1                    -4.38398  -4.12512  -2.69474  
 1                    -3.58631   0.97141   0.23146  
 1                    -3.38857   5.67077  -0.65306  
 1                    -1.42455   5.87393   0.86985  
 8                     2.41767  -0.862     3.31168  
 6                     3.66175  -0.46837   4.02417  
 6                     3.99371  -1.54718   5.04529  
 6                     3.25109   0.83451   4.69266  
 6                     4.77358  -0.24344   3.01004  
 1                     2.39554   0.67696   5.35444  
 1                     4.24585  -2.4918    4.55947  
 1                     4.85866  -1.22235   5.63013  
 1                     5.59967   0.27382   3.50664  
 1                     4.40195   0.38036   2.19312  
 1                     5.14543  -1.18095   2.59416  
 1                     2.98294   1.58162   3.9406  
 1                     4.08506   1.21722   5.28594  
 1                     3.15571  -1.69968   5.73122  
 
E[M06–2X] = –2837.0691869 
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Boc-L-Cha-AGly-L-(π-Me)-His-L-Phe-OMe (13) 
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Boc-L-(π-Me)-His-5,7-Me2-AGly-L-Cha-L-Phe-OMe (207) 
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Boc-L- (π-Me)-His-5-Me-AGly-L-Cha-L-Phe-OMe (208) 	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Boc-L-(π-Me)-His-MAACA-L-Cha-L-Phe-OMe (209) 	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Boc-L-(π-Me)-His-AAMCA-L-Cha-L-Phe-OMe (210) 
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Boc-L- (π-Me)-His-MAAMCA-L-Cha-L-Phe-OMe (211) 	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Boc-L-(π-Me)-His-3-Abz-L-Cha-L-Phe-OMe (212) 	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Boc-L-(π-Me)-His-4-Abz-L-Cha-L-Phe-OMe (213) 
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Boc-L-(π-Me)-His-AGly-L-β-Ala-L-Phe-OMe (214) 
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Boc-L-( π-Me)-His-A Gly-L-Phg-L-Phe-OMe (217) 
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Boc-L-(π-Me)-His-A Gly-L-His(Trt)-L-Phe-OMe (218) 
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Boc-β-(4-Taz)-AGly-L-Cha-L-Phe-OMe (236) 
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Boc-β-(4-MeTaz)I-AGly-L-Cha-L-Phe-OMe (237)	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Boc-L-(π, τ-Dime-His)I-L-AGly-L-Cha-L-Phe-OMe (235) 
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Trans-2-hydroxycyclohexyl 4-nitrobenzenesulfonate (93) 
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Trans-2-hydroxycyclohexyl diphenyl phosphate (94-Ph): 
	  	  
	  	  	  
 
OH
O P
O
OPh
OPh
NMR-Spectra 	  
	  292 
Trans-2-hydroxycyclohexyl diethyl phosphate (94-Et): 	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Trans-cyclohexane-1,2-diyl bis(4-nitrobenzenesulfonate) (122) 
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2-Tert-butyl 3-methyl bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate (129) 
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Trans-N-(2-aminocyclohexyl)-isobutyramide (141) 
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Trans-N-(2-hydroxycyclohexyl)-isobutyramide (144)  
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1-(9-Fluorenyl)methoxycarbonylaminotricyclo[3.3.1.13.7]decan-3-methylcarboxylic acid 
(157) 
	  
	  
	  
NHFmoc
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3-(9-Fluorenyl)methoxycarbonylmethylaminotricyclo[3.3.1.13.7]decan-1-carboxylic acid 
(158) 
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3-(9-Fluorenyl)methoxycarbonylmethyltricyclo[3.3.1.13.7]decan-1-methylcarboxylic acid 
(159) 
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1-Acetamidotricyclo[3.3.1.13.7]decan-3-methylcarboxylic acid (167) 
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1-Aminotricyclo[3.3.1.13.7]decan-3-methylcarboxylic acid hydrochloride (168) 
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1-Chloroacetamidotricyclo[3.3.1.13.7]decan-3-methylcarboxylic acid (176)	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1-Aminotricyclo[3.3.1.13.7]decan-3-methylcarboxylic acid (177) 
 
 
 
 
 
 
COOH
NH2
NMR-Spectra 	  
	  304 
3-Chloroacetamidotricyclo[3.3.1.13.7]decan-1-carboxylic acid (179) 
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3-Methylaminotricyclo[3.3.1.13.7]decan-1-methylcarboxylic acid (185) 
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E- 5-S-α-Methylbenzylaminotricyclo[3.3.1.13.7]decane-2-ol (200)	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L-Benzoyl-N,N’-dimethyl histidine methyl ester iodide (233) 
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Boc-L-N,N’-Dimethylhistidine iodide (234) 
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N-N’-Dimethylimidazolium Hydrogen Carbonate (245a) 
	  
	  
	  
	  
N
N
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Abbreviations 
 
°C   degree Celcius 
Å   Angstrøm 
Ar   aromatic 
Ac2O   acetic anhydride 
Boc-   tert-butoxycarbonyl 
BOC-ON  [2-(tert-butoxycarbonyloxyimino)-2-phenylacetonitrile] 
bs   broad singulet 
d   doublet  
DBU   1,8-diazabicycloundec-7-ene 
DCM   dichloromethane 
DIC   N,N'-diisopropylcarbodiimide 
DiPEA   Diisopropylethylamine 
DMAP   N-4-dimethylaminopyridine 
DMF   N,N-dimethylformamide 
DMSO   dimethyl sulfoxide 
ee   enantiomeric excess 
EDC · HCl  N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
e.g.   for example 
eq.   equivalent 
ESI   electrospray ionization 
Et   ethyl 
et al.   et alii (and others) 
Et3N   triethylamine 
EtOAc   ethyl acetate 
EtOH   ethanol 
FID   flame ionization detector 
Fmoc-   9-flourenylmethoxycarbonyl 
GC   gas chromatography 
h   hour 
HOBt   1-hydroxybenzotriazole 
HPLC   high performance liquid chromatography 
Hz   hertz 
KOtBu   potassium tert.-butoxide 
Me   methyl 
MeI   iodomethane 
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MeCN   acetonitrile 
MeOH   methanol 
m   multiplet 
mbar   millibar 
mg   milligram 
MHz   megahertz 
min   minute 
mL   milliliter 
µL   microliter 
NaOMe  sodium methanolate 
n.d.   not detected 
NHC   N-heterocyclic carbene 
nm   nanometer 
NMI   N-methylimidazole 
NMR   nuclear magnetic resonance 
PEMP   pentamethylpiperidine  
ppm   parts per million 
p-TsOH  p-toluenesulfonic acid  
q   quartett 
quin   quintett 
r.t.   room temperature 
s   singlet 
sept   septet 
sext   sextet 
SPPS   solid phase peptide synthesis 
t   triplet 
THF   tetrahydrofuran 
TLC   thin layer chromatography 
 
Abreviations of the Amino Acids 
 
Alanine    Ala 
β-Alanine    β-Ala 
3-Aminobenzoic acid   3-Abz 
4-Aminobenzoic acid   4-Abz 
2-Aminoisobutyric acid  AiB 
Aspartic acid    Asp 
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Cyclohexylalanine   Cha 
Glycine    Gly 
τ-benzylhistidine   (τ-Bzl)-His 
π-methylhistidine   (π-Me)-His 
τ-trityl-histidine   (τ-Trt)-His 
Isoleucine    Ile 
Leucine    Leu 
Phenylalanine    Phe 
Phenylglycine    Phg 
Proline     Pro 
Serine     Ser 
Thiazolylalanine   Taz 
Tyrosine    Tyr 
Valine     Val 
γ-Adamantane amino acids  AGly 
 
 
Positions of the amino acids in peptides: 
 
 
N
H
H
N O-tBu
H
NN
H
O
O
O
O
N N
O OMe
Boc-L-(!-Me)-His-AGly-L-Cha-L-Phe-OMe
ii + 1i + 2i + 3
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